"Proprietary Name","NDC Package Code","Strength","Dosage Form","Route","Appl. No.","Labeler Name","Product NDC","Nonproprietary Name","Substance Name","Product Type Name","Start Marketing Date","End Marketing Date","Market Category","Package Description","Pharm Class","DEA","Sample Package","Listing Record Certified Through:"
"70% alcohol hand sanitizer (no water)","76618-001-01","70 mL/100mL","GEL","TOPICAL","part333A","Star USA Imports Inc","76618-001","ALCOHOL","ALCOHOL","HUMAN OTC DRUG","04/22/2020","N/A","OTC MONOGRAPH NOT FINAL","295 mL in 1 BOTTLE (76618-001-01)","N/A","N/A","No","12/31/2024"
"Above Mouthwash Antiseptic","73306-1160-1",".075 mg/500g,                         .3  mg/500g,                         .25  mg/500g","MOUTHWASH","BUCCAL; DENTAL","M021","BASTON INDUSTRIA DE AEROSSOIS LTDA","73306-1160","Above Mouthwash Antiseptic","CETYLPYRIDINIUM CHLORIDE;  MENTHOL;  METHYL SALICYLATE","HUMAN OTC DRUG","07/24/2023","N/A","OTC MONOGRAPH FINAL","500 g in 1 BOTTLE, PLASTIC (73306-1160-1)","N/A","N/A","No","12/31/2024"
"Acarbose","71335-9725-1","50 mg/1","TABLET","ORAL","ANDA202271","Bryant Ranch Prepack","71335-9725","Acarbose","ACARBOSE","HUMAN PRESCRIPTION DRUG","05/30/2023","N/A","ANDA","30 TABLET in 1 BOTTLE (71335-9725-1)","alpha Glucosidase Inhibitors [MoA],  alpha-Glucosidase Inhibitor [EPC]","N/A","No","12/31/2024"
"Acarbose","71335-9725-2","50 mg/1","TABLET","ORAL","ANDA202271","Bryant Ranch Prepack","71335-9725","Acarbose","ACARBOSE","HUMAN PRESCRIPTION DRUG","05/30/2023","N/A","ANDA","90 TABLET in 1 BOTTLE (71335-9725-2)","alpha Glucosidase Inhibitors [MoA],  alpha-Glucosidase Inhibitor [EPC]","N/A","No","12/31/2024"
"Acarbose","71335-9725-3","50 mg/1","TABLET","ORAL","ANDA202271","Bryant Ranch Prepack","71335-9725","Acarbose","ACARBOSE","HUMAN PRESCRIPTION DRUG","05/30/2023","N/A","ANDA","100 TABLET in 1 BOTTLE (71335-9725-3)","alpha Glucosidase Inhibitors [MoA],  alpha-Glucosidase Inhibitor [EPC]","N/A","No","12/31/2024"
"Acetylcholine Chloride","43742-0817-1","6 [hp_X]/mL","LIQUID","ORAL","","Deseret Biologicals, Inc.","43742-0817","Acetylcholine Chloride","ACETYLCHOLINE CHLORIDE","HUMAN OTC DRUG","07/21/2016","09/15/2028","UNAPPROVED HOMEOPATHIC","30 mL in 1 BOTTLE, DROPPER (43742-0817-1)","Cholinergic Agonists [MoA],  Cholinergic Receptor Agonist [EPC]","N/A","No","N/A"
"Acyclovir","43063-589-30","800 mg/1","TABLET","ORAL","ANDA203834","PD-Rx Pharmaceuticals, Inc.","43063-589","Acyclovir","ACYCLOVIR","HUMAN PRESCRIPTION DRUG","09/29/2015","N/A","ANDA","30 TABLET in 1 BOTTLE, PLASTIC (43063-589-30)","DNA Polymerase Inhibitors [MoA],  Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC],  Herpes Zoster Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC],  Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor [EPC],  Nucleoside Analog [EXT]","N/A","No","12/31/2024"
"Acyclovir","43063-589-35","800 mg/1","TABLET","ORAL","ANDA203834","PD-Rx Pharmaceuticals, Inc.","43063-589","Acyclovir","ACYCLOVIR","HUMAN PRESCRIPTION DRUG","08/06/2015","N/A","ANDA","35 TABLET in 1 BOTTLE, PLASTIC (43063-589-35)","DNA Polymerase Inhibitors [MoA],  Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC],  Herpes Zoster Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC],  Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor [EPC],  Nucleoside Analog [EXT]","N/A","No","12/31/2024"
"Acyclovir","43063-589-10","800 mg/1","TABLET","ORAL","ANDA203834","PD-Rx Pharmaceuticals, Inc.","43063-589","Acyclovir","ACYCLOVIR","HUMAN PRESCRIPTION DRUG","08/04/2016","N/A","ANDA","10 TABLET in 1 BOTTLE, PLASTIC (43063-589-10)","DNA Polymerase Inhibitors [MoA],  Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC],  Herpes Zoster Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC],  Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor [EPC],  Nucleoside Analog [EXT]","N/A","No","12/31/2024"
"Acyclovir","43063-589-50","800 mg/1","TABLET","ORAL","ANDA203834","PD-Rx Pharmaceuticals, Inc.","43063-589","Acyclovir","ACYCLOVIR","HUMAN PRESCRIPTION DRUG","09/11/2015","N/A","ANDA","50 TABLET in 1 BOTTLE, PLASTIC (43063-589-50)","DNA Polymerase Inhibitors [MoA],  Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC],  Herpes Zoster Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC],  Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor [EPC],  Nucleoside Analog [EXT]","N/A","No","12/31/2024"
"ADAPALENE AND BENZOYL PEROXIDE","72162-1432-2","3 mg/g,                         25  mg/g","GEL","TOPICAL","ANDA212464","Bryant Ranch Prepack","72162-1432","adapalene and benzoyl peroxide","ADAPALENE;  BENZOYL PEROXIDE","HUMAN PRESCRIPTION DRUG","03/13/2024","N/A","ANDA","45 g in 1 BOTTLE, PUMP (72162-1432-2)","Retinoid [EPC],  Retinoids [CS]","N/A","No","12/31/2025"
"ADCETRIS","51144-050-01","50 mg/10.5mL","INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION","INTRAVENOUS","BLA125388","SEAGEN INC.","51144-050","brentuximab vedotin","BRENTUXIMAB VEDOTIN","HUMAN PRESCRIPTION DRUG","08/25/2011","N/A","BLA","1 VIAL, SINGLE-DOSE in 1 BOX (51144-050-01)  / 10.5 mL in 1 VIAL, SINGLE-DOSE","CD30-directed Antibody Interactions [MoA],  CD30-directed Immunoconjugate [EPC],  Immunoconjugates [CS],  Microtubule Inhibition [PE]","N/A","No","12/31/2024"
"Advanced Hand Sanitizer","76806-018-01",".75 mL/mL","GEL","TOPICAL","505G(a)(3)","Logomark Inc","76806-018","ALCOHOL","ALCOHOL","HUMAN OTC DRUG","06/20/2020","01/31/2026","OTC MONOGRAPH DRUG","2 mL in 1 BAG (76806-018-01)","N/A","N/A","No","N/A"
"Advil","0573-0133-01","256 mg/1","TABLET, COATED","ORAL","NDA201803","Haleon US Holdings LLC","0573-0133","ibuprofen sodium","IBUPROFEN SODIUM","HUMAN OTC DRUG","08/11/2014","N/A","NDA","3000 PACKET in 1 CASE (0573-0133-01)  / 2 TABLET, COATED in 1 PACKET","Anti-Inflammatory Agents,  Non-Steroidal [CS],  Cyclooxygenase Inhibitors [MoA],  Nonsteroidal Anti-inflammatory Drug [EPC]","N/A","No","12/31/2025"
"Advil","0573-0133-02","256 mg/1","TABLET, COATED","ORAL","NDA201803","Haleon US Holdings LLC","0573-0133","ibuprofen sodium","IBUPROFEN SODIUM","HUMAN OTC DRUG","07/08/2013","N/A","NDA","50 PACKET in 1 TRAY (0573-0133-02)  / 2 TABLET, COATED in 1 PACKET","Anti-Inflammatory Agents,  Non-Steroidal [CS],  Cyclooxygenase Inhibitors [MoA],  Nonsteroidal Anti-inflammatory Drug [EPC]","N/A","No","12/31/2025"
"Advil","0573-0133-04","256 mg/1","TABLET, COATED","ORAL","NDA201803","Haleon US Holdings LLC","0573-0133","ibuprofen sodium","IBUPROFEN SODIUM","HUMAN OTC DRUG","07/08/2013","N/A","NDA","2 PACKET in 1 BLISTER PACK (0573-0133-04)  / 2 TABLET, COATED in 1 PACKET","Anti-Inflammatory Agents,  Non-Steroidal [CS],  Cyclooxygenase Inhibitors [MoA],  Nonsteroidal Anti-inflammatory Drug [EPC]","N/A","No","12/31/2025"
"Advil","0573-0133-05","256 mg/1","TABLET, COATED","ORAL","NDA201803","Haleon US Holdings LLC","0573-0133","ibuprofen sodium","IBUPROFEN SODIUM","HUMAN OTC DRUG","07/08/2013","N/A","NDA","2 PACKET in 1 CARTON (0573-0133-05)  / 2 TABLET, COATED in 1 PACKET","Anti-Inflammatory Agents,  Non-Steroidal [CS],  Cyclooxygenase Inhibitors [MoA],  Nonsteroidal Anti-inflammatory Drug [EPC]","N/A","No","12/31/2025"
"Advil","0573-0133-20","256 mg/1","TABLET, COATED","ORAL","NDA201803","Haleon US Holdings LLC","0573-0133","ibuprofen sodium","IBUPROFEN SODIUM","HUMAN OTC DRUG","07/08/2013","N/A","NDA","1 BOTTLE in 1 CARTON (0573-0133-20)  / 20 TABLET, COATED in 1 BOTTLE","Anti-Inflammatory Agents,  Non-Steroidal [CS],  Cyclooxygenase Inhibitors [MoA],  Nonsteroidal Anti-inflammatory Drug [EPC]","N/A","No","12/31/2025"
"Advil","0573-0133-91","256 mg/1","TABLET, COATED","ORAL","NDA201803","Haleon US Holdings LLC","0573-0133","ibuprofen sodium","IBUPROFEN SODIUM","HUMAN OTC DRUG","12/01/2014","N/A","NDA","1 BOTTLE in 1 CARTON (0573-0133-91)  / 180 TABLET, COATED in 1 BOTTLE","Anti-Inflammatory Agents,  Non-Steroidal [CS],  Cyclooxygenase Inhibitors [MoA],  Nonsteroidal Anti-inflammatory Drug [EPC]","N/A","No","12/31/2025"
"Advil","0573-0133-40","256 mg/1","TABLET, COATED","ORAL","NDA201803","Haleon US Holdings LLC","0573-0133","ibuprofen sodium","IBUPROFEN SODIUM","HUMAN OTC DRUG","07/08/2013","N/A","NDA","1 BOTTLE in 1 CARTON (0573-0133-40)  / 40 TABLET, COATED in 1 BOTTLE","Anti-Inflammatory Agents,  Non-Steroidal [CS],  Cyclooxygenase Inhibitors [MoA],  Nonsteroidal Anti-inflammatory Drug [EPC]","N/A","No","12/31/2025"
"Advil","0573-0133-41","256 mg/1","TABLET, COATED","ORAL","NDA201803","Haleon US Holdings LLC","0573-0133","ibuprofen sodium","IBUPROFEN SODIUM","HUMAN OTC DRUG","08/12/2015","N/A","NDA","1 BOTTLE in 1 CARTON (0573-0133-41)  / 40 TABLET, COATED in 1 BOTTLE","Anti-Inflammatory Agents,  Non-Steroidal [CS],  Cyclooxygenase Inhibitors [MoA],  Nonsteroidal Anti-inflammatory Drug [EPC]","N/A","No","12/31/2025"
"Advil","0573-0133-80","256 mg/1","TABLET, COATED","ORAL","NDA201803","Haleon US Holdings LLC","0573-0133","ibuprofen sodium","IBUPROFEN SODIUM","HUMAN OTC DRUG","07/08/2013","N/A","NDA","1 BOTTLE in 1 CARTON (0573-0133-80)  / 80 TABLET, COATED in 1 BOTTLE","Anti-Inflammatory Agents,  Non-Steroidal [CS],  Cyclooxygenase Inhibitors [MoA],  Nonsteroidal Anti-inflammatory Drug [EPC]","N/A","No","12/31/2025"
"Advil","0573-0133-81","256 mg/1","TABLET, COATED","ORAL","NDA201803","Haleon US Holdings LLC","0573-0133","ibuprofen sodium","IBUPROFEN SODIUM","HUMAN OTC DRUG","07/08/2013","N/A","NDA","1 BOTTLE in 1 CARTON (0573-0133-81)  / 100 TABLET, COATED in 1 BOTTLE","Anti-Inflammatory Agents,  Non-Steroidal [CS],  Cyclooxygenase Inhibitors [MoA],  Nonsteroidal Anti-inflammatory Drug [EPC]","N/A","No","12/31/2025"
"Advil","0573-0133-88","256 mg/1","TABLET, COATED","ORAL","NDA201803","Haleon US Holdings LLC","0573-0133","ibuprofen sodium","IBUPROFEN SODIUM","HUMAN OTC DRUG","07/08/2013","N/A","NDA","2 BOTTLE in 1 PACKAGE (0573-0133-88)  / 120 TABLET, COATED in 1 BOTTLE","Anti-Inflammatory Agents,  Non-Steroidal [CS],  Cyclooxygenase Inhibitors [MoA],  Nonsteroidal Anti-inflammatory Drug [EPC]","N/A","No","12/31/2025"
"Advil","0573-0133-89","256 mg/1","TABLET, COATED","ORAL","NDA201803","Haleon US Holdings LLC","0573-0133","ibuprofen sodium","IBUPROFEN SODIUM","HUMAN OTC DRUG","07/08/2013","N/A","NDA","1 BOTTLE in 1 CARTON (0573-0133-89)  / 160 TABLET, COATED in 1 BOTTLE","Anti-Inflammatory Agents,  Non-Steroidal [CS],  Cyclooxygenase Inhibitors [MoA],  Nonsteroidal Anti-inflammatory Drug [EPC]","N/A","No","12/31/2025"
"ADVIL","0573-0161-35","200 mg/1","TABLET, COATED","ORAL","NDA018989","Haleon US Holdings LLC","0573-0161","ibuprofen","IBUPROFEN","HUMAN OTC DRUG","05/18/1984","N/A","NDA","1 BOTTLE in 1 CARTON (0573-0161-35)  / 150 TABLET, COATED in 1 BOTTLE","Anti-Inflammatory Agents,  Non-Steroidal [CS],  Cyclooxygenase Inhibitors [MoA],  Nonsteroidal Anti-inflammatory Drug [EPC]","N/A","No","12/31/2025"
"ADVIL","0573-0161-51","200 mg/1","TABLET, COATED","ORAL","NDA018989","Haleon US Holdings LLC","0573-0161","ibuprofen","IBUPROFEN","HUMAN OTC DRUG","05/18/1984","N/A","NDA","1 BOTTLE in 1 CARTON (0573-0161-51)  / 200 TABLET, COATED in 1 BOTTLE","Anti-Inflammatory Agents,  Non-Steroidal [CS],  Cyclooxygenase Inhibitors [MoA],  Nonsteroidal Anti-inflammatory Drug [EPC]","N/A","No","12/31/2025"
"ADVIL","0573-0161-85","200 mg/1","TABLET, COATED","ORAL","NDA018989","Haleon US Holdings LLC","0573-0161","ibuprofen","IBUPROFEN","HUMAN OTC DRUG","05/18/1984","N/A","NDA","1 BOTTLE in 1 CARTON (0573-0161-85)  / 225 TABLET, COATED in 1 BOTTLE","Anti-Inflammatory Agents,  Non-Steroidal [CS],  Cyclooxygenase Inhibitors [MoA],  Nonsteroidal Anti-inflammatory Drug [EPC]","N/A","No","12/31/2025"
"ADVIL","0573-0161-65","200 mg/1","TABLET, COATED","ORAL","NDA018989","Haleon US Holdings LLC","0573-0161","ibuprofen","IBUPROFEN","HUMAN OTC DRUG","05/01/2017","N/A","NDA","65 TABLET, COATED in 1 BOTTLE (0573-0161-65)","Anti-Inflammatory Agents,  Non-Steroidal [CS],  Cyclooxygenase Inhibitors [MoA],  Nonsteroidal Anti-inflammatory Drug [EPC]","N/A","No","12/31/2025"
"ADVIL ALLERGY SINUS","0573-0188-10","2 mg/1,                         200  mg/1,                         30  mg/1","TABLET, COATED","ORAL","NDA021441","Haleon US Holdings LLC","0573-0188","chlorpheniramine maleate, ibuprofen, pseudoephedrine HCl","CHLORPHENIRAMINE MALEATE;  IBUPROFEN;  PSEUDOEPHEDRINE HYDROCHLORIDE","HUMAN OTC DRUG","12/20/2002","N/A","NDA","20 BLISTER PACK in 1 CARTON (0573-0188-10)  / 1 TABLET, COATED in 1 BLISTER PACK","Adrenergic alpha-Agonists [MoA],  Anti-Inflammatory Agents,  Non-Steroidal [CS],  Cyclooxygenase Inhibitors [MoA],  Histamine H1 Receptor Antagonists [MoA],  Histamine-1 Receptor Antagonist [EPC],  Nonsteroidal Anti-inflammatory Drug [EPC],  alpha-Adrenergic Agonist [EPC]","N/A","No","12/31/2025"
"AGAMREE","69616-264-38","","KIT","ORAL","NDA215239","Catalyst Pharmaceuticals, Inc.","69616-264","VAMOROLONE","","HUMAN PRESCRIPTION DRUG","02/01/2024","N/A","NDA","1 KIT in 1 CARTON (69616-264-38)  *  100 mL in 1 BOTTLE, GLASS (69616-265-38)","N/A","N/A","No","12/31/2025"
"Agaricus muscarius","0220-0110-41","6 [hp_C]/6[hp_C]","PELLET","ORAL","","Boiron","0220-0110","AMANITA MUSCARIA FRUITING BODY","AMANITA MUSCARIA FRUITING BODY","HUMAN OTC DRUG","03/03/1983","N/A","UNAPPROVED HOMEOPATHIC","6 [hp_C] in 1 TUBE (0220-0110-41)","N/A","N/A","No","12/31/2024"
"Agaricus Phosphorus","48951-1022-1","8 [hp_X]/mL,                         3  [hp_X]/mL,                         6  [hp_X]/mL,                         6  [hp_X]/mL,                         6  [hp_X]/mL","LIQUID","ORAL","","Uriel Pharmacy Inc.","48951-1022","Agaricus Phosphorus","AMANITA MUSCARIA FRUITING BODY;  DRYOPTERIS FILIX-MAS ROOT;  OSTREA EDULIS SHELL;  PHOSPHORUS;  SILVER FLUORIDE","HUMAN OTC DRUG","09/01/2009","N/A","UNAPPROVED HOMEOPATHIC","10 AMPULE in 1 BOX (48951-1022-1)  / 1 mL in 1 AMPULE","N/A","N/A","No","12/31/2025"
"Albuterol Sulfate","47335-703-49",".83 mg/mL","SOLUTION","RESPIRATORY (INHALATION)","ANDA207857","Sun Pharmaceutical Industries, Inc.","47335-703","albuterol sulfate","ALBUTEROL SULFATE","HUMAN PRESCRIPTION DRUG","06/11/2021","N/A","ANDA","5 POUCH in 1 CARTON (47335-703-49)  / 5 VIAL in 1 POUCH / 3 mL in 1 VIAL","Adrenergic beta2-Agonists [MoA],  beta2-Adrenergic Agonist [EPC]","N/A","No","12/31/2024"
"Albuterol Sulfate","47335-703-52",".83 mg/mL","SOLUTION","RESPIRATORY (INHALATION)","ANDA207857","Sun Pharmaceutical Industries, Inc.","47335-703","albuterol sulfate","ALBUTEROL SULFATE","HUMAN PRESCRIPTION DRUG","06/11/2021","N/A","ANDA","6 POUCH in 1 CARTON (47335-703-52)  / 5 VIAL in 1 POUCH / 3 mL in 1 VIAL","Adrenergic beta2-Agonists [MoA],  beta2-Adrenergic Agonist [EPC]","N/A","No","12/31/2024"
"Albuterol Sulfate","47335-703-54",".83 mg/mL","SOLUTION","RESPIRATORY (INHALATION)","ANDA207857","Sun Pharmaceutical Industries, Inc.","47335-703","albuterol sulfate","ALBUTEROL SULFATE","HUMAN PRESCRIPTION DRUG","06/11/2021","N/A","ANDA","12 POUCH in 1 CARTON (47335-703-54)  / 5 VIAL in 1 POUCH / 3 mL in 1 VIAL","Adrenergic beta2-Agonists [MoA],  beta2-Adrenergic Agonist [EPC]","N/A","No","12/31/2024"
"Alcohol","68786-300-01",".7 mL/mL","SWAB","TOPICAL","M003","Sion Biotext Medical Ltd","68786-300","Alcohol","ISOPROPYL ALCOHOL","HUMAN OTC DRUG","10/09/2020","N/A","OTC MONOGRAPH DRUG","10 BOX in 1 CASE (68786-300-01)  / 50 POUCH in 1 BOX / 1 PATCH in 1 POUCH / 1.4 mL in 1 PATCH","N/A","N/A","No","12/31/2025"
"Alcohol","68786-300-02",".7 mL/mL","SWAB","TOPICAL","M003","Sion Biotext Medical Ltd","68786-300","Alcohol","ISOPROPYL ALCOHOL","HUMAN OTC DRUG","10/09/2020","N/A","OTC MONOGRAPH DRUG","10 BOX in 1 CASE (68786-300-02)  / 75 POUCH in 1 BOX / 3 PATCH in 1 POUCH / 1.4 mL in 1 PATCH","N/A","N/A","No","12/31/2025"
"Alcohol","11344-849-20","62 mL/100mL","LIQUID","TOPICAL","505G(a)(3)","Vi-Jon, LLC","11344-849","Alcohol","ALCOHOL","HUMAN OTC DRUG","11/09/2023","N/A","OTC MONOGRAPH DRUG","1 BOTTLE, PLASTIC in 1 CARTON (11344-849-20)  / 59 mL in 1 BOTTLE, PLASTIC","N/A","N/A","No","12/31/2024"
"Alcohol","11344-849-27","62 mL/100mL","LIQUID","TOPICAL","505G(a)(3)","Vi-Jon, LLC","11344-849","Alcohol","ALCOHOL","HUMAN OTC DRUG","04/29/2020","N/A","OTC MONOGRAPH DRUG","1150 mL in 1 BOTTLE, PLASTIC (11344-849-27)","N/A","N/A","No","12/31/2024"
"Alcohol","11344-849-08","62 mL/100mL","LIQUID","TOPICAL","505G(a)(3)","Vi-Jon, LLC","11344-849","Alcohol","ALCOHOL","HUMAN OTC DRUG","04/29/2020","N/A","OTC MONOGRAPH DRUG","3785 mL in 1 BOTTLE, PLASTIC (11344-849-08)","N/A","N/A","No","12/31/2024"
"Alcohol","11344-849-68","62 mL/100mL","LIQUID","TOPICAL","505G(a)(3)","Vi-Jon, LLC","11344-849","Alcohol","ALCOHOL","HUMAN OTC DRUG","04/29/2020","N/A","OTC MONOGRAPH DRUG","2000 mL in 1 BOTTLE, PLASTIC (11344-849-68)","N/A","N/A","No","12/31/2024"
"Alcohol","11344-849-86","62 mL/100mL","LIQUID","TOPICAL","505G(a)(3)","Vi-Jon, LLC","11344-849","Alcohol","ALCOHOL","HUMAN OTC DRUG","04/29/2020","N/A","OTC MONOGRAPH DRUG","1000 mL in 1 BOTTLE, PLASTIC (11344-849-86)","N/A","N/A","No","12/31/2024"
"Alcohol","11344-849-45","62 mL/100mL","LIQUID","TOPICAL","505G(a)(3)","Vi-Jon, LLC","11344-849","Alcohol","ALCOHOL","HUMAN OTC DRUG","04/29/2020","N/A","OTC MONOGRAPH DRUG","946 mL in 1 BOTTLE, PLASTIC (11344-849-45)","N/A","N/A","No","12/31/2024"
"Alcohol","11344-849-48","62 mL/100mL","LIQUID","TOPICAL","505G(a)(3)","Vi-Jon, LLC","11344-849","Alcohol","ALCOHOL","HUMAN OTC DRUG","04/29/2020","N/A","OTC MONOGRAPH DRUG","1.005 mL in 1 BOTTLE, PLASTIC (11344-849-48)","N/A","N/A","No","12/31/2024"
"Alcohol","11344-849-49","62 mL/100mL","LIQUID","TOPICAL","505G(a)(3)","Vi-Jon, LLC","11344-849","Alcohol","ALCOHOL","HUMAN OTC DRUG","04/29/2020","N/A","OTC MONOGRAPH DRUG","443 mL in 1 BOTTLE, PLASTIC (11344-849-49)","N/A","N/A","No","12/31/2024"
"Alcohol","11344-849-55","62 mL/100mL","LIQUID","TOPICAL","505G(a)(3)","Vi-Jon, LLC","11344-849","Alcohol","ALCOHOL","HUMAN OTC DRUG","04/29/2020","N/A","OTC MONOGRAPH DRUG","2082 mL in 1 DRUM (11344-849-55)","N/A","N/A","No","12/31/2024"
"Alcohol","11344-849-63","62 mL/100mL","LIQUID","TOPICAL","505G(a)(3)","Vi-Jon, LLC","11344-849","Alcohol","ALCOHOL","HUMAN OTC DRUG","04/29/2020","N/A","OTC MONOGRAPH DRUG","199 mL in 1 BOTTLE, PLASTIC (11344-849-63)","N/A","N/A","No","12/31/2024"
"Alcohol","11344-849-64","62 mL/100mL","LIQUID","TOPICAL","505G(a)(3)","Vi-Jon, LLC","11344-849","Alcohol","ALCOHOL","HUMAN OTC DRUG","04/29/2020","N/A","OTC MONOGRAPH DRUG","1892 mL in 1 BOTTLE, PLASTIC (11344-849-64)","N/A","N/A","No","12/31/2024"
"Alcohol","11344-849-16","62 mL/100mL","LIQUID","TOPICAL","505G(a)(3)","Vi-Jon, LLC","11344-849","Alcohol","ALCOHOL","HUMAN OTC DRUG","04/29/2020","N/A","OTC MONOGRAPH DRUG","59 mL in 1 BOTTLE, PLASTIC (11344-849-16)","N/A","N/A","No","12/31/2024"
"Alcohol","11344-849-21","62 mL/100mL","LIQUID","TOPICAL","505G(a)(3)","Vi-Jon, LLC","11344-849","Alcohol","ALCOHOL","HUMAN OTC DRUG","04/29/2020","N/A","OTC MONOGRAPH DRUG","89 mL in 1 BOTTLE, PLASTIC (11344-849-21)","N/A","N/A","No","12/31/2024"
"Alcohol","11344-849-32","62 mL/100mL","LIQUID","TOPICAL","505G(a)(3)","Vi-Jon, LLC","11344-849","Alcohol","ALCOHOL","HUMAN OTC DRUG","04/29/2020","N/A","OTC MONOGRAPH DRUG","355 mL in 1 BOTTLE, PLASTIC (11344-849-32)","N/A","N/A","No","12/31/2024"
"Alcohol","11344-849-34","62 mL/100mL","LIQUID","TOPICAL","505G(a)(3)","Vi-Jon, LLC","11344-849","Alcohol","ALCOHOL","HUMAN OTC DRUG","04/29/2020","N/A","OTC MONOGRAPH DRUG","236 mL in 1 BOTTLE, PLASTIC (11344-849-34)","N/A","N/A","No","12/31/2024"
"Alcohol","11344-849-38","62 mL/100mL","LIQUID","TOPICAL","505G(a)(3)","Vi-Jon, LLC","11344-849","Alcohol","ALCOHOL","HUMAN OTC DRUG","04/29/2020","N/A","OTC MONOGRAPH DRUG","295 mL in 1 BOTTLE, PLASTIC (11344-849-38)","N/A","N/A","No","12/31/2024"
"Alcohol","11344-849-43","62 mL/100mL","LIQUID","TOPICAL","505G(a)(3)","Vi-Jon, LLC","11344-849","Alcohol","ALCOHOL","HUMAN OTC DRUG","04/29/2020","N/A","OTC MONOGRAPH DRUG","473 mL in 1 BOTTLE, PLASTIC (11344-849-43)","N/A","N/A","No","12/31/2024"
"ALKA-SELTZER ORIGINAL","29485-7535-2","1000 mg/1,                         325  mg/1,                         1916  mg/1","TABLET, EFFERVESCENT","ORAL","M013","Lil' Drug Store Products, Inc.","29485-7535","anhydrous citric acid, aspirin, and sodium bicarbonate tablet, effervescent","ANHYDROUS CITRIC ACID;  ASPIRIN;  SODIUM BICARBONATE","HUMAN OTC DRUG","07/10/2020","12/31/2025","OTC MONOGRAPH DRUG","25 PACKET in 1 BOX (29485-7535-2)  / 2 TABLET, EFFERVESCENT in 1 PACKET","Acidifying Activity [MoA],  Alkalinizing Activity [MoA],  Anti-Inflammatory Agents,  Non-Steroidal [CS],  Anti-coagulant [EPC],  Calcium Chelating Activity [MoA],  Calculi Dissolution Agent [EPC],  Cyclooxygenase Inhibitors [MoA],  Decreased Coagulation Factor Activity [PE],  Decreased Platelet Aggregation [PE],  Decreased Prostaglandin Production [PE],  Nonsteroidal Anti-inflammatory Drug [EPC],  Platelet Aggregation Inhibitor [EPC]","N/A","No","N/A"
"ALKA-SELTZER ORIGINAL","29485-7535-3","1000 mg/1,                         325  mg/1,                         1916  mg/1","TABLET, EFFERVESCENT","ORAL","M013","Lil' Drug Store Products, Inc.","29485-7535","anhydrous citric acid, aspirin, and sodium bicarbonate tablet, effervescent","ANHYDROUS CITRIC ACID;  ASPIRIN;  SODIUM BICARBONATE","HUMAN OTC DRUG","11/17/2016","12/31/2025","OTC MONOGRAPH DRUG","30 PACKET in 1 BOX (29485-7535-3)  / 2 TABLET, EFFERVESCENT in 1 PACKET","Acidifying Activity [MoA],  Alkalinizing Activity [MoA],  Anti-Inflammatory Agents,  Non-Steroidal [CS],  Anti-coagulant [EPC],  Calcium Chelating Activity [MoA],  Calculi Dissolution Agent [EPC],  Cyclooxygenase Inhibitors [MoA],  Decreased Coagulation Factor Activity [PE],  Decreased Platelet Aggregation [PE],  Decreased Prostaglandin Production [PE],  Nonsteroidal Anti-inflammatory Drug [EPC],  Platelet Aggregation Inhibitor [EPC]","N/A","No","N/A"
"Allergy Relief","69517-106-24","25 mg/1","TABLET","ORAL","M012","HealthLife of USA","69517-106","Diphenhydramine Hydrochloride","DIPHENHYDRAMINE HYDROCHLORIDE","HUMAN OTC DRUG","01/01/2016","N/A","OTC MONOGRAPH DRUG","24 CARTON in 1 BOTTLE (69517-106-24)  / 1 TABLET in 1 CARTON","Histamine H1 Receptor Antagonists [MoA],  Histamine-1 Receptor Antagonist [EPC]","N/A","No","12/31/2024"
"Allergy Relief","69517-106-30","25 mg/1","TABLET","ORAL","M012","HealthLife of USA","69517-106","Diphenhydramine Hydrochloride","DIPHENHYDRAMINE HYDROCHLORIDE","HUMAN OTC DRUG","06/05/2017","N/A","OTC MONOGRAPH DRUG","1 BOTTLE in 1 CARTON (69517-106-30)  / 30 TABLET in 1 BOTTLE","Histamine H1 Receptor Antagonists [MoA],  Histamine-1 Receptor Antagonist [EPC]","N/A","No","12/31/2024"
"Allergy Relief","69517-106-06","25 mg/1","TABLET","ORAL","M012","HealthLife of USA","69517-106","Diphenhydramine Hydrochloride","DIPHENHYDRAMINE HYDROCHLORIDE","HUMAN OTC DRUG","05/12/2012","N/A","OTC MONOGRAPH DRUG","600 TABLET in 1 BOTTLE (69517-106-06)","Histamine H1 Receptor Antagonists [MoA],  Histamine-1 Receptor Antagonist [EPC]","N/A","No","12/31/2024"
"Allergy Relief","69517-106-10","25 mg/1","TABLET","ORAL","M012","HealthLife of USA","69517-106","Diphenhydramine Hydrochloride","DIPHENHYDRAMINE HYDROCHLORIDE","HUMAN OTC DRUG","05/12/2012","N/A","OTC MONOGRAPH DRUG","1000 TABLET in 1 BOTTLE (69517-106-10)","Histamine H1 Receptor Antagonists [MoA],  Histamine-1 Receptor Antagonist [EPC]","N/A","No","12/31/2024"
"Allergy Relief","68788-7769-0","10 mg/1","TABLET","ORAL","ANDA075209","Preferred Pharmaceuticals, Inc.","68788-7769","Loratadine","LORATADINE","HUMAN OTC DRUG","08/03/2020","N/A","ANDA","10 TABLET in 1 BOTTLE, PLASTIC (68788-7769-0)","N/A","N/A","No","12/31/2024"
"Allergy Relief","68788-7769-1","10 mg/1","TABLET","ORAL","ANDA075209","Preferred Pharmaceuticals, Inc.","68788-7769","Loratadine","LORATADINE","HUMAN OTC DRUG","08/03/2020","N/A","ANDA","14 TABLET in 1 BOTTLE, PLASTIC (68788-7769-1)","N/A","N/A","No","12/31/2024"
"Allergy Relief","68788-7769-3","10 mg/1","TABLET","ORAL","ANDA075209","Preferred Pharmaceuticals, Inc.","68788-7769","Loratadine","LORATADINE","HUMAN OTC DRUG","08/03/2020","N/A","ANDA","30 TABLET in 1 BOTTLE, PLASTIC (68788-7769-3)","N/A","N/A","No","12/31/2024"
"Allergy Relief","68788-7769-5","10 mg/1","TABLET","ORAL","ANDA075209","Preferred Pharmaceuticals, Inc.","68788-7769","Loratadine","LORATADINE","HUMAN OTC DRUG","08/03/2020","N/A","ANDA","15 TABLET in 1 BOTTLE, PLASTIC (68788-7769-5)","N/A","N/A","No","12/31/2024"
"Allergy Relief","68788-7769-9","10 mg/1","TABLET","ORAL","ANDA075209","Preferred Pharmaceuticals, Inc.","68788-7769","Loratadine","LORATADINE","HUMAN OTC DRUG","08/03/2020","N/A","ANDA","90 TABLET in 1 BOTTLE, PLASTIC (68788-7769-9)","N/A","N/A","No","12/31/2024"
"Allscale","22840-1300-1",".001 g/mL","SOLUTION","INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS","BLA101833","Greer Laboratories, Inc.","22840-1300","Atriplex polycarpa","ATRIPLEX POLYCARPA POLLEN","NON-STANDARDIZED ALLERGENIC","09/15/1981","N/A","BLA","5 mL in 1 VIAL, MULTI-DOSE (22840-1300-1)","Allergens [CS],  Cell-mediated Immunity [PE],  Increased Histamine Release [PE],  Increased IgG Production [PE],  Non-Standardized Pollen Allergenic Extract [EPC],  Pollen [CS]","N/A","No","12/31/2024"
"Alo Therapeutic Massage","51457-000-04",".1 g/100g,                         3  g/100g","CREAM","TOPICAL","M017","Theraplex Solutions","51457-000","MENTHOL, HISTAMINE DIHYDROCHLORIDE","HISTAMINE DIHYDROCHLORIDE;  MENTHOL","HUMAN OTC DRUG","02/03/2017","N/A","OTC MONOGRAPH DRUG","118 g in 1 TUBE (51457-000-04)","N/A","N/A","No","12/31/2024"
"Alo Therapeutic Massage","71061-765-28","1 mg/mL,                         30  mg/mL","CREAM","TOPICAL","M017","CMI Therapy Solutions","71061-765","MENTHOL, HISTAMINE DIHYDROCHLORIDE","HISTAMINE DIHYDROCHLORIDE;  MENTHOL","HUMAN OTC DRUG","11/10/2016","N/A","OTC MONOGRAPH DRUG","3785 mL in 1 BOTTLE (71061-765-28)","N/A","N/A","No","12/31/2024"
"Alvimopan","0591-2312-15","12 mg/1","CAPSULE","ORAL","ANDA208295","Actavis Pharma, Inc.","0591-2312","Alvimopan","ALVIMOPAN","HUMAN PRESCRIPTION DRUG","12/01/2020","N/A","ANDA","30 BLISTER PACK in 1 CARTON (0591-2312-15)  / 1 CAPSULE in 1 BLISTER PACK (0591-2312-45)","Opioid Antagonist [EPC],  Opioid Antagonists [MoA]","N/A","No","12/31/2025"
"Amazonic Natural Sunscreen SPF 30 Broad Spectrum UVA/UVB","71522-834-01","60 mg/g,                         60  mg/g","CREAM","TOPICAL","M020","Amazonic Products","71522-834","TITANIUM DIOXIDE, ZINC OXIDE","TITANIUM DIOXIDE;  ZINC OXIDE","HUMAN OTC DRUG","06/28/2017","N/A","OTC MONOGRAPH DRUG","118 g in 1 TUBE (71522-834-01)","Copper Absorption Inhibitor [EPC],  Decreased Copper Ion Absorption [PE]","N/A","No","12/31/2024"
"Amoxicillin","72789-225-82","500 mg/1","CAPSULE","ORAL","ANDA065291","PD-Rx Pharmaceuticals, Inc.","72789-225","Amoxicillin","AMOXICILLIN","HUMAN PRESCRIPTION DRUG","02/10/2022","N/A","ANDA","500 CAPSULE in 1 BOTTLE, PLASTIC (72789-225-82)","Penicillin-class Antibacterial [EPC],  Penicillins [CS]","N/A","No","12/31/2025"
"Amoxicillin and Clavulanate Potassium","53002-0104-1","400 mg/5mL,                         57  mg/5mL","POWDER, FOR SUSPENSION","ORAL","ANDA201090","RPK Pharmaceuticals, Inc.","53002-0104","Amoxicillin and Clavulanate Potassium","AMOXICILLIN;  CLAVULANATE POTASSIUM","HUMAN PRESCRIPTION DRUG","01/01/2024","N/A","ANDA","50 mL in 1 BOTTLE (53002-0104-1)","Penicillin-class Antibacterial [EPC],  Penicillins [CS],  beta Lactamase Inhibitor [EPC],  beta Lactamase Inhibitors [MoA]","N/A","No","12/31/2025"
"Amoxicillin and Clavulanate Potassium","53002-0104-2","400 mg/5mL,                         57  mg/5mL","POWDER, FOR SUSPENSION","ORAL","ANDA201090","RPK Pharmaceuticals, Inc.","53002-0104","Amoxicillin and Clavulanate Potassium","AMOXICILLIN;  CLAVULANATE POTASSIUM","HUMAN PRESCRIPTION DRUG","01/01/2024","N/A","ANDA","100 mL in 1 BOTTLE (53002-0104-2)","Penicillin-class Antibacterial [EPC],  Penicillins [CS],  beta Lactamase Inhibitor [EPC],  beta Lactamase Inhibitors [MoA]","N/A","No","12/31/2025"
"Amoxicillin and Clavulanate Potassium","50090-3179-0","875 mg/1,                         125  mg/1","TABLET","ORAL","ANDA203824","A-S Medication Solutions","50090-3179","Amoxicillin and Clavulanate Potassium","AMOXICILLIN;  CLAVULANATE POTASSIUM","HUMAN PRESCRIPTION DRUG","10/16/2017","N/A","ANDA","20 TABLET in 1 BOTTLE (50090-3179-0)","Penicillin-class Antibacterial [EPC],  Penicillins [CS],  beta Lactamase Inhibitor [EPC],  beta Lactamase Inhibitors [MoA]","N/A","No","12/31/2024"
"Amoxicillin and Clavulanate Potassium","50090-3179-1","875 mg/1,                         125  mg/1","TABLET","ORAL","ANDA203824","A-S Medication Solutions","50090-3179","Amoxicillin and Clavulanate Potassium","AMOXICILLIN;  CLAVULANATE POTASSIUM","HUMAN PRESCRIPTION DRUG","12/22/2017","N/A","ANDA","10 TABLET in 1 BOTTLE (50090-3179-1)","Penicillin-class Antibacterial [EPC],  Penicillins [CS],  beta Lactamase Inhibitor [EPC],  beta Lactamase Inhibitors [MoA]","N/A","No","12/31/2024"
"Amoxicillin and Clavulanate Potassium","50090-3179-2","875 mg/1,                         125  mg/1","TABLET","ORAL","ANDA203824","A-S Medication Solutions","50090-3179","Amoxicillin and Clavulanate Potassium","AMOXICILLIN;  CLAVULANATE POTASSIUM","HUMAN PRESCRIPTION DRUG","11/01/2017","N/A","ANDA","14 TABLET in 1 BOTTLE (50090-3179-2)","Penicillin-class Antibacterial [EPC],  Penicillins [CS],  beta Lactamase Inhibitor [EPC],  beta Lactamase Inhibitors [MoA]","N/A","No","12/31/2024"
"Amoxicillin and Clavulanate Potassium","50090-3179-3","875 mg/1,                         125  mg/1","TABLET","ORAL","ANDA203824","A-S Medication Solutions","50090-3179","Amoxicillin and Clavulanate Potassium","AMOXICILLIN;  CLAVULANATE POTASSIUM","HUMAN PRESCRIPTION DRUG","03/29/2018","N/A","ANDA","28 TABLET in 1 BOTTLE (50090-3179-3)","Penicillin-class Antibacterial [EPC],  Penicillins [CS],  beta Lactamase Inhibitor [EPC],  beta Lactamase Inhibitors [MoA]","N/A","No","12/31/2024"
"Amoxicillin and Clavulanate Potassium","50090-3179-5","875 mg/1,                         125  mg/1","TABLET","ORAL","ANDA203824","A-S Medication Solutions","50090-3179","Amoxicillin and Clavulanate Potassium","AMOXICILLIN;  CLAVULANATE POTASSIUM","HUMAN PRESCRIPTION DRUG","03/13/2018","N/A","ANDA","1 TABLET in 1 BOTTLE (50090-3179-5)","Penicillin-class Antibacterial [EPC],  Penicillins [CS],  beta Lactamase Inhibitor [EPC],  beta Lactamase Inhibitors [MoA]","N/A","No","12/31/2024"
"AMPHETAMINE SULFATE","0527-2524-37","5 mg/1","TABLET","ORAL","ANDA212901","Lannett Company, Inc.","0527-2524","amphetamine sulfate","AMPHETAMINE SULFATE","HUMAN PRESCRIPTION DRUG","06/01/2020","N/A","ANDA","100 TABLET in 1 BOTTLE (0527-2524-37)","Central Nervous System Stimulant [EPC],  Central Nervous System Stimulation [PE]","CII","No","12/31/2025"
"Antibacterial Foam","71907-201-41",".1 g/L","SOAP","TOPICAL","505G(a)(3)","Dade Paper & Bag, LLC","71907-201","PCMX, Hand Soap","CHLOROXYLENOL","HUMAN OTC DRUG","02/03/2023","N/A","OTC MONOGRAPH DRUG","3.78 L in 1 BOTTLE, PLASTIC (71907-201-41)","N/A","N/A","No","12/31/2024"
"Antibacterial Hand Refill","71906-701-41","1 g/L","SOAP","TOPICAL","505G(a)(3)","Essendant Co.","71906-701","PMCX","CHLOROXYLENOL","HUMAN OTC DRUG","02/11/2022","N/A","OTC MONOGRAPH DRUG","3.78 L in 1 BOTTLE, PLASTIC (71906-701-41)","N/A","N/A","No","12/31/2024"
"Antidiarrheal Relief","0498-1071-07","2 mg/1","TABLET","ORAL","ANDA074091","Honeywell Safety Products USA, Inc","0498-1071","Loperamide HCl","LOPERAMIDE HYDROCHLORIDE","HUMAN OTC DRUG","11/07/2018","N/A","ANDA","100 PACKET in 1 CARTON (0498-1071-07)  / 1 TABLET in 1 PACKET (0498-1071-00)","Opioid Agonist [EPC],  Opioid Agonists [MoA]","N/A","No","12/31/2025"
"Antiplaque solution","53462-275-60",".5 mg/mL","MOUTHWASH","BUCCAL","part356","Sage Products LLC","53462-275","CETYLPYRIDINIUM CHLORIDE","CETYLPYRIDINIUM CHLORIDE","HUMAN OTC DRUG","01/09/2009","N/A","OTC MONOGRAPH NOT FINAL","7 mL in 1 PACKET (53462-275-60)","N/A","N/A","No","12/31/2024"
"Antiseptic","55316-318-69",".92 mg/mL,                         .42  mg/mL,                         .6  mg/mL,                         .64  mg/mL","RINSE","ORAL","part356","DZA Brands, LLC","55316-318","EUCALYPTOL, Menthol, Methyl salicylate, thymol","EUCALYPTOL;  MENTHOL;  METHYL SALICYLATE;  THYMOL","HUMAN OTC DRUG","02/05/2008","N/A","OTC MONOGRAPH NOT FINAL","250 mL in 1 BOTTLE, PLASTIC (55316-318-69)","N/A","N/A","No","12/31/2024"
"Antiseptic","55316-318-86",".92 mg/mL,                         .42  mg/mL,                         .6  mg/mL,                         .64  mg/mL","RINSE","ORAL","part356","DZA Brands, LLC","55316-318","EUCALYPTOL, Menthol, Methyl salicylate, thymol","EUCALYPTOL;  MENTHOL;  METHYL SALICYLATE;  THYMOL","HUMAN OTC DRUG","02/05/2008","N/A","OTC MONOGRAPH NOT FINAL","1000 mL in 1 BOTTLE, PLASTIC (55316-318-86)","N/A","N/A","No","12/31/2024"
"Antiseptic BZK Towelette","63517-501-83","1.3 mg/g","CLOTH","TOPICAL","M003","Cardinal Health 200, Inc.","63517-501","BENZALKONIUM CHLORIDE","BENZALKONIUM CHLORIDE","HUMAN OTC DRUG","06/02/2016","N/A","OTC MONOGRAPH DRUG","100 POUCH in 1 CARTON (63517-501-83)  / 1.8 g in 1 POUCH","N/A","N/A","No","12/31/2024"
"Aplicare Povidone-Iodine","52380-1905-3","10 mg/mL","SOLUTION","TOPICAL","505G(a)(3)","Aplicare Products, LLC","52380-1905","Povidone-Iodine","POVIDONE-IODINE","HUMAN OTC DRUG","09/01/1998","N/A","OTC MONOGRAPH DRUG","90 mL in 1 BOTTLE (52380-1905-3)","N/A","N/A","No","12/31/2025"
"Aplicare Povidone-Iodine","52380-1905-0","10 mg/mL","SOLUTION","TOPICAL","505G(a)(3)","Aplicare Products, LLC","52380-1905","Povidone-Iodine","POVIDONE-IODINE","HUMAN OTC DRUG","09/01/1998","N/A","OTC MONOGRAPH DRUG","60 mL in 1 BOTTLE, SPRAY (52380-1905-0)","N/A","N/A","No","12/31/2025"
"Aplicare Povidone-iodine Scrub","52380-2802-8","7.5 mg/mL","SOLUTION","TOPICAL","505G(a)(3)","Aplicare Products, LLC","52380-2802","Povidone-iodine","POVIDONE-IODINE","HUMAN OTC DRUG","01/01/1998","N/A","OTC MONOGRAPH DRUG","59 mL in 1 BOTTLE (52380-2802-8)","N/A","N/A","No","12/31/2025"
"Aralia racemosa","0220-0442-41","30 [hp_C]/30[hp_C]","PELLET","ORAL","","Boiron","0220-0442","ARALIA RACEMOSA ROOT","ARALIA RACEMOSA ROOT","HUMAN OTC DRUG","03/03/1983","N/A","UNAPPROVED HOMEOPATHIC","30 [hp_C] in 1 TUBE (0220-0442-41)","N/A","N/A","No","12/31/2024"
"ARC","69423-888-16",".1 mg/mL","RINSE","ORAL","M021","The Procter & Gamble Manufacturing Company","69423-888","Sodium Fluoride","SODIUM FLUORIDE","HUMAN OTC DRUG","06/01/2021","N/A","OTC MONOGRAPH DRUG","475 mL in 1 BOTTLE, PLASTIC (69423-888-16)","N/A","N/A","No","12/31/2024"
"Argatroban","42023-182-89","250 mg/2.5mL","INJECTION","INTRAVENOUS","ANDA091665","Par Pharmaceutical, Inc.","42023-182","Argatroban","ARGATROBAN","HUMAN PRESCRIPTION DRUG","06/01/2015","N/A","ANDA","1 VIAL in 1 CARTON (42023-182-89)  / 2.5 mL in 1 VIAL","Anti-coagulant [EPC],  Direct Thrombin Inhibitor [EPC],  Thrombin Inhibitors [MoA]","N/A","No","12/31/2024"
"Aripiprazole","53002-2765-3","5 mg/1","TABLET","ORAL","ANDA203908","RPK Pharmaceuticals, Inc.","53002-2765","Aripiprazole","ARIPIPRAZOLE","HUMAN PRESCRIPTION DRUG","01/01/2024","N/A","ANDA","30 TABLET in 1 BOTTLE (53002-2765-3)","Atypical Antipsychotic [EPC]","N/A","No","12/31/2025"
"Aripiprazole","70518-2806-2","20 mg/1","TABLET","ORAL","ANDA207105","REMEDYREPACK INC.","70518-2806","Aripiprazole","ARIPIPRAZOLE","HUMAN PRESCRIPTION DRUG","05/12/2021","N/A","ANDA","30 TABLET in 1 BLISTER PACK (70518-2806-2)","Atypical Antipsychotic [EPC]","N/A","No","12/31/2025"
"Aripiprazole","70518-2806-3","20 mg/1","TABLET","ORAL","ANDA207105","REMEDYREPACK INC.","70518-2806","Aripiprazole","ARIPIPRAZOLE","HUMAN PRESCRIPTION DRUG","12/07/2023","N/A","ANDA","30 TABLET in 1 BLISTER PACK (70518-2806-3)","Atypical Antipsychotic [EPC]","N/A","No","12/31/2025"
"Aripiprazole","31722-828-01","15 mg/1","TABLET","ORAL","ANDA205064","Camber Pharmaceuticals, Inc.","31722-828","Aripiprazole","ARIPIPRAZOLE","HUMAN PRESCRIPTION DRUG","04/28/2015","N/A","ANDA","100 TABLET in 1 BOTTLE (31722-828-01)","Atypical Antipsychotic [EPC]","N/A","No","12/31/2025"
"Aripiprazole","31722-828-30","15 mg/1","TABLET","ORAL","ANDA205064","Camber Pharmaceuticals, Inc.","31722-828","Aripiprazole","ARIPIPRAZOLE","HUMAN PRESCRIPTION DRUG","04/28/2015","N/A","ANDA","30 TABLET in 1 BOTTLE (31722-828-30)","Atypical Antipsychotic [EPC]","N/A","No","12/31/2025"
"Aripiprazole","31722-828-31","15 mg/1","TABLET","ORAL","ANDA205064","Camber Pharmaceuticals, Inc.","31722-828","Aripiprazole","ARIPIPRAZOLE","HUMAN PRESCRIPTION DRUG","04/28/2015","N/A","ANDA","10 TABLET in 1 BLISTER PACK (31722-828-31)","Atypical Antipsychotic [EPC]","N/A","No","12/31/2025"
"Aripiprazole","31722-828-32","15 mg/1","TABLET","ORAL","ANDA205064","Camber Pharmaceuticals, Inc.","31722-828","Aripiprazole","ARIPIPRAZOLE","HUMAN PRESCRIPTION DRUG","04/28/2015","N/A","ANDA","250 TABLET in 1 CARTON (31722-828-32)","Atypical Antipsychotic [EPC]","N/A","No","12/31/2025"
"Aripiprazole","31722-828-05","15 mg/1","TABLET","ORAL","ANDA205064","Camber Pharmaceuticals, Inc.","31722-828","Aripiprazole","ARIPIPRAZOLE","HUMAN PRESCRIPTION DRUG","02/02/2024","N/A","ANDA","500 TABLET in 1 BOTTLE (31722-828-05)","Atypical Antipsychotic [EPC]","N/A","No","12/31/2025"
"Armodafinil","65862-805-30","50 mg/1","TABLET","ORAL","ANDA206069","Aurobindo Pharma Limited","65862-805","Armodafinil","ARMODAFINIL","HUMAN PRESCRIPTION DRUG","03/06/2018","N/A","ANDA","30 TABLET in 1 BOTTLE (65862-805-30)","N/A","CIV","No","12/31/2025"
"Armodafinil","65862-805-05","50 mg/1","TABLET","ORAL","ANDA206069","Aurobindo Pharma Limited","65862-805","Armodafinil","ARMODAFINIL","HUMAN PRESCRIPTION DRUG","03/06/2018","N/A","ANDA","500 TABLET in 1 BOTTLE (65862-805-05)","N/A","CIV","No","12/31/2025"
"Armodafinil","65862-805-60","50 mg/1","TABLET","ORAL","ANDA206069","Aurobindo Pharma Limited","65862-805","Armodafinil","ARMODAFINIL","HUMAN PRESCRIPTION DRUG","03/06/2018","N/A","ANDA","60 TABLET in 1 BOTTLE (65862-805-60)","N/A","CIV","No","12/31/2025"
"Arnica Nettle","48951-1348-5","1 [hp_X]/g,                         2  [hp_X]/g,                         2  [hp_X]/g,                         2  [hp_X]/g,                         7  [hp_X]/g,                         8  [hp_X]/g,                         2  [hp_X]/g,                         1  [hp_X]/g","CREAM","TOPICAL","","Uriel Pharmacy Inc.","48951-1348","Arnica Nettle","ARNICA MONTANA FLOWER;  CALENDULA OFFICINALIS FLOWERING TOP;  COMFREY ROOT;  LARIX DECIDUA RESIN;  LYTTA VESICATORIA;  SILVER;  THUJA OCCIDENTALIS WHOLE;  URTICA URENS","HUMAN OTC DRUG","09/01/2009","N/A","UNAPPROVED HOMEOPATHIC","60 g in 1 TUBE (48951-1348-5)","N/A","N/A","No","12/31/2025"
"Arsenicum iodatum","0220-0561-41","5 [hp_C]/5[hp_C]","PELLET","ORAL","","Boiron","0220-0561","ARSENIC TRIIODIDE","ARSENIC TRIIODIDE","HUMAN OTC DRUG","03/03/1983","N/A","UNAPPROVED HOMEOPATHIC","5 [hp_C] in 1 TUBE (0220-0561-41)","N/A","N/A","No","12/31/2024"
"Arthmed Topical Analgesic","72876-007-04",".25 mg/mL,                         100  mg/mL,                         150  mg/mL","CREAM","TOPICAL","M017","Fusion Health and Vitality","72876-007","METHYL SALICYLATE, MENTHOL, CAPSAICIN","CAPSAICIN;  MENTHOL;  METHYL SALICYLATE","HUMAN OTC DRUG","12/20/2018","N/A","OTC MONOGRAPH DRUG","118 mL in 1 CYLINDER (72876-007-04)","N/A","N/A","No","12/31/2024"
"ARTICAINE","50227-1040-5","40 mg/mL,                         .01  mg/mL","INJECTION, SOLUTION","SUBMUCOSAL","NDA020971","Patterson Dental","50227-1040","Articaine Hydrochloride and Epinephrine","ARTICAINE HYDROCHLORIDE;  EPINEPHRINE BITARTRATE","HUMAN PRESCRIPTION DRUG","12/22/2014","N/A","NDA AUTHORIZED GENERIC","50 CARTRIDGE in 1 CARTON (50227-1040-5)  / 1.7 mL in 1 CARTRIDGE","Adrenergic alpha-Agonists [MoA],  Adrenergic beta-Agonists [MoA],  Amide Local Anesthetic [EPC],  Amides [CS],  Catecholamine [EPC],  Catecholamines [CS],  Local Anesthesia [PE],  alpha-Adrenergic Agonist [EPC],  beta-Adrenergic Agonist [EPC]","N/A","No","12/31/2025"
"Artistry Youth Xtend Lifting Smoothing Foundation Shade Cream","50390-229-00","75 mg/mL,                         5  mg/mL","CREAM","TOPICAL","M020","Amway Corp","50390-229","OCTINOXATE, OXYBENZONE","OCTINOXATE;  OXYBENZONE","HUMAN OTC DRUG","05/06/2013","N/A","OTC MONOGRAPH DRUG","1 BOTTLE, PLASTIC in 1 CARTON (50390-229-00)  / 30 mL in 1 BOTTLE, PLASTIC","N/A","N/A","No","12/31/2024"
"Artistry Youth Xtend Lifting Smoothing Foundation Shade Golden","50390-240-00","75 mg/mL,                         5  mg/mL","CREAM","TOPICAL","M020","Amway Corp","50390-240","OCTINOXATE, OXYBENZONE","OCTINOXATE;  OXYBENZONE","HUMAN OTC DRUG","05/06/2013","N/A","OTC MONOGRAPH DRUG","1 BOTTLE, PLASTIC in 1 CARTON (50390-240-00)  / 30 mL in 1 BOTTLE, PLASTIC","N/A","N/A","No","12/31/2024"
"Artistry Youth Xtend Lifting Smoothing Foundation Shade Mink","50390-230-00","75 mg/mL,                         5  mg/mL","CREAM","TOPICAL","M020","Amway Corp","50390-230","OCTINOXATE, OXYBENZONE","OCTINOXATE;  OXYBENZONE","HUMAN OTC DRUG","05/06/2013","N/A","OTC MONOGRAPH DRUG","1 BOTTLE, PLASTIC in 1 CARTON (50390-230-00)  / 30 mL in 1 BOTTLE, PLASTIC","N/A","N/A","No","12/31/2024"
"Arum triphyllum","0220-0564-41","6 [hp_X]/1","PELLET","ORAL","","Boiron","0220-0564","ARISAEMA TRIPHYLLUM ROOT","ARISAEMA TRIPHYLLUM ROOT","HUMAN OTC DRUG","03/03/1983","N/A","UNAPPROVED HOMEOPATHIC","80 PELLET in 1 TUBE (0220-0564-41)","N/A","N/A","No","12/31/2024"
"Asarum europaeum","0220-0577-41","30 [hp_C]/30[hp_C]","PELLET","ORAL","","Boiron","0220-0577","ASARUM EUROPAEUM","ASARUM EUROPAEUM","HUMAN OTC DRUG","03/03/1983","N/A","UNAPPROVED HOMEOPATHIC","30 [hp_C] in 1 TUBE (0220-0577-41)","N/A","N/A","No","12/31/2024"
"Aspirin 81 mg","55681-402-03","81 mg/1","TABLET, DELAYED RELEASE","ORAL","M013","TWIN MED LLC","55681-402","Aspirin Enteric Coated Tablets 81 mg","ASPIRIN","HUMAN OTC DRUG","11/01/2022","N/A","OTC MONOGRAPH DRUG","300 TABLET, DELAYED RELEASE in 1 BOTTLE (55681-402-03)","Anti-Inflammatory Agents,  Non-Steroidal [CS],  Cyclooxygenase Inhibitors [MoA],  Decreased Platelet Aggregation [PE],  Decreased Prostaglandin Production [PE],  Nonsteroidal Anti-inflammatory Drug [EPC],  Platelet Aggregation Inhibitor [EPC]","N/A","No","12/31/2025"
"ASTONEA CARE Muscle and Join Pain Relief Cream","77338-212-02","100 mg/g,                         150  mg/g","CREAM","TOPICAL","M017","ASTONEA LABS PRIVATE LIMITED","77338-212","Menthol, Methyl Salicylate","MENTHOL, UNSPECIFIED FORM;  METHYL SALICYLATE","HUMAN OTC DRUG","03/05/2024","N/A","OTC MONOGRAPH DRUG","1 TUBE in 1 CARTON (77338-212-02)  / 56.6 g in 1 TUBE","N/A","N/A","No","12/31/2025"
"ATORVASTATIN CALCIUM","55154-7289-0","80 mg/1","TABLET, FILM COATED","ORAL","ANDA090548","Cardinal Health 107, LLC","55154-7289","ATORVASTATIN CALCIUM","ATORVASTATIN CALCIUM PROPYLENE GLYCOL SOLVATE","HUMAN PRESCRIPTION DRUG","10/31/2014","N/A","ANDA","10 BLISTER PACK in 1 BAG (55154-7289-0)  / 1 TABLET, FILM COATED in 1 BLISTER PACK","HMG-CoA Reductase Inhibitor [EPC],  Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]","N/A","No","12/31/2025"
"Atorvastatin Calcium","0093-5059-10","20 mg/1","TABLET, FILM COATED","ORAL","ANDA205300","Teva Pharmaceuticals USA, Inc.","0093-5059","Atorvastatin Calcium","ATORVASTATIN CALCIUM TRIHYDRATE","HUMAN PRESCRIPTION DRUG","05/23/2022","N/A","ANDA","1000 TABLET, FILM COATED in 1 BOTTLE (0093-5059-10)","HMG-CoA Reductase Inhibitor [EPC],  Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]","N/A","No","12/31/2024"
"Atorvastatin Calcium","0093-5059-98","20 mg/1","TABLET, FILM COATED","ORAL","ANDA205300","Teva Pharmaceuticals USA, Inc.","0093-5059","Atorvastatin Calcium","ATORVASTATIN CALCIUM TRIHYDRATE","HUMAN PRESCRIPTION DRUG","05/04/2017","N/A","ANDA","90 TABLET, FILM COATED in 1 BOTTLE (0093-5059-98)","HMG-CoA Reductase Inhibitor [EPC],  Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]","N/A","No","12/31/2024"
"ATORVASTATIN CALCIUM","50090-6482-0","20 mg/1","TABLET, FILM COATED","ORAL","ANDA090548","A-S Medication Solutions","50090-6482","ATORVASTATIN CALCIUM","ATORVASTATIN CALCIUM PROPYLENE GLYCOL SOLVATE","HUMAN PRESCRIPTION DRUG","05/17/2023","N/A","ANDA","90 TABLET, FILM COATED in 1 BOTTLE (50090-6482-0)","HMG-CoA Reductase Inhibitor [EPC],  Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]","N/A","No","12/31/2024"
"Atorvastatin Calcium","50090-6890-0","40 mg/1","TABLET, FILM COATED","ORAL","ANDA216436","A-S Medication Solutions","50090-6890","atorvastatin calcium","ATORVASTATIN CALCIUM TRIHYDRATE","HUMAN PRESCRIPTION DRUG","12/06/2023","N/A","ANDA","30 TABLET, FILM COATED in 1 BOTTLE (50090-6890-0)","HMG-CoA Reductase Inhibitor [EPC],  Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]","N/A","No","12/31/2024"
"Atorvastatin Calcium","50090-6890-1","40 mg/1","TABLET, FILM COATED","ORAL","ANDA216436","A-S Medication Solutions","50090-6890","atorvastatin calcium","ATORVASTATIN CALCIUM TRIHYDRATE","HUMAN PRESCRIPTION DRUG","12/06/2023","N/A","ANDA","90 TABLET, FILM COATED in 1 BOTTLE (50090-6890-1)","HMG-CoA Reductase Inhibitor [EPC],  Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]","N/A","No","12/31/2024"
"Atorvastatin Calcium","50090-6890-2","40 mg/1","TABLET, FILM COATED","ORAL","ANDA216436","A-S Medication Solutions","50090-6890","atorvastatin calcium","ATORVASTATIN CALCIUM TRIHYDRATE","HUMAN PRESCRIPTION DRUG","12/06/2023","N/A","ANDA","100 TABLET, FILM COATED in 1 BOTTLE (50090-6890-2)","HMG-CoA Reductase Inhibitor [EPC],  Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]","N/A","No","12/31/2024"
"ATTITUDE Little Leaves Hand Sanitizer - Mango","61649-813-01","78.8 mL/100mL","SOLUTION","TOPICAL","505G(a)(3)","9055-7588 Quebec Inc. DBA Attitude","61649-813","Ethyl alcohol","ALCOHOL","HUMAN OTC DRUG","12/11/2023","N/A","OTC MONOGRAPH DRUG","100 mL in 1 BOTTLE, SPRAY (61649-813-01)","N/A","N/A","No","12/31/2024"
"ATTITUDE Little Leaves Hand Sanitizer Vanilla and Pear","61649-513-01","78.8 mL/100mL","SOLUTION","TOPICAL","505G(a)(3)","9055-7588 Quebec Inc. DBA Attitude","61649-513","Ethyl alcohol","ALCOHOL","HUMAN OTC DRUG","12/11/2023","N/A","OTC MONOGRAPH DRUG","100 mL in 1 BOTTLE, SPRAY (61649-513-01)","N/A","N/A","No","12/31/2024"
"ATTITUDE Super Leaves Hand Sanitizer Olive Leaves","61649-390-01","78.8 mL/100mL","SOLUTION","TOPICAL","505G(a)(3)","9055-7588 Quebec Inc. DBA Attitude","61649-390","Ethyl alcohol","ALCOHOL","HUMAN OTC DRUG","12/11/2023","N/A","OTC MONOGRAPH DRUG","100 mL in 1 BOTTLE, SPRAY (61649-390-01)","N/A","N/A","No","12/31/2024"
"Aurum Stibium Hyoscyamus","48951-1205-1","8 [hp_X]/mL,                         10  [hp_X]/mL,                         4  [hp_X]/mL,                         3  [hp_X]/mL,                         3  [hp_X]/mL","LIQUID","ORAL","","Uriel Pharmacy Inc.","48951-1205","Aurum Stibium Hyoscyamus","ANTIMONY;  GOLD;  HYOSCYAMUS NIGER LEAF;  ONOPORDUM ACANTHIUM FLOWER;  PRIMULA VERIS FLOWER","HUMAN OTC DRUG","09/01/2009","N/A","UNAPPROVED HOMEOPATHIC","10 AMPULE in 1 BOX (48951-1205-1)  / 1 mL in 1 AMPULE","Allergens [CS],  Cell-mediated Immunity [PE],  Increased Histamine Release [PE],  Standardized Chemical Allergen [EPC]","N/A","No","12/31/2024"
"Australian Gold","58443-0630-3","30.09 mg/mL,                         75.23  mg/mL,                         50.15  mg/mL,                         50.15  mg/mL","LOTION","TOPICAL","M020","Prime Enterprises, Inc.","58443-0630","Avobenzone, Homosalate, Octisalate, Octocrylene","AVOBENZONE;  HOMOSALATE;  OCTISALATE;  OCTOCRYLENE","HUMAN OTC DRUG","08/04/2023","N/A","OTC MONOGRAPH FINAL","100 mL in 1 TUBE (58443-0630-3)","N/A","N/A","No","12/31/2024"
"Avena sativa","0220-0656-41","6 [hp_X]/6[hp_X]","PELLET","ORAL","","Boiron","0220-0656","AVENA SATIVA FLOWERING TOP","AVENA SATIVA FLOWERING TOP","HUMAN OTC DRUG","03/03/1983","N/A","UNAPPROVED HOMEOPATHIC","6 [hp_X] in 1 TUBE (0220-0656-41)","N/A","N/A","No","12/31/2024"
"Avene Solaire UV Mineral Sunscreen","64760-724-01","120 mg/mL","LOTION","TOPICAL","M020","Pierre Fabre USA Inc.","64760-724","Zinc Oxide","ZINC OXIDE","HUMAN OTC DRUG","05/17/2021","11/06/2025","OTC MONOGRAPH DRUG","1 BOTTLE in 1 CARTON (64760-724-01)  / 50 mL in 1 BOTTLE","N/A","N/A","No","N/A"
"Avobenzone, Homosalate, Octisalate","11822-0941-1","30 mg/g,                         100  mg/g,                         50  mg/g","SPRAY","TOPICAL","part352","Rite Aid","11822-0941","Avobenzone, Homosalate, Octisalate","AVOBENZONE;  HOMOSALATE;  OCTISALATE","HUMAN OTC DRUG","07/25/2023","N/A","OTC MONOGRAPH FINAL","156 g in 1 BOTTLE, SPRAY (11822-0941-1)","N/A","N/A","No","12/31/2024"
"Avobenzone, Homosalate, Octisalate","11822-9833-1","30 mg/mL,                         120  mg/mL,                         50  mg/mL","LOTION","TOPICAL","part352","Rite Aid","11822-9833","Avobenzone, Homosalate, Octisalate","AVOBENZONE;  HOMOSALATE;  OCTISALATE","HUMAN OTC DRUG","07/25/2023","N/A","OTC MONOGRAPH FINAL","88 mL in 1 TUBE (11822-9833-1)","N/A","N/A","No","12/31/2024"
"Avobenzone, Homosalate, Octisalate","11822-9835-1","30 mg/mL,                         150  mg/mL,                         50  mg/mL","LOTION","TOPICAL","part352","Rite Aid","11822-9835","Avobenzone, Homosalate, Octisalate","AVOBENZONE;  HOMOSALATE;  OCTISALATE","HUMAN OTC DRUG","07/25/2023","N/A","OTC MONOGRAPH FINAL","88 mL in 1 TUBE (11822-9835-1)","N/A","N/A","No","12/31/2024"
"azelaic acid","68462-626-52",".15 g/g","GEL","TOPICAL","ANDA204637","Glenmark Pharmaceuticals Inc., USA","68462-626","azelaic acid","AZELAIC ACID","HUMAN PRESCRIPTION DRUG","11/19/2018","N/A","ANDA","1 TUBE in 1 CARTON (68462-626-52)  / 50 g in 1 TUBE","Decreased Protein Synthesis [PE],  Decreased Sebaceous Gland Activity [PE]","N/A","No","12/31/2025"
"Azithromycin","50111-788-10","500 mg/1","TABLET, FILM COATED","ORAL","ANDA065223","Teva Pharmaceuticals USA, Inc.","50111-788","Azithromycin","AZITHROMYCIN MONOHYDRATE","HUMAN PRESCRIPTION DRUG","01/06/2006","N/A","ANDA","30 TABLET, FILM COATED in 1 BOTTLE (50111-788-10)","Macrolide Antimicrobial [EPC],  Macrolides [CS]","N/A","No","12/31/2024"
"Azithromycin","50111-788-55","500 mg/1","TABLET, FILM COATED","ORAL","ANDA065223","Teva Pharmaceuticals USA, Inc.","50111-788","Azithromycin","AZITHROMYCIN MONOHYDRATE","HUMAN PRESCRIPTION DRUG","02/18/2014","N/A","ANDA","1 BLISTER PACK in 1 CARTON (50111-788-55)  / 3 TABLET, FILM COATED in 1 BLISTER PACK","Macrolide Antimicrobial [EPC],  Macrolides [CS]","N/A","No","12/31/2024"
"Azithromycin","50111-788-67","500 mg/1","TABLET, FILM COATED","ORAL","ANDA065223","Teva Pharmaceuticals USA, Inc.","50111-788","Azithromycin","AZITHROMYCIN MONOHYDRATE","HUMAN PRESCRIPTION DRUG","01/06/2006","N/A","ANDA","3 CARTON in 1 PACKAGE (50111-788-67)  / 1 BLISTER PACK in 1 CARTON / 3 TABLET, FILM COATED in 1 BLISTER PACK","Macrolide Antimicrobial [EPC],  Macrolides [CS]","N/A","No","12/31/2024"
"azithromycin dihydrate","68180-862-06","500 mg/1","TABLET","ORAL","ANDA065399","Lupin Pharmaceuticals, Inc.","68180-862","azithromycin dihydrate","AZITHROMYCIN DIHYDRATE","HUMAN PRESCRIPTION DRUG","11/17/2022","N/A","ANDA","30 TABLET in 1 CONTAINER (68180-862-06)","Macrolide Antimicrobial [EPC],  Macrolides [CS]","N/A","No","12/31/2024"
"azithromycin dihydrate","68180-862-11","500 mg/1","TABLET","ORAL","ANDA065399","Lupin Pharmaceuticals, Inc.","68180-862","azithromycin dihydrate","AZITHROMYCIN DIHYDRATE","HUMAN PRESCRIPTION DRUG","11/17/2022","N/A","ANDA","1 BLISTER PACK in 1 CARTON (68180-862-11)  / 3 TABLET in 1 BLISTER PACK","Macrolide Antimicrobial [EPC],  Macrolides [CS]","N/A","No","12/31/2024"
"Azithromycin monohydrate","68083-199-10","500 mg/10mL","INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION","INTRAVENOUS","ANDA065501","Gland Pharma Limited","68083-199","Azithromycin monohydrate","AZITHROMYCIN MONOHYDRATE","HUMAN PRESCRIPTION DRUG","11/09/2009","N/A","ANDA","10 VIAL in 1 CARTON (68083-199-10)  / 10 mL in 1 VIAL","Macrolide Antimicrobial [EPC],  Macrolides [CS]","N/A","No","12/31/2024"
"Baby Mantra Diaper Cream","76348-825-34","10 g/100mL","OINTMENT","TOPICAL","M016","Renu Laboratories, Inc.","76348-825","Zinc Oxide 10%","ZINC OXIDE","HUMAN OTC DRUG","01/03/2024","N/A","OTC MONOGRAPH DRUG","100 mL in 1 TUBE (76348-825-34)","N/A","N/A","No","12/31/2025"
"Baclofen","0832-1054-10","10 mg/1","TABLET","ORAL","ANDA074584","Upsher-Smith Laboratories, LLC","0832-1054","Baclofen","BACLOFEN","HUMAN PRESCRIPTION DRUG","02/27/2018","N/A","ANDA","1000 TABLET in 1 BOTTLE (0832-1054-10)","GABA A Agonists [MoA],  GABA B Agonists [MoA],  gamma-Aminobutyric Acid-ergic Agonist [EPC]","N/A","No","12/31/2024"
"Baclofen","0832-1054-11","10 mg/1","TABLET","ORAL","ANDA074584","Upsher-Smith Laboratories, LLC","0832-1054","Baclofen","BACLOFEN","HUMAN PRESCRIPTION DRUG","02/27/2018","N/A","ANDA","100 TABLET in 1 BOTTLE (0832-1054-11)","GABA A Agonists [MoA],  GABA B Agonists [MoA],  gamma-Aminobutyric Acid-ergic Agonist [EPC]","N/A","No","12/31/2024"
"Baclofen","0832-1054-15","10 mg/1","TABLET","ORAL","ANDA074584","Upsher-Smith Laboratories, LLC","0832-1054","Baclofen","BACLOFEN","HUMAN PRESCRIPTION DRUG","02/27/2018","N/A","ANDA","500 TABLET in 1 BOTTLE (0832-1054-15)","GABA A Agonists [MoA],  GABA B Agonists [MoA],  gamma-Aminobutyric Acid-ergic Agonist [EPC]","N/A","No","12/31/2024"
"Baclofen","0832-1054-90","10 mg/1","TABLET","ORAL","ANDA074584","Upsher-Smith Laboratories, LLC","0832-1054","Baclofen","BACLOFEN","HUMAN PRESCRIPTION DRUG","02/27/2018","N/A","ANDA","90 TABLET in 1 BOTTLE (0832-1054-90)","GABA A Agonists [MoA],  GABA B Agonists [MoA],  gamma-Aminobutyric Acid-ergic Agonist [EPC]","N/A","No","12/31/2024"
"Bakers Best Arthritis Pain Relief","76102-030-02",".3 mg/g","CREAM","TOPICAL","M017","Baker's Best Health Products, LLC","76102-030","HISTAMINE DIHYDROCHLORIDE","HISTAMINE DIHYDROCHLORIDE","HUMAN OTC DRUG","07/08/2019","N/A","OTC MONOGRAPH DRUG","56.7 g in 1 JAR (76102-030-02)","N/A","N/A","No","12/31/2024"
"bareMinerals Complexion Rescue Broad Spectrum SPF 30","98132-755-01","62 mg/mL","LIQUID","TOPICAL","M020","Orveon Global US, LLC","98132-755","Titanium Dioxide","TITANIUM DIOXIDE","HUMAN OTC DRUG","01/01/2015","N/A","OTC MONOGRAPH DRUG","1 TUBE in 1 BOX (98132-755-01)  / 35 mL in 1 TUBE","N/A","N/A","No","12/31/2024"
"bareMinerals Complexion Rescue Tinted Hydrating Broad Spectrum SPF 30","98132-280-10","62 mg/mL","GEL","TOPICAL","M020","Orveon Global US LLC","98132-280","Titanium Dioxide","TITANIUM DIOXIDE","HUMAN OTC DRUG","12/01/2019","N/A","OTC MONOGRAPH DRUG","1 BOTTLE in 1 BOX (98132-280-10)  / 35 mL in 1 BOTTLE","N/A","N/A","No","12/31/2024"
"bareMinerals Complexion Rescue Tinted Hydrating Broad Spectrum SPF 30","98132-281-10","62 mg/mL","GEL","TOPICAL","M020","Orveon Global US LLC","98132-281","Titanium Dioxide","TITANIUM DIOXIDE","HUMAN OTC DRUG","12/01/2019","N/A","OTC MONOGRAPH DRUG","1 BOTTLE in 1 BOX (98132-281-10)  / 35 mL in 1 BOTTLE","N/A","N/A","No","12/31/2024"
"bareMinerals Complexion Rescue Tinted Hydrating Broad Spectrum SPF 30","98132-282-10","62 mg/mL","GEL","TOPICAL","M020","Orveon Global US LLC","98132-282","Titanium Dioxide","TITANIUM DIOXIDE","HUMAN OTC DRUG","12/01/2019","N/A","OTC MONOGRAPH DRUG","1 BOTTLE in 1 BOX (98132-282-10)  / 35 mL in 1 BOTTLE","N/A","N/A","No","12/31/2024"
"bareMinerals Multi-Tasking SPF 20 Concealer","98132-007-02","400 mg/2g,                         400  mg/2g","POWDER","TOPICAL","M020","Orveon Global US LLC","98132-007","Titanium Dioxide and Zinc Oxide","TITANIUM DIOXIDE;  ZINC OXIDE","HUMAN OTC DRUG","08/01/2021","N/A","OTC MONOGRAPH DRUG","2 g in 1 JAR (98132-007-02)","N/A","N/A","No","12/31/2024"
"bareMinerals Original Foundation Broad Spectrum SPF 15","98132-009-08","2000 mg/8g","POWDER","TOPICAL","M020","Orveon Global US LLC","98132-009","TITANIUM DIOXIDE","TITANIUM DIOXIDE","HUMAN OTC DRUG","08/01/2021","N/A","OTC MONOGRAPH DRUG","8 g in 1 JAR (98132-009-08)","N/A","N/A","No","12/31/2024"
"bareMinerals Original Foundation Broad Spectrum SPF 15","98132-013-08","777 mg/8g,                         1600  mg/8g","POWDER","TOPICAL","M020","Orveon Global US LLC","98132-013","TITANIUM DIOXIDE and ZINC OXIDE","TITANIUM DIOXIDE;  ZINC OXIDE","HUMAN OTC DRUG","08/01/2021","N/A","OTC MONOGRAPH DRUG","8 g in 1 JAR (98132-013-08)","N/A","N/A","No","12/31/2024"
"bareMinerals Original Foundation Broad Spectrum SPF 15","98132-023-08","2000 mg/8g","POWDER","TOPICAL","M020","Orveon Global US LLC","98132-023","TITANIUM DIOXIDE","TITANIUM DIOXIDE","HUMAN OTC DRUG","08/01/2021","N/A","OTC MONOGRAPH DRUG","8 g in 1 JAR (98132-023-08)","N/A","N/A","No","12/31/2024"
"bareMinerals Original Foundation Broad Spectrum SPF 15","98132-899-02","25 g/100g","POWDER","TOPICAL","M020","Orveon Global US LLC","98132-899","Titanium Dioxide","TITANIUM DIOXIDE","HUMAN OTC DRUG","02/01/2017","N/A","OTC MONOGRAPH DRUG","2 g in 1 JAR (98132-899-02)","N/A","N/A","No","12/31/2024"
"bareMinerals Original Foundation Broad Spectrum SPF 15","98132-899-08","25 g/100g","POWDER","TOPICAL","M020","Orveon Global US LLC","98132-899","Titanium Dioxide","TITANIUM DIOXIDE","HUMAN OTC DRUG","02/01/2017","N/A","OTC MONOGRAPH DRUG","8 g in 1 JAR (98132-899-08)","N/A","N/A","No","12/31/2024"
"bareMinerals Original Foundation Broad Spectrum SPF 15","98132-899-75","25 g/100g","POWDER","TOPICAL","M020","Orveon Global US LLC","98132-899","Titanium Dioxide","TITANIUM DIOXIDE","HUMAN OTC DRUG","02/01/2017","N/A","OTC MONOGRAPH DRUG",".75 g in 1 JAR (98132-899-75)","N/A","N/A","No","12/31/2024"
"bareMinerals ORIGINAL Liquid Mineral Foundation Broad Spectrum SPF 20 Sunscreen","98132-044-10",".747 mg/mL","LIQUID","TOPICAL","M020","Orveon Global US, LLC","98132-044","Titanium Dioxide","TITANIUM DIOXIDE","HUMAN OTC DRUG","12/23/2022","N/A","OTC MONOGRAPH DRUG","1 TUBE in 1 BOX (98132-044-10)  / 30 mL in 1 TUBE","N/A","N/A","No","12/31/2024"
"Benzonatate","68071-1395-3","200 mg/1","CAPSULE","ORAL","ANDA206948","NuCare Pharmaceuticals,Inc.","68071-1395","Benzonatate","BENZONATATE","HUMAN PRESCRIPTION DRUG","10/04/2019","N/A","ANDA","30 CAPSULE in 1 BOTTLE (68071-1395-3)","Decreased Tracheobronchial Stretch Receptor Activity [PE],  Non-narcotic Antitussive [EPC]","N/A","No","12/31/2024"
"Benzonatate","68071-1395-5","200 mg/1","CAPSULE","ORAL","ANDA206948","NuCare Pharmaceuticals,Inc.","68071-1395","Benzonatate","BENZONATATE","HUMAN PRESCRIPTION DRUG","10/04/2019","N/A","ANDA","45 CAPSULE in 1 BOTTLE (68071-1395-5)","Decreased Tracheobronchial Stretch Receptor Activity [PE],  Non-narcotic Antitussive [EPC]","N/A","No","12/31/2024"
"Benztropine Mesylate","70518-0132-1","1 mg/1","TABLET","ORAL","ANDA040742","REMEDYREPACK INC.","70518-0132","benztropine mesylate","BENZTROPINE MESYLATE","HUMAN PRESCRIPTION DRUG","06/08/2023","N/A","ANDA","30 TABLET in 1 BLISTER PACK (70518-0132-1)","Anticholinergic [EPC],  Antihistamine [EPC],  Cholinergic Antagonists [MoA],  Histamine Receptor Antagonists [MoA]","N/A","No","12/31/2025"
"Berry Breezer Throat Drops","55910-073-40","7 mg/1","LOZENGE","ORAL","M012","Dollar General Corporation","55910-073","Pectin","PECTIN","HUMAN OTC DRUG","03/22/2016","N/A","OTC MONOGRAPH DRUG","40 LOZENGE in 1 BAG (55910-073-40)","N/A","N/A","No","12/31/2024"
"Betaloan SUIK","80425-0347-1","3 mg/mL,                         3  mg/mL","INJECTION, SUSPENSION","INTRA-ARTICULAR; INTRALESIONAL; INTRAMUSCULAR","","Advanced Rx Pharmacy of Tennessee, LLC","80425-0347","Betamethasone Sodium Phosphate and Betamethasone Acetate","BETAMETHASONE ACETATE;  BETAMETHASONE SODIUM PHOSPHATE","HUMAN PRESCRIPTION DRUG","07/26/2023","N/A","UNAPPROVED DRUG OTHER","1 VIAL, MULTI-DOSE in 1 CARTON (80425-0347-1)  / 5 mL in 1 VIAL, MULTI-DOSE","Corticosteroid Hormone Receptor Agonists [MoA],  Corticosteroid Hormone Receptor Agonists [MoA],  Corticosteroid [EPC],  Corticosteroid [EPC]","N/A","No","12/31/2024"
"Betamethasone Valerate","53002-9210-1","1 mg/g","CREAM","TOPICAL","NDA018861","RPK Pharmaceuticals, Inc.","53002-9210","betamethasone valerate","BETAMETHASONE VALERATE","HUMAN PRESCRIPTION DRUG","10/01/2018","N/A","NDA","15 g in 1 TUBE (53002-9210-1)","Corticosteroid Hormone Receptor Agonists [MoA],  Corticosteroid [EPC]","N/A","No","12/31/2024"
"Bisoprolol Fumarate and Hydrochlorothiazide","42799-920-01","2.5 mg/1,                         6.25  mg/1","TABLET, FILM COATED","ORAL","ANDA212678","Edenbridge Pharmaceuticals LLC.","42799-920","Bisoprolol Fumarate and Hydrochlorothiazide","BISOPROLOL FUMARATE;  HYDROCHLOROTHIAZIDE","HUMAN PRESCRIPTION DRUG","04/30/2019","N/A","ANDA","100 TABLET, FILM COATED in 1 BOTTLE (42799-920-01)","Adrenergic beta-Antagonists [MoA],  Increased Diuresis [PE],  Thiazide Diuretic [EPC],  Thiazides [CS],  beta-Adrenergic Blocker [EPC]","N/A","No","12/31/2025"
"Bisoprolol Fumarate and Hydrochlorothiazide","42799-920-02","2.5 mg/1,                         6.25  mg/1","TABLET, FILM COATED","ORAL","ANDA212678","Edenbridge Pharmaceuticals LLC.","42799-920","Bisoprolol Fumarate and Hydrochlorothiazide","BISOPROLOL FUMARATE;  HYDROCHLOROTHIAZIDE","HUMAN PRESCRIPTION DRUG","04/30/2019","N/A","ANDA","500 TABLET, FILM COATED in 1 BOTTLE (42799-920-02)","Adrenergic beta-Antagonists [MoA],  Increased Diuresis [PE],  Thiazide Diuretic [EPC],  Thiazides [CS],  beta-Adrenergic Blocker [EPC]","N/A","No","12/31/2025"
"Bisoprolol Fumarate and Hydrochlorothiazide","42799-920-30","2.5 mg/1,                         6.25  mg/1","TABLET, FILM COATED","ORAL","ANDA212678","Edenbridge Pharmaceuticals LLC.","42799-920","Bisoprolol Fumarate and Hydrochlorothiazide","BISOPROLOL FUMARATE;  HYDROCHLOROTHIAZIDE","HUMAN PRESCRIPTION DRUG","04/30/2019","N/A","ANDA","30 TABLET, FILM COATED in 1 BOTTLE (42799-920-30)","Adrenergic beta-Antagonists [MoA],  Increased Diuresis [PE],  Thiazide Diuretic [EPC],  Thiazides [CS],  beta-Adrenergic Blocker [EPC]","N/A","No","12/31/2025"
"Black Girl Sunscreen","58443-0629-3","28.5 mg/mL,                         95  mg/mL,                         47.5  mg/mL,                         95  mg/mL","GEL","TOPICAL","M020","Prime Enterprises, Inc.","58443-0629","Avobenzone, Homosalate, Octisalate, Octocrylene","AVOBENZONE;  HOMOSALATE;  OCTISALATE;  OCTOCRYLENE","HUMAN OTC DRUG","08/04/2023","N/A","OTC MONOGRAPH FINAL","50 mL in 1 TUBE (58443-0629-3)","N/A","N/A","No","12/31/2024"
"Black Girl Sunscreen","58443-0632-2","26.7 mg/mL,                         40.05  mg/mL,                         44.5  mg/mL,                         80.1  mg/mL","GEL","TOPICAL","M020","Prime Enterprises","58443-0632","Octocrylene, Octisalate, Homosalate, Avobenzone","AVOBENZONE;  HOMOSALATE;  OCTISALATE;  OCTOCRYLENE","HUMAN OTC DRUG","08/04/2023","N/A","OTC MONOGRAPH FINAL","4 mL in 1 BOTTLE, WITH APPLICATOR (58443-0632-2)","N/A","N/A","No","12/31/2024"
"Black Girl Sunscreen","58443-0639-3","29.4 mg/mL,                         98  mg/mL,                         49  mg/mL,                         26.95  mg/mL","LOTION","TOPICAL","M020","Prime Enterprises Inc.","58443-0639","Avobenzone, Homosalate, Octisalate, and Octocrylene","AVOBENZONE;  HOMOSALATE;  OCTISALATE;  OCTOCRYLENE","HUMAN OTC DRUG","08/04/2023","N/A","OTC MONOGRAPH FINAL","59 mL in 1 TUBE (58443-0639-3)","N/A","N/A","No","12/31/2024"
"BODY ACTION PRODUCTS Endless Love for Men","70742-284-00","50 mg/mL","GEL","TOPICAL","M017","PRODUCT MAX GROUP INC","70742-284","BENZOCAINE","BENZOCAINE","HUMAN OTC DRUG","04/29/2022","N/A","OTC MONOGRAPH DRUG","50 mL in 1 BOTTLE (70742-284-00)","Allergens [CS],  Cell-mediated Immunity [PE],  Increased Histamine Release [PE],  Standardized Chemical Allergen [EPC]","N/A","No","12/31/2024"
"BODY ACTION PRODUCTS Higher Control Male Climax","70742-292-00","50 mg/mL","GEL","TOPICAL","M017","PRODUCT MAX GROUP INC","70742-292","BENZOCAINE","BENZOCAINE","HUMAN OTC DRUG","04/29/2022","N/A","OTC MONOGRAPH DRUG","60 mL in 1 BOTTLE (70742-292-00)","Allergens [CS],  Cell-mediated Immunity [PE],  Increased Histamine Release [PE],  Standardized Chemical Allergen [EPC]","N/A","No","12/31/2024"
"Bosley MD Regular Strength for Women","69113-001-01","2 g/100mL","SOLUTION","TOPICAL","ANDA078176","Scientific Hair Research, LLC","69113-001","Minoxidil 2%","MINOXIDIL","HUMAN OTC DRUG","05/21/2020","N/A","ANDA","2 BOTTLE in 1 BOX (69113-001-01)  / 60 mL in 1 BOTTLE","Arteriolar Vasodilation [PE],  Arteriolar Vasodilator [EPC]","N/A","No","12/31/2025"
"Brazilian Booty Cream","84037-0004-1","30 mg/mL","CREAM","TOPICAL","M016","YH CONSULTING LIMITED","84037-0004","Dimethicone","DIMETHICONE","HUMAN OTC DRUG","01/22/2024","N/A","OTC MONOGRAPH DRUG","55 mL in 1 BOTTLE (84037-0004-1)","Skin Barrier Activity [PE]","N/A","No","12/31/2025"
"Bronkaid","69536-250-24","25 mg/1","TABLET, COATED","ORAL","M012","Foundation Consumer Healthcare LLC","69536-250","EPHEDRINE SULFATE","EPHEDRINE SULFATE","HUMAN OTC DRUG","09/01/2020","N/A","OTC MONOGRAPH DRUG","4 BLISTER PACK in 1 CARTON (69536-250-24)  / 6 TABLET, COATED in 1 BLISTER PACK","Adrenergic alpha-Agonists [MoA],  Adrenergic beta-Agonists [MoA],  Increased Norepinephrine Activity [PE],  Norepinephrine Releasing Agent [EPC],  alpha-Adrenergic Agonist [EPC],  beta-Adrenergic Agonist [EPC]","N/A","No","12/31/2025"
"Bronkaid","69536-250-60","25 mg/1","TABLET, COATED","ORAL","M012","Foundation Consumer Healthcare LLC","69536-250","EPHEDRINE SULFATE","EPHEDRINE SULFATE","HUMAN OTC DRUG","09/01/2020","N/A","OTC MONOGRAPH DRUG","5 BLISTER PACK in 1 CARTON (69536-250-60)  / 12 TABLET, COATED in 1 BLISTER PACK","Adrenergic alpha-Agonists [MoA],  Adrenergic beta-Agonists [MoA],  Increased Norepinephrine Activity [PE],  Norepinephrine Releasing Agent [EPC],  alpha-Adrenergic Agonist [EPC],  beta-Adrenergic Agonist [EPC]","N/A","No","12/31/2025"
"Bumetanide","72572-040-10",".25 mg/mL","INJECTION","INTRAMUSCULAR; INTRAVENOUS","ANDA079196","Civica, Inc.","72572-040","Bumetanide","BUMETANIDE","HUMAN PRESCRIPTION DRUG","03/07/2022","N/A","ANDA","10 VIAL in 1 CARTON (72572-040-10)  / 4 mL in 1 VIAL (72572-040-01)","Increased Diuresis at Loop of Henle [PE],  Loop Diuretic [EPC]","N/A","No","12/31/2024"
"BZK Antiseptic Wipe","59050-262-01","1.3 mg/g","CLOTH","TOPICAL","505G(a)(3)","Changzhou Maokang Medical Products Co., Ltd","59050-262","BENZALKONIUM CHLORIDE","BENZALKONIUM CHLORIDE","HUMAN OTC DRUG","11/30/2021","N/A","OTC MONOGRAPH DRUG","1 PATCH in 1 POUCH (59050-262-01)  / .34 g in 1 PATCH","N/A","N/A","No","12/31/2024"
"Caffeine Citrate Oral Solution","72485-110-10","60 mg/3mL","SOLUTION","ORAL","ANDA213202","Armas Pharmaceuticals Inc.","72485-110","Caffeine Citrate","CAFFEINE CITRATE","HUMAN PRESCRIPTION DRUG","03/01/2020","N/A","ANDA","10 VIAL, SINGLE-DOSE in 1 BOX (72485-110-10)  / 3 mL in 1 VIAL, SINGLE-DOSE","Central Nervous System Stimulant [EPC],  Central Nervous System Stimulation [PE],  Methylxanthine [EPC],  Xanthines [CS]","N/A","No","12/31/2024"
"CALC FLUOR 6X","54973-4087-1","6 [hp_X]/1","TABLET, SOLUBLE","ORAL","","Hyland's Inc.","54973-4087","CALCIUM FLUORIDE","CALCIUM FLUORIDE","HUMAN OTC DRUG","12/06/2021","N/A","UNAPPROVED HOMEOPATHIC","1 BOTTLE, PLASTIC in 1 CARTON (54973-4087-1)  / 100 TABLET, SOLUBLE in 1 BOTTLE, PLASTIC","N/A","N/A","No","12/31/2025"
"Calcium Gluconate","65219-164-50","20 mg/mL","INJECTION, SOLUTION","INTRAVENOUS","NDA208418","Fresenius Kabi USA, LLC","65219-164","Calcium Gluconate","CALCIUM GLUCONATE MONOHYDRATE","HUMAN PRESCRIPTION DRUG","06/17/2021","N/A","NDA","24 BAG in 1 CASE (65219-164-50)  / 100 mL in 1 BAG (65219-164-01)","Blood Coagulation Factor [EPC],  Calcium [CS],  Cations,  Divalent [CS],  Increased Coagulation Factor Activity [PE],  Phosphate Binder [EPC],  Phosphate Chelating Activity [MoA]","N/A","No","12/31/2024"
"Calcium Polycarbophil","69842-846-02","625 mg/1","TABLET, FILM COATED","ORAL","M007","CVS Pharmacy, Inc","69842-846","Calcium Polycarbophil","CALCIUM POLYCARBOPHIL","HUMAN OTC DRUG","05/17/2021","N/A","OTC MONOGRAPH DRUG","250 TABLET, FILM COATED in 1 BOTTLE (69842-846-02)","N/A","N/A","No","12/31/2024"
"Camptosar","0009-7529-03","20 mg/mL","INJECTION, SOLUTION","INTRAVENOUS","NDA020571","Pharmacia & Upjohn Company LLC","0009-7529","irinotecan hydrochloride","IRINOTECAN HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","06/14/1996","N/A","NDA","1 VIAL, SINGLE-DOSE in 1 CARTON (0009-7529-03)  / 5 mL in 1 VIAL, SINGLE-DOSE","Topoisomerase Inhibitor [EPC],  Topoisomerase Inhibitors [MoA]","N/A","No","12/31/2024"
"Camptosar","0009-7529-04","20 mg/mL","INJECTION, SOLUTION","INTRAVENOUS","NDA020571","Pharmacia & Upjohn Company LLC","0009-7529","irinotecan hydrochloride","IRINOTECAN HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","06/14/1996","N/A","NDA","1 VIAL, SINGLE-DOSE in 1 CARTON (0009-7529-04)  / 2 mL in 1 VIAL, SINGLE-DOSE","Topoisomerase Inhibitor [EPC],  Topoisomerase Inhibitors [MoA]","N/A","No","12/31/2024"
"Camptosar","0009-7529-05","20 mg/mL","INJECTION, SOLUTION","INTRAVENOUS","NDA020571","Pharmacia & Upjohn Company LLC","0009-7529","irinotecan hydrochloride","IRINOTECAN HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","06/14/1996","N/A","NDA","1 VIAL, SINGLE-DOSE in 1 CARTON (0009-7529-05)  / 15 mL in 1 VIAL, SINGLE-DOSE","Topoisomerase Inhibitor [EPC],  Topoisomerase Inhibitors [MoA]","N/A","No","12/31/2024"
"CANAFARMA Spot On Acne Treatment Cleanser","80818-245-04","10 mg/mL","CREAM","TOPICAL","M006","Canafarma Corp.","80818-245","SALICYLIC ACID","SALICYLIC ACID","HUMAN OTC DRUG","10/01/2020","N/A","OTC MONOGRAPH DRUG","118.29 mL in 1 TUBE (80818-245-04)","N/A","N/A","No","12/31/2024"
"Candesartan cilexetil","62559-687-99","8 mg/1","TABLET","ORAL","NDA020838","ANI Pharmaceuticals, Inc.","62559-687","Candesartan cilexetil","CANDESARTAN CILEXETIL","HUMAN PRESCRIPTION DRUG","03/15/2024","N/A","NDA AUTHORIZED GENERIC","50000 TABLET in 1 BOX (62559-687-99)","Angiotensin 2 Receptor Antagonists [MoA],  Angiotensin 2 Receptor Blocker [EPC]","N/A","No","12/31/2025"
"Candesartan cilexetil","62559-689-98","32 mg/1","TABLET","ORAL","NDA020838","ANI Pharmaceuticals, Inc.","62559-689","Candesartan cilexetil","CANDESARTAN CILEXETIL","HUMAN PRESCRIPTION DRUG","03/15/2024","N/A","NDA AUTHORIZED GENERIC","25000 TABLET in 1 BOX (62559-689-98)","Angiotensin 2 Receptor Antagonists [MoA],  Angiotensin 2 Receptor Blocker [EPC]","N/A","No","12/31/2025"
"Carbidopa and levodopa","0228-2538-50","10 mg/1,                         100  mg/1","TABLET","ORAL","ANDA074260","Actavis Pharma, Inc.","0228-2538","Carbidopa and levodopa","CARBIDOPA;  LEVODOPA","HUMAN PRESCRIPTION DRUG","09/01/1993","09/30/2024","ANDA","500 TABLET in 1 BOTTLE (0228-2538-50)","Amino Acids,  Aromatic [CS],  Aromatic Amino Acid [EPC]","N/A","No","N/A"
"Carbidopa and levodopa","0228-2539-10","25 mg/1,                         100  mg/1","TABLET","ORAL","ANDA074260","Actavis Pharma, Inc.","0228-2539","Carbidopa and levodopa","CARBIDOPA;  LEVODOPA","HUMAN PRESCRIPTION DRUG","09/01/1993","10/31/2024","ANDA","100 TABLET in 1 BOTTLE (0228-2539-10)","Amino Acids,  Aromatic [CS],  Aromatic Amino Acid [EPC]","N/A","No","N/A"
"Carbidopa and levodopa","0228-2539-50","25 mg/1,                         100  mg/1","TABLET","ORAL","ANDA074260","Actavis Pharma, Inc.","0228-2539","Carbidopa and levodopa","CARBIDOPA;  LEVODOPA","HUMAN PRESCRIPTION DRUG","09/01/1993","11/30/2024","ANDA","500 TABLET in 1 BOTTLE (0228-2539-50)","Amino Acids,  Aromatic [CS],  Aromatic Amino Acid [EPC]","N/A","No","N/A"
"Carbidopa and levodopa","0228-2539-96","25 mg/1,                         100  mg/1","TABLET","ORAL","ANDA074260","Actavis Pharma, Inc.","0228-2539","Carbidopa and levodopa","CARBIDOPA;  LEVODOPA","HUMAN PRESCRIPTION DRUG","09/01/1993","10/31/2024","ANDA","1000 TABLET in 1 BOTTLE (0228-2539-96)","Amino Acids,  Aromatic [CS],  Aromatic Amino Acid [EPC]","N/A","No","N/A"
"Carbidopa and levodopa","0228-2540-10","25 mg/1,                         250  mg/1","TABLET","ORAL","ANDA074260","Actavis Pharma, Inc.","0228-2540","Carbidopa and levodopa","CARBIDOPA;  LEVODOPA","HUMAN PRESCRIPTION DRUG","09/01/1993","05/31/2026","ANDA","100 TABLET in 1 BOTTLE (0228-2540-10)","Amino Acids,  Aromatic [CS],  Aromatic Amino Acid [EPC]","N/A","No","N/A"
"Carbidopa and levodopa","0228-2540-50","25 mg/1,                         250  mg/1","TABLET","ORAL","ANDA074260","Actavis Pharma, Inc.","0228-2540","Carbidopa and levodopa","CARBIDOPA;  LEVODOPA","HUMAN PRESCRIPTION DRUG","09/01/1993","03/31/2026","ANDA","500 TABLET in 1 BOTTLE (0228-2540-50)","Amino Acids,  Aromatic [CS],  Aromatic Amino Acid [EPC]","N/A","No","N/A"
"Carbidopa and levodopa","0228-2540-96","25 mg/1,                         250  mg/1","TABLET","ORAL","ANDA074260","Actavis Pharma, Inc.","0228-2540","Carbidopa and levodopa","CARBIDOPA;  LEVODOPA","HUMAN PRESCRIPTION DRUG","09/01/1993","05/31/2026","ANDA","1000 TABLET in 1 BOTTLE (0228-2540-96)","Amino Acids,  Aromatic [CS],  Aromatic Amino Acid [EPC]","N/A","No","N/A"
"Carboprost Tromethamine","43598-698-58","250 ug/mL","INJECTION, SOLUTION","INTRAMUSCULAR","ANDA211941","Dr. Reddy's Laboratories Inc.","43598-698","Carboprost Tromethamine","CARBOPROST TROMETHAMINE","HUMAN PRESCRIPTION DRUG","07/02/2019","N/A","ANDA","10 VIAL, SINGLE-DOSE in 1 CARTON (43598-698-58)  / 1 mL in 1 VIAL, SINGLE-DOSE (43598-698-11)","Prostaglandin Analog [EPC],  Prostaglandins [CS]","N/A","No","12/31/2025"
"carboxymethylcellulose sodium","50268-067-30","5 mg/mL","SOLUTION/ DROPS","OPHTHALMIC","M018","AvPAK","50268-067","carboxymethylcellulose sodium","CARBOXYMETHYLCELLULOSE SODIUM","HUMAN OTC DRUG","11/19/2020","N/A","OTC MONOGRAPH DRUG","30 VIAL, SINGLE-USE in 1 CARTON (50268-067-30)  / .4 mL in 1 VIAL, SINGLE-USE","N/A","N/A","No","12/31/2025"
"carboxymethylcellulose sodium","50268-067-50","5 mg/mL","SOLUTION/ DROPS","OPHTHALMIC","M018","AvPAK","50268-067","carboxymethylcellulose sodium","CARBOXYMETHYLCELLULOSE SODIUM","HUMAN OTC DRUG","11/19/2020","N/A","OTC MONOGRAPH DRUG","50 VIAL, SINGLE-USE in 1 CARTON (50268-067-50)  / .4 mL in 1 VIAL, SINGLE-USE","N/A","N/A","No","12/31/2025"
"carboxymethylcellulose sodium","50268-067-70","5 mg/mL","SOLUTION/ DROPS","OPHTHALMIC","M018","AvPAK","50268-067","carboxymethylcellulose sodium","CARBOXYMETHYLCELLULOSE SODIUM","HUMAN OTC DRUG","11/19/2020","N/A","OTC MONOGRAPH DRUG","70 VIAL, SINGLE-USE in 1 CARTON (50268-067-70)  / .4 mL in 1 VIAL, SINGLE-USE","N/A","N/A","No","12/31/2025"
"careone childrens ibuprofen","41520-633-62","100 mg/1","TABLET, CHEWABLE","ORAL","ANDA076359","American Sales Company","41520-633","ibuprofen","IBUPROFEN","HUMAN OTC DRUG","07/08/2019","N/A","ANDA","1 BOTTLE in 1 CARTON (41520-633-62)  / 24 TABLET, CHEWABLE in 1 BOTTLE","Anti-Inflammatory Agents,  Non-Steroidal [CS],  Cyclooxygenase Inhibitors [MoA],  Nonsteroidal Anti-inflammatory Drug [EPC]","N/A","No","12/31/2024"
"Carvedilol","70518-0123-0","6.25 mg/1","TABLET, FILM COATED","ORAL","ANDA078332","REMEDYREPACK INC.","70518-0123","Carvedilol","CARVEDILOL","HUMAN PRESCRIPTION DRUG","01/13/2017","N/A","ANDA","30 TABLET, FILM COATED in 1 BLISTER PACK (70518-0123-0)","Adrenergic alpha-Antagonists [MoA],  Adrenergic beta1-Antagonists [MoA],  Adrenergic beta2-Antagonists [MoA],  alpha-Adrenergic Blocker [EPC],  beta-Adrenergic Blocker [EPC]","N/A","No","12/31/2025"
"Carvedilol","53002-2572-0","3.125 mg/1","TABLET, FILM COATED","ORAL","ANDA076373","RPK Pharmaceuticals, Inc.","53002-2572","Carvedilol","CARVEDILOL","HUMAN PRESCRIPTION DRUG","01/01/2024","N/A","ANDA","100 TABLET, FILM COATED in 1 BOTTLE (53002-2572-0)","Adrenergic alpha-Antagonists [MoA],  Adrenergic beta1-Antagonists [MoA],  Adrenergic beta2-Antagonists [MoA],  alpha-Adrenergic Blocker [EPC],  beta-Adrenergic Blocker [EPC]","N/A","No","12/31/2025"
"Carvedilol","53002-2572-3","3.125 mg/1","TABLET, FILM COATED","ORAL","ANDA076373","RPK Pharmaceuticals, Inc.","53002-2572","Carvedilol","CARVEDILOL","HUMAN PRESCRIPTION DRUG","01/01/2024","N/A","ANDA","30 TABLET, FILM COATED in 1 BOTTLE (53002-2572-3)","Adrenergic alpha-Antagonists [MoA],  Adrenergic beta1-Antagonists [MoA],  Adrenergic beta2-Antagonists [MoA],  alpha-Adrenergic Blocker [EPC],  beta-Adrenergic Blocker [EPC]","N/A","No","12/31/2025"
"Carvedilol","53002-2573-0","12.5 mg/1","TABLET, FILM COATED","ORAL","ANDA076373","RPK Pharmaceuticals, Inc.","53002-2573","Carvedilol","CARVEDILOL","HUMAN PRESCRIPTION DRUG","01/01/2024","N/A","ANDA","100 TABLET, FILM COATED in 1 BOTTLE (53002-2573-0)","Adrenergic alpha-Antagonists [MoA],  Adrenergic beta1-Antagonists [MoA],  Adrenergic beta2-Antagonists [MoA],  alpha-Adrenergic Blocker [EPC],  beta-Adrenergic Blocker [EPC]","N/A","No","12/31/2025"
"Carvedilol","53002-2573-3","12.5 mg/1","TABLET, FILM COATED","ORAL","ANDA076373","RPK Pharmaceuticals, Inc.","53002-2573","Carvedilol","CARVEDILOL","HUMAN PRESCRIPTION DRUG","01/01/2024","N/A","ANDA","30 TABLET, FILM COATED in 1 BOTTLE (53002-2573-3)","Adrenergic alpha-Antagonists [MoA],  Adrenergic beta1-Antagonists [MoA],  Adrenergic beta2-Antagonists [MoA],  alpha-Adrenergic Blocker [EPC],  beta-Adrenergic Blocker [EPC]","N/A","No","12/31/2025"
"Carvedilol Phosphate","16714-227-01","10 mg/1","CAPSULE, EXTENDED RELEASE","ORAL","ANDA090132","NorthStar RxLLC","16714-227","Carvedilol Phosphate","CARVEDILOL PHOSPHATE","HUMAN PRESCRIPTION DRUG","07/22/2021","N/A","ANDA","30 CAPSULE, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (16714-227-01)","Adrenergic alpha-Antagonists [MoA],  Adrenergic beta1-Antagonists [MoA],  Adrenergic beta2-Antagonists [MoA],  alpha-Adrenergic Blocker [EPC],  beta-Adrenergic Blocker [EPC]","N/A","No","12/31/2025"
"Carvedilol Phosphate","16714-230-01","80 mg/1","CAPSULE, EXTENDED RELEASE","ORAL","ANDA090132","NorthStar RxLLC","16714-230","Carvedilol Phosphate","CARVEDILOL PHOSPHATE","HUMAN PRESCRIPTION DRUG","07/22/2021","N/A","ANDA","30 CAPSULE, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (16714-230-01)","Adrenergic alpha-Antagonists [MoA],  Adrenergic beta1-Antagonists [MoA],  Adrenergic beta2-Antagonists [MoA],  alpha-Adrenergic Blocker [EPC],  beta-Adrenergic Blocker [EPC]","N/A","No","12/31/2025"
"Cefadroxil","57237-096-50","500 mg/1","CAPSULE","ORAL","ANDA065352","Rising Pharma Holdings, Inc.","57237-096","Cefadroxil","CEFADROXIL","HUMAN PRESCRIPTION DRUG","01/25/2007","N/A","ANDA","50 CAPSULE in 1 BOTTLE (57237-096-50)","Cephalosporin Antibacterial [EPC],  Cephalosporins [CS]","N/A","No","12/31/2025"
"Cefadroxil","57237-096-01","500 mg/1","CAPSULE","ORAL","ANDA065352","Rising Pharma Holdings, Inc.","57237-096","Cefadroxil","CEFADROXIL","HUMAN PRESCRIPTION DRUG","01/25/2007","N/A","ANDA","100 CAPSULE in 1 BOTTLE (57237-096-01)","Cephalosporin Antibacterial [EPC],  Cephalosporins [CS]","N/A","No","12/31/2025"
"CHEEKY BONSAI Cramp Killer PAIN RELIEF PATCHES","81860-001-04","10 g/100g","PATCH","TOPICAL","M017","Ixxa, Inc.","81860-001","Menthol","MENTHOL, UNSPECIFIED FORM","HUMAN OTC DRUG","03/05/2024","N/A","OTC MONOGRAPH DRUG","4 PATCH in 1 POUCH (81860-001-04)  / .15 g in 1 PATCH","N/A","N/A","No","12/31/2025"
"CHEEKY BONSAI Cramp Killer PAIN RELIEF PATCHES","81860-001-24","10 g/100g","PATCH","TOPICAL","M017","Ixxa, Inc.","81860-001","Menthol","MENTHOL, UNSPECIFIED FORM","HUMAN OTC DRUG","03/05/2024","N/A","OTC MONOGRAPH DRUG","6 POUCH in 1 BOX (81860-001-24)  / 4 PATCH in 1 POUCH / .15 g in 1 PATCH","N/A","N/A","No","12/31/2025"
"Childrens Ibuprofen Oral Suspension","76281-128-24","100 mg/5mL","SUSPENSION","ORAL","ANDA210602","AptaPharma Inc.","76281-128","IBUPROFEN","IBUPROFEN","HUMAN OTC DRUG","11/01/2023","N/A","ANDA","1 BOTTLE in 1 CARTON (76281-128-24)  / 118 mL in 1 BOTTLE","Anti-Inflammatory Agents,  Non-Steroidal [CS],  Cyclooxygenase Inhibitors [MoA],  Nonsteroidal Anti-inflammatory Drug [EPC]","N/A","No","12/31/2024"
"Childrens Loratadine","68788-8266-1","5 mg/5mL","SOLUTION","ORAL","ANDA076805","Preferred Pharmaceuticals Inc.","68788-8266","Loratadine","LORATADINE","HUMAN OTC DRUG","09/23/2022","N/A","ANDA","1 BOTTLE in 1 CARTON (68788-8266-1)  / 120 mL in 1 BOTTLE","N/A","N/A","No","12/31/2024"
"Chlorpromazine Hydrochloride","68462-862-01","25 mg/1","TABLET, FILM COATED","ORAL","ANDA212144","Glenmark Pharmaceuticals Inc., USA","68462-862","Chlorpromazine Hydrochloride","CHLORPROMAZINE HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","03/23/2021","N/A","ANDA","100 TABLET, FILM COATED in 1 BOTTLE (68462-862-01)","Phenothiazine [EPC],  Phenothiazines [CS]","N/A","No","12/31/2025"
"Chlorpromazine Hydrochloride","68462-862-10","25 mg/1","TABLET, FILM COATED","ORAL","ANDA212144","Glenmark Pharmaceuticals Inc., USA","68462-862","Chlorpromazine Hydrochloride","CHLORPROMAZINE HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","03/23/2021","N/A","ANDA","1000 TABLET, FILM COATED in 1 BOTTLE (68462-862-10)","Phenothiazine [EPC],  Phenothiazines [CS]","N/A","No","12/31/2025"
"CHLORZOXAZONE","71335-2009-1","500 mg/1","TABLET","ORAL","ANDA089853","Bryant Ranch Prepack","71335-2009","CHLORZOXAZONE","CHLORZOXAZONE","HUMAN PRESCRIPTION DRUG","02/10/2022","N/A","ANDA","20 TABLET in 1 BOTTLE (71335-2009-1)","Centrally-mediated Muscle Relaxation [PE],  Muscle Relaxant [EPC]","N/A","No","12/31/2024"
"CHLORZOXAZONE","71335-2009-2","500 mg/1","TABLET","ORAL","ANDA089853","Bryant Ranch Prepack","71335-2009","CHLORZOXAZONE","CHLORZOXAZONE","HUMAN PRESCRIPTION DRUG","02/10/2022","N/A","ANDA","30 TABLET in 1 BOTTLE (71335-2009-2)","Centrally-mediated Muscle Relaxation [PE],  Muscle Relaxant [EPC]","N/A","No","12/31/2024"
"CHLORZOXAZONE","71335-2009-3","500 mg/1","TABLET","ORAL","ANDA089853","Bryant Ranch Prepack","71335-2009","CHLORZOXAZONE","CHLORZOXAZONE","HUMAN PRESCRIPTION DRUG","02/10/2022","N/A","ANDA","40 TABLET in 1 BOTTLE (71335-2009-3)","Centrally-mediated Muscle Relaxation [PE],  Muscle Relaxant [EPC]","N/A","No","12/31/2024"
"CHLORZOXAZONE","71335-2009-4","500 mg/1","TABLET","ORAL","ANDA089853","Bryant Ranch Prepack","71335-2009","CHLORZOXAZONE","CHLORZOXAZONE","HUMAN PRESCRIPTION DRUG","02/10/2022","N/A","ANDA","90 TABLET in 1 BOTTLE (71335-2009-4)","Centrally-mediated Muscle Relaxation [PE],  Muscle Relaxant [EPC]","N/A","No","12/31/2024"
"CHLORZOXAZONE","71335-2009-5","500 mg/1","TABLET","ORAL","ANDA089853","Bryant Ranch Prepack","71335-2009","CHLORZOXAZONE","CHLORZOXAZONE","HUMAN PRESCRIPTION DRUG","02/10/2022","N/A","ANDA","60 TABLET in 1 BOTTLE (71335-2009-5)","Centrally-mediated Muscle Relaxation [PE],  Muscle Relaxant [EPC]","N/A","No","12/31/2024"
"CHLORZOXAZONE","71335-2009-6","500 mg/1","TABLET","ORAL","ANDA089853","Bryant Ranch Prepack","71335-2009","CHLORZOXAZONE","CHLORZOXAZONE","HUMAN PRESCRIPTION DRUG","02/10/2022","N/A","ANDA","100 TABLET in 1 BOTTLE (71335-2009-6)","Centrally-mediated Muscle Relaxation [PE],  Muscle Relaxant [EPC]","N/A","No","12/31/2024"
"CHLORZOXAZONE","71335-2009-7","500 mg/1","TABLET","ORAL","ANDA089853","Bryant Ranch Prepack","71335-2009","CHLORZOXAZONE","CHLORZOXAZONE","HUMAN PRESCRIPTION DRUG","02/10/2022","N/A","ANDA","14 TABLET in 1 BOTTLE (71335-2009-7)","Centrally-mediated Muscle Relaxation [PE],  Muscle Relaxant [EPC]","N/A","No","12/31/2024"
"CHLORZOXAZONE","71335-2009-8","500 mg/1","TABLET","ORAL","ANDA089853","Bryant Ranch Prepack","71335-2009","CHLORZOXAZONE","CHLORZOXAZONE","HUMAN PRESCRIPTION DRUG","02/10/2022","N/A","ANDA","7 TABLET in 1 BOTTLE (71335-2009-8)","Centrally-mediated Muscle Relaxation [PE],  Muscle Relaxant [EPC]","N/A","No","12/31/2024"
"CHLORZOXAZONE","71335-2009-9","500 mg/1","TABLET","ORAL","ANDA089853","Bryant Ranch Prepack","71335-2009","CHLORZOXAZONE","CHLORZOXAZONE","HUMAN PRESCRIPTION DRUG","02/10/2022","N/A","ANDA","120 TABLET in 1 BOTTLE (71335-2009-9)","Centrally-mediated Muscle Relaxation [PE],  Muscle Relaxant [EPC]","N/A","No","12/31/2024"
"Cinnabar Dandelion","48951-3225-2","10 [hp_X]/1,                         3  [hp_X]/1,                         3  [hp_X]/1,                         20  [hp_X]/1,                         2  [hp_X]/1","PELLET","ORAL","","Uriel Pharmacy Inc.","48951-3225","Cinnabar Dandelion","CARBONATE ION;  ELYMUS REPENS ROOT;  FERROUS CATION;  MERCURIC CATION;  TARAXACUM OFFICINALE","HUMAN OTC DRUG","09/01/2009","N/A","UNAPPROVED HOMEOPATHIC","1350 PELLET in 1 BOTTLE, GLASS (48951-3225-2)","N/A","N/A","No","12/31/2025"
"CLARIFAST One Step Acne Treatment","82908-358-00","5 mg/mL","CREAM","TOPICAL","M006","VIREO SYSTEMS, INC.","82908-358","SALICYLIC ACID","SALICYLIC ACID","HUMAN OTC DRUG","08/08/2022","N/A","OTC MONOGRAPH DRUG","81.33 mL in 1 JAR (82908-358-00)","N/A","N/A","No","12/31/2024"
"Clear Future Mattifying Treatment","42508-311-06",".5 mg/50mL","LOTION","TOPICAL","part333D","Arbonne International, LLC","42508-311","SALICYLIC ACID","SALICYLIC ACID","HUMAN OTC DRUG","04/01/2015","N/A","OTC MONOGRAPH FINAL","1 TUBE in 1 CARTON (42508-311-06)  / 50 mL in 1 TUBE","N/A","N/A","No","12/31/2024"
"Clindamycin hydrochloride","50090-7006-0","150 mg/1","CAPSULE","ORAL","ANDA065061","A-S Medication Solutions","50090-7006","Clindamycin hydrochloride","CLINDAMYCIN HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","01/04/2024","N/A","ANDA","30 CAPSULE in 1 BOTTLE (50090-7006-0)","Decreased Sebaceous Gland Activity [PE],  Lincosamide Antibacterial [EPC],  Lincosamides [CS],  Neuromuscular Blockade [PE]","N/A","No","12/31/2025"
"Clindamycin hydrochloride","50090-7006-1","150 mg/1","CAPSULE","ORAL","ANDA065061","A-S Medication Solutions","50090-7006","Clindamycin hydrochloride","CLINDAMYCIN HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","01/04/2024","N/A","ANDA","15 CAPSULE in 1 BOTTLE (50090-7006-1)","Decreased Sebaceous Gland Activity [PE],  Lincosamide Antibacterial [EPC],  Lincosamides [CS],  Neuromuscular Blockade [PE]","N/A","No","12/31/2025"
"Clindamycin hydrochloride","50090-7006-3","150 mg/1","CAPSULE","ORAL","ANDA065061","A-S Medication Solutions","50090-7006","Clindamycin hydrochloride","CLINDAMYCIN HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","01/04/2024","N/A","ANDA","4 CAPSULE in 1 BOTTLE (50090-7006-3)","Decreased Sebaceous Gland Activity [PE],  Lincosamide Antibacterial [EPC],  Lincosamides [CS],  Neuromuscular Blockade [PE]","N/A","No","12/31/2025"
"Clindamycin hydrochloride","50090-7006-4","150 mg/1","CAPSULE","ORAL","ANDA065061","A-S Medication Solutions","50090-7006","Clindamycin hydrochloride","CLINDAMYCIN HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","01/04/2024","N/A","ANDA","100 CAPSULE in 1 BOTTLE (50090-7006-4)","Decreased Sebaceous Gland Activity [PE],  Lincosamide Antibacterial [EPC],  Lincosamides [CS],  Neuromuscular Blockade [PE]","N/A","No","12/31/2025"
"Clindamycin hydrochloride","50090-7006-6","150 mg/1","CAPSULE","ORAL","ANDA065061","A-S Medication Solutions","50090-7006","Clindamycin hydrochloride","CLINDAMYCIN HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","01/04/2024","N/A","ANDA","21 CAPSULE in 1 BOTTLE (50090-7006-6)","Decreased Sebaceous Gland Activity [PE],  Lincosamide Antibacterial [EPC],  Lincosamides [CS],  Neuromuscular Blockade [PE]","N/A","No","12/31/2025"
"Clindamycin hydrochloride","50090-7006-7","150 mg/1","CAPSULE","ORAL","ANDA065061","A-S Medication Solutions","50090-7006","Clindamycin hydrochloride","CLINDAMYCIN HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","01/04/2024","N/A","ANDA","42 CAPSULE in 1 BOTTLE (50090-7006-7)","Decreased Sebaceous Gland Activity [PE],  Lincosamide Antibacterial [EPC],  Lincosamides [CS],  Neuromuscular Blockade [PE]","N/A","No","12/31/2025"
"clindamycin palmitate hydrochloride","59762-0016-1","75 mg/5mL","SOLUTION","ORAL","ANDA062644","Greenstone LLC","59762-0016","clindamycin palmitate hydrochloride","CLINDAMYCIN PALMITATE HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","04/07/1986","N/A","ANDA","1 BOTTLE in 1 CARTON (59762-0016-1)  / 100 mL in 1 BOTTLE","Decreased Sebaceous Gland Activity [PE],  Lincosamide Antibacterial [EPC],  Lincosamides [CS],  Neuromuscular Blockade [PE]","N/A","No","12/31/2024"
"Clindamycin Phosphate","50090-5958-0","10 mg/g","GEL","TOPICAL","ANDA212438","A-S Medication Solutions","50090-5958","Clindamycin Phosphate USP, 1%","CLINDAMYCIN PHOSPHATE","HUMAN PRESCRIPTION DRUG","04/07/2022","N/A","ANDA","1 TUBE in 1 CARTON (50090-5958-0)  / 30 g in 1 TUBE","Decreased Sebaceous Gland Activity [PE],  Lincosamide Antibacterial [EPC],  Lincosamides [CS],  Neuromuscular Blockade [PE]","N/A","No","12/31/2025"
"Clomipramine Hydrochloride","59651-382-01","50 mg/1","CAPSULE","ORAL","ANDA216440","Aurobindo Pharma Limited","59651-382","Clomipramine Hydrochloride","CLOMIPRAMINE HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","03/20/2023","N/A","ANDA","100 CAPSULE in 1 BOTTLE (59651-382-01)","Tricyclic Antidepressant [EPC]","N/A","No","12/31/2024"
"Clomipramine Hydrochloride","59651-382-30","50 mg/1","CAPSULE","ORAL","ANDA216440","Aurobindo Pharma Limited","59651-382","Clomipramine Hydrochloride","CLOMIPRAMINE HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","03/20/2023","N/A","ANDA","30 CAPSULE in 1 BOTTLE (59651-382-30)","Tricyclic Antidepressant [EPC]","N/A","No","12/31/2024"
"Clomipramine Hydrochloride","59651-382-90","50 mg/1","CAPSULE","ORAL","ANDA216440","Aurobindo Pharma Limited","59651-382","Clomipramine Hydrochloride","CLOMIPRAMINE HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","03/20/2023","N/A","ANDA","90 CAPSULE in 1 BOTTLE (59651-382-90)","Tricyclic Antidepressant [EPC]","N/A","No","12/31/2024"
"CLOZAPINE","65862-847-05","200 mg/1","TABLET","ORAL","ANDA206433","Aurobindo Pharma Limited","65862-847","CLOZAPINE","CLOZAPINE","HUMAN PRESCRIPTION DRUG","11/29/2016","N/A","ANDA","500 TABLET in 1 BOTTLE (65862-847-05)","Atypical Antipsychotic [EPC]","N/A","No","12/31/2025"
"CLOZAPINE","65862-847-78","200 mg/1","TABLET","ORAL","ANDA206433","Aurobindo Pharma Limited","65862-847","CLOZAPINE","CLOZAPINE","HUMAN PRESCRIPTION DRUG","11/29/2016","N/A","ANDA","10 BLISTER PACK in 1 CARTON (65862-847-78)  / 10 TABLET in 1 BLISTER PACK (65862-847-10)","Atypical Antipsychotic [EPC]","N/A","No","12/31/2025"
"CLOZAPINE","65862-847-01","200 mg/1","TABLET","ORAL","ANDA206433","Aurobindo Pharma Limited","65862-847","CLOZAPINE","CLOZAPINE","HUMAN PRESCRIPTION DRUG","11/29/2016","N/A","ANDA","100 TABLET in 1 BOTTLE (65862-847-01)","Atypical Antipsychotic [EPC]","N/A","No","12/31/2025"
"COCO AND EVE DAILY RADIANCE PRIMER SPF 50","82931-002-50","3 g/100mL,                         8  g/100mL,                         5  g/100mL,                         6  g/100mL","LOTION","TOPICAL","part352","Supernova USA Inc.","82931-002","COCO AND EVE DAILY RADIANCE PRIMER SPF 50","AVOBENZONE;  HOMOSALATE;  OCTISALATE;  OCTOCRYLENE","HUMAN OTC DRUG","04/01/2023","N/A","OTC MONOGRAPH FINAL","1 BOTTLE, PUMP in 1 CARTON (82931-002-50)  / 50 mL in 1 BOTTLE, PUMP","N/A","N/A","No","12/31/2024"
"Colgate Total SF Whitening Gel","35000-175-66","1.1 mg/g","PASTE, DENTIFRICE","DENTAL","M021","Colgate-Palmolive Company","35000-175","Stannous Fluoride","STANNOUS FLUORIDE","HUMAN OTC DRUG","12/27/2021","N/A","OTC MONOGRAPH DRUG","1 TUBE in 1 CARTON (35000-175-66)  / 144 g in 1 TUBE","N/A","N/A","No","12/31/2025"
"Colgate Total SF Whitening Gel","35000-175-96","1.1 mg/g","PASTE, DENTIFRICE","DENTAL","M021","Colgate-Palmolive Company","35000-175","Stannous Fluoride","STANNOUS FLUORIDE","HUMAN OTC DRUG","11/01/2018","12/30/2024","OTC MONOGRAPH DRUG","2 TUBE in 1 CARTON (35000-175-96)  / 136 g in 1 TUBE","N/A","N/A","No","12/31/2025"
"Colgate Total SF Whitening Gel","35000-175-65","1.1 mg/g","PASTE, DENTIFRICE","DENTAL","M021","Colgate-Palmolive Company","35000-175","Stannous Fluoride","STANNOUS FLUORIDE","HUMAN OTC DRUG","12/01/2021","N/A","OTC MONOGRAPH DRUG","2 TUBE in 1 CARTON (35000-175-65)  / 144 g in 1 TUBE","N/A","N/A","No","12/31/2025"
"Colgate Total SF Whitening Gel","35000-175-60","1.1 mg/g","PASTE, DENTIFRICE","DENTAL","M021","Colgate-Palmolive Company","35000-175","Stannous Fluoride","STANNOUS FLUORIDE","HUMAN OTC DRUG","02/10/2021","N/A","OTC MONOGRAPH DRUG","1 TUBE in 1 CARTON (35000-175-60)  / 170 g in 1 TUBE","N/A","N/A","No","12/31/2025"
"Colgate Total SF Whitening Gel","35000-175-32","1.1 mg/g","PASTE, DENTIFRICE","DENTAL","M021","Colgate-Palmolive Company","35000-175","Stannous Fluoride","STANNOUS FLUORIDE","HUMAN OTC DRUG","11/01/2018","N/A","OTC MONOGRAPH DRUG","1 TUBE in 1 CARTON (35000-175-32)  / 93 g in 1 TUBE","N/A","N/A","No","12/31/2025"
"Colgate Total SF Whitening Gel","35000-175-48","1.1 mg/g","PASTE, DENTIFRICE","DENTAL","M021","Colgate-Palmolive Company","35000-175","Stannous Fluoride","STANNOUS FLUORIDE","HUMAN OTC DRUG","11/01/2018","12/30/2024","OTC MONOGRAPH DRUG","1 TUBE in 1 CARTON (35000-175-48)  / 136 g in 1 TUBE","N/A","N/A","No","12/31/2025"
"Colgate Total SF Whitening Gel","35000-175-78","1.1 mg/g","PASTE, DENTIFRICE","DENTAL","M021","Colgate-Palmolive Company","35000-175","Stannous Fluoride","STANNOUS FLUORIDE","HUMAN OTC DRUG","11/01/2018","12/30/2024","OTC MONOGRAPH DRUG","1 TUBE in 1 CARTON (35000-175-78)  / 221 g in 1 TUBE","N/A","N/A","No","12/31/2025"
"Colgate Total SF Whitening Gel","35000-175-95","1.1 mg/g","PASTE, DENTIFRICE","DENTAL","M021","Colgate-Palmolive Company","35000-175","Stannous Fluoride","STANNOUS FLUORIDE","HUMAN OTC DRUG","11/01/2018","12/30/2024","OTC MONOGRAPH DRUG","1 TUBE in 1 CARTON (35000-175-95)  / 178 g in 1 TUBE","N/A","N/A","No","12/31/2025"
"Cough Drops Dollar General Menthol 30ct","75712-033-01","5.4 mg/1","LOZENGE","ORAL","M012","Dollar General Corporation","75712-033","MENTHOL","LEVOMENTHOL","HUMAN OTC DRUG","03/15/2024","N/A","OTC MONOGRAPH DRUG","9 BAG in 1 CARTON (75712-033-01)  / 30 LOZENGE in 1 BAG","N/A","N/A","No","12/31/2025"
"Cream","61354-051-04","4.55 mg/100mg,                         3.5  mg/100mg","LOTION","TOPICAL","part352","OXYGEN DEVELOPMENT, LLC","61354-051","Titanium Dioxide, Zinc Oxide","TITANIUM DIOXIDE;  ZINC OXIDE","HUMAN OTC DRUG","02/22/2021","N/A","OTC MONOGRAPH FINAL","1 TUBE in 1 CARTON (61354-051-04)  / 30 mg in 1 TUBE","N/A","N/A","No","12/31/2024"
"Cream","61354-051-25","4.55 mg/100mg,                         3.5  mg/100mg","LOTION","TOPICAL","part352","OXYGEN DEVELOPMENT, LLC","61354-051","Titanium Dioxide, Zinc Oxide","TITANIUM DIOXIDE;  ZINC OXIDE","HUMAN OTC DRUG","02/22/2021","N/A","OTC MONOGRAPH FINAL","1 TUBE in 1 CARTON (61354-051-25)  / 30 mg in 1 TUBE","N/A","N/A","No","12/31/2024"
"Crest 3D White Stain Eraser","58933-879-23","1.5 mg/g","PASTE, DENTIFRICE","DENTAL","M021","Procter & Gamble Manufactura, S. de R.L. de C.V.","58933-879","Sodium Fluoride","SODIUM FLUORIDE","HUMAN OTC DRUG","07/04/2016","N/A","OTC MONOGRAPH DRUG","1 TUBE in 1 CARTON (58933-879-23)  / 65 g in 1 TUBE","N/A","N/A","No","12/31/2024"
"Crest Anti-Cavity","58933-470-03","1.5 mg/g","PASTE, DENTIFRICE","DENTAL","M021","Procter & Gamble Manufactura S de RL de CV","58933-470","SODIUM FLUORIDE","SODIUM FLUORIDE","HUMAN OTC DRUG","08/01/2008","N/A","OTC MONOGRAPH DRUG","1 TUBE in 1 CARTON (58933-470-03)  / 99 g in 1 TUBE","N/A","N/A","No","12/31/2024"
"Crest Cavity Protection","58933-005-04","1.5 mg/g","PASTE, DENTIFRICE","DENTAL","M021","Procter & Gamble Manufactura, S. de R.L. de C.V.","58933-005","Sodium Fluoride","SODIUM FLUORIDE","HUMAN OTC DRUG","02/01/2015","N/A","OTC MONOGRAPH DRUG","1 TUBE in 1 CARTON (58933-005-04)  / 181 g in 1 TUBE","N/A","N/A","No","12/31/2024"
"Crest Cavity Protection","58933-005-05","1.5 mg/g","PASTE, DENTIFRICE","DENTAL","M021","Procter & Gamble Manufactura, S. de R.L. de C.V.","58933-005","Sodium Fluoride","SODIUM FLUORIDE","HUMAN OTC DRUG","02/01/2015","N/A","OTC MONOGRAPH DRUG","1 TUBE in 1 CARTON (58933-005-05)  / 232 g in 1 TUBE","N/A","N/A","No","12/31/2024"
"Crest Cavity Protection","58933-005-08","1.5 mg/g","PASTE, DENTIFRICE","DENTAL","M021","Procter & Gamble Manufactura, S. de R.L. de C.V.","58933-005","Sodium Fluoride","SODIUM FLUORIDE","HUMAN OTC DRUG","02/01/2015","N/A","OTC MONOGRAPH DRUG","1 TUBE in 1 CARTON (58933-005-08)  / 24 g in 1 TUBE (58933-005-10)","N/A","N/A","No","12/31/2024"
"Crest Cavity Protection","58933-005-11","1.5 mg/g","PASTE, DENTIFRICE","DENTAL","M021","Procter & Gamble Manufactura, S. de R.L. de C.V.","58933-005","Sodium Fluoride","SODIUM FLUORIDE","HUMAN OTC DRUG","02/01/2015","N/A","OTC MONOGRAPH DRUG","1 TUBE in 1 CARTON (58933-005-11)  / 82 g in 1 TUBE","N/A","N/A","No","12/31/2024"
"Crest Cavity Protection","58933-005-57","1.5 mg/g","PASTE, DENTIFRICE","DENTAL","M021","Procter & Gamble Manufactura, S. de R.L. de C.V.","58933-005","Sodium Fluoride","SODIUM FLUORIDE","HUMAN OTC DRUG","09/10/2021","N/A","OTC MONOGRAPH DRUG","1 TUBE in 1 CARTON (58933-005-57)  / 161 g in 1 TUBE","N/A","N/A","No","12/31/2024"
"Crest Cavity Protection","58933-005-82","1.5 mg/g","PASTE, DENTIFRICE","DENTAL","M021","Procter & Gamble Manufactura, S. de R.L. de C.V.","58933-005","Sodium Fluoride","SODIUM FLUORIDE","HUMAN OTC DRUG","09/10/2021","N/A","OTC MONOGRAPH DRUG","1 TUBE in 1 CARTON (58933-005-82)  / 232 g in 1 TUBE","N/A","N/A","No","12/31/2024"
"Crest Cavity Protection","58933-005-24","1.5 mg/g","PASTE, DENTIFRICE","DENTAL","M021","Procter & Gamble Manufactura, S. de R.L. de C.V.","58933-005","Sodium Fluoride","SODIUM FLUORIDE","HUMAN OTC DRUG","02/01/2015","N/A","OTC MONOGRAPH DRUG","1 TUBE in 1 CARTON (58933-005-24)  / 68 g in 1 TUBE","N/A","N/A","No","12/31/2024"
"Crest Cavity Protection","58933-005-85","1.5 mg/g","PASTE, DENTIFRICE","DENTAL","M021","Procter & Gamble Manufactura, S. de R.L. de C.V.","58933-005","Sodium Fluoride","SODIUM FLUORIDE","HUMAN OTC DRUG","02/01/2015","N/A","OTC MONOGRAPH DRUG","24 g in 1 TUBE (58933-005-85)","N/A","N/A","Yes","12/31/2024"
"Crest Kids Advanced Color Changing","58933-012-29","1.6 mg/g","PASTE, DENTIFRICE","DENTAL","M022","Procter & Gamble Manufactura, S de R.L. de C.V.","58933-012","Sodium Monofluorophosphate","SODIUM MONOFLUOROPHOSPHATE","HUMAN OTC DRUG","01/01/2023","N/A","OTC MONOGRAPH DRUG","1 TUBE in 1 CARTON (58933-012-29)  / 82 g in 1 TUBE","N/A","N/A","No","12/31/2024"
"Crest Kids Advanced Color Changing","58933-012-42","1.6 mg/g","PASTE, DENTIFRICE","DENTAL","M022","Procter & Gamble Manufactura, S de R.L. de C.V.","58933-012","Sodium Monofluorophosphate","SODIUM MONOFLUOROPHOSPHATE","HUMAN OTC DRUG","01/01/2023","N/A","OTC MONOGRAPH DRUG","1 TUBE in 1 CARTON (58933-012-42)  / 119 g in 1 TUBE","N/A","N/A","No","12/31/2024"
"Crest Kids Advanced Color Changing","58933-012-85","1.6 mg/g","PASTE, DENTIFRICE","DENTAL","M022","Procter & Gamble Manufactura, S de R.L. de C.V.","58933-012","Sodium Monofluorophosphate","SODIUM MONOFLUOROPHOSPHATE","HUMAN OTC DRUG","01/01/2023","N/A","OTC MONOGRAPH DRUG","1 TUBE in 1 CARTON (58933-012-85)  / 24 g in 1 TUBE","N/A","N/A","No","12/31/2024"
"Crest Plus Baking Soda and Peroxide","69423-814-11","1.6 mg/g","PASTE, DENTIFRICE","DENTAL","M021","The Procter & Gamble Manufacturing Company","69423-814","Sodium Fluoride","SODIUM FLUORIDE","HUMAN OTC DRUG","11/13/2023","N/A","OTC MONOGRAPH DRUG","2 TUBE in 1 CELLO PACK (69423-814-11)  / 161 g in 1 TUBE","N/A","N/A","No","12/31/2024"
"Crest Plus Baking Soda and Peroxide","69423-814-24","1.6 mg/g","PASTE, DENTIFRICE","DENTAL","M021","The Procter & Gamble Manufacturing Company","69423-814","Sodium Fluoride","SODIUM FLUORIDE","HUMAN OTC DRUG","11/13/2023","N/A","OTC MONOGRAPH DRUG","1 TUBE in 1 CARTON (69423-814-24)  / 68 g in 1 TUBE","N/A","N/A","No","12/31/2024"
"Crest Plus Baking Soda and Peroxide","69423-814-42","1.6 mg/g","PASTE, DENTIFRICE","DENTAL","M021","The Procter & Gamble Manufacturing Company","69423-814","Sodium Fluoride","SODIUM FLUORIDE","HUMAN OTC DRUG","11/13/2023","N/A","OTC MONOGRAPH DRUG","1 TUBE in 1 CARTON (69423-814-42)  / 119 g in 1 TUBE","N/A","N/A","No","12/31/2024"
"Crest Plus Baking Soda and Peroxide","69423-814-57","1.6 mg/g","PASTE, DENTIFRICE","DENTAL","M021","The Procter & Gamble Manufacturing Company","69423-814","Sodium Fluoride","SODIUM FLUORIDE","HUMAN OTC DRUG","11/13/2023","N/A","OTC MONOGRAPH DRUG","1 TUBE in 1 CARTON (69423-814-57)  / 161 g in 1 TUBE","N/A","N/A","No","12/31/2024"
"Crest Plus Baking Soda and Peroxide","69423-814-82","1.6 mg/g","PASTE, DENTIFRICE","DENTAL","M021","The Procter & Gamble Manufacturing Company","69423-814","Sodium Fluoride","SODIUM FLUORIDE","HUMAN OTC DRUG","11/13/2023","N/A","OTC MONOGRAPH DRUG","1 TUBE in 1 CARTON (69423-814-82)  / 232 g in 1 TUBE","N/A","N/A","No","12/31/2024"
"Crest Pro-Health","69423-878-51","1.6 mg/g","GEL, DENTIFRICE","DENTAL","M021","The Procter & Gamble Manufacturing Company","69423-878","Stannous Fluoride","STANNOUS FLUORIDE","HUMAN OTC DRUG","01/01/2022","N/A","OTC MONOGRAPH DRUG","1 TUBE in 1 CARTON (69423-878-51)  / 144 g in 1 TUBE","N/A","N/A","No","12/31/2024"
"Crest Pro-Health","37000-604-46","1.4 mg/g","PASTE, DENTIFRICE","DENTAL","part355","The Procter & Gamble Manufacturing Company","37000-604","Stannous fluoride","STANNOUS FLUORIDE","HUMAN OTC DRUG","06/17/2017","N/A","OTC MONOGRAPH FINAL","1 TUBE in 1 CARTON (37000-604-46)  / 130 g in 1 TUBE","N/A","N/A","No","12/31/2024"
"Crest Pro-Health","37000-931-41","1.4 mg/g","PASTE, DENTIFRICE","DENTAL","part355","The Procter & Gamble Manufacturing Company","37000-931","Stannous Fluoride","STANNOUS FLUORIDE","HUMAN OTC DRUG","07/01/2019","N/A","OTC MONOGRAPH FINAL","1 TUBE in 1 CARTON (37000-931-41)  / 116 g in 1 TUBE","N/A","N/A","No","12/31/2024"
"Crest Pro-Health","37000-931-85","1.4 mg/g","PASTE, DENTIFRICE","DENTAL","part355","The Procter & Gamble Manufacturing Company","37000-931","Stannous Fluoride","STANNOUS FLUORIDE","HUMAN OTC DRUG","07/01/2019","N/A","OTC MONOGRAPH FINAL","1 TUBE in 1 CARTON (37000-931-85)  / 24 g in 1 TUBE","N/A","N/A","No","12/31/2024"
"Crest Pro-Health","37000-865-01",".1 mg/mL","RINSE","ORAL","part355","The Procter & Gamble Manufacturing Company","37000-865","Sodium Fluoride","SODIUM FLUORIDE","HUMAN OTC DRUG","07/29/2016","N/A","OTC MONOGRAPH FINAL","500 mL in 1 BOTTLE, PLASTIC (37000-865-01)","N/A","N/A","No","12/31/2024"
"Crest Pro-Health","37000-865-02",".1 mg/mL","RINSE","ORAL","part355","The Procter & Gamble Manufacturing Company","37000-865","Sodium Fluoride","SODIUM FLUORIDE","HUMAN OTC DRUG","07/29/2016","N/A","OTC MONOGRAPH FINAL","1000 mL in 1 BOTTLE, PLASTIC (37000-865-02)","N/A","N/A","No","12/31/2024"
"Crest Pro-Health","37000-865-36",".1 mg/mL","RINSE","ORAL","part355","The Procter & Gamble Manufacturing Company","37000-865","Sodium Fluoride","SODIUM FLUORIDE","HUMAN OTC DRUG","07/29/2016","N/A","OTC MONOGRAPH FINAL","36 mL in 1 BOTTLE, PLASTIC (37000-865-36)","N/A","N/A","No","12/31/2024"
"Crest Tartar Protection","58933-009-62","1.5 mg/g","GEL, DENTIFRICE","DENTAL","M021","Procter & Gamble Manufactura, S. de R.L. de C.V.","58933-009","Sodium Fluoride","SODIUM FLUORIDE","HUMAN OTC DRUG","06/16/1995","N/A","OTC MONOGRAPH DRUG","1 TUBE in 1 CARTON (58933-009-62)  / 175 g in 1 TUBE","N/A","N/A","No","12/31/2024"
"CUREFINI Skin Protection Cream","69981-194-01","300 mg/mL","CREAM","TOPICAL","M016","Rev Pharma Corp","69981-194","PETROLATUM","PETROLATUM","HUMAN OTC DRUG","07/12/2021","N/A","OTC MONOGRAPH DRUG","30 mL in 1 JAR (69981-194-01)","N/A","N/A","No","12/31/2024"
"CUREFINI Skin Protection Cream","69981-194-02","300 mg/mL","CREAM","TOPICAL","M016","Rev Pharma Corp","69981-194","PETROLATUM","PETROLATUM","HUMAN OTC DRUG","07/12/2021","N/A","OTC MONOGRAPH DRUG","60 mL in 1 JAR (69981-194-02)","N/A","N/A","No","12/31/2024"
"CUREFINI Skin Protection Cream","69981-194-04","300 mg/mL","CREAM","TOPICAL","M016","Rev Pharma Corp","69981-194","PETROLATUM","PETROLATUM","HUMAN OTC DRUG","07/12/2021","N/A","OTC MONOGRAPH DRUG","120 mL in 1 JAR (69981-194-04)","N/A","N/A","No","12/31/2024"
"CUREFINI Skin Protection Cream","69981-194-08","300 mg/mL","CREAM","TOPICAL","M016","Rev Pharma Corp","69981-194","PETROLATUM","PETROLATUM","HUMAN OTC DRUG","07/12/2021","N/A","OTC MONOGRAPH DRUG","240 mL in 1 JAR (69981-194-08)","N/A","N/A","No","12/31/2024"
"CVS Health Isopropyl Rubbing Alcohol","59779-756-40",".7 g/g","CLOTH","TOPICAL","M003","CVS Health","59779-756","Isopropyl Alcohol","ISOPROPYL ALCOHOL","HUMAN OTC DRUG","01/19/2017","N/A","OTC MONOGRAPH DRUG","180 g in 1 CANISTER (59779-756-40)","N/A","N/A","No","12/31/2024"
"Cyanocobalamin","0143-9620-10","1000 ug/mL","INJECTION","INTRAMUSCULAR; SUBCUTANEOUS","ANDA080515","Hikma Pharmaceuticals USA Inc.","0143-9620","cyanocobalamin","CYANOCOBALAMIN","HUMAN PRESCRIPTION DRUG","10/20/1971","N/A","ANDA","10 VIAL, MULTI-DOSE in 1 BOX (0143-9620-10)  / 10 mL in 1 VIAL, MULTI-DOSE (0143-9620-01)","Vitamin B 12 [CS],  Vitamin B12 [EPC]","N/A","No","12/31/2024"
"Cyclobenzaprine Hydrochloride","43063-494-60","5 mg/1","TABLET, FILM COATED","ORAL","ANDA078048","PD-Rx Pharmaceuticals, Inc.","43063-494","Cyclobenzaprine Hydrochloride","CYCLOBENZAPRINE HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","07/31/2014","N/A","ANDA","60 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (43063-494-60)","Centrally-mediated Muscle Relaxation [PE],  Muscle Relaxant [EPC]","N/A","No","12/31/2024"
"Cyclobenzaprine Hydrochloride","43063-494-90","5 mg/1","TABLET, FILM COATED","ORAL","ANDA078048","PD-Rx Pharmaceuticals, Inc.","43063-494","Cyclobenzaprine Hydrochloride","CYCLOBENZAPRINE HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","07/31/2014","N/A","ANDA","90 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (43063-494-90)","Centrally-mediated Muscle Relaxation [PE],  Muscle Relaxant [EPC]","N/A","No","12/31/2024"
"Cyclobenzaprine Hydrochloride","43063-494-14","5 mg/1","TABLET, FILM COATED","ORAL","ANDA078048","PD-Rx Pharmaceuticals, Inc.","43063-494","Cyclobenzaprine Hydrochloride","CYCLOBENZAPRINE HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","07/31/2014","N/A","ANDA","14 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (43063-494-14)","Centrally-mediated Muscle Relaxation [PE],  Muscle Relaxant [EPC]","N/A","No","12/31/2024"
"Cyclobenzaprine Hydrochloride","43063-494-30","5 mg/1","TABLET, FILM COATED","ORAL","ANDA078048","PD-Rx Pharmaceuticals, Inc.","43063-494","Cyclobenzaprine Hydrochloride","CYCLOBENZAPRINE HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","07/31/2014","N/A","ANDA","30 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (43063-494-30)","Centrally-mediated Muscle Relaxation [PE],  Muscle Relaxant [EPC]","N/A","No","12/31/2024"
"Cyclobenzaprine Hydrochloride","43063-494-01","5 mg/1","TABLET, FILM COATED","ORAL","ANDA078048","PD-Rx Pharmaceuticals, Inc.","43063-494","Cyclobenzaprine Hydrochloride","CYCLOBENZAPRINE HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","12/05/2018","N/A","ANDA","100 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (43063-494-01)","Centrally-mediated Muscle Relaxation [PE],  Muscle Relaxant [EPC]","N/A","No","12/31/2024"
"Cyclobenzaprine Hydrochloride","43063-494-20","5 mg/1","TABLET, FILM COATED","ORAL","ANDA078048","PD-Rx Pharmaceuticals, Inc.","43063-494","Cyclobenzaprine Hydrochloride","CYCLOBENZAPRINE HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","09/04/2019","N/A","ANDA","20 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (43063-494-20)","Centrally-mediated Muscle Relaxation [PE],  Muscle Relaxant [EPC]","N/A","No","12/31/2024"
"Cyclobenzaprine Hydrochloride","43063-494-82","5 mg/1","TABLET, FILM COATED","ORAL","ANDA078048","PD-Rx Pharmaceuticals, Inc.","43063-494","Cyclobenzaprine Hydrochloride","CYCLOBENZAPRINE HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","12/05/2018","N/A","ANDA","500 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (43063-494-82)","Centrally-mediated Muscle Relaxation [PE],  Muscle Relaxant [EPC]","N/A","No","12/31/2024"
"Cyclobenzaprine Hydrochloride","43063-494-95","5 mg/1","TABLET, FILM COATED","ORAL","ANDA078048","PD-Rx Pharmaceuticals, Inc.","43063-494","Cyclobenzaprine Hydrochloride","CYCLOBENZAPRINE HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","12/04/2018","N/A","ANDA","1000 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (43063-494-95)","Centrally-mediated Muscle Relaxation [PE],  Muscle Relaxant [EPC]","N/A","No","12/31/2024"
"Cyclobenzaprine Hydrochloride","43063-494-10","5 mg/1","TABLET, FILM COATED","ORAL","ANDA078048","PD-Rx Pharmaceuticals, Inc.","43063-494","Cyclobenzaprine Hydrochloride","CYCLOBENZAPRINE HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","07/31/2014","N/A","ANDA","10 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (43063-494-10)","Centrally-mediated Muscle Relaxation [PE],  Muscle Relaxant [EPC]","N/A","No","12/31/2024"
"Cyclobenzaprine Hydrochloride","43063-494-15","5 mg/1","TABLET, FILM COATED","ORAL","ANDA078048","PD-Rx Pharmaceuticals, Inc.","43063-494","Cyclobenzaprine Hydrochloride","CYCLOBENZAPRINE HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","07/31/2014","N/A","ANDA","15 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (43063-494-15)","Centrally-mediated Muscle Relaxation [PE],  Muscle Relaxant [EPC]","N/A","No","12/31/2024"
"Cyclobenzaprine Hydrochloride","43063-494-21","5 mg/1","TABLET, FILM COATED","ORAL","ANDA078048","PD-Rx Pharmaceuticals, Inc.","43063-494","Cyclobenzaprine Hydrochloride","CYCLOBENZAPRINE HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","07/31/2014","N/A","ANDA","21 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (43063-494-21)","Centrally-mediated Muscle Relaxation [PE],  Muscle Relaxant [EPC]","N/A","No","12/31/2024"
"Dapsone","42291-008-01","25 mg/1","TABLET","ORAL","ANDA086841","AvKARE","42291-008","Dapsone","DAPSONE","HUMAN PRESCRIPTION DRUG","03/06/2024","N/A","ANDA","100 TABLET in 1 BOTTLE (42291-008-01)","Sulfone [EPC],  Sulfones [CS]","N/A","No","12/31/2025"
"DARK SPOT CORRWXTOR FOR All SKIN TYPE","83872-211-01","50 mg/g,                         30  mg/g","CREAM","TOPICAL","M016","Shenzhen Xiaomai Manufacturing Co., Ltd.","83872-211","DARK SPOT CORRWXTOR","NIACINAMIDE;  TRANEXAMIC ACID","HUMAN OTC DRUG","03/06/2024","N/A","OTC MONOGRAPH DRUG","50 g in 1 BOTTLE (83872-211-01)","Antifibrinolytic Agent [EPC],  Decreased Fibrinolysis [PE]","N/A","No","12/31/2025"
"Darunavir 600 and 800 mg","69097-248-03","600 mg/1","TABLET","ORAL","ANDA206288","Cipla USA Inc.","69097-248","darunavir","DARUNAVIR HYDRATE","HUMAN PRESCRIPTION DRUG","11/29/2023","N/A","ANDA","60 TABLET in 1 BOTTLE (69097-248-03)","Cytochrome P450 2D6 Inhibitors [MoA],  Cytochrome P450 3A Inhibitors [MoA],  HIV Protease Inhibitors [MoA],  Protease Inhibitor [EPC]","N/A","No","12/31/2025"
"Daytime Cold and Flu Relief","30142-722-12","650 mg/30mL,                         20  mg/30mL,                         400  mg/30mL,                         10  mg/30mL","LIQUID","ORAL","part341","The Kroger Co.","30142-722","ACETAMINOHPEN, DEXTROMETHORPHAN HBr, GUAIFENESIN PHENYLEPHRINE HCL","ACETAMINOPHEN;  DEXTROMETHORPHAN HYDROBROMIDE;  GUAIFENESIN;  PHENYLEPHRINE HYDROCHLORIDE","HUMAN OTC DRUG","01/28/2020","N/A","OTC MONOGRAPH FINAL","354 mL in 1 BOTTLE, PLASTIC (30142-722-12)","Adrenergic alpha1-Agonists [MoA],  Decreased Respiratory Secretion Viscosity [PE],  Expectorant [EPC],  Increased Respiratory Secretions [PE],  Sigma-1 Agonist [EPC],  Sigma-1 Receptor Agonists [MoA],  Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC],  Uncompetitive NMDA Receptor Antagonists [MoA],  alpha-1 Adrenergic Agonist [EPC]","N/A","No","12/31/2024"
"Daytime Severe Cold and Flu Relief","69842-787-24","325 mg/1,                         10  mg/1,                         200  mg/1,                         5  mg/1","CAPSULE, LIQUID FILLED","ORAL","M012","CVS Pharmacy","69842-787","ACETAMINOHPEN, DEXTROMETHORPHAN HBr, Guaifenesin, PHENYLEPHRINE HCl","ACETAMINOPHEN;  DEXTROMETHORPHAN HYDROBROMIDE;  GUAIFENESIN;  PHENYLEPHRINE HYDROCHLORIDE","HUMAN OTC DRUG","08/25/2021","N/A","OTC MONOGRAPH DRUG","2 BLISTER PACK in 1 CARTON (69842-787-24)  / 12 CAPSULE, LIQUID FILLED in 1 BLISTER PACK","Adrenergic alpha1-Agonists [MoA],  Decreased Respiratory Secretion Viscosity [PE],  Expectorant [EPC],  Increased Respiratory Secretions [PE],  Sigma-1 Agonist [EPC],  Sigma-1 Receptor Agonists [MoA],  Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC],  Uncompetitive NMDA Receptor Antagonists [MoA],  alpha-1 Adrenergic Agonist [EPC]","N/A","No","12/31/2024"
"DAYVIGO","62856-410-30","10 mg/1","TABLET, FILM COATED","ORAL","NDA212028","Eisai Inc.","62856-410","lemborexant","LEMBOREXANT","HUMAN PRESCRIPTION DRUG","04/07/2020","N/A","NDA","30 TABLET, FILM COATED in 1 BOTTLE (62856-410-30)","Cytochrome P450 2B6 Inducers [MoA],  Orexin Receptor Antagonist [EPC],  Orexin Receptor Antagonists [MoA]","CIV","No","12/31/2025"
"DAYVIGO","62856-410-90","10 mg/1","TABLET, FILM COATED","ORAL","NDA212028","Eisai Inc.","62856-410","lemborexant","LEMBOREXANT","HUMAN PRESCRIPTION DRUG","04/07/2020","N/A","NDA","90 TABLET, FILM COATED in 1 BOTTLE (62856-410-90)","Cytochrome P450 2B6 Inducers [MoA],  Orexin Receptor Antagonist [EPC],  Orexin Receptor Antagonists [MoA]","CIV","No","12/31/2025"
"DD Cream Dermatologically Defining BB Cream Broad Spectrum SPF 30","59735-565-01","3.3 g/100g,                         12.05  g/100g","CREAM","TOPICAL","M020","MANA Products, INC.","59735-565","DD Cream Dermatologically Defining BB Cream Broad Spectrum SPF 30","TITANIUM DIOXIDE;  ZINC OXIDE","HUMAN OTC DRUG","12/12/2016","N/A","OTC MONOGRAPH DRUG","1 TUBE in 1 CARTON (59735-565-01)  / 40 g in 1 TUBE","N/A","N/A","No","12/31/2025"
"DentiCalm","82765-0043-0","20 g/100mL","EMULSION","TOPICAL","M017","NFUSE LLC","82765-0043","Topical Analgesic","MENTHOL","HUMAN OTC DRUG","02/01/2024","N/A","OTC MONOGRAPH DRUG","1 PACKAGE in 1 PACKAGE (82765-0043-0)  / .47 mL in 1 PACKAGE (82765-0043-1)","N/A","N/A","No","12/31/2025"
"Derma Glide","82160-641-01","50 mg/g","GEL","RECTAL; TOPICAL; VAGINAL","","Pella Pharmaceuticals Co. Ltd","82160-641","Glycerin","GLYCERIN","HUMAN OTC DRUG","05/31/2022","N/A","UNAPPROVED DRUG OTHER","75 g in 1 TUBE (82160-641-01)","Allergens [CS],  Cell-mediated Immunity [PE],  Glycerol [CS],  Increased Histamine Release [PE],  Increased IgG Production [PE],  Non-Standardized Chemical Allergen [EPC]","N/A","No","12/31/2024"
"DERMAKA Broad Spectrum SPF-42 Sunscreen","82240-223-00","60 mg/mL,                         77  mg/mL","CREAM","TOPICAL","M020","DERMAKA SKIN PRODUCTS","82240-223","TITANIUM DIOXIDE, ZINC OXIDE","TITANIUM DIOXIDE;  ZINC OXIDE","HUMAN OTC DRUG","09/21/2021","N/A","OTC MONOGRAPH DRUG","100 mL in 1 TUBE (82240-223-00)","Copper Absorption Inhibitor [EPC],  Decreased Copper Ion Absorption [PE]","N/A","No","12/31/2024"
"dermalogica dynamic skin recovery spf 50","68479-382-01","3 g/100mL,                         5  g/100mL,                         3  g/100mL,                         7  g/100mL","LOTION","TOPICAL","M020","Dermalogica, LLC","68479-382","Sunscreen","AVOBENZONE;  HOMOSALATE;  OCTISALATE;  OCTOCRYLENE","HUMAN OTC DRUG","01/17/2022","N/A","OTC MONOGRAPH DRUG","12 mL in 1 TUBE (68479-382-01)","N/A","N/A","No","12/31/2024"
"dermalogica dynamic skin recovery spf 50","68479-382-02","3 g/100mL,                         5  g/100mL,                         3  g/100mL,                         7  g/100mL","LOTION","TOPICAL","M020","Dermalogica, LLC","68479-382","Sunscreen","AVOBENZONE;  HOMOSALATE;  OCTISALATE;  OCTOCRYLENE","HUMAN OTC DRUG","01/17/2022","N/A","OTC MONOGRAPH DRUG","50 mL in 1 BOTTLE, PUMP (68479-382-02)","N/A","N/A","No","12/31/2024"
"dermalogica dynamic skin recovery spf 50","68479-382-00","3 g/100mL,                         5  g/100mL,                         3  g/100mL,                         7  g/100mL","LOTION","TOPICAL","M020","Dermalogica, LLC","68479-382","Sunscreen","AVOBENZONE;  HOMOSALATE;  OCTISALATE;  OCTOCRYLENE","HUMAN OTC DRUG","10/01/2023","N/A","OTC MONOGRAPH DRUG","2 mL in 1 POUCH (68479-382-00)","N/A","N/A","No","12/31/2024"
"dermalogica dynamic skin recovery spf 50","68479-382-03","3 g/100mL,                         5  g/100mL,                         3  g/100mL,                         7  g/100mL","LOTION","TOPICAL","M020","Dermalogica, LLC","68479-382","Sunscreen","AVOBENZONE;  HOMOSALATE;  OCTISALATE;  OCTOCRYLENE","HUMAN OTC DRUG","10/01/2023","N/A","OTC MONOGRAPH DRUG","1 BOTTLE in 1 CARTON (68479-382-03)  / 100 mL in 1 BOTTLE","N/A","N/A","No","12/31/2024"
"dermalogica dynamic skin recovery spf 50","68479-382-41","3 g/100mL,                         5  g/100mL,                         3  g/100mL,                         7  g/100mL","LOTION","TOPICAL","M020","Dermalogica, LLC","68479-382","Sunscreen","AVOBENZONE;  HOMOSALATE;  OCTISALATE;  OCTOCRYLENE","HUMAN OTC DRUG","10/01/2023","N/A","OTC MONOGRAPH DRUG","118 mL in 1 TUBE (68479-382-41)","N/A","N/A","No","12/31/2024"
"DESIPRAMINE HYDROCHLORIDE","50742-112-01","10 mg/1","TABLET","ORAL","ANDA204963","Ingenus Pharmaceuticals, LLC","50742-112","desipramine hydrochloride","DESIPRAMINE HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","09/19/2018","N/A","ANDA","100 TABLET in 1 BOTTLE (50742-112-01)","Tricyclic Antidepressant [EPC]","N/A","No","12/31/2024"
"Dexamethasone","0054-4179-25",".5 mg/1","TABLET","ORAL","ANDA084611","Hikma Pharmaceuticals USA, Inc.","0054-4179","Dexamethasone","DEXAMETHASONE","HUMAN PRESCRIPTION DRUG","07/25/1975","N/A","ANDA","100 TABLET in 1 BOTTLE, PLASTIC (0054-4179-25)","Corticosteroid Hormone Receptor Agonists [MoA],  Corticosteroid [EPC]","N/A","No","12/31/2025"
"Dexamethasone","80425-0346-1","1.5 mg/1","TABLET","ORAL","ANDA201270","Advanced Rx Pharmacy of Tennessee, LLC","80425-0346","Dexamethasone","DEXAMETHASONE","HUMAN PRESCRIPTION DRUG","07/31/2023","N/A","ANDA","21 TABLET in 1 BOTTLE (80425-0346-1)","Corticosteroid Hormone Receptor Agonists [MoA],  Corticosteroid [EPC]","N/A","No","12/31/2024"
"Dexamethasone","80425-0346-2","1.5 mg/1","TABLET","ORAL","ANDA201270","Advanced Rx Pharmacy of Tennessee, LLC","80425-0346","Dexamethasone","DEXAMETHASONE","HUMAN PRESCRIPTION DRUG","07/31/2023","N/A","ANDA","27 TABLET in 1 BOTTLE (80425-0346-2)","Corticosteroid Hormone Receptor Agonists [MoA],  Corticosteroid [EPC]","N/A","No","12/31/2024"
"Dexamethasone","80425-0346-3","1.5 mg/1","TABLET","ORAL","ANDA201270","Advanced Rx Pharmacy of Tennessee, LLC","80425-0346","Dexamethasone","DEXAMETHASONE","HUMAN PRESCRIPTION DRUG","07/31/2023","N/A","ANDA","49 TABLET in 1 BOTTLE (80425-0346-3)","Corticosteroid Hormone Receptor Agonists [MoA],  Corticosteroid [EPC]","N/A","No","12/31/2024"
"Dexmethylphenidate hydrochloride","16714-568-01","35 mg/1","CAPSULE, EXTENDED RELEASE","ORAL","ANDA206734","Northstar Rx LLC","16714-568","Dexmethylphenidate hydrochloride","DEXMETHYLPHENIDATE HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","01/21/2022","N/A","ANDA","100 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (16714-568-01)","Central Nervous System Stimulant [EPC],  Central Nervous System Stimulation [PE]","CII","No","12/31/2025"
"Dexmethylphenidate Hydrochloride","72162-1284-1","2.5 mg/1","TABLET","ORAL","ANDA207901","Bryant Ranch Prepack","72162-1284","dexmethylphenidate hydrochloride","DEXMETHYLPHENIDATE HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","02/01/2024","N/A","ANDA","100 TABLET in 1 BOTTLE, PLASTIC (72162-1284-1)","Central Nervous System Stimulant [EPC],  Central Nervous System Stimulation [PE]","CII","No","12/31/2025"
"Dexmethylphenidate Hydrochloride","72162-1286-1","10 mg/1","TABLET","ORAL","ANDA207901","Bryant Ranch Prepack","72162-1286","dexmethylphenidate hydrochloride","DEXMETHYLPHENIDATE HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","02/01/2024","N/A","ANDA","100 TABLET in 1 BOTTLE, PLASTIC (72162-1286-1)","Central Nervous System Stimulant [EPC],  Central Nervous System Stimulation [PE]","CII","No","12/31/2025"
"dextroamphetamine saccharate, amphetamine aspartate monohydrate, dextroamphetamine sulfate and amphetamine sulfate","70010-032-01","5 mg/1,                         5  mg/1,                         5  mg/1,                         5  mg/1","CAPSULE, EXTENDED RELEASE","ORAL","ANDA217027","Granules Pharmaceuticals Inc.","70010-032","dextroamphetamine saccharate, amphetamine aspartate monohydrate, dextroamphetamine sulfate and amphetamine sulfate","AMPHETAMINE ASPARTATE MONOHYDRATE;  AMPHETAMINE SULFATE;  DEXTROAMPHETAMINE SACCHARATE;  DEXTROAMPHETAMINE SULFATE","HUMAN PRESCRIPTION DRUG","02/20/2023","N/A","ANDA","100 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (70010-032-01)","Central Nervous System Stimulant [EPC],  Central Nervous System Stimulant [EPC],  Central Nervous System Stimulant [EPC],  Central Nervous System Stimulant [EPC],  Central Nervous System Stimulation [PE],  Central Nervous System Stimulation [PE],  Central Nervous System Stimulation [PE],  Central Nervous System Stimulation [PE]","CII","No","12/31/2024"
"Dextroamphetamine Saccharate, Amphetamine Aspartate, Dextroamphetamine Sulfate and Amphetamine Sulfate","16714-948-01","1.25 mg/1,                         1.25  mg/1,                         1.25  mg/1,                         1.25  mg/1","TABLET","ORAL","ANDA202424","NorthStar RxLLC","16714-948","Dextroamphetamine Saccharate, Amphetamine Aspartate, Dextroamphetamine Sulfate and Amphetamine Sulfate","AMPHETAMINE ASPARTATE MONOHYDRATE;  AMPHETAMINE SULFATE;  DEXTROAMPHETAMINE SACCHARATE;  DEXTROAMPHETAMINE SULFATE","HUMAN PRESCRIPTION DRUG","03/20/2019","N/A","ANDA","100 TABLET in 1 BOTTLE (16714-948-01)","Central Nervous System Stimulant [EPC],  Central Nervous System Stimulant [EPC],  Central Nervous System Stimulant [EPC],  Central Nervous System Stimulant [EPC],  Central Nervous System Stimulation [PE],  Central Nervous System Stimulation [PE],  Central Nervous System Stimulation [PE],  Central Nervous System Stimulation [PE]","CII","No","12/31/2024"
"DEXTROAMPHETAMINE SULFATE","72162-1234-1","10 mg/1","TABLET","ORAL","ANDA210059","Bryant Ranch Prepack","72162-1234","dextroamphetamine sulfate","DEXTROAMPHETAMINE SULFATE","HUMAN PRESCRIPTION DRUG","07/04/2018","N/A","ANDA","100 TABLET in 1 BOTTLE (72162-1234-1)","Central Nervous System Stimulant [EPC],  Central Nervous System Stimulation [PE]","CII","No","12/31/2025"
"Dial Antibacterial Defense Pomegranate and Tangerine","54340-177-02",".13 g/100mL","SOLUTION","TOPICAL","505G(a)(3)","Henkel Corporation","54340-177","BENZALKONIUM CHLORIDE","BENZALKONIUM CHLORIDE","HUMAN OTC DRUG","05/01/2023","N/A","OTC MONOGRAPH DRUG","12 BOTTLE, PUMP in 1 CARTON (54340-177-02)  / 325 mL in 1 BOTTLE, PUMP","N/A","N/A","No","12/31/2024"
"Dial Antibacterial Defense Pomegranate and Tangerine","54340-177-01",".13 g/100mL","SOLUTION","TOPICAL","505G(a)(3)","Henkel Corporation","54340-177","BENZALKONIUM CHLORIDE","BENZALKONIUM CHLORIDE","HUMAN OTC DRUG","05/01/2023","N/A","OTC MONOGRAPH DRUG","325 mL in 1 BOTTLE, PUMP (54340-177-01)","N/A","N/A","No","12/31/2024"
"Dial Foaming Antibacterial Defense Power Berries","54340-191-01",".13 g/100mL","SOLUTION","TOPICAL","505G(a)(3)","Henkel Corporation","54340-191","BENZALKONIUM CHLORIDE","BENZALKONIUM CHLORIDE","HUMAN OTC DRUG","05/01/2023","N/A","OTC MONOGRAPH DRUG","221 mL in 1 BOTTLE, PUMP (54340-191-01)","N/A","N/A","No","12/31/2024"
"Dial Foaming Antibacterial Defense Power Berries","54340-191-02",".13 g/100mL","SOLUTION","TOPICAL","505G(a)(3)","Henkel Corporation","54340-191","BENZALKONIUM CHLORIDE","BENZALKONIUM CHLORIDE","HUMAN OTC DRUG","05/01/2023","N/A","OTC MONOGRAPH DRUG","296 mL in 1 BOTTLE, PUMP (54340-191-02)","N/A","N/A","No","12/31/2024"
"Dial Foaming Antibacterial Defense Power Berries","54340-191-03",".13 g/100mL","SOLUTION","TOPICAL","505G(a)(3)","Henkel Corporation","54340-191","BENZALKONIUM CHLORIDE","BENZALKONIUM CHLORIDE","HUMAN OTC DRUG","05/01/2023","N/A","OTC MONOGRAPH DRUG","6 BOTTLE, PUMP in 1 CARTON (54340-191-03)  / 221 mL in 1 BOTTLE, PUMP","N/A","N/A","No","12/31/2024"
"Dial Foaming Antibacterial Defense Power Berries","54340-191-04",".13 g/100mL","SOLUTION","TOPICAL","505G(a)(3)","Henkel Corporation","54340-191","BENZALKONIUM CHLORIDE","BENZALKONIUM CHLORIDE","HUMAN OTC DRUG","05/01/2023","N/A","OTC MONOGRAPH DRUG","8 BOTTLE, PUMP in 1 CARTON (54340-191-04)  / 296 mL in 1 BOTTLE, PUMP","N/A","N/A","No","12/31/2024"
"Dial Foaming Antibacterial Defense Soothing White Tea","54340-186-01",".13 g/100mL","SOLUTION","TOPICAL","505G(a)(3)","Henkel Corporation","54340-186","BENZALKONIUM CHLORIDE","BENZALKONIUM CHLORIDE","HUMAN OTC DRUG","05/01/2023","N/A","OTC MONOGRAPH DRUG","221 mL in 1 BOTTLE, PUMP (54340-186-01)","N/A","N/A","No","12/31/2024"
"Dial Foaming Antibacterial Defense Soothing White Tea","54340-186-02",".13 g/100mL","SOLUTION","TOPICAL","505G(a)(3)","Henkel Corporation","54340-186","BENZALKONIUM CHLORIDE","BENZALKONIUM CHLORIDE","HUMAN OTC DRUG","05/01/2023","N/A","OTC MONOGRAPH DRUG","296 mL in 1 BOTTLE, PUMP (54340-186-02)","N/A","N/A","No","12/31/2024"
"Dial Foaming Antibacterial Defense Soothing White Tea","54340-186-03",".13 g/100mL","SOLUTION","TOPICAL","505G(a)(3)","Henkel Corporation","54340-186","BENZALKONIUM CHLORIDE","BENZALKONIUM CHLORIDE","HUMAN OTC DRUG","05/01/2023","N/A","OTC MONOGRAPH DRUG","887 mL in 1 BOTTLE, DISPENSING (54340-186-03)","N/A","N/A","No","12/31/2024"
"Dial Foaming Antibacterial Defense Soothing White Tea","54340-186-04",".13 g/100mL","SOLUTION","TOPICAL","505G(a)(3)","Henkel Corporation","54340-186","BENZALKONIUM CHLORIDE","BENZALKONIUM CHLORIDE","HUMAN OTC DRUG","05/01/2023","N/A","OTC MONOGRAPH DRUG","6 BOTTLE, PUMP in 1 CARTON (54340-186-04)  / 221 mL in 1 BOTTLE, PUMP","N/A","N/A","No","12/31/2024"
"Dial Foaming Antibacterial Defense Soothing White Tea","54340-186-05",".13 g/100mL","SOLUTION","TOPICAL","505G(a)(3)","Henkel Corporation","54340-186","BENZALKONIUM CHLORIDE","BENZALKONIUM CHLORIDE","HUMAN OTC DRUG","05/01/2023","N/A","OTC MONOGRAPH DRUG","8 BOTTLE, PUMP in 1 CARTON (54340-186-05)  / 296 mL in 1 BOTTLE, PUMP","N/A","N/A","No","12/31/2024"
"Dial Foaming Antibacterial Sensitive Aloe","54340-193-01",".13 g/100mL","SOLUTION","TOPICAL","505G(a)(3)","Henkel Corporation","54340-193","BENZALKONIUM CHLORIDE","BENZALKONIUM CHLORIDE","HUMAN OTC DRUG","05/01/2023","N/A","OTC MONOGRAPH DRUG","221 mL in 1 BOTTLE, PUMP (54340-193-01)","N/A","N/A","No","12/31/2024"
"Dial Foaming Antibacterial Sensitive Aloe","54340-193-02",".13 g/100mL","SOLUTION","TOPICAL","505G(a)(3)","Henkel Corporation","54340-193","BENZALKONIUM CHLORIDE","BENZALKONIUM CHLORIDE","HUMAN OTC DRUG","05/01/2023","N/A","OTC MONOGRAPH DRUG","296 mL in 1 BOTTLE, PUMP (54340-193-02)","N/A","N/A","No","12/31/2024"
"Dial Foaming Antibacterial Sensitive Aloe","54340-193-03",".13 g/100mL","SOLUTION","TOPICAL","505G(a)(3)","Henkel Corporation","54340-193","BENZALKONIUM CHLORIDE","BENZALKONIUM CHLORIDE","HUMAN OTC DRUG","05/01/2023","N/A","OTC MONOGRAPH DRUG","6 BOTTLE, PUMP in 1 CARTON (54340-193-03)  / 221 mL in 1 BOTTLE, PUMP","N/A","N/A","No","12/31/2024"
"Dial Foaming Antibacterial Sensitive Aloe","54340-193-04",".13 g/100mL","SOLUTION","TOPICAL","505G(a)(3)","Henkel Corporation","54340-193","BENZALKONIUM CHLORIDE","BENZALKONIUM CHLORIDE","HUMAN OTC DRUG","05/01/2023","N/A","OTC MONOGRAPH DRUG","8 BOTTLE, PUMP in 1 CARTON (54340-193-04)  / 296 mL in 1 BOTTLE, PUMP","N/A","N/A","No","12/31/2024"
"Dial Foaming Antibacterial Sensitive Fragrance Free","54340-194-01",".13 g/100mL","SOLUTION","TOPICAL","505G(a)(3)","Henkel Corporation","54340-194","BENZALKONIUM CHLORIDE","BENZALKONIUM CHLORIDE","HUMAN OTC DRUG","05/01/2023","N/A","OTC MONOGRAPH DRUG","221 mL in 1 BOTTLE, PUMP (54340-194-01)","N/A","N/A","No","12/31/2024"
"Dial Foaming Antibacterial Sensitive Fragrance Free","54340-194-02",".13 g/100mL","SOLUTION","TOPICAL","505G(a)(3)","Henkel Corporation","54340-194","BENZALKONIUM CHLORIDE","BENZALKONIUM CHLORIDE","HUMAN OTC DRUG","05/01/2023","N/A","OTC MONOGRAPH DRUG","6 BOTTLE, PUMP in 1 CARTON (54340-194-02)  / 221 mL in 1 BOTTLE, PUMP","N/A","N/A","No","12/31/2024"
"diclofenac potassium","73352-095-60","25 mg/1","CAPSULE, LIQUID FILLED","ORAL","ANDA210078","Trifluent Pharma LLC","73352-095","diclofenac potassium","DICLOFENAC POTASSIUM","HUMAN PRESCRIPTION DRUG","05/20/2022","N/A","ANDA","60 CAPSULE, LIQUID FILLED in 1 BOTTLE (73352-095-60)","Anti-Inflammatory Agents,  Non-Steroidal [CS],  Cyclooxygenase Inhibitors [MoA],  Decreased Prostaglandin Production [PE],  Nonsteroidal Anti-inflammatory Drug [EPC]","N/A","No","12/31/2024"
"Diclofenac Sodium","72162-1734-1","75 mg/1","TABLET, DELAYED RELEASE","ORAL","ANDA075185","Bryant Ranch Prepack","72162-1734","Diclofenac Sodium","DICLOFENAC SODIUM","HUMAN PRESCRIPTION DRUG","05/08/2023","N/A","ANDA","100 TABLET, DELAYED RELEASE in 1 BOTTLE, PLASTIC (72162-1734-1)","Anti-Inflammatory Agents,  Non-Steroidal [CS],  Cyclooxygenase Inhibitors [MoA],  Decreased Prostaglandin Production [PE],  Nonsteroidal Anti-inflammatory Drug [EPC]","N/A","No","12/31/2025"
"Diclofenac Sodium","72162-1734-0","75 mg/1","TABLET, DELAYED RELEASE","ORAL","ANDA075185","Bryant Ranch Prepack","72162-1734","Diclofenac Sodium","DICLOFENAC SODIUM","HUMAN PRESCRIPTION DRUG","05/08/2023","N/A","ANDA","1000 TABLET, DELAYED RELEASE in 1 BOTTLE, PLASTIC (72162-1734-0)","Anti-Inflammatory Agents,  Non-Steroidal [CS],  Cyclooxygenase Inhibitors [MoA],  Decreased Prostaglandin Production [PE],  Nonsteroidal Anti-inflammatory Drug [EPC]","N/A","No","12/31/2025"
"Diclofenac Sodium","72162-1734-5","75 mg/1","TABLET, DELAYED RELEASE","ORAL","ANDA075185","Bryant Ranch Prepack","72162-1734","Diclofenac Sodium","DICLOFENAC SODIUM","HUMAN PRESCRIPTION DRUG","05/08/2023","N/A","ANDA","500 TABLET, DELAYED RELEASE in 1 BOTTLE, PLASTIC (72162-1734-5)","Anti-Inflammatory Agents,  Non-Steroidal [CS],  Cyclooxygenase Inhibitors [MoA],  Decreased Prostaglandin Production [PE],  Nonsteroidal Anti-inflammatory Drug [EPC]","N/A","No","12/31/2025"
"Diclofenac Sodium","72162-1734-3","75 mg/1","TABLET, DELAYED RELEASE","ORAL","ANDA075185","Bryant Ranch Prepack","72162-1734","Diclofenac Sodium","DICLOFENAC SODIUM","HUMAN PRESCRIPTION DRUG","05/08/2023","N/A","ANDA","30 TABLET, DELAYED RELEASE in 1 BOTTLE, PLASTIC (72162-1734-3)","Anti-Inflammatory Agents,  Non-Steroidal [CS],  Cyclooxygenase Inhibitors [MoA],  Decreased Prostaglandin Production [PE],  Nonsteroidal Anti-inflammatory Drug [EPC]","N/A","No","12/31/2025"
"Diclofenac Sodium","72162-1734-4","75 mg/1","TABLET, DELAYED RELEASE","ORAL","ANDA075185","Bryant Ranch Prepack","72162-1734","Diclofenac Sodium","DICLOFENAC SODIUM","HUMAN PRESCRIPTION DRUG","05/08/2023","N/A","ANDA","20 TABLET, DELAYED RELEASE in 1 BOTTLE, PLASTIC (72162-1734-4)","Anti-Inflammatory Agents,  Non-Steroidal [CS],  Cyclooxygenase Inhibitors [MoA],  Decreased Prostaglandin Production [PE],  Nonsteroidal Anti-inflammatory Drug [EPC]","N/A","No","12/31/2025"
"Diclofenac Sodium","72162-1734-6","75 mg/1","TABLET, DELAYED RELEASE","ORAL","ANDA075185","Bryant Ranch Prepack","72162-1734","Diclofenac Sodium","DICLOFENAC SODIUM","HUMAN PRESCRIPTION DRUG","05/08/2023","N/A","ANDA","60 TABLET, DELAYED RELEASE in 1 BOTTLE, PLASTIC (72162-1734-6)","Anti-Inflammatory Agents,  Non-Steroidal [CS],  Cyclooxygenase Inhibitors [MoA],  Decreased Prostaglandin Production [PE],  Nonsteroidal Anti-inflammatory Drug [EPC]","N/A","No","12/31/2025"
"Diclofenac Sodium","72162-1734-7","75 mg/1","TABLET, DELAYED RELEASE","ORAL","ANDA075185","Bryant Ranch Prepack","72162-1734","Diclofenac Sodium","DICLOFENAC SODIUM","HUMAN PRESCRIPTION DRUG","05/08/2023","N/A","ANDA","14 TABLET, DELAYED RELEASE in 1 BOTTLE, PLASTIC (72162-1734-7)","Anti-Inflammatory Agents,  Non-Steroidal [CS],  Cyclooxygenase Inhibitors [MoA],  Decreased Prostaglandin Production [PE],  Nonsteroidal Anti-inflammatory Drug [EPC]","N/A","No","12/31/2025"
"Diclofenac Sodium","72162-1734-8","75 mg/1","TABLET, DELAYED RELEASE","ORAL","ANDA075185","Bryant Ranch Prepack","72162-1734","Diclofenac Sodium","DICLOFENAC SODIUM","HUMAN PRESCRIPTION DRUG","05/08/2023","N/A","ANDA","15 TABLET, DELAYED RELEASE in 1 BOTTLE, PLASTIC (72162-1734-8)","Anti-Inflammatory Agents,  Non-Steroidal [CS],  Cyclooxygenase Inhibitors [MoA],  Decreased Prostaglandin Production [PE],  Nonsteroidal Anti-inflammatory Drug [EPC]","N/A","No","12/31/2025"
"Diclofenac Sodium","72162-1734-9","75 mg/1","TABLET, DELAYED RELEASE","ORAL","ANDA075185","Bryant Ranch Prepack","72162-1734","Diclofenac Sodium","DICLOFENAC SODIUM","HUMAN PRESCRIPTION DRUG","05/08/2023","N/A","ANDA","90 TABLET, DELAYED RELEASE in 1 BOTTLE, PLASTIC (72162-1734-9)","Anti-Inflammatory Agents,  Non-Steroidal [CS],  Cyclooxygenase Inhibitors [MoA],  Decreased Prostaglandin Production [PE],  Nonsteroidal Anti-inflammatory Drug [EPC]","N/A","No","12/31/2025"
"Diphenhydramine Hydrochloride","72485-101-25","50 mg/mL","INJECTION, SOLUTION","INTRAMUSCULAR; INTRAVENOUS","ANDA205723","Armas Pharmaceuticals Inc.","72485-101","Diphenhydramine Hydrochloride","DIPHENHYDRAMINE HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","05/01/2019","N/A","ANDA","25 VIAL, SINGLE-DOSE in 1 CARTON (72485-101-25)  / 1 mL in 1 VIAL, SINGLE-DOSE (72485-101-01)","Histamine H1 Receptor Antagonists [MoA],  Histamine-1 Receptor Antagonist [EPC]","N/A","No","12/31/2024"
"Diphenhydramine Hydrochloride","72485-101-05","50 mg/mL","INJECTION, SOLUTION","INTRAMUSCULAR; INTRAVENOUS","ANDA205723","Armas Pharmaceuticals Inc.","72485-101","Diphenhydramine Hydrochloride","DIPHENHYDRAMINE HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","05/05/2023","N/A","ANDA","5 VIAL, SINGLE-DOSE in 1 CARTON (72485-101-05)  / 1 mL in 1 VIAL, SINGLE-DOSE (72485-101-01)","Histamine H1 Receptor Antagonists [MoA],  Histamine-1 Receptor Antagonist [EPC]","N/A","No","12/31/2024"
"Diphenoxylate Hydrochloride and Atropine Sulfate","68071-2328-1",".025 mg/1,                         2.5  mg/1","TABLET","ORAL","ANDA213413","NuCare Pharmaceuticals,Inc.","68071-2328","diphenoxylate hydrochloride and atropine sulfate","ATROPINE SULFATE;  DIPHENOXYLATE HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","01/11/2021","N/A","ANDA","10 TABLET in 1 BOTTLE (68071-2328-1)","Anticholinergic [EPC],  Antidiarrheal [EPC],  Cholinergic Antagonists [MoA],  Cholinergic Muscarinic Antagonist [EPC],  Cholinergic Muscarinic Antagonists [MoA]","CV","No","12/31/2024"
"Diphenoxylate Hydrochloride and Atropine Sulfate","68071-2328-3",".025 mg/1,                         2.5  mg/1","TABLET","ORAL","ANDA213413","NuCare Pharmaceuticals,Inc.","68071-2328","diphenoxylate hydrochloride and atropine sulfate","ATROPINE SULFATE;  DIPHENOXYLATE HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","01/11/2021","N/A","ANDA","30 TABLET in 1 BOTTLE (68071-2328-3)","Anticholinergic [EPC],  Antidiarrheal [EPC],  Cholinergic Antagonists [MoA],  Cholinergic Muscarinic Antagonist [EPC],  Cholinergic Muscarinic Antagonists [MoA]","CV","No","12/31/2024"
"Divalproex Sodium","37662-2869-2","10 [hp_M]/1","PELLET","ORAL","","Hahnemann Laboratories, INC.","37662-2869","Divalproex Sodium","VALPROATE SODIUM","HUMAN OTC DRUG","03/28/2023","N/A","UNAPPROVED HOMEOPATHIC","500 PELLET in 1 VIAL, GLASS (37662-2869-2)","Anti-epileptic Agent [EPC],  Decreased Central Nervous System Disorganized Electrical Activity [PE],  Mood Stabilizer [EPC]","N/A","No","12/31/2024"
"Divalproex Sodium","37662-2869-3","10 [hp_M]/1","PELLET","ORAL","","Hahnemann Laboratories, INC.","37662-2869","Divalproex Sodium","VALPROATE SODIUM","HUMAN OTC DRUG","03/28/2023","N/A","UNAPPROVED HOMEOPATHIC","3000 PELLET in 1 BOTTLE, GLASS (37662-2869-3)","Anti-epileptic Agent [EPC],  Decreased Central Nervous System Disorganized Electrical Activity [PE],  Mood Stabilizer [EPC]","N/A","No","12/31/2024"
"Divalproex Sodium","37662-2869-4","10 [hp_M]/1","PELLET","ORAL","","Hahnemann Laboratories, INC.","37662-2869","Divalproex Sodium","VALPROATE SODIUM","HUMAN OTC DRUG","03/28/2023","N/A","UNAPPROVED HOMEOPATHIC","10000 PELLET in 1 BOTTLE, GLASS (37662-2869-4)","Anti-epileptic Agent [EPC],  Decreased Central Nervous System Disorganized Electrical Activity [PE],  Mood Stabilizer [EPC]","N/A","No","12/31/2024"
"Divalproex Sodium","37662-2869-1","10 [hp_M]/1","PELLET","ORAL","","Hahnemann Laboratories, INC.","37662-2869","Divalproex Sodium","VALPROATE SODIUM","HUMAN OTC DRUG","03/28/2023","N/A","UNAPPROVED HOMEOPATHIC","200 PELLET in 1 VIAL, GLASS (37662-2869-1)","Anti-epileptic Agent [EPC],  Decreased Central Nervous System Disorganized Electrical Activity [PE],  Mood Stabilizer [EPC]","N/A","No","12/31/2024"
"Divalproex sodium","16714-484-01","250 mg/1","TABLET, FILM COATED, EXTENDED RELEASE","ORAL","ANDA202419","NorthStar Rx LLC","16714-484","Divalproex sodium","DIVALPROEX SODIUM","HUMAN PRESCRIPTION DRUG","06/02/2014","N/A","ANDA","100 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (16714-484-01)","Anti-epileptic Agent [EPC],  Decreased Central Nervous System Disorganized Electrical Activity [PE],  Mood Stabilizer [EPC]","N/A","No","12/31/2024"
"Divalproex sodium","16714-484-02","250 mg/1","TABLET, FILM COATED, EXTENDED RELEASE","ORAL","ANDA202419","NorthStar Rx LLC","16714-484","Divalproex sodium","DIVALPROEX SODIUM","HUMAN PRESCRIPTION DRUG","06/02/2014","N/A","ANDA","500 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (16714-484-02)","Anti-epileptic Agent [EPC],  Decreased Central Nervous System Disorganized Electrical Activity [PE],  Mood Stabilizer [EPC]","N/A","No","12/31/2024"
"Docusate Mini Enema","0904-6920-93","283 mg/5mL","LIQUID","RECTAL","M007","Major Pharmaceuticals","0904-6920","docusate sodium","DOCUSATE SODIUM","HUMAN OTC DRUG","08/26/2019","N/A","OTC MONOGRAPH DRUG","30 TUBE in 1 JAR (0904-6920-93)  / 5 mL in 1 TUBE","N/A","N/A","No","12/31/2024"
"Doxycycline Hyclate","67296-1456-4","100 mg/1","TABLET, FILM COATED","ORAL","ANDA062505","Redpharm Drug, Inc.","67296-1456","Doxycycline Hyclate","DOXYCYCLINE HYCLATE","HUMAN PRESCRIPTION DRUG","09/11/1984","N/A","ANDA","14 TABLET, FILM COATED in 1 BOTTLE (67296-1456-4)","Tetracycline-class Drug [EPC],  Tetracyclines [CS]","N/A","No","12/31/2024"
"DRUGGIST DARK SPOT ARBUTIN CORRWXTOR","83872-214-01","50 mg/g,                         70  mg/g,                         30  mg/g","CREAM","TOPICAL","M016","Shenzhen Xiaomai Manufacturing Co., Ltd.","83872-214","DARK SPOT ARBUTIN CORRWXTOR","4-BUTYLRESORCINOL;  ARBUTIN;  NIACINAMIDE","HUMAN OTC DRUG","03/06/2024","N/A","OTC MONOGRAPH DRUG","50 g in 1 BOTTLE (83872-214-01)","N/A","N/A","No","12/31/2025"
"DRUGGIST VISIBLE RESULT DARK SPOT","83872-206-01","50 mg/g,                         70  mg/g,                         30  mg/g,                         30  mg/g","CREAM","TOPICAL","M016","Shenzhen Xiaomai Manufacturing Co., Ltd.","83872-206","DARK SPOTDARK SPOT CORRWXTOR","4-BUTYLRESORCINOL;  ARBUTIN;  NIACINAMIDE;  TOCOPHEROL","HUMAN OTC DRUG","03/05/2024","N/A","OTC MONOGRAPH DRUG","50 g in 1 BOTTLE (83872-206-01)","N/A","N/A","No","12/31/2025"
"Dry Scalp","63941-952-15","10 mg/mL","SHAMPOO","TOPICAL","M032","Valu Merchandisers Co.","63941-952","Pyrithione zinc","PYRITHIONE ZINC","HUMAN OTC DRUG","01/06/2009","N/A","OTC MONOGRAPH DRUG","420 mL in 1 BOTTLE, PLASTIC (63941-952-15)","N/A","N/A","No","12/31/2024"
"Dry Scalp","63941-952-32","10 mg/mL","SHAMPOO","TOPICAL","M032","Valu Merchandisers Co.","63941-952","Pyrithione zinc","PYRITHIONE ZINC","HUMAN OTC DRUG","11/15/2023","N/A","OTC MONOGRAPH DRUG","370 mL in 1 BOTTLE, PLASTIC (63941-952-32)","N/A","N/A","No","12/31/2024"
"E2 SANITIZING HAND","50865-017-03",".003 mg/mL","SOAP","TOPICAL","part333A","KUTOL PRODUCTS COMPANY","50865-017","E2 SANITIZING HAND","BENZALKONIUM CHLORIDE","HUMAN OTC DRUG","09/15/2015","N/A","OTC MONOGRAPH NOT FINAL","209000 mL in 1 DRUM (50865-017-03)","N/A","N/A","No","12/31/2024"
"E2 SANITIZING HAND","50865-017-07",".003 mg/mL","SOAP","TOPICAL","part333A","KUTOL PRODUCTS COMPANY","50865-017","E2 SANITIZING HAND","BENZALKONIUM CHLORIDE","HUMAN OTC DRUG","09/15/2015","N/A","OTC MONOGRAPH NOT FINAL","4000 mL in 1 BOTTLE, PLASTIC (50865-017-07)","N/A","N/A","No","12/31/2024"
"E2 SANITIZING HAND","50865-017-09",".003 mg/mL","SOAP","TOPICAL","part333A","KUTOL PRODUCTS COMPANY","50865-017","E2 SANITIZING HAND","BENZALKONIUM CHLORIDE","HUMAN OTC DRUG","09/15/2015","N/A","OTC MONOGRAPH NOT FINAL","4000 mL in 1 BOTTLE, PLASTIC (50865-017-09)","N/A","N/A","No","12/31/2024"
"E2 SANITIZING HAND","50865-017-41",".003 mg/mL","SOAP","TOPICAL","part333A","KUTOL PRODUCTS COMPANY","50865-017","E2 SANITIZING HAND","BENZALKONIUM CHLORIDE","HUMAN OTC DRUG","09/15/2015","N/A","OTC MONOGRAPH NOT FINAL","1000 mL in 1 BAG (50865-017-41)","N/A","N/A","No","12/31/2024"
"E2 SANITIZING HAND","50865-017-65",".003 mg/mL","SOAP","TOPICAL","part333A","KUTOL PRODUCTS COMPANY","50865-017","E2 SANITIZING HAND","BENZALKONIUM CHLORIDE","HUMAN OTC DRUG","09/15/2015","N/A","OTC MONOGRAPH NOT FINAL","800 mL in 1 BAG (50865-017-65)","N/A","N/A","No","12/31/2024"
"E2 SANITIZING HAND","50865-017-67",".003 mg/mL","SOAP","TOPICAL","part333A","KUTOL PRODUCTS COMPANY","50865-017","E2 SANITIZING HAND","BENZALKONIUM CHLORIDE","HUMAN OTC DRUG","09/15/2015","N/A","OTC MONOGRAPH NOT FINAL","2000 mL in 1 BOTTLE, PLASTIC (50865-017-67)","N/A","N/A","No","12/31/2024"
"Edarbi","60631-080-30","80 mg/1","TABLET","ORAL","NDA200796","Azurity Pharmaceuticals, Inc.","60631-080","Azilsartan kamedoxomil","AZILSARTAN KAMEDOXOMIL","HUMAN PRESCRIPTION DRUG","02/01/2013","N/A","NDA","30 TABLET in 1 BOTTLE (60631-080-30)","Angiotensin 2 Receptor Blocker [EPC],  Angiotensin 2 Type 1 Receptor Antagonists [MoA],  Decreased Blood Pressure [PE]","N/A","No","12/31/2025"
"Edarbi","60631-080-77","80 mg/1","TABLET","ORAL","NDA200796","Azurity Pharmaceuticals, Inc.","60631-080","Azilsartan kamedoxomil","AZILSARTAN KAMEDOXOMIL","HUMAN PRESCRIPTION DRUG","02/01/2017","N/A","NDA","7 TABLET in 1 BOTTLE (60631-080-77)","Angiotensin 2 Receptor Blocker [EPC],  Angiotensin 2 Type 1 Receptor Antagonists [MoA],  Decreased Blood Pressure [PE]","N/A","No","12/31/2025"
"ELIGARD","62935-753-75","","KIT","SUBCUTANEOUS","NDA021343","TOLMAR Inc.","62935-753","Leuprolide Acetate","","HUMAN PRESCRIPTION DRUG","05/15/2002","N/A","NDA","1 KIT in 1 CARTON (62935-753-75)  *  .25 mL in 1 SYRINGE (62935-754-74)  *  .25 mL in 1 SYRINGE (62935-755-75)","N/A","N/A","No","12/31/2024"
"English Plantain","22840-1367-2","40000 [PNU]/mL","SOLUTION","INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS","BLA101833","Greer Laboratories, Inc.","22840-1367","Plantago lanceolata","PLANTAGO LANCEOLATA POLLEN","NON-STANDARDIZED ALLERGENIC","09/15/1981","N/A","BLA","10 mL in 1 VIAL, MULTI-DOSE (22840-1367-2)","Allergens [CS],  Cell-mediated Immunity [PE],  Increased Histamine Release [PE],  Increased IgG Production [PE],  Non-Standardized Pollen Allergenic Extract [EPC],  Pollen [CS]","N/A","No","12/31/2024"
"English Plantain","22840-1367-4","40000 [PNU]/mL","SOLUTION","INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS","BLA101833","Greer Laboratories, Inc.","22840-1367","Plantago lanceolata","PLANTAGO LANCEOLATA POLLEN","NON-STANDARDIZED ALLERGENIC","09/15/1981","N/A","BLA","50 mL in 1 VIAL, MULTI-DOSE (22840-1367-4)","Allergens [CS],  Cell-mediated Immunity [PE],  Increased Histamine Release [PE],  Increased IgG Production [PE],  Non-Standardized Pollen Allergenic Extract [EPC],  Pollen [CS]","N/A","No","12/31/2024"
"ERBORIAN CC RED CORRECT","83573-100-15","60 mg/mL,                         20  mg/mL,                         23.4  mg/mL,                         38.4  mg/mL","CREAM","TOPICAL","M020","Kolmask Co., Ld.","83573-100","ERBORIAN CC RED CORRECT SPF 25- octinoxate, octisalate, titanium dioxide, zinc oxide cream","OCTINOXATE;  OCTISALATE;  TITANIUM DIOXIDE;  ZINC OXIDE","HUMAN OTC DRUG","11/13/2023","N/A","OTC MONOGRAPH DRUG","1 TUBE in 1 BOX (83573-100-15)  / 15 mL in 1 TUBE (83573-100-14)","N/A","N/A","No","12/31/2024"
"ERBORIAN CC RED CORRECT","83573-100-45","60 mg/mL,                         20  mg/mL,                         23.4  mg/mL,                         38.4  mg/mL","CREAM","TOPICAL","M020","Kolmask Co., Ld.","83573-100","ERBORIAN CC RED CORRECT SPF 25- octinoxate, octisalate, titanium dioxide, zinc oxide cream","OCTINOXATE;  OCTISALATE;  TITANIUM DIOXIDE;  ZINC OXIDE","HUMAN OTC DRUG","11/13/2023","N/A","OTC MONOGRAPH DRUG","1 TUBE in 1 BOX (83573-100-45)  / 45 mL in 1 TUBE (83573-100-44)","N/A","N/A","No","12/31/2024"
"escitalopram oxalate","72162-2240-1","20 mg/1","TABLET","ORAL","ANDA090939","Bryant Ranch Prepack","72162-2240","escitalopram oxalate","ESCITALOPRAM OXALATE","HUMAN PRESCRIPTION DRUG","01/19/2024","N/A","ANDA","100 TABLET in 1 BOTTLE (72162-2240-1)","Serotonin Reuptake Inhibitor [EPC],  Serotonin Uptake Inhibitors [MoA]","N/A","No","12/31/2025"
"ESTRADIOL","70518-2829-0","2 mg/1","TABLET","ORAL","ANDA040275","REMEDYREPACK INC.","70518-2829","ESTRADIOL","ESTRADIOL","HUMAN PRESCRIPTION DRUG","08/07/2020","N/A","ANDA","100 POUCH in 1 BOX (70518-2829-0)  / 1 TABLET in 1 POUCH (70518-2829-1)","Estradiol Congeners [CS],  Estrogen Receptor Agonists [MoA],  Estrogen [EPC]","N/A","No","12/31/2025"
"Eucalyptol, Menthol, Methyl Salicylate, Thymol","70677-1234-1",".92 mg/mL,                         .42  mg/mL,                         .6  mg/mL,                         .64  mg/mL","MOUTHWASH","ORAL","part356","Strategic Sourcing Services LLC","70677-1234","Eucalyptol, Menthol, Methyl salicylate, Thymol","EUCALYPTOL;  MENTHOL;  METHYL SALICYLATE;  THYMOL","HUMAN OTC DRUG","02/09/2017","N/A","OTC MONOGRAPH NOT FINAL","1000 mL in 1 BOTTLE, PLASTIC (70677-1234-1)","N/A","N/A","No","12/31/2024"
"Excedrin PM Triple Action Caplets","0067-2056-91","250 mg/1,                         250  mg/1,                         38  mg/1","TABLET, COATED","ORAL","M013","Haleon US Holdings LLC","0067-2056","Acetaminophen, Aspirin (NSAID) and Diphenhydramine Citrate","ACETAMINOPHEN;  ASPIRIN;  DIPHENHYDRAMINE CITRATE","HUMAN OTC DRUG","09/24/2014","N/A","OTC MONOGRAPH DRUG","1 BOTTLE in 1 CARTON (0067-2056-91)  / 100 TABLET, COATED in 1 BOTTLE","Anti-Inflammatory Agents,  Non-Steroidal [CS],  Cyclooxygenase Inhibitors [MoA],  Decreased Platelet Aggregation [PE],  Decreased Prostaglandin Production [PE],  Histamine H1 Receptor Antagonists [MoA],  Histamine-1 Receptor Antagonist [EPC],  Nonsteroidal Anti-inflammatory Drug [EPC],  Platelet Aggregation Inhibitor [EPC]","N/A","No","12/31/2025"
"Excedrin PM Triple Action Caplets","0067-2056-24","250 mg/1,                         250  mg/1,                         38  mg/1","TABLET, COATED","ORAL","M013","Haleon US Holdings LLC","0067-2056","Acetaminophen, Aspirin (NSAID) and Diphenhydramine Citrate","ACETAMINOPHEN;  ASPIRIN;  DIPHENHYDRAMINE CITRATE","HUMAN OTC DRUG","09/24/2014","N/A","OTC MONOGRAPH DRUG","1 BOTTLE in 1 CARTON (0067-2056-24)  / 24 TABLET, COATED in 1 BOTTLE","Anti-Inflammatory Agents,  Non-Steroidal [CS],  Cyclooxygenase Inhibitors [MoA],  Decreased Platelet Aggregation [PE],  Decreased Prostaglandin Production [PE],  Histamine H1 Receptor Antagonists [MoA],  Histamine-1 Receptor Antagonist [EPC],  Nonsteroidal Anti-inflammatory Drug [EPC],  Platelet Aggregation Inhibitor [EPC]","N/A","No","12/31/2025"
"ezetimibe and simvastatin","50090-7047-0","10 mg/1,                         40  mg/1","TABLET","ORAL","ANDA208699","A-S Medication Solutions","50090-7047","ezetimibe and simvastatin","EZETIMIBE;  SIMVASTATIN","HUMAN PRESCRIPTION DRUG","01/15/2024","N/A","ANDA","90 TABLET in 1 BOTTLE (50090-7047-0)","Decreased Cholesterol Absorption [PE],  Dietary Cholesterol Absorption Inhibitor [EPC],  HMG-CoA Reductase Inhibitor [EPC],  Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]","N/A","No","12/31/2025"
"Famotidine","72657-112-20","10 mg/1","TABLET, FILM COATED","ORAL","ANDA215822","GLENMARK THERAPEUTICS INC., USA","72657-112","Famotidine","FAMOTIDINE","HUMAN OTC DRUG","06/01/2022","N/A","ANDA","1 BOTTLE in 1 CARTON (72657-112-20)  / 200 TABLET, FILM COATED in 1 BOTTLE","Histamine H2 Receptor Antagonists [MoA],  Histamine-2 Receptor Antagonist [EPC]","N/A","No","12/31/2025"
"Famotidine","72657-112-90","10 mg/1","TABLET, FILM COATED","ORAL","ANDA215822","GLENMARK THERAPEUTICS INC., USA","72657-112","Famotidine","FAMOTIDINE","HUMAN OTC DRUG","06/01/2022","N/A","ANDA","1 BOTTLE in 1 CARTON (72657-112-90)  / 90 TABLET, FILM COATED in 1 BOTTLE","Histamine H2 Receptor Antagonists [MoA],  Histamine-2 Receptor Antagonist [EPC]","N/A","No","12/31/2025"
"FARXIGA","55154-6933-8","10 mg/1","TABLET, FILM COATED","ORAL","NDA202293","Cardinal Health 107, LLC","55154-6933","DAPAGLIFLOZIN","DAPAGLIFLOZIN PROPANEDIOL","HUMAN PRESCRIPTION DRUG","01/05/2015","N/A","NDA","840 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (55154-6933-8)","Sodium-Glucose Cotransporter 2 Inhibitor [EPC],  Sodium-Glucose Transporter 2 Inhibitors [MoA]","N/A","No","12/31/2024"
"FEEL GOOD LAB Natural Pain Cream","70554-339-00","12.5 mg/mL","CREAM","TOPICAL","M017","THE FEEL GOOD LAB, LLC","70554-339","MENTHOL","MENTHOL","HUMAN OTC DRUG","07/15/2022","N/A","OTC MONOGRAPH DRUG","5 mL in 1 PACKET (70554-339-00)","N/A","N/A","No","12/31/2024"
"FEEL GOOD LABS NATURAL PAIN","70554-260-05","12.5 mg/mL","LOTION","TOPICAL","M017","The Feel Good Lab","70554-260","MENTHOL","MENTHOL","HUMAN OTC DRUG","08/15/2018","N/A","OTC MONOGRAPH DRUG","5 mL in 1 PACKET (70554-260-05)","N/A","N/A","No","12/31/2024"
"FEEL GOOD LABS NATURAL PAIN","70554-260-00","12.5 mg/mL","LOTION","TOPICAL","M017","The Feel Good Lab","70554-260","MENTHOL","MENTHOL","HUMAN OTC DRUG","08/15/2018","N/A","OTC MONOGRAPH DRUG","1 BOTTLE in 1 BOX (70554-260-00)  / 100 mL in 1 BOTTLE","N/A","N/A","No","12/31/2024"
"Female Tonic","60986-1033-7","1 [hp_X]/100mL,                         3  [hp_X]/100mL,                         4  [hp_X]/100mL,                         2  [hp_X]/100mL,                         3  [hp_X]/100mL,                         2  [hp_X]/100mL,                         3  [hp_X]/100mL,                         3  [hp_X]/100mL,                         4  [hp_X]/100mL,                         1  [hp_X]/100mL,                         3  [hp_X]/100mL,                         4  [hp_X]/100mL,                         1  [hp_X]/100mL,                         1  [hp_X]/100mL,                         8  [hp_X]/100mL,                         4  [hp_X]/100mL,                         1  [hp_X]/100mL,                         3  [hp_X]/100mL,                         3  [hp_X]/100mL,                         1  [hp_X]/100mL,                         1  [hp_X]/100mL","LIQUID","ORAL","","Marco Pharma International LLC.","60986-1033","Alchemilla Vulgaris, Asperula Odorata, Chamomilla, Viola Odorata, Cinchona Officinalis, Mentha Piperita, Rosmarinus Officinalis, Valeriana Officinalis, Helonia Dioica, Agnus Castus, Cimicifuga Racemosa, Convallaria Majalis, Crocus Sativus, Cyclamen Europaeum, Damiana, Hydrastis Canadensis, Caulophyllum Thalictroides, Lilium Tigrinum, Senecio Aureus, Staphysagria, Naja Tripudians","ALCHEMILLA XANTHOCHLORA FLOWERING TOP;  BLACK COHOSH;  CAULOPHYLLUM THALICTROIDES ROOT;  CHAMAELIRIUM LUTEUM ROOT;  CHASTE TREE;  CINCHONA OFFICINALIS BARK;  CONVALLARIA MAJALIS;  CYCLAMEN PURPURASCENS TUBER;  DELPHINIUM STAPHISAGRIA SEED;  GALIUM ODORATUM;  GOLDENSEAL;  LILIUM LANCIFOLIUM FLOWERING TOP;  MATRICARIA RECUTITA;  MENTHA PIPERITA;  NAJA NAJA VENOM;  PACKERA AUREA;  ROSMARINUS OFFICINALIS FLOWERING TOP;  SAFFRON;  TURNERA DIFFUSA LEAFY TWIG;  VALERIAN;  VIOLA ODORATA","HUMAN OTC DRUG","02/28/2018","N/A","UNAPPROVED HOMEOPATHIC","236 mL in 1 BOTTLE, GLASS (60986-1033-7)","N/A","N/A","No","12/31/2024"
"fenofibrate","68462-580-01","67 mg/1","CAPSULE","ORAL","ANDA205566","Glenmark Pharmaceuticals Inc., USA","68462-580","fenofibrate","FENOFIBRATE","HUMAN PRESCRIPTION DRUG","04/07/2017","N/A","ANDA","100 CAPSULE in 1 BOTTLE (68462-580-01)","Peroxisome Proliferator Receptor alpha Agonist [EPC]","N/A","No","12/31/2025"
"Fenofibrate","63629-1099-1","160 mg/1","TABLET, FILM COATED","ORAL","ANDA076635","Bryant Ranch Prepack","63629-1099","Fenofibrate","FENOFIBRATE","HUMAN PRESCRIPTION DRUG","11/18/2020","N/A","ANDA","30 TABLET, FILM COATED in 1 BOTTLE (63629-1099-1)","Peroxisome Proliferator Receptor alpha Agonist [EPC]","N/A","No","12/31/2024"
"Fenofibrate","63629-1099-3","160 mg/1","TABLET, FILM COATED","ORAL","ANDA076635","Bryant Ranch Prepack","63629-1099","Fenofibrate","FENOFIBRATE","HUMAN PRESCRIPTION DRUG","11/02/2020","N/A","ANDA","90 TABLET, FILM COATED in 1 BOTTLE (63629-1099-3)","Peroxisome Proliferator Receptor alpha Agonist [EPC]","N/A","No","12/31/2024"
"Fenofibrate","63629-1099-4","160 mg/1","TABLET, FILM COATED","ORAL","ANDA076635","Bryant Ranch Prepack","63629-1099","Fenofibrate","FENOFIBRATE","HUMAN PRESCRIPTION DRUG","05/17/2021","N/A","ANDA","50 TABLET, FILM COATED in 1 BOTTLE (63629-1099-4)","Peroxisome Proliferator Receptor alpha Agonist [EPC]","N/A","No","12/31/2024"
"Fenofibrate","63629-1099-2","160 mg/1","TABLET, FILM COATED","ORAL","ANDA076635","Bryant Ranch Prepack","63629-1099","Fenofibrate","FENOFIBRATE","HUMAN PRESCRIPTION DRUG","05/25/2021","N/A","ANDA","60 TABLET, FILM COATED in 1 BOTTLE (63629-1099-2)","Peroxisome Proliferator Receptor alpha Agonist [EPC]","N/A","No","12/31/2024"
"Fenofibric Acid","70436-168-03","45 mg/1","CAPSULE, DELAYED RELEASE","ORAL","ANDA212562","Slate Run Pharmaceuticals, LLC","70436-168","Fenofibric Acid","FENOFIBRIC ACID","HUMAN PRESCRIPTION DRUG","04/11/2022","N/A","ANDA","1000 CAPSULE, DELAYED RELEASE in 1 BOTTLE (70436-168-03)","Peroxisome Proliferator Receptor alpha Agonist [EPC]","N/A","No","12/31/2024"
"Fenofibric Acid","70436-168-06","45 mg/1","CAPSULE, DELAYED RELEASE","ORAL","ANDA212562","Slate Run Pharmaceuticals, LLC","70436-168","Fenofibric Acid","FENOFIBRIC ACID","HUMAN PRESCRIPTION DRUG","04/11/2022","N/A","ANDA","90 CAPSULE, DELAYED RELEASE in 1 BOTTLE (70436-168-06)","Peroxisome Proliferator Receptor alpha Agonist [EPC]","N/A","No","12/31/2024"
"Firebush Kochia","22840-1326-2",".05 g/mL","SOLUTION","INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS","BLA101833","Greer Laboratories, Inc.","22840-1326","Kochia scoparia","BASSIA SCOPARIA POLLEN","NON-STANDARDIZED ALLERGENIC","09/15/1981","N/A","BLA","10 mL in 1 VIAL, MULTI-DOSE (22840-1326-2)","Allergens [CS],  Cell-mediated Immunity [PE],  Increased Histamine Release [PE],  Increased IgG Production [PE],  Non-Standardized Pollen Allergenic Extract [EPC],  Pollen [CS]","N/A","No","12/31/2024"
"Firebush Kochia","22840-1326-4",".05 g/mL","SOLUTION","INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS","BLA101833","Greer Laboratories, Inc.","22840-1326","Kochia scoparia","BASSIA SCOPARIA POLLEN","NON-STANDARDIZED ALLERGENIC","09/15/1981","N/A","BLA","50 mL in 1 VIAL, MULTI-DOSE (22840-1326-4)","Allergens [CS],  Cell-mediated Immunity [PE],  Increased Histamine Release [PE],  Increased IgG Production [PE],  Non-Standardized Pollen Allergenic Extract [EPC],  Pollen [CS]","N/A","No","12/31/2024"
"First honey Burn Salve","81995-056-02","5 mg/mL","CREAM","TOPICAL","M016","First Honey, LLC","81995-056","ALLANTOIN","ALLANTOIN","HUMAN OTC DRUG","06/01/2023","N/A","OTC MONOGRAPH DRUG","1 POUCH in 1 CARTON (81995-056-02)  / 5 mL in 1 POUCH","N/A","N/A","No","12/31/2024"
"First honey Burn Salve","81995-056-01","5 mg/mL","CREAM","TOPICAL","M016","First Honey, LLC","81995-056","ALLANTOIN","ALLANTOIN","HUMAN OTC DRUG","05/10/2022","N/A","OTC MONOGRAPH DRUG","1 TUBE in 1 CARTON (81995-056-01)  / 100 mL in 1 TUBE","N/A","N/A","No","12/31/2024"
"FITGLOW Vita Shield Hyaluronic Primer SPF-30","72975-277-01","140 mg/mL","CREAM","TOPICAL","M020","FITGLOW BEAUTY LLC","72975-277","ZINC OXIDE","ZINC OXIDE","HUMAN OTC DRUG","03/23/2022","N/A","OTC MONOGRAPH DRUG","5 mL in 1 PACKET (72975-277-01)","Copper Absorption Inhibitor [EPC],  Decreased Copper Ion Absorption [PE]","N/A","Yes","12/31/2024"
"FITGLOW Vita Shield Hyaluronic Primer SPF-30","72975-277-00","140 mg/mL","CREAM","TOPICAL","M020","FITGLOW BEAUTY LLC","72975-277","ZINC OXIDE","ZINC OXIDE","HUMAN OTC DRUG","02/21/2022","N/A","OTC MONOGRAPH DRUG","1 BOTTLE, PUMP in 1 BOX (72975-277-00)  / 45 mL in 1 BOTTLE, PUMP","Copper Absorption Inhibitor [EPC],  Decreased Copper Ion Absorption [PE]","N/A","No","12/31/2024"
"Fluconazole","82804-030-30","200 mg/1","TABLET","ORAL","ANDA077731","Proficient Rx LP","82804-030","Fluconazole","FLUCONAZOLE","HUMAN PRESCRIPTION DRUG","10/20/2023","N/A","ANDA","30 TABLET in 1 BOTTLE (82804-030-30)","Azole Antifungal [EPC],  Azoles [CS],  Cytochrome P450 2C19 Inhibitors [MoA],  Cytochrome P450 2C9 Inhibitors [MoA],  Cytochrome P450 3A4 Inhibitors [MoA]","N/A","No","12/31/2024"
"Fluconazole","82804-030-60","200 mg/1","TABLET","ORAL","ANDA077731","Proficient Rx LP","82804-030","Fluconazole","FLUCONAZOLE","HUMAN PRESCRIPTION DRUG","10/20/2023","N/A","ANDA","60 TABLET in 1 BOTTLE (82804-030-60)","Azole Antifungal [EPC],  Azoles [CS],  Cytochrome P450 2C19 Inhibitors [MoA],  Cytochrome P450 2C9 Inhibitors [MoA],  Cytochrome P450 3A4 Inhibitors [MoA]","N/A","No","12/31/2024"
"Fluconazole","82804-030-90","200 mg/1","TABLET","ORAL","ANDA077731","Proficient Rx LP","82804-030","Fluconazole","FLUCONAZOLE","HUMAN PRESCRIPTION DRUG","10/20/2023","N/A","ANDA","90 TABLET in 1 BOTTLE (82804-030-90)","Azole Antifungal [EPC],  Azoles [CS],  Cytochrome P450 2C19 Inhibitors [MoA],  Cytochrome P450 2C9 Inhibitors [MoA],  Cytochrome P450 3A4 Inhibitors [MoA]","N/A","No","12/31/2024"
"FLUSH Maximum Strength Antifungal formula","80569-084-15","250 mg/mL","LIQUID","TOPICAL","M005","Triple Point Group, LLC","80569-084","UNDECYLENIC ACID","UNDECYLENIC ACID","HUMAN OTC DRUG","09/17/2020","N/A","OTC MONOGRAPH DRUG","15 mL in 1 BOTTLE, GLASS (80569-084-15)","N/A","N/A","No","12/31/2024"
"FLUTICASONE PROPIONATE","69842-757-08","50 ug/1","SPRAY, METERED","NASAL","ANDA207957","CVS Pharmacy","69842-757","Fluticasone Propionate","FLUTICASONE PROPIONATE","HUMAN OTC DRUG","09/03/2023","N/A","ANDA","1 BOTTLE in 1 CARTON (69842-757-08)  / 72 SPRAY, METERED in 1 BOTTLE","Corticosteroid Hormone Receptor Agonists [MoA],  Corticosteroid [EPC]","N/A","No","12/31/2024"
"FLUTICASONE PROPIONATE","69842-757-02","50 ug/1","SPRAY, METERED","NASAL","ANDA207957","CVS Pharmacy","69842-757","Fluticasone Propionate","FLUTICASONE PROPIONATE","HUMAN OTC DRUG","06/25/2018","N/A","ANDA","1 BOTTLE in 1 CARTON (69842-757-02)  / 60 SPRAY, METERED in 1 BOTTLE","Corticosteroid Hormone Receptor Agonists [MoA],  Corticosteroid [EPC]","N/A","No","12/31/2024"
"Fluvoxamine Maleate","10370-175-10","100 mg/1","CAPSULE, EXTENDED RELEASE","ORAL","ANDA091476","Par Pharmaceutical, Inc.","10370-175","Fluvoxamine Maleate","FLUVOXAMINE MALEATE","HUMAN PRESCRIPTION DRUG","03/13/2013","N/A","ANDA","1000 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (10370-175-10)","Serotonin Reuptake Inhibitor [EPC],  Serotonin Uptake Inhibitors [MoA]","N/A","No","12/31/2025"
"Fluvoxamine Maleate","10370-175-11","100 mg/1","CAPSULE, EXTENDED RELEASE","ORAL","ANDA091476","Par Pharmaceutical, Inc.","10370-175","Fluvoxamine Maleate","FLUVOXAMINE MALEATE","HUMAN PRESCRIPTION DRUG","03/13/2013","N/A","ANDA","30 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (10370-175-11)","Serotonin Reuptake Inhibitor [EPC],  Serotonin Uptake Inhibitors [MoA]","N/A","No","12/31/2025"
"Foamy Blue","65585-526-02","1 mg/mL","SOLUTION","TOPICAL","part333E","Whisk Products, Inc.","65585-526","Benzalkonium Chloride","BENZALKONIUM CHLORIDE","HUMAN OTC DRUG","01/18/2023","01/31/2025","OTC MONOGRAPH NOT FINAL","1000 mL in 1 BAG (65585-526-02)","N/A","N/A","No","N/A"
"Fosaprepitant","16714-248-01","150 mg/5mL","INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION","INTRAVENOUS","ANDA214616","NorthStar RxLLC","16714-248","Fosaprepitant dimeglumine","FOSAPREPITANT DIMEGLUMINE","HUMAN PRESCRIPTION DRUG","01/28/2023","N/A","ANDA","1 VIAL, SINGLE-DOSE in 1 CARTON (16714-248-01)  / 5 mL in 1 VIAL, SINGLE-DOSE","Cytochrome P450 2C9 Inducers [MoA],  Cytochrome P450 3A4 Inducers [MoA],  Cytochrome P450 3A4 Inhibitors [MoA],  Neurokinin 1 Antagonists [MoA],  Substance P/Neurokinin-1 Receptor Antagonist [EPC]","N/A","No","12/31/2024"
"Fungal Nail Liquid","84033-006-01","1 g/100mL","LIQUID","TOPICAL","M005","Qingdao Kuajie Online Electronic Technology Co., Ltd","84033-006","Tolnaftate","TOLNAFTATE","HUMAN OTC DRUG","04/09/2024","N/A","OTC MONOGRAPH DRUG","30 mL in 1 BOTTLE (84033-006-01)","N/A","N/A","No","12/31/2025"
"Gabapentin","0904-6665-61","100 mg/1","CAPSULE","ORAL","ANDA090858","Major Pharmaceuticals","0904-6665","Gabapentin","GABAPENTIN","HUMAN PRESCRIPTION DRUG","01/29/2011","N/A","ANDA","100 BLISTER PACK in 1 CARTON (0904-6665-61)  / 1 CAPSULE in 1 BLISTER PACK","Anti-epileptic Agent [EPC],  Decreased Central Nervous System Disorganized Electrical Activity [PE]","N/A","No","12/31/2024"
"Gabapentin","45865-194-30","300 mg/1","CAPSULE","ORAL","ANDA204989","Medsource Pharmaceuticals","45865-194","Gabapentin","GABAPENTIN","HUMAN PRESCRIPTION DRUG","08/31/2021","N/A","ANDA","30 CAPSULE in 1 BOTTLE (45865-194-30)","Decreased Central Nervous System Disorganized Electrical Activity [PE]","N/A","No","12/31/2025"
"Gabapentin","45865-194-51","300 mg/1","CAPSULE","ORAL","ANDA204989","Medsource Pharmaceuticals","45865-194","Gabapentin","GABAPENTIN","HUMAN PRESCRIPTION DRUG","10/18/2022","N/A","ANDA","120 CAPSULE in 1 BOTTLE (45865-194-51)","Decreased Central Nervous System Disorganized Electrical Activity [PE]","N/A","No","12/31/2025"
"Gabapentin","45865-194-60","300 mg/1","CAPSULE","ORAL","ANDA204989","Medsource Pharmaceuticals","45865-194","Gabapentin","GABAPENTIN","HUMAN PRESCRIPTION DRUG","09/09/2021","N/A","ANDA","60 CAPSULE in 1 BOTTLE (45865-194-60)","Decreased Central Nervous System Disorganized Electrical Activity [PE]","N/A","No","12/31/2025"
"Gabapentin","45865-194-90","300 mg/1","CAPSULE","ORAL","ANDA204989","Medsource Pharmaceuticals","45865-194","Gabapentin","GABAPENTIN","HUMAN PRESCRIPTION DRUG","08/26/2021","N/A","ANDA","90 CAPSULE in 1 BOTTLE (45865-194-90)","Decreased Central Nervous System Disorganized Electrical Activity [PE]","N/A","No","12/31/2025"
"Gabapentin","70518-2776-2","800 mg/1","TABLET","ORAL","ANDA205101","REMEDYREPACK INC.","70518-2776","Gabapentin","GABAPENTIN","HUMAN PRESCRIPTION DRUG","08/15/2022","N/A","ANDA","180 TABLET in 1 BOTTLE, PLASTIC (70518-2776-2)","Decreased Central Nervous System Disorganized Electrical Activity [PE]","N/A","No","12/31/2025"
"Gabapentin","71335-1198-0","100 mg/1","CAPSULE","ORAL","ANDA090858","Bryant Ranch Prepack","71335-1198","Gabapentin","GABAPENTIN","HUMAN PRESCRIPTION DRUG","09/20/2022","N/A","ANDA","65 CAPSULE in 1 BOTTLE (71335-1198-0)","Decreased Central Nervous System Disorganized Electrical Activity [PE]","N/A","No","12/31/2024"
"Gabapentin","71335-1198-1","100 mg/1","CAPSULE","ORAL","ANDA090858","Bryant Ranch Prepack","71335-1198","Gabapentin","GABAPENTIN","HUMAN PRESCRIPTION DRUG","09/20/2022","N/A","ANDA","56 CAPSULE in 1 BOTTLE (71335-1198-1)","Decreased Central Nervous System Disorganized Electrical Activity [PE]","N/A","No","12/31/2024"
"Gabapentin","71335-1198-2","100 mg/1","CAPSULE","ORAL","ANDA090858","Bryant Ranch Prepack","71335-1198","Gabapentin","GABAPENTIN","HUMAN PRESCRIPTION DRUG","05/14/2019","N/A","ANDA","90 CAPSULE in 1 BOTTLE (71335-1198-2)","Decreased Central Nervous System Disorganized Electrical Activity [PE]","N/A","No","12/31/2024"
"Gabapentin","71335-1198-3","100 mg/1","CAPSULE","ORAL","ANDA090858","Bryant Ranch Prepack","71335-1198","Gabapentin","GABAPENTIN","HUMAN PRESCRIPTION DRUG","05/13/2019","N/A","ANDA","30 CAPSULE in 1 BOTTLE (71335-1198-3)","Decreased Central Nervous System Disorganized Electrical Activity [PE]","N/A","No","12/31/2024"
"Gabapentin","71335-1198-4","100 mg/1","CAPSULE","ORAL","ANDA090858","Bryant Ranch Prepack","71335-1198","Gabapentin","GABAPENTIN","HUMAN PRESCRIPTION DRUG","05/03/2019","N/A","ANDA","60 CAPSULE in 1 BOTTLE (71335-1198-4)","Decreased Central Nervous System Disorganized Electrical Activity [PE]","N/A","No","12/31/2024"
"Gabapentin","71335-1198-5","100 mg/1","CAPSULE","ORAL","ANDA090858","Bryant Ranch Prepack","71335-1198","Gabapentin","GABAPENTIN","HUMAN PRESCRIPTION DRUG","09/20/2022","N/A","ANDA","28 CAPSULE in 1 BOTTLE (71335-1198-5)","Decreased Central Nervous System Disorganized Electrical Activity [PE]","N/A","No","12/31/2024"
"Gabapentin","71335-1198-6","100 mg/1","CAPSULE","ORAL","ANDA090858","Bryant Ranch Prepack","71335-1198","Gabapentin","GABAPENTIN","HUMAN PRESCRIPTION DRUG","09/20/2022","N/A","ANDA","360 CAPSULE in 1 BOTTLE (71335-1198-6)","Decreased Central Nervous System Disorganized Electrical Activity [PE]","N/A","No","12/31/2024"
"Gabapentin","71335-1198-7","100 mg/1","CAPSULE","ORAL","ANDA090858","Bryant Ranch Prepack","71335-1198","Gabapentin","GABAPENTIN","HUMAN PRESCRIPTION DRUG","05/15/2019","N/A","ANDA","120 CAPSULE in 1 BOTTLE (71335-1198-7)","Decreased Central Nervous System Disorganized Electrical Activity [PE]","N/A","No","12/31/2024"
"Gabapentin","71335-1198-8","100 mg/1","CAPSULE","ORAL","ANDA090858","Bryant Ranch Prepack","71335-1198","Gabapentin","GABAPENTIN","HUMAN PRESCRIPTION DRUG","06/22/2020","N/A","ANDA","100 CAPSULE in 1 BOTTLE (71335-1198-8)","Decreased Central Nervous System Disorganized Electrical Activity [PE]","N/A","No","12/31/2024"
"Gabapentin","71335-1198-9","100 mg/1","CAPSULE","ORAL","ANDA090858","Bryant Ranch Prepack","71335-1198","Gabapentin","GABAPENTIN","HUMAN PRESCRIPTION DRUG","09/20/2022","N/A","ANDA","84 CAPSULE in 1 BOTTLE (71335-1198-9)","Decreased Central Nervous System Disorganized Electrical Activity [PE]","N/A","No","12/31/2024"
"Gabapentin","68788-8546-1","400 mg/1","CAPSULE","ORAL","ANDA207099","Preferred Pharmaceuticals Inc.","68788-8546","Gabapentin","GABAPENTIN","HUMAN PRESCRIPTION DRUG","11/07/2023","N/A","ANDA","100 CAPSULE in 1 BOTTLE (68788-8546-1)","Decreased Central Nervous System Disorganized Electrical Activity [PE]","N/A","No","12/31/2024"
"Gabapentin","68788-8546-3","400 mg/1","CAPSULE","ORAL","ANDA207099","Preferred Pharmaceuticals Inc.","68788-8546","Gabapentin","GABAPENTIN","HUMAN PRESCRIPTION DRUG","11/07/2023","N/A","ANDA","30 CAPSULE in 1 BOTTLE (68788-8546-3)","Decreased Central Nervous System Disorganized Electrical Activity [PE]","N/A","No","12/31/2024"
"Gabapentin","68788-8546-6","400 mg/1","CAPSULE","ORAL","ANDA207099","Preferred Pharmaceuticals Inc.","68788-8546","Gabapentin","GABAPENTIN","HUMAN PRESCRIPTION DRUG","11/07/2023","N/A","ANDA","60 CAPSULE in 1 BOTTLE (68788-8546-6)","Decreased Central Nervous System Disorganized Electrical Activity [PE]","N/A","No","12/31/2024"
"Gabapentin","68788-8546-8","400 mg/1","CAPSULE","ORAL","ANDA207099","Preferred Pharmaceuticals Inc.","68788-8546","Gabapentin","GABAPENTIN","HUMAN PRESCRIPTION DRUG","11/07/2023","N/A","ANDA","120 CAPSULE in 1 BOTTLE (68788-8546-8)","Decreased Central Nervous System Disorganized Electrical Activity [PE]","N/A","No","12/31/2024"
"Gabapentin","68788-8546-9","400 mg/1","CAPSULE","ORAL","ANDA207099","Preferred Pharmaceuticals Inc.","68788-8546","Gabapentin","GABAPENTIN","HUMAN PRESCRIPTION DRUG","11/07/2023","N/A","ANDA","90 CAPSULE in 1 BOTTLE (68788-8546-9)","Decreased Central Nervous System Disorganized Electrical Activity [PE]","N/A","No","12/31/2024"
"Galantamine","24979-722-04","4 mg/1","TABLET, FILM COATED","ORAL","ANDA077604","TWi Pharmaceuticals USA, Inc.","24979-722","galantamine","GALANTAMINE HYDROBROMIDE","HUMAN PRESCRIPTION DRUG","03/06/2024","N/A","ANDA","60 TABLET, FILM COATED in 1 BOTTLE (24979-722-04)","Cholinesterase Inhibitor [EPC],  Cholinesterase Inhibitors [MoA]","N/A","No","12/31/2025"
"Gas Relief","68210-4182-3","125 mg/1","CAPSULE, LIQUID FILLED","ORAL","M002","Spirit Pharmaceuticals LLC","68210-4182","Simethicone","DIMETHICONE","HUMAN OTC DRUG","11/19/2021","N/A","OTC MONOGRAPH DRUG","30 CAPSULE, LIQUID FILLED in 1 POUCH (68210-4182-3)","Skin Barrier Activity [PE]","N/A","No","12/31/2024"
"Gas Relief","68210-4232-8","125 mg/1","CAPSULE, LIQUID FILLED","ORAL","M002","Spirit Pharmaceuticals LLC","68210-4232","Simethicone","DIMETHICONE","HUMAN OTC DRUG","11/17/2022","N/A","OTC MONOGRAPH DRUG","82 CAPSULE, LIQUID FILLED in 1 POUCH (68210-4232-8)","Skin Barrier Activity [PE]","N/A","No","12/31/2024"
"Gas Relief","37808-487-10","125 mg/1","CAPSULE, LIQUID FILLED","ORAL","part347","H E B","37808-487","SIMETHICONE","DIMETHICONE","HUMAN OTC DRUG","07/31/2018","07/31/2025","OTC MONOGRAPH FINAL","100 CAPSULE, LIQUID FILLED in 1 BOTTLE, PLASTIC (37808-487-10)","Skin Barrier Activity [PE]","N/A","No","N/A"
"Gel-Kam Mint","0126-0192-93","1 mg/g","GEL, DENTIFRICE","DENTAL","M021","Colgate Oral Pharmaceuticals, Inc.","0126-0192","Stannous Fluoride","STANNOUS FLUORIDE","HUMAN OTC DRUG","01/01/1990","N/A","OTC MONOGRAPH DRUG","1 TUBE in 1 CARTON (0126-0192-93)  / 122 g in 1 TUBE","N/A","N/A","No","12/31/2025"
"Gentle Laxative","46122-767-11","5 mg/1","TABLET, DELAYED RELEASE","ORAL","505G(a)(3)","Amerisource Bergen","46122-767","Bisacodyl","BISACODYL","HUMAN OTC DRUG","04/01/2013","N/A","OTC MONOGRAPH DRUG","1 BLISTER PACK in 1 CARTON (46122-767-11)  / 25 TABLET, DELAYED RELEASE in 1 BLISTER PACK","Increased Large Intestinal Motility [PE],  Stimulant Laxative [EPC],  Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]","N/A","No","12/31/2025"
"GeriGentle Alcohol Pads","69771-015-01","70 mL/100mL","CLOTH","TOPICAL","505G(a)(3)","Geri-Gentle Corporation","69771-015","ISOPROPYL ALCOHOL","ISOPROPYL ALCOHOL","HUMAN OTC DRUG","10/01/2023","N/A","OTC MONOGRAPH DRUG","1 PATCH in 1 BOX (69771-015-01)  / .045 mL in 1 PATCH","N/A","N/A","No","12/31/2024"
"GeriGentle Alcohol Pads","69771-015-05","70 mL/100mL","CLOTH","TOPICAL","505G(a)(3)","Geri-Gentle Corporation","69771-015","ISOPROPYL ALCOHOL","ISOPROPYL ALCOHOL","HUMAN OTC DRUG","10/01/2023","N/A","OTC MONOGRAPH DRUG","10 PATCH in 1 BOX (69771-015-05)  / .045 mL in 1 PATCH","N/A","N/A","No","12/31/2024"
"GeriGentle Alcohol Pads","69771-015-10","70 mL/100mL","CLOTH","TOPICAL","505G(a)(3)","Geri-Gentle Corporation","69771-015","ISOPROPYL ALCOHOL","ISOPROPYL ALCOHOL","HUMAN OTC DRUG","10/01/2023","N/A","OTC MONOGRAPH DRUG","100 PATCH in 1 BOX (69771-015-10)  / .045 mL in 1 PATCH","N/A","N/A","No","12/31/2024"
"GeriGentle FrostyHeat Pain Relief Patch 4 Lodocaine Back","69771-010-05","40 mg/mL","PATCH","TOPICAL","M017","Geri-Gentle Corporation","69771-010","LIDOCAINE","LIDOCAINE","HUMAN OTC DRUG","07/16/2022","N/A","OTC MONOGRAPH DRUG","4 PACKAGE in 1 POUCH (69771-010-05)  / .0242 mL in 1 PACKAGE","Amide Local Anesthetic [EPC],  Amides [CS],  Antiarrhythmic [EPC],  Local Anesthesia [PE]","N/A","No","12/31/2024"
"GeriGentle FrostyHeat Pain Relief Patch Arm and Neck","69771-011-05","50 mg/mL","PATCH","TOPICAL","M017","Geri-Gentle Corporation","69771-011","MENTHOL","MENTHOL","HUMAN OTC DRUG","07/16/2022","N/A","OTC MONOGRAPH DRUG","5 PACKAGE in 1 POUCH (69771-011-05)  / .0154 mL in 1 PACKAGE","N/A","N/A","No","12/31/2024"
"Glycopyrrolate","76045-206-10",".2 mg/mL","INJECTION, SOLUTION","INTRAMUSCULAR; INTRAVENOUS","ANDA209024","Fresenius Kabi USA, LLC","76045-206","Glycopyrrolate","GLYCOPYRROLATE","HUMAN PRESCRIPTION DRUG","10/30/2020","N/A","ANDA","24 BLISTER PACK in 1 CARTON (76045-206-10)  / 1 SYRINGE, GLASS in 1 BLISTER PACK (76045-206-01)  / 1 mL in 1 SYRINGE, GLASS","Anticholinergic [EPC],  Cholinergic Antagonists [MoA]","N/A","No","12/31/2024"
"Glycopyrrolate","63323-578-05",".2 mg/mL","INJECTION, SOLUTION","INTRAMUSCULAR; INTRAVENOUS","ANDA209328","Fresenius Kabi USA, LLC","63323-578","Glycopyrrolate","GLYCOPYRROLATE","HUMAN PRESCRIPTION DRUG","10/27/2017","N/A","ANDA","25 VIAL, MULTI-DOSE in 1 CARTON (63323-578-05)  / 5 mL in 1 VIAL, MULTI-DOSE (63323-578-07)","Anticholinergic [EPC],  Cholinergic Antagonists [MoA]","N/A","No","12/31/2024"
"Glytone Age Defense UV Mineral Sunscreen Serum Broad Spectrum SPF 50 PLUS","64760-730-01","120 mg/mL","LOTION","TOPICAL","M020","Pierre Fabre USA Inc.","64760-730","Zinc Oxide","ZINC OXIDE","HUMAN OTC DRUG","05/17/2021","07/01/2024","OTC MONOGRAPH DRUG","1 TUBE in 1 CARTON (64760-730-01)  / 50 mL in 1 TUBE","N/A","N/A","No","N/A"
"Green Guard Cramp Relief","47682-049-80","500 mg/1,                         25  mg/1,                         15  mg/1","TABLET, FILM COATED","ORAL","M027","Unifirst First Aid Corporation","47682-049","Acetaminophen, Pamabrom, Pyrilamine Maleate","ACETAMINOPHEN;  PAMABROM;  PYRILAMINE MALEATE","HUMAN OTC DRUG","09/26/2022","N/A","OTC MONOGRAPH DRUG","40 PACKET in 1 BOX (47682-049-80)  / 2 TABLET, FILM COATED in 1 PACKET (47682-049-99)","N/A","N/A","No","12/31/2025"
"Green Guard Extra Strength Pain Relief","47682-048-80","500 mg/1,                         32.5  mg/1","TABLET, FILM COATED","ORAL","M013","Unifirst First Aid Corporation","47682-048","Aspirin. Caffeine","ASPIRIN;  CAFFEINE","HUMAN OTC DRUG","09/26/2022","N/A","OTC MONOGRAPH DRUG","40 PACKET in 1 BOX (47682-048-80)  / 2 TABLET, FILM COATED in 1 PACKET (47682-048-99)","Anti-Inflammatory Agents,  Non-Steroidal [CS],  Central Nervous System Stimulant [EPC],  Central Nervous System Stimulation [PE],  Cyclooxygenase Inhibitors [MoA],  Decreased Platelet Aggregation [PE],  Decreased Prostaglandin Production [PE],  Methylxanthine [EPC],  Nonsteroidal Anti-inflammatory Drug [EPC],  Platelet Aggregation Inhibitor [EPC],  Xanthines [CS]","N/A","No","12/31/2025"
"Green Guard Sterile Alcohol Wipes","47682-035-99",".7 mL/mL","SWAB","TOPICAL","M003","Unifirst First Aid Corporation","47682-035","Isopropyl alcohol 70%","ISOPROPYL ALCOHOL","HUMAN OTC DRUG","08/18/2017","N/A","OTC MONOGRAPH DRUG",".7 mL in 1 PACKET (47682-035-99)","N/A","N/A","No","12/31/2025"
"Green Guard Sterile Alcohol Wipes","47682-035-50",".7 mL/mL","SWAB","TOPICAL","M003","Unifirst First Aid Corporation","47682-035","Isopropyl alcohol 70%","ISOPROPYL ALCOHOL","HUMAN OTC DRUG","08/18/2017","N/A","OTC MONOGRAPH DRUG","50 PACKET in 1 BOX (47682-035-50)  / .7 mL in 1 PACKET (47682-035-99)","N/A","N/A","No","12/31/2025"
"Guaifenesin and Dextromethorphan HBr","58602-714-08","30 mg/1,                         600  mg/1","TABLET, EXTENDED RELEASE","ORAL","ANDA206941","Aurohealth LLC","58602-714","Guaifenesin and Dextromethorphan HBr","DEXTROMETHORPHAN HYDROBROMIDE;  GUAIFENESIN","HUMAN OTC DRUG","03/17/2017","N/A","ANDA","4 BLISTER PACK in 1 CARTON (58602-714-08)  / 10 TABLET, EXTENDED RELEASE in 1 BLISTER PACK (58602-714-03)","Decreased Respiratory Secretion Viscosity [PE],  Expectorant [EPC],  Increased Respiratory Secretions [PE],  Sigma-1 Agonist [EPC],  Sigma-1 Receptor Agonists [MoA],  Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC],  Uncompetitive NMDA Receptor Antagonists [MoA]","N/A","No","12/31/2025"
"Guaifenesin and Dextromethorphan HBr","58602-714-66","30 mg/1,                         600  mg/1","TABLET, EXTENDED RELEASE","ORAL","ANDA206941","Aurohealth LLC","58602-714","Guaifenesin and Dextromethorphan HBr","DEXTROMETHORPHAN HYDROBROMIDE;  GUAIFENESIN","HUMAN OTC DRUG","03/17/2017","N/A","ANDA","1 BOTTLE in 1 CARTON (58602-714-66)  / 58 TABLET, EXTENDED RELEASE in 1 BOTTLE","Decreased Respiratory Secretion Viscosity [PE],  Expectorant [EPC],  Increased Respiratory Secretions [PE],  Sigma-1 Agonist [EPC],  Sigma-1 Receptor Agonists [MoA],  Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC],  Uncompetitive NMDA Receptor Antagonists [MoA]","N/A","No","12/31/2025"
"Guaifenesin and Dextromethorphan HBr","58602-714-15","30 mg/1,                         600  mg/1","TABLET, EXTENDED RELEASE","ORAL","ANDA206941","Aurohealth LLC","58602-714","Guaifenesin and Dextromethorphan HBr","DEXTROMETHORPHAN HYDROBROMIDE;  GUAIFENESIN","HUMAN OTC DRUG","03/17/2017","N/A","ANDA","1 BOTTLE in 1 CARTON (58602-714-15)  / 60 TABLET, EXTENDED RELEASE in 1 BOTTLE","Decreased Respiratory Secretion Viscosity [PE],  Expectorant [EPC],  Increased Respiratory Secretions [PE],  Sigma-1 Agonist [EPC],  Sigma-1 Receptor Agonists [MoA],  Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC],  Uncompetitive NMDA Receptor Antagonists [MoA]","N/A","No","12/31/2025"
"Guaifenesin and Dextromethorphan HBr","58602-714-73","30 mg/1,                         600  mg/1","TABLET, EXTENDED RELEASE","ORAL","ANDA206941","Aurohealth LLC","58602-714","Guaifenesin and Dextromethorphan HBr","DEXTROMETHORPHAN HYDROBROMIDE;  GUAIFENESIN","HUMAN OTC DRUG","03/17/2017","N/A","ANDA","1 BOTTLE in 1 CARTON (58602-714-73)  / 20 TABLET, EXTENDED RELEASE in 1 BOTTLE","Decreased Respiratory Secretion Viscosity [PE],  Expectorant [EPC],  Increased Respiratory Secretions [PE],  Sigma-1 Agonist [EPC],  Sigma-1 Receptor Agonists [MoA],  Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC],  Uncompetitive NMDA Receptor Antagonists [MoA]","N/A","No","12/31/2025"
"Guaifenesin and Dextromethorphan HBr","58602-714-09","30 mg/1,                         600  mg/1","TABLET, EXTENDED RELEASE","ORAL","ANDA206941","Aurohealth LLC","58602-714","Guaifenesin and Dextromethorphan HBr","DEXTROMETHORPHAN HYDROBROMIDE;  GUAIFENESIN","HUMAN OTC DRUG","03/17/2017","N/A","ANDA","1 BOTTLE in 1 CARTON (58602-714-09)  / 30 TABLET, EXTENDED RELEASE in 1 BOTTLE","Decreased Respiratory Secretion Viscosity [PE],  Expectorant [EPC],  Increased Respiratory Secretions [PE],  Sigma-1 Agonist [EPC],  Sigma-1 Receptor Agonists [MoA],  Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC],  Uncompetitive NMDA Receptor Antagonists [MoA]","N/A","No","12/31/2025"
"Guaifenesin and Dextromethorphan HBr","58602-714-12","30 mg/1,                         600  mg/1","TABLET, EXTENDED RELEASE","ORAL","ANDA206941","Aurohealth LLC","58602-714","Guaifenesin and Dextromethorphan HBr","DEXTROMETHORPHAN HYDROBROMIDE;  GUAIFENESIN","HUMAN OTC DRUG","03/17/2017","N/A","ANDA","1 BOTTLE in 1 CARTON (58602-714-12)  / 40 TABLET, EXTENDED RELEASE in 1 BOTTLE","Decreased Respiratory Secretion Viscosity [PE],  Expectorant [EPC],  Increased Respiratory Secretions [PE],  Sigma-1 Agonist [EPC],  Sigma-1 Receptor Agonists [MoA],  Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC],  Uncompetitive NMDA Receptor Antagonists [MoA]","N/A","No","12/31/2025"
"Guaifenesin and Dextromethorphan HBr","58602-714-05","30 mg/1,                         600  mg/1","TABLET, EXTENDED RELEASE","ORAL","ANDA206941","Aurohealth LLC","58602-714","Guaifenesin and Dextromethorphan HBr","DEXTROMETHORPHAN HYDROBROMIDE;  GUAIFENESIN","HUMAN OTC DRUG","03/17/2017","N/A","ANDA","1 BOTTLE in 1 CARTON (58602-714-05)  / 14 TABLET, EXTENDED RELEASE in 1 BOTTLE","Decreased Respiratory Secretion Viscosity [PE],  Expectorant [EPC],  Increased Respiratory Secretions [PE],  Sigma-1 Agonist [EPC],  Sigma-1 Receptor Agonists [MoA],  Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC],  Uncompetitive NMDA Receptor Antagonists [MoA]","N/A","No","12/31/2025"
"Guaifenesin and Dextromethorphan HBr","58602-714-07","30 mg/1,                         600  mg/1","TABLET, EXTENDED RELEASE","ORAL","ANDA206941","Aurohealth LLC","58602-714","Guaifenesin and Dextromethorphan HBr","DEXTROMETHORPHAN HYDROBROMIDE;  GUAIFENESIN","HUMAN OTC DRUG","03/17/2017","N/A","ANDA","6 BLISTER PACK in 1 CARTON (58602-714-07)  / 10 TABLET, EXTENDED RELEASE in 1 BLISTER PACK (58602-714-03)","Decreased Respiratory Secretion Viscosity [PE],  Expectorant [EPC],  Increased Respiratory Secretions [PE],  Sigma-1 Agonist [EPC],  Sigma-1 Receptor Agonists [MoA],  Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC],  Uncompetitive NMDA Receptor Antagonists [MoA]","N/A","No","12/31/2025"
"Guaifenesin and Dextromethorphan HBr","58602-714-67","30 mg/1,                         600  mg/1","TABLET, EXTENDED RELEASE","ORAL","ANDA206941","Aurohealth LLC","58602-714","Guaifenesin and Dextromethorphan HBr","DEXTROMETHORPHAN HYDROBROMIDE;  GUAIFENESIN","HUMAN OTC DRUG","03/17/2017","N/A","ANDA","2 BLISTER PACK in 1 CARTON (58602-714-67)  / 10 TABLET, EXTENDED RELEASE in 1 BLISTER PACK (58602-714-03)","Decreased Respiratory Secretion Viscosity [PE],  Expectorant [EPC],  Increased Respiratory Secretions [PE],  Sigma-1 Agonist [EPC],  Sigma-1 Receptor Agonists [MoA],  Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC],  Uncompetitive NMDA Receptor Antagonists [MoA]","N/A","No","12/31/2025"
"Guanfacine","70518-2771-0","1 mg/1","TABLET, EXTENDED RELEASE","ORAL","ANDA201408","REMEDYREPACK INC.","70518-2771","Guanfacine","GUANFACINE","HUMAN PRESCRIPTION DRUG","06/08/2020","N/A","ANDA","30 TABLET, EXTENDED RELEASE in 1 BLISTER PACK (70518-2771-0)","Adrenergic alpha2-Agonists [MoA],  Central alpha-2 Adrenergic Agonist [EPC]","N/A","No","12/31/2025"
"Guanfacine","24979-538-01","4 mg/1","TABLET, EXTENDED RELEASE","ORAL","ANDA201408","TWi Pharmaceuticals, Inc.","24979-538","Guanfacine","GUANFACINE","HUMAN PRESCRIPTION DRUG","07/07/2017","N/A","ANDA","100 TABLET, EXTENDED RELEASE in 1 BOTTLE (24979-538-01)","Adrenergic alpha2-Agonists [MoA],  Central alpha-2 Adrenergic Agonist [EPC]","N/A","No","12/31/2025"
"Guanfacine","24979-538-10","4 mg/1","TABLET, EXTENDED RELEASE","ORAL","ANDA201408","TWi Pharmaceuticals, Inc.","24979-538","Guanfacine","GUANFACINE","HUMAN PRESCRIPTION DRUG","07/07/2017","N/A","ANDA","1000 TABLET, EXTENDED RELEASE in 1 BOTTLE (24979-538-10)","Adrenergic alpha2-Agonists [MoA],  Central alpha-2 Adrenergic Agonist [EPC]","N/A","No","12/31/2025"
"HAIRCARE Physicians Recommended","82499-267-00","30 mg/mL","SHAMPOO","TOPICAL","M032","LAWRENCE E SAMUELS MD INC","82499-267","SALICYLIC ACID","SALICYLIC ACID","HUMAN OTC DRUG","01/15/2022","N/A","OTC MONOGRAPH DRUG","237 mL in 1 BOTTLE (82499-267-00)","N/A","N/A","No","12/31/2024"
"Hamamelis Virginica","37662-2936-4","30 [hp_C]/1","PELLET","ORAL","","Hahnemann Laboratories, INC.","37662-2936","Hamamelis Virginica","HAMAMELIS VIRGINIANA ROOT BARK/STEM BARK","HUMAN OTC DRUG","04/07/2023","N/A","UNAPPROVED HOMEOPATHIC","4000 PELLET in 1 BOTTLE, GLASS (37662-2936-4)","N/A","N/A","No","12/31/2024"
"Hamamelis Virginica","37662-2936-1","30 [hp_C]/1","PELLET","ORAL","","Hahnemann Laboratories, INC.","37662-2936","Hamamelis Virginica","HAMAMELIS VIRGINIANA ROOT BARK/STEM BARK","HUMAN OTC DRUG","04/07/2023","N/A","UNAPPROVED HOMEOPATHIC","80 PELLET in 1 VIAL, GLASS (37662-2936-1)","N/A","N/A","No","12/31/2024"
"Hamamelis Virginica","37662-2936-2","30 [hp_C]/1","PELLET","ORAL","","Hahnemann Laboratories, INC.","37662-2936","Hamamelis Virginica","HAMAMELIS VIRGINIANA ROOT BARK/STEM BARK","HUMAN OTC DRUG","04/07/2023","N/A","UNAPPROVED HOMEOPATHIC","200 PELLET in 1 VIAL, GLASS (37662-2936-2)","N/A","N/A","No","12/31/2024"
"Hamamelis Virginica","37662-2936-3","30 [hp_C]/1","PELLET","ORAL","","Hahnemann Laboratories, INC.","37662-2936","Hamamelis Virginica","HAMAMELIS VIRGINIANA ROOT BARK/STEM BARK","HUMAN OTC DRUG","04/07/2023","N/A","UNAPPROVED HOMEOPATHIC","1200 PELLET in 1 BOTTLE, GLASS (37662-2936-3)","N/A","N/A","No","12/31/2024"
"Hand Recovery","70741-007-06","70 mL/100mL","LOTION","TOPICAL","part333A","Derma Glove","70741-007","Alcohol","ALCOHOL","HUMAN OTC DRUG","01/06/2017","N/A","OTC MONOGRAPH NOT FINAL","947.2 mL in 1 PACKAGE (70741-007-06)","N/A","N/A","No","12/31/2024"
"Hand Recovery","70741-007-01","70 mL/100mL","LOTION","TOPICAL","part333A","Derma Glove","70741-007","Alcohol","ALCOHOL","HUMAN OTC DRUG","01/06/2017","N/A","OTC MONOGRAPH NOT FINAL","25 mL in 1 PACKAGE (70741-007-01)","N/A","N/A","No","12/31/2024"
"HAND SANITIZING","55814-101-12","62 mL/100mL","SPRAY","TOPICAL","M003","DR. BRONNER'S MAGIC SOAPS","55814-101","ALCOHOL","ALCOHOL","HUMAN OTC DRUG","02/18/2012","N/A","OTC MONOGRAPH DRUG","59 mL in 1 BOTTLE (55814-101-12)","N/A","N/A","No","12/31/2024"
"Helleborus e pl. tota 12","48951-5108-1","12 [hp_X]/mL","LIQUID","ORAL","","Uriel Pharmacy Inc.","48951-5108","Helleborus e pl. tota 12","HELLEBORUS FOETIDUS ROOT","HUMAN OTC DRUG","09/01/2009","N/A","UNAPPROVED HOMEOPATHIC","10 AMPULE in 1 BOX (48951-5108-1)  / 1 mL in 1 AMPULE","N/A","N/A","No","12/31/2025"
"Hello Sunday The Invisible One Sunscreen Plus Primer SPF 50","10596-801-01","30 mg/mL,                         73  mg/mL,                         50  mg/mL,                         90  mg/mL","EMULSION","TOPICAL","M020","Kao USA Inc.","10596-801","Avobenzone, Homosalate, Octisalate, Octocrylene","AVOBENZONE;  HOMOSALATE;  OCTISALATE;  OCTOCRYLENE","HUMAN OTC DRUG","02/01/2024","N/A","OTC MONOGRAPH DRUG","1 TUBE in 1 CARTON (10596-801-01)  / 50 mL in 1 TUBE","N/A","N/A","No","12/31/2024"
"Hello Sunday The Mineral One Lightweight Serum SPF 50","10596-804-01","175.2 mg/mL","EMULSION","TOPICAL","M020","Kao USA Inc.","10596-804","Zinc Oxide","ZINC OXIDE","HUMAN OTC DRUG","02/01/2024","N/A","OTC MONOGRAPH DRUG","1 BOTTLE in 1 CARTON (10596-804-01)  / 30 mL in 1 BOTTLE","N/A","N/A","No","12/31/2024"
"Holmium Metallicum","37662-2949-1","1 [hp_Q]/1","PELLET","ORAL","","Hahnemann Laboratories, INC.","37662-2949","Holmium Metallicum","HOLMIUM","HUMAN OTC DRUG","04/07/2023","N/A","UNAPPROVED HOMEOPATHIC","10000 PELLET in 1 BOTTLE, GLASS (37662-2949-1)","N/A","N/A","No","12/31/2024"
"HurriCaine","0283-0610-11","200 mg/g","SPRAY","DENTAL; PERIODONTAL","M022","Beutlich Pharmaceuticals LLC","0283-0610","Topical Anesthetic","BENZOCAINE","HUMAN OTC DRUG","04/01/2016","N/A","OTC MONOGRAPH DRUG","2 APPLICATOR in 1 BOX (0283-0610-11)  / .492 g in 1 APPLICATOR (0283-0610-43)","Allergens [CS],  Cell-mediated Immunity [PE],  Increased Histamine Release [PE],  Standardized Chemical Allergen [EPC]","N/A","No","12/31/2025"
"HurriCaine","0283-0610-26","200 mg/g","SPRAY","DENTAL; PERIODONTAL","M022","Beutlich Pharmaceuticals LLC","0283-0610","Topical Anesthetic","BENZOCAINE","HUMAN OTC DRUG","04/01/2016","N/A","OTC MONOGRAPH DRUG","25 APPLICATOR in 1 BOX (0283-0610-26)  / .492 g in 1 APPLICATOR (0283-0610-43)","Allergens [CS],  Cell-mediated Immunity [PE],  Increased Histamine Release [PE],  Standardized Chemical Allergen [EPC]","N/A","No","12/31/2025"
"Hydralazine Hydrochloride","68084-447-01","10 mg/1","TABLET, FILM COATED","ORAL","ANDA086242","American Health Packaging","68084-447","Hydralazine Hydrochloride","HYDRALAZINE HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","09/03/2010","11/30/2025","ANDA","100 BLISTER PACK in 1 BOX, UNIT-DOSE (68084-447-01)  / 1 TABLET, FILM COATED in 1 BLISTER PACK (68084-447-11)","Arteriolar Vasodilation [PE],  Arteriolar Vasodilator [EPC]","N/A","No","N/A"
"Hydrating Camo CC Cream SPF30 Deep 500 W","76354-790-01","50 mg/g,                         45  mg/g,                         30  mg/g,                         60  mg/g,                         63  mg/g","CREAM","TOPICAL","M020","e.l.f. Cosmetics, Inc.","76354-790","ZINC OXIDE, TITANIUM DIOXIDE, HOMOSALATE, OCTISALATE, OCTOCRYLENE","HOMOSALATE;  OCTISALATE;  OCTOCRYLENE;  TITANIUM DIOXIDE;  ZINC OXIDE","HUMAN OTC DRUG","08/15/2023","N/A","OTC MONOGRAPH DRUG","1 TUBE in 1 CARTON (76354-790-01)  / 30 g in 1 TUBE","Copper Absorption Inhibitor [EPC],  Decreased Copper Ion Absorption [PE]","N/A","No","12/31/2025"
"Hydrating Camo CC Cream SPF30 Deep 510 C","76354-791-01","50 mg/g,                         45  mg/g,                         30  mg/g,                         60  mg/g,                         63  mg/g","CREAM","TOPICAL","M020","e.l.f. Cosmetics, Inc.","76354-791","ZINC OXIDE, TITANIUM DIOXIDE, HOMOSALATE, OCTISALATE, OCTOCRYLENE","HOMOSALATE;  OCTISALATE;  OCTOCRYLENE;  TITANIUM DIOXIDE;  ZINC OXIDE","HUMAN OTC DRUG","08/15/2023","N/A","OTC MONOGRAPH DRUG","1 TUBE in 1 CARTON (76354-791-01)  / 30 g in 1 TUBE","Copper Absorption Inhibitor [EPC],  Decreased Copper Ion Absorption [PE]","N/A","No","12/31/2025"
"Hydrating Camo CC Cream SPF30 Light 240 W","76354-777-01","50 mg/g,                         45  mg/g,                         30  mg/g,                         60  mg/g,                         63  mg/g","CREAM","TOPICAL","M020","e.l.f. Cosmetics, Inc.","76354-777","ZINC OXIDE, TITANIUM DIOXIDE, HOMOSALATE, OCTISALATE, OCTOCRYLENE","HOMOSALATE;  OCTISALATE;  OCTOCRYLENE;  TITANIUM DIOXIDE;  ZINC OXIDE","HUMAN OTC DRUG","08/15/2023","N/A","OTC MONOGRAPH DRUG","1 TUBE in 1 CARTON (76354-777-01)  / 30 g in 1 TUBE","Copper Absorption Inhibitor [EPC],  Decreased Copper Ion Absorption [PE]","N/A","No","12/31/2025"
"Hydrating Camo CC Cream SPF30 Tan 425 N","76354-787-01","50 mg/g,                         45  mg/g,                         30  mg/g,                         60  mg/g,                         63  mg/g","CREAM","TOPICAL","M020","e.l.f. Cosmetics, Inc.","76354-787","ZINC OXIDE, TITANIUM DIOXIDE, HOMOSALATE, OCTISALATE, OCTOCRYLENE","HOMOSALATE;  OCTISALATE;  OCTOCRYLENE;  TITANIUM DIOXIDE;  ZINC OXIDE","HUMAN OTC DRUG","08/15/2023","N/A","OTC MONOGRAPH DRUG","1 TUBE in 1 CARTON (76354-787-01)  / 30 g in 1 TUBE","Copper Absorption Inhibitor [EPC],  Decreased Copper Ion Absorption [PE]","N/A","No","12/31/2025"
"Hydration Complex","43742-2053-1","8 [hp_X]/mL,                         1  [hp_X]/mL,                         1  [hp_X]/mL,                         1  [hp_X]/mL,                         6  [hp_X]/mL,                         1  [hp_X]/mL,                         8  [hp_X]/mL,                         6  [hp_X]/mL,                         3  [hp_X]/mL,                         1  [hp_X]/mL,                         1  [hp_X]/mL,                         1  [hp_X]/mL,                         6  [hp_X]/mL,                         6  [hp_X]/mL,                         8  [hp_X]/mL,                         1  [hp_X]/mL,                         8  [hp_X]/mL","LIQUID","ORAL","","Deseret Biologicals, Inc.","43742-2053","Boldo, Carduus Benedictus, Carduus Marianus, Chelidonium Majus, Coffea Tosta, Equisetum Arvense, Petroselinum Sativum, Taraxacum Officinale, Hypericum Perforatum, Ginkgo Biloba, Kali Muriaticum, Kali Phosphoricum, Kali Sulphuricum, Germanium Sesquioxide, Silicea, Calcarea Fluorica, Calcarea Phosphorica","CALCIUM FLUORIDE;  CENTAUREA BENEDICTA;  CHELIDONIUM MAJUS WHOLE;  COFFEA ARABICA SEED, ROASTED;  DIBASIC POTASSIUM PHOSPHATE;  EQUISETUM ARVENSE TOP;  GERMANIUM SESQUIOXIDE;  GINKGO;  HYPERICUM PERFORATUM WHOLE;  MILK THISTLE;  PETROSELINUM CRISPUM WHOLE;  PEUMUS BOLDUS LEAF;  POTASSIUM CHLORIDE;  POTASSIUM SULFATE;  SILICON DIOXIDE;  TARAXACUM OFFICINALE;  TRIBASIC CALCIUM PHOSPHATE","HUMAN OTC DRUG","05/04/2022","N/A","UNAPPROVED HOMEOPATHIC","60 mL in 1 BOTTLE, DROPPER (43742-2053-1)","Blood Coagulation Factor [EPC],  Calcium [CS],  Cations,  Divalent [CS],  Increased Coagulation Factor Activity [PE],  Increased Large Intestinal Motility [PE],  Increased Large Intestinal Motility [PE],  Inhibition Large Intestine Fluid/Electrolyte Absorption [PE],  Inhibition Large Intestine Fluid/Electrolyte Absorption [PE],  Osmotic Activity [MoA],  Osmotic Activity [MoA],  Osmotic Laxative [EPC],  Osmotic Laxative [EPC],  Phosphate Binder [EPC],  Phosphate Chelating Activity [MoA],  Potassium Compounds [CS],  Potassium Compounds [CS],  Potassium Salt [EPC],  Potassium Salt [EPC]","N/A","No","12/31/2025"
"HYDROCODONE BITARTRATE AND ACETAMINOPHEN","60429-592-01","325 mg/1,                         10  mg/1","TABLET","ORAL","ANDA040400","Golden State Medical Supply, Inc.","60429-592","HYDROCODONE BITARTRATE AND ACETAMINOPHEN","ACETAMINOPHEN;  HYDROCODONE BITARTRATE","HUMAN PRESCRIPTION DRUG","05/09/2019","N/A","ANDA","100 TABLET in 1 BOTTLE (60429-592-01)","Opioid Agonist [EPC],  Opioid Agonists [MoA]","CII","No","12/31/2025"
"HYDROCODONE BITARTRATE AND ACETAMINOPHEN","60429-592-05","325 mg/1,                         10  mg/1","TABLET","ORAL","ANDA040400","Golden State Medical Supply, Inc.","60429-592","HYDROCODONE BITARTRATE AND ACETAMINOPHEN","ACETAMINOPHEN;  HYDROCODONE BITARTRATE","HUMAN PRESCRIPTION DRUG","05/09/2019","N/A","ANDA","500 TABLET in 1 BOTTLE (60429-592-05)","Opioid Agonist [EPC],  Opioid Agonists [MoA]","CII","No","12/31/2025"
"Hydrocodone Bitartrate and Acetaminophen","71335-9602-1","325 mg/1,                         10  mg/1","TABLET","ORAL","ANDA211487","Bryant Ranch Prepack","71335-9602","Hydrocodone Bitartrate and Acetaminophen","ACETAMINOPHEN;  HYDROCODONE BITARTRATE","HUMAN PRESCRIPTION DRUG","12/12/2022","N/A","ANDA","21 TABLET in 1 BOTTLE (71335-9602-1)","Opioid Agonist [EPC],  Opioid Agonists [MoA]","CII","No","12/31/2024"
"Hydrocodone Bitartrate and Acetaminophen","71335-9602-2","325 mg/1,                         10  mg/1","TABLET","ORAL","ANDA211487","Bryant Ranch Prepack","71335-9602","Hydrocodone Bitartrate and Acetaminophen","ACETAMINOPHEN;  HYDROCODONE BITARTRATE","HUMAN PRESCRIPTION DRUG","12/12/2022","N/A","ANDA","15 TABLET in 1 BOTTLE (71335-9602-2)","Opioid Agonist [EPC],  Opioid Agonists [MoA]","CII","No","12/31/2024"
"Hydrocodone Bitartrate and Acetaminophen","71335-9602-3","325 mg/1,                         10  mg/1","TABLET","ORAL","ANDA211487","Bryant Ranch Prepack","71335-9602","Hydrocodone Bitartrate and Acetaminophen","ACETAMINOPHEN;  HYDROCODONE BITARTRATE","HUMAN PRESCRIPTION DRUG","12/12/2022","N/A","ANDA","10 TABLET in 1 BOTTLE (71335-9602-3)","Opioid Agonist [EPC],  Opioid Agonists [MoA]","CII","No","12/31/2024"
"Hydrocodone Bitartrate and Acetaminophen","0527-1651-01","325 mg/1,                         10  mg/1","TABLET","ORAL","ANDA207172","Lannett Company, Inc.","0527-1651","Hydrocodone Bitartrate and Acetaminophen","ACETAMINOPHEN;  HYDROCODONE BITARTRATE","HUMAN PRESCRIPTION DRUG","06/22/2017","N/A","ANDA","100 TABLET in 1 BOTTLE (0527-1651-01)","Opioid Agonist [EPC],  Opioid Agonists [MoA]","CII","No","12/31/2025"
"Hydrocodone Bitartrate and Acetaminophen","0527-1651-05","325 mg/1,                         10  mg/1","TABLET","ORAL","ANDA207172","Lannett Company, Inc.","0527-1651","Hydrocodone Bitartrate and Acetaminophen","ACETAMINOPHEN;  HYDROCODONE BITARTRATE","HUMAN PRESCRIPTION DRUG","06/22/2017","N/A","ANDA","500 TABLET in 1 BOTTLE (0527-1651-05)","Opioid Agonist [EPC],  Opioid Agonists [MoA]","CII","No","12/31/2025"
"Hydroxychloroquine Sulfate","69238-1544-5","200 mg/1","TABLET, FILM COATED","ORAL","ANDA210577","Amneal Pharmaceuticals NY LLC","69238-1544","Hydroxychloroquine Sulfate","HYDROXYCHLOROQUINE SULFATE","HUMAN PRESCRIPTION DRUG","09/17/2019","N/A","ANDA","500 TABLET, FILM COATED in 1 BOTTLE (69238-1544-5)","Antimalarial [EPC],  Antirheumatic Agent [EPC]","N/A","No","12/31/2025"
"Hydroxychloroquine Sulfate","69238-1544-1","200 mg/1","TABLET, FILM COATED","ORAL","ANDA210577","Amneal Pharmaceuticals NY LLC","69238-1544","Hydroxychloroquine Sulfate","HYDROXYCHLOROQUINE SULFATE","HUMAN PRESCRIPTION DRUG","05/17/2018","N/A","ANDA","100 TABLET, FILM COATED in 1 BOTTLE (69238-1544-1)","Antimalarial [EPC],  Antirheumatic Agent [EPC]","N/A","No","12/31/2025"
"Hydroxyzine Pamoate","70518-2769-0","100 mg/1","CAPSULE","ORAL","ANDA088488","REMEDYREPACK INC.","70518-2769","Hydroxyzine Pamoate","HYDROXYZINE PAMOATE","HUMAN PRESCRIPTION DRUG","06/08/2020","N/A","ANDA","30 CAPSULE in 1 BLISTER PACK (70518-2769-0)","Antihistamine [EPC],  Histamine Receptor Antagonists [MoA]","N/A","No","12/31/2025"
"Hydroxyzine Pamoate","68084-847-01","25 mg/1","CAPSULE","ORAL","ANDA087479","American Health Packaging","68084-847","Hydroxyzine Pamoate","HYDROXYZINE PAMOATE","HUMAN PRESCRIPTION DRUG","02/10/2015","05/31/2025","ANDA","100 BLISTER PACK in 1 BOX, UNIT-DOSE (68084-847-01)  / 1 CAPSULE in 1 BLISTER PACK (68084-847-11)","Antihistamine [EPC],  Histamine Receptor Antagonists [MoA]","N/A","No","N/A"
"Ibrance","63539-284-03","75 mg/1","TABLET, FILM COATED","ORAL","NDA212436","U.S. Pharmaceuticals","63539-284","palbociclib","PALBOCICLIB","HUMAN PRESCRIPTION DRUG","03/30/2020","N/A","NDA","3 DOSE PACK in 1 CARTON (63539-284-03)  / 7 TABLET, FILM COATED in 1 DOSE PACK (63539-284-07)","Cytochrome P450 3A Inhibitors [MoA],  Kinase Inhibitor [EPC],  Kinase Inhibitors [MoA]","N/A","No","12/31/2025"
"ICATIBANT","60505-6214-1","30 mg/3mL","INJECTION, SOLUTION","SUBCUTANEOUS","ANDA212081","Apotex Corp.","60505-6214","icatibant acetate","ICATIBANT ACETATE","HUMAN PRESCRIPTION DRUG","04/15/2021","N/A","ANDA","1 SYRINGE, GLASS in 1 CARTON (60505-6214-1)  / 3 mL in 1 SYRINGE, GLASS","Bradykinin B2 Receptor Antagonist [EPC],  Bradykinin B2 Receptor Antagonists [MoA]","N/A","No","12/31/2025"
"ICOSAPENT ETHYL","43602-547-05",".5 g/1","CAPSULE","ORAL","ANDA216811","Ascent Pharmaceuticals, Inc","43602-547","Icosapent ethyl","ICOSAPENT ETHYL","HUMAN PRESCRIPTION DRUG","09/02/2022","N/A","ANDA","500 CAPSULE in 1 BOTTLE (43602-547-05)","N/A","N/A","No","12/31/2025"
"ICOSAPENT ETHYL","43602-547-30",".5 g/1","CAPSULE","ORAL","ANDA216811","Ascent Pharmaceuticals, Inc","43602-547","Icosapent ethyl","ICOSAPENT ETHYL","HUMAN PRESCRIPTION DRUG","09/02/2022","N/A","ANDA","30 CAPSULE in 1 BOTTLE (43602-547-30)","N/A","N/A","No","12/31/2025"
"Icy Hot with Lidocaine No-Mess","41167-1715-3","4 g/100g,                         1  g/100g","LIQUID","TOPICAL","M017","Chattem, Inc.","41167-1715","menthol and lidocaine","LIDOCAINE;  MENTHOL","HUMAN OTC DRUG","01/21/2021","N/A","OTC MONOGRAPH DRUG","42.5 g in 1 BOTTLE (41167-1715-3)","Amide Local Anesthetic [EPC],  Amides [CS],  Antiarrhythmic [EPC],  Local Anesthesia [PE]","N/A","No","12/31/2024"
"Icy Hot with Lidocaine No-Mess","41167-1715-1","4 g/100g,                         1  g/100g","LIQUID","TOPICAL","M017","Chattem, Inc.","41167-1715","menthol and lidocaine","LIDOCAINE;  MENTHOL","HUMAN OTC DRUG","01/01/2018","N/A","OTC MONOGRAPH DRUG","70.8 g in 1 BOTTLE (41167-1715-1)","Amide Local Anesthetic [EPC],  Amides [CS],  Antiarrhythmic [EPC],  Local Anesthesia [PE]","N/A","No","12/31/2024"
"IMPECCABLE SKIN - MOCHA","69949-157-01","150 mg/g","CREAM","TOPICAL","M020","Synchronicity Spa, Inc. DBA Suntegrity","69949-157","Zinc Oxide","ZINC OXIDE","HUMAN OTC DRUG","10/01/2023","N/A","OTC MONOGRAPH DRUG","56.7 g in 1 TUBE (69949-157-01)","N/A","N/A","No","12/31/2024"
"Indomethacin","68462-406-10","25 mg/1","CAPSULE","ORAL","ANDA091276","Glenmark Pharmaceuticals Inc., USA","68462-406","Indomethacin","INDOMETHACIN","HUMAN PRESCRIPTION DRUG","12/22/2010","N/A","ANDA","1000 CAPSULE in 1 BOTTLE (68462-406-10)","Anti-Inflammatory Agents,  Non-Steroidal [CS],  Cyclooxygenase Inhibitors [MoA],  Nonsteroidal Anti-inflammatory Drug [EPC]","N/A","No","12/31/2025"
"Indomethacin","68462-406-01","25 mg/1","CAPSULE","ORAL","ANDA091276","Glenmark Pharmaceuticals Inc., USA","68462-406","Indomethacin","INDOMETHACIN","HUMAN PRESCRIPTION DRUG","12/22/2010","N/A","ANDA","100 CAPSULE in 1 BOTTLE (68462-406-01)","Anti-Inflammatory Agents,  Non-Steroidal [CS],  Cyclooxygenase Inhibitors [MoA],  Nonsteroidal Anti-inflammatory Drug [EPC]","N/A","No","12/31/2025"
"Indomethacin","70954-637-10","25 mg/5mL","SUSPENSION","ORAL","ANDA217883","ANI Pharmaceuticals, Inc.","70954-637","Indomethacin","INDOMETHACIN","HUMAN PRESCRIPTION DRUG","01/12/2024","N/A","ANDA","1 BOTTLE in 1 CARTON (70954-637-10)  / 237 mL in 1 BOTTLE","Anti-Inflammatory Agents,  Non-Steroidal [CS],  Cyclooxygenase Inhibitors [MoA],  Nonsteroidal Anti-inflammatory Drug [EPC]","N/A","No","12/31/2025"
"IRINOTECAN HYDROCHLORIDE","55150-354-01","20 mg/mL","INJECTION, SOLUTION","INTRAVENOUS","ANDA213278","Eugia US LLC","55150-354","IRINOTECAN HYDROCHLORIDE","IRINOTECAN HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","02/11/2020","N/A","ANDA","1 VIAL, SINGLE-DOSE in 1 CARTON (55150-354-01)  / 15 mL in 1 VIAL, SINGLE-DOSE","Topoisomerase Inhibitor [EPC],  Topoisomerase Inhibitors [MoA]","N/A","No","12/31/2024"
"Isopropyl Alcohol","68016-804-43","91 mL/100mL","LIQUID","TOPICAL","part333A","Pharmacy Value Alliance LLC","68016-804","Isopropyl Alcohol","ISOPROPYL ALCOHOL","HUMAN OTC DRUG","08/15/2003","N/A","OTC MONOGRAPH NOT FINAL","473 mL in 1 BOTTLE, PLASTIC (68016-804-43)","N/A","N/A","No","12/31/2024"
"Isopropyl Alcohol","68016-804-45","91 mL/100mL","LIQUID","TOPICAL","part333A","Pharmacy Value Alliance LLC","68016-804","Isopropyl Alcohol","ISOPROPYL ALCOHOL","HUMAN OTC DRUG","08/15/2003","N/A","OTC MONOGRAPH NOT FINAL","946 mL in 1 BOTTLE, PLASTIC (68016-804-45)","N/A","N/A","No","12/31/2024"
"Isopropyl alcohol","11673-077-32","91 mL/100mL","LIQUID","TOPICAL","M003","TARGET Corporation","11673-077","Isopropyl alcohol","ISOPROPYL ALCOHOL","HUMAN OTC DRUG","01/11/2018","N/A","OTC MONOGRAPH DRUG","946 mL in 1 BOTTLE, PLASTIC (11673-077-32)","N/A","N/A","No","12/31/2024"
"JAFRA Fruteria Coco Fresco Lip Balm","68828-010-01","1 g/100mL","GEL","TOPICAL","part347","Jafra Cosmetics International, Inc.","68828-010","DIMETHICONE","DIMETHICONE","HUMAN OTC DRUG","06/01/2023","N/A","OTC MONOGRAPH FINAL","1 TUBE in 1 CARTON (68828-010-01)  / 15 mL in 1 TUBE","Skin Barrier Activity [PE]","N/A","No","12/31/2024"
"JUANCHI Tattoo Numbing","83603-001-02","5 g/100g","CREAM","TOPICAL","M017","Shenzhen Langmi Technology Co., Ltd.","83603-001","Lidocaine","LIDOCAINE","HUMAN OTC DRUG","08/07/2023","N/A","OTC MONOGRAPH FINAL","1 BOTTLE in 1 PACKAGE (83603-001-02)  / 50 g in 1 BOTTLE","Amide Local Anesthetic [EPC],  Amides [CS],  Antiarrhythmic [EPC],  Local Anesthesia [PE]","N/A","No","12/31/2024"
"KERA HC","44577-623-02","1 g/100g","CREAM","TOPICAL","M017","Clinical Therapeutic Solutions","44577-623","HYDROCORTISONE","HYDROCORTISONE","HUMAN OTC DRUG","02/06/2017","N/A","OTC MONOGRAPH DRUG","56 g in 1 TUBE (44577-623-02)","Corticosteroid Hormone Receptor Agonists [MoA],  Corticosteroid [EPC]","N/A","No","12/31/2024"
"Kerendia","50419-540-01","10 mg/1","TABLET, FILM COATED","ORAL","NDA215341","Bayer Healthcare Pharmaceuticals Inc.","50419-540","finerenone","FINERENONE","HUMAN PRESCRIPTION DRUG","07/09/2021","N/A","NDA","30 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (50419-540-01)","Mineralocorticoid Receptor Antagonists [MoA],  Nonsteroidal Mineralocorticoid-Receptor Antagonist [EPC]","N/A","No","12/31/2024"
"Kerendia","50419-540-02","10 mg/1","TABLET, FILM COATED","ORAL","NDA215341","Bayer Healthcare Pharmaceuticals Inc.","50419-540","finerenone","FINERENONE","HUMAN PRESCRIPTION DRUG","07/09/2021","N/A","NDA","90 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (50419-540-02)","Mineralocorticoid Receptor Antagonists [MoA],  Nonsteroidal Mineralocorticoid-Receptor Antagonist [EPC]","N/A","No","12/31/2024"
"Kerendia","50419-540-70","10 mg/1","TABLET, FILM COATED","ORAL","NDA215341","Bayer Healthcare Pharmaceuticals Inc.","50419-540","finerenone","FINERENONE","HUMAN PRESCRIPTION DRUG","07/09/2021","N/A","NDA","7 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (50419-540-70)","Mineralocorticoid Receptor Antagonists [MoA],  Nonsteroidal Mineralocorticoid-Receptor Antagonist [EPC]","N/A","No","12/31/2024"
"Kids Pain and Fever","69676-0089-9","160 mg/5mL","LIQUID","ORAL","part343","Genexa Inc.","69676-0089","Acetaminophen","ACETAMINOPHEN","HUMAN OTC DRUG","05/30/2023","N/A","OTC MONOGRAPH NOT FINAL","2 BOTTLE, PLASTIC in 1 CARTON (69676-0089-9)  / 118 mL in 1 BOTTLE, PLASTIC","N/A","N/A","No","12/31/2024"
"KINETIC ICE Muscle and Joint Pain Relief Cream","81050-108-00","100 mg/mL","CREAM","TOPICAL","M017","No Reason, LLC","81050-108","MENTHOL","MENTHOL","HUMAN OTC DRUG","11/10/2020","N/A","OTC MONOGRAPH DRUG","118 mL in 1 JAR (81050-108-00)","N/A","N/A","No","12/31/2024"
"Kirkland Signature Nicotine","63981-190-37","4 mg/1","LOZENGE","ORAL","ANDA090711","Costco Wholesale Company","63981-190","nicotine","NICOTINE","HUMAN OTC DRUG","05/08/2020","N/A","ANDA","10 CONTAINER in 1 PACKAGE (63981-190-37)  / 27 LOZENGE in 1 CONTAINER","Cholinergic Nicotinic Agonist [EPC],  Nicotine [CS]","N/A","No","12/31/2024"
"Kopari Sunglaze Sheer Body Mist Sunscreen SPF42","84130-000-00","30 mg/mL,                         5  mg/mL,                         50  mg/mL,                         100  mg/mL","SPRAY","TOPICAL","M020","Kopari Beauty","84130-000","AVOBENZONE, HOMOSALATE, OCTISALATE, OCTOCRYLENE","AVOBENZONE;  HOMOSALATE;  OCTISALATE;  OCTOCRYLENE","HUMAN OTC DRUG","02/05/2024","N/A","OTC MONOGRAPH DRUG","140 mL in 1 BOTTLE (84130-000-00)","N/A","N/A","No","12/31/2025"
"LA Bodies Eclipse Sunscreen SPF 30","20146-4007-1","20 mg/g,                         130  mg/g,                         50  mg/g,                         20  mg/g,                         40  mg/g","LOTION","TOPICAL","M020","SAMSON PHARMACEUTICAL","20146-4007","Avobenzone, Homosalate, Octisalate, Octocrylene, and Oxybenzone","AVOBENZONE;  HOMOSALATE;  OCTISALATE;  OCTOCRYLENE;  OXYBENZONE","HUMAN OTC DRUG","01/01/2015","N/A","OTC MONOGRAPH DRUG","28 g in 1 TUBE (20146-4007-1)","N/A","N/A","No","12/31/2025"
"LA Bodies Eclipse Sunscreen SPF 30","20146-4007-2","20 mg/g,                         130  mg/g,                         50  mg/g,                         20  mg/g,                         40  mg/g","LOTION","TOPICAL","M020","SAMSON PHARMACEUTICAL","20146-4007","Avobenzone, Homosalate, Octisalate, Octocrylene, and Oxybenzone","AVOBENZONE;  HOMOSALATE;  OCTISALATE;  OCTOCRYLENE;  OXYBENZONE","HUMAN OTC DRUG","01/01/2015","N/A","OTC MONOGRAPH DRUG","85 g in 1 TUBE (20146-4007-2)","N/A","N/A","No","12/31/2025"
"Lactulose Solution","64980-592-12","10 g/15mL","SOLUTION","ORAL; RECTAL","ANDA076645","Rising Pharmaceuticals, Inc.","64980-592","Lactulose Solution USP, 10 g/15 mL","LACTULOSE","HUMAN PRESCRIPTION DRUG","05/25/2023","N/A","ANDA","118 mL in 1 BOTTLE (64980-592-12)","Acidifying Activity [MoA],  Osmotic Activity [MoA],  Osmotic Laxative [EPC],  Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]","N/A","No","12/31/2024"
"Lactulose Solution","64980-592-24","10 g/15mL","SOLUTION","ORAL; RECTAL","ANDA076645","Rising Pharmaceuticals, Inc.","64980-592","Lactulose Solution USP, 10 g/15 mL","LACTULOSE","HUMAN PRESCRIPTION DRUG","05/25/2023","N/A","ANDA","236 mL in 1 BOTTLE (64980-592-24)","Acidifying Activity [MoA],  Osmotic Activity [MoA],  Osmotic Laxative [EPC],  Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]","N/A","No","12/31/2024"
"Lactulose Solution","64980-592-48","10 g/15mL","SOLUTION","ORAL; RECTAL","ANDA076645","Rising Pharmaceuticals, Inc.","64980-592","Lactulose Solution USP, 10 g/15 mL","LACTULOSE","HUMAN PRESCRIPTION DRUG","05/25/2023","N/A","ANDA","473 mL in 1 BOTTLE (64980-592-48)","Acidifying Activity [MoA],  Osmotic Activity [MoA],  Osmotic Laxative [EPC],  Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]","N/A","No","12/31/2024"
"Lactulose Solution","64980-592-95","10 g/15mL","SOLUTION","ORAL; RECTAL","ANDA076645","Rising Pharmaceuticals, Inc.","64980-592","Lactulose Solution USP, 10 g/15 mL","LACTULOSE","HUMAN PRESCRIPTION DRUG","05/25/2023","N/A","ANDA","946 mL in 1 BOTTLE (64980-592-95)","Acidifying Activity [MoA],  Osmotic Activity [MoA],  Osmotic Laxative [EPC],  Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]","N/A","No","12/31/2024"
"Lambs Quarter","22840-1341-1",".001 g/mL","SOLUTION","INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS","BLA101833","Greer Laboratories, Inc.","22840-1341","Chenopodium album","CHENOPODIUM ALBUM POLLEN","NON-STANDARDIZED ALLERGENIC","09/15/1981","N/A","BLA","5 mL in 1 VIAL, MULTI-DOSE (22840-1341-1)","Allergens [CS],  Cell-mediated Immunity [PE],  Increased Histamine Release [PE],  Increased IgG Production [PE],  Non-Standardized Pollen Allergenic Extract [EPC],  Pollen [CS]","N/A","No","12/31/2024"
"Lantus Solostar","50090-1398-0","100 [iU]/mL","INJECTION, SOLUTION","SUBCUTANEOUS","BLA021081","A-S Medication Solutions","50090-1398","insulin glargine","INSULIN GLARGINE","HUMAN PRESCRIPTION DRUG","11/28/2014","N/A","BLA","5 SYRINGE in 1 PACKAGE (50090-1398-0)  / 3 mL in 1 SYRINGE","Insulin Analog [EPC],  Insulin [CS]","N/A","No","12/31/2024"
"Laxative","55910-792-56","5 mg/1","TABLET, DELAYED RELEASE","ORAL","505G(a)(3)","DOLGENCORP, LLC","55910-792","Bisacodyl","BISACODYL","HUMAN OTC DRUG","01/24/2024","N/A","OTC MONOGRAPH DRUG","1 BLISTER PACK in 1 CARTON (55910-792-56)  / 25 TABLET, DELAYED RELEASE in 1 BLISTER PACK","Increased Large Intestinal Motility [PE],  Stimulant Laxative [EPC],  Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]","N/A","No","12/31/2025"
"LC FOUNDATION SPF 15","59735-401-01","5 g/100g,                         5  g/100g","CREAM","TOPICAL","M020","MANA Products INC.","59735-401","LC FOUNDATION SPF 15","TITANIUM DIOXIDE;  ZINC OXIDE","HUMAN OTC DRUG","08/25/2020","N/A","OTC MONOGRAPH DRUG","30 g in 1 TUBE (59735-401-01)","N/A","N/A","No","12/31/2025"
"Leader Cooling Pain Relief","70000-0618-1","40 mg/mL","GEL","TOPICAL","M017","Cardinal Health, 110 dba LEADER","70000-0618","MENTHOL, UNSPECIFIED FORM","MENTHOL, UNSPECIFIED FORM","HUMAN OTC DRUG","11/03/2022","N/A","OTC MONOGRAPH DRUG","89 mL in 1 TUBE (70000-0618-1)","N/A","N/A","No","12/31/2025"
"Leader Dry Eye Relief Eye Drops","70000-0502-1",".2 g/100mL,                         .2  g/100mL,                         1  g/100mL","SOLUTION/ DROPS","OPHTHALMIC","M018","Cardinal Health","70000-0502","Glycerin, Hypromellose, Polyethylene glycol 400","GLYCERIN;  HYPROMELLOSE, UNSPECIFIED;  POLYETHYLENE GLYCOL 400","HUMAN OTC DRUG","04/30/2019","N/A","OTC MONOGRAPH DRUG","1 BOTTLE, PLASTIC in 1 CARTON (70000-0502-1)  / 15 mL in 1 BOTTLE, PLASTIC","Allergens [CS],  Cell-mediated Immunity [PE],  Glycerol [CS],  Increased Histamine Release [PE],  Increased IgG Production [PE],  Non-Standardized Chemical Allergen [EPC]","N/A","No","12/31/2024"
"Leader Dry Eye Relief Eye Drops","70000-0502-2",".2 g/100mL,                         .2  g/100mL,                         1  g/100mL","SOLUTION/ DROPS","OPHTHALMIC","M018","Cardinal Health","70000-0502","Glycerin, Hypromellose, Polyethylene glycol 400","GLYCERIN;  HYPROMELLOSE, UNSPECIFIED;  POLYETHYLENE GLYCOL 400","HUMAN OTC DRUG","04/30/2019","N/A","OTC MONOGRAPH DRUG","2 BOTTLE, PLASTIC in 1 CARTON (70000-0502-2)  / 15 mL in 1 BOTTLE, PLASTIC","Allergens [CS],  Cell-mediated Immunity [PE],  Glycerol [CS],  Increased Histamine Release [PE],  Increased IgG Production [PE],  Non-Standardized Chemical Allergen [EPC]","N/A","No","12/31/2024"
"Leader Medicated Dandruff","70000-0531-1","10 mg/mL","SHAMPOO","TOPICAL","M032","Cardinal Health, 110 dba LEADER","70000-0531","Selenium Sulfide","SELENIUM SULFIDE","HUMAN OTC DRUG","11/05/2019","N/A","OTC MONOGRAPH DRUG","207 mL in 1 BOTTLE, PLASTIC (70000-0531-1)","N/A","N/A","No","12/31/2025"
"Leader Therapeutic Dandruff","70000-0550-1","30 mg/mL","SHAMPOO","TOPICAL","M032","Cardinal Health","70000-0550","Salicylic Acid","SALICYLIC ACID","HUMAN OTC DRUG","08/30/2022","N/A","OTC MONOGRAPH DRUG","133 mL in 1 BOTTLE, PLASTIC (70000-0550-1)","N/A","N/A","No","12/31/2025"
"Leena","51862-471-06","","KIT","","NDA018977","Mayne Pharma Inc.","51862-471","Norethindrone and Ethinyl Estradiol","","HUMAN PRESCRIPTION DRUG","08/03/2016","11/30/2025","NDA AUTHORIZED GENERIC","6 BLISTER PACK in 1 CARTON (51862-471-06)  / 1 KIT in 1 BLISTER PACK (51862-471-01)","N/A","N/A","No","N/A"
"Lenscale Quailbrush","22840-1343-2","20000 [PNU]/mL","SOLUTION","INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS","BLA101833","Greer Laboratories, Inc.","22840-1343","Atriplex lentiformis","ATRIPLEX LENTIFORMIS POLLEN","NON-STANDARDIZED ALLERGENIC","09/15/1981","N/A","BLA","10 mL in 1 VIAL, MULTI-DOSE (22840-1343-2)","Allergens [CS],  Cell-mediated Immunity [PE],  Increased Histamine Release [PE],  Increased IgG Production [PE],  Non-Standardized Pollen Allergenic Extract [EPC],  Pollen [CS]","N/A","No","12/31/2024"
"Levetiracetam","67457-265-10","10 mg/mL","INJECTION","INTRAVENOUS","NDA202543","Mylan Institutional LLC","67457-265","Levetiracetam","LEVETIRACETAM","HUMAN PRESCRIPTION DRUG","01/16/2012","N/A","NDA","10 BAG in 1 CARTON (67457-265-10)  / 100 mL in 1 BAG (67457-265-00)","Decreased Central Nervous System Disorganized Electrical Activity [PE]","N/A","No","12/31/2025"
"Lidocaine 5%","24689-124-01","5 g/100g","CREAM","RECTAL; TOPICAL","M015","Apnar Pharma LP","24689-124","Lidocaine","LIDOCAINE","HUMAN OTC DRUG","11/01/2021","N/A","OTC MONOGRAPH DRUG","1 TUBE in 1 CARTON (24689-124-01)  / 30 g in 1 TUBE","Amide Local Anesthetic [EPC],  Amides [CS],  Antiarrhythmic [EPC],  Local Anesthesia [PE]","N/A","No","12/31/2024"
"Lidocaine Hydrochloride and Dextrose","0264-9594-10","5 g/100mL,                         .4  g/100mL","INJECTION, SOLUTION","INTRAVENOUS","NDA019830","B. Braun Medical Inc.","0264-9594","LIDOCAINE HYDROCHLORIDE ANHYDROUS and DEXTROSE MONOHYDRATE","DEXTROSE MONOHYDRATE;  LIDOCAINE HYDROCHLORIDE ANHYDROUS","HUMAN PRESCRIPTION DRUG","04/08/1992","N/A","NDA","24 CONTAINER in 1 CASE (0264-9594-10)  / 500 mL in 1 CONTAINER","Amide Local Anesthetic [EPC],  Amides [CS],  Antiarrhythmic [EPC],  Local Anesthesia [PE]","N/A","No","12/31/2024"
"Lidocaine Hydrochloride and Dextrose","0264-9594-20","5 g/100mL,                         .4  g/100mL","INJECTION, SOLUTION","INTRAVENOUS","NDA019830","B. Braun Medical Inc.","0264-9594","LIDOCAINE HYDROCHLORIDE ANHYDROUS and DEXTROSE MONOHYDRATE","DEXTROSE MONOHYDRATE;  LIDOCAINE HYDROCHLORIDE ANHYDROUS","HUMAN PRESCRIPTION DRUG","04/08/1992","N/A","NDA","24 CONTAINER in 1 CASE (0264-9594-20)  / 250 mL in 1 CONTAINER","Amide Local Anesthetic [EPC],  Amides [CS],  Antiarrhythmic [EPC],  Local Anesthesia [PE]","N/A","No","12/31/2024"
"Lidocaine Pain Relief with Lavender","66902-057-03","38 mg/mL","LIQUID","TOPICAL","part348","Natural Essentials, Inc.","66902-057","LIDOCAINE HYDROCHLORIDE","LIDOCAINE HYDROCHLORIDE","HUMAN OTC DRUG","01/22/2021","N/A","OTC MONOGRAPH NOT FINAL","1 BOTTLE, WITH APPLICATOR in 1 CARTON (66902-057-03)  / 73 mL in 1 BOTTLE, WITH APPLICATOR","Amide Local Anesthetic [EPC],  Amides [CS],  Antiarrhythmic [EPC],  Local Anesthesia [PE]","N/A","No","12/31/2024"
"Lilikoi Mineral Defense Sport Sunscreen SPF 30","15751-3040-6","200 mg/mL","CREAM","TOPICAL","M020","Eminence Organic Skin Care Ltd.","15751-3040","ZINC OXIDE","ZINC OXIDE","HUMAN OTC DRUG","03/01/2019","N/A","OTC MONOGRAPH DRUG","3 mL in 1 PACKET (15751-3040-6)","Copper Absorption Inhibitor [EPC],  Decreased Copper Ion Absorption [PE]","N/A","Yes","12/31/2024"
"Lilikoi Mineral Defense Sport Sunscreen SPF 30","15751-3040-5","200 mg/mL","CREAM","TOPICAL","M020","Eminence Organic Skin Care Ltd.","15751-3040","ZINC OXIDE","ZINC OXIDE","HUMAN OTC DRUG","03/01/2019","N/A","OTC MONOGRAPH DRUG","1 TUBE in 1 BOX (15751-3040-5)  / 147 mL in 1 TUBE","Copper Absorption Inhibitor [EPC],  Decreased Copper Ion Absorption [PE]","N/A","No","12/31/2024"
"Lip Clear Lysine Plus","70084-320-07","1 mg/g","OINTMENT","TOPICAL","part341","Quantum, Inc.","70084-320","Menthol, Unspecified Form","MENTHOL, UNSPECIFIED FORM","HUMAN OTC DRUG","10/01/1984","N/A","OTC MONOGRAPH FINAL","1 TUBE in 1 CARTON (70084-320-07)  / 7 g in 1 TUBE","N/A","N/A","No","12/31/2024"
"Lithostat","0178-0500-01","250 mg/1","TABLET","ORAL","NDA018749","Mission Pharmacal Company","0178-0500","acetohydroxamic acid","ACETOHYDROXAMIC ACID","HUMAN PRESCRIPTION DRUG","05/31/1983","N/A","NDA","100 TABLET in 1 BOTTLE (0178-0500-01)","Urease Inhibitor [EPC],  Urease Inhibitors [MoA]","N/A","No","12/31/2025"
"LOKELMA","50090-6502-0","5 g/5g","POWDER, FOR SUSPENSION","ORAL","NDA207078","A-S Medication Solutions","50090-6502","sodium zirconium cyclosilicate","SODIUM ZIRCONIUM CYCLOSILICATE","HUMAN PRESCRIPTION DRUG","05/25/2023","N/A","NDA","30 PACKET in 1 BOX (50090-6502-0)  / 5 g in 1 PACKET","N/A","N/A","No","12/31/2024"
"Lorazepam","68788-7533-1","2 mg/1","TABLET","ORAL","ANDA203572","Preferred Pharmaceuticals, Inc.","68788-7533","Lorazepam","LORAZEPAM","HUMAN PRESCRIPTION DRUG","10/04/2019","N/A","ANDA","100 TABLET in 1 BOTTLE (68788-7533-1)","Benzodiazepine [EPC],  Benzodiazepines [CS]","CIV","No","12/31/2024"
"Lorazepam","68788-7533-3","2 mg/1","TABLET","ORAL","ANDA203572","Preferred Pharmaceuticals, Inc.","68788-7533","Lorazepam","LORAZEPAM","HUMAN PRESCRIPTION DRUG","10/04/2019","N/A","ANDA","30 TABLET in 1 BOTTLE (68788-7533-3)","Benzodiazepine [EPC],  Benzodiazepines [CS]","CIV","No","12/31/2024"
"Lorazepam","68788-7533-6","2 mg/1","TABLET","ORAL","ANDA203572","Preferred Pharmaceuticals, Inc.","68788-7533","Lorazepam","LORAZEPAM","HUMAN PRESCRIPTION DRUG","10/04/2019","N/A","ANDA","60 TABLET in 1 BOTTLE (68788-7533-6)","Benzodiazepine [EPC],  Benzodiazepines [CS]","CIV","No","12/31/2024"
"Lorazepam","68788-7533-8","2 mg/1","TABLET","ORAL","ANDA203572","Preferred Pharmaceuticals, Inc.","68788-7533","Lorazepam","LORAZEPAM","HUMAN PRESCRIPTION DRUG","10/04/2019","N/A","ANDA","120 TABLET in 1 BOTTLE (68788-7533-8)","Benzodiazepine [EPC],  Benzodiazepines [CS]","CIV","No","12/31/2024"
"Lorazepam","68788-7533-9","2 mg/1","TABLET","ORAL","ANDA203572","Preferred Pharmaceuticals, Inc.","68788-7533","Lorazepam","LORAZEPAM","HUMAN PRESCRIPTION DRUG","10/04/2019","N/A","ANDA","90 TABLET in 1 BOTTLE (68788-7533-9)","Benzodiazepine [EPC],  Benzodiazepines [CS]","CIV","No","12/31/2024"
"Losartan Potassium","68788-8186-3","100 mg/1","TABLET, FILM COATED","ORAL","ANDA091497","Preferred Pharmaceuticals Inc.","68788-8186","Losartan Potassium","LOSARTAN POTASSIUM","HUMAN PRESCRIPTION DRUG","05/06/2022","N/A","ANDA","30 TABLET, FILM COATED in 1 BOTTLE (68788-8186-3)","Angiotensin 2 Receptor Antagonists [MoA],  Angiotensin 2 Receptor Blocker [EPC]","N/A","No","12/31/2024"
"Losartan Potassium","68788-8186-6","100 mg/1","TABLET, FILM COATED","ORAL","ANDA091497","Preferred Pharmaceuticals Inc.","68788-8186","Losartan Potassium","LOSARTAN POTASSIUM","HUMAN PRESCRIPTION DRUG","05/06/2022","N/A","ANDA","60 TABLET, FILM COATED in 1 BOTTLE (68788-8186-6)","Angiotensin 2 Receptor Antagonists [MoA],  Angiotensin 2 Receptor Blocker [EPC]","N/A","No","12/31/2024"
"Losartan Potassium","68788-8186-9","100 mg/1","TABLET, FILM COATED","ORAL","ANDA091497","Preferred Pharmaceuticals Inc.","68788-8186","Losartan Potassium","LOSARTAN POTASSIUM","HUMAN PRESCRIPTION DRUG","05/06/2022","N/A","ANDA","90 TABLET, FILM COATED in 1 BOTTLE (68788-8186-9)","Angiotensin 2 Receptor Antagonists [MoA],  Angiotensin 2 Receptor Blocker [EPC]","N/A","No","12/31/2024"
"Losartan Potassium","68788-8186-1","100 mg/1","TABLET, FILM COATED","ORAL","ANDA091497","Preferred Pharmaceuticals Inc.","68788-8186","Losartan Potassium","LOSARTAN POTASSIUM","HUMAN PRESCRIPTION DRUG","05/06/2022","N/A","ANDA","100 TABLET, FILM COATED in 1 BOTTLE (68788-8186-1)","Angiotensin 2 Receptor Antagonists [MoA],  Angiotensin 2 Receptor Blocker [EPC]","N/A","No","12/31/2024"
"LOTEMAX","24208-503-07","5 mg/g","GEL","OPHTHALMIC","NDA202872","Bausch & Lomb Incorporated","24208-503","loteprednol etabonate","LOTEPREDNOL ETABONATE","HUMAN PRESCRIPTION DRUG","10/12/2012","N/A","NDA","1 BOTTLE in 1 CARTON (24208-503-07)  / 5 g in 1 BOTTLE","Corticosteroid Hormone Receptor Agonists [MoA],  Corticosteroid [EPC]","N/A","No","12/31/2024"
"LOTEMAX","24208-503-48","5 mg/g","GEL","OPHTHALMIC","NDA202872","Bausch & Lomb Incorporated","24208-503","loteprednol etabonate","LOTEPREDNOL ETABONATE","HUMAN PRESCRIPTION DRUG","10/12/2012","N/A","NDA","1 BOTTLE in 1 CARTON (24208-503-48)  / .5 g in 1 BOTTLE","Corticosteroid Hormone Receptor Agonists [MoA],  Corticosteroid [EPC]","N/A","No","12/31/2024"
"LOTEMAX","24208-503-96","5 mg/g","GEL","OPHTHALMIC","NDA202872","Bausch & Lomb Incorporated","24208-503","loteprednol etabonate","LOTEPREDNOL ETABONATE","HUMAN PRESCRIPTION DRUG","10/12/2012","N/A","NDA","1 BOTTLE in 1 CARTON (24208-503-96)  / 5 g in 1 BOTTLE","Corticosteroid Hormone Receptor Agonists [MoA],  Corticosteroid [EPC]","N/A","No","12/31/2024"
"Lovastatin","43063-548-95","40 mg/1","TABLET","ORAL","ANDA075991","PD-Rx Pharmaceuticals, Inc.","43063-548","Lovastatin","LOVASTATIN","HUMAN PRESCRIPTION DRUG","09/16/2022","N/A","ANDA","1000 TABLET in 1 BOTTLE, PLASTIC (43063-548-95)","HMG-CoA Reductase Inhibitor [EPC],  Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]","N/A","No","12/31/2025"
"Lovastatin","43063-548-93","40 mg/1","TABLET","ORAL","ANDA075991","PD-Rx Pharmaceuticals, Inc.","43063-548","Lovastatin","LOVASTATIN","HUMAN PRESCRIPTION DRUG","12/24/2014","N/A","ANDA","180 TABLET in 1 BOTTLE, PLASTIC (43063-548-93)","HMG-CoA Reductase Inhibitor [EPC],  Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]","N/A","No","12/31/2025"
"Lovastatin","43063-548-30","40 mg/1","TABLET","ORAL","ANDA075991","PD-Rx Pharmaceuticals, Inc.","43063-548","Lovastatin","LOVASTATIN","HUMAN PRESCRIPTION DRUG","11/15/2014","N/A","ANDA","30 TABLET in 1 BOTTLE, PLASTIC (43063-548-30)","HMG-CoA Reductase Inhibitor [EPC],  Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]","N/A","No","12/31/2025"
"Lovastatin","43063-548-90","40 mg/1","TABLET","ORAL","ANDA075991","PD-Rx Pharmaceuticals, Inc.","43063-548","Lovastatin","LOVASTATIN","HUMAN PRESCRIPTION DRUG","11/15/2014","N/A","ANDA","90 TABLET in 1 BOTTLE, PLASTIC (43063-548-90)","HMG-CoA Reductase Inhibitor [EPC],  Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]","N/A","No","12/31/2025"
"Lovastatin","43063-548-14","40 mg/1","TABLET","ORAL","ANDA075991","PD-Rx Pharmaceuticals, Inc.","43063-548","Lovastatin","LOVASTATIN","HUMAN PRESCRIPTION DRUG","11/15/2014","N/A","ANDA","14 TABLET in 1 BOTTLE, PLASTIC (43063-548-14)","HMG-CoA Reductase Inhibitor [EPC],  Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]","N/A","No","12/31/2025"
"Lurasidone hydrochloride","68382-967-01","80 mg/1","TABLET, COATED","ORAL","ANDA208052","Zydus Pharmaceuticals USA Inc.","68382-967","Lurasidone hydrochloride","LURASIDONE HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","02/01/2023","N/A","ANDA","100 TABLET, COATED in 1 BOTTLE (68382-967-01)","Atypical Antipsychotic [EPC]","N/A","No","12/31/2024"
"Lurasidone hydrochloride","68382-967-05","80 mg/1","TABLET, COATED","ORAL","ANDA208052","Zydus Pharmaceuticals USA Inc.","68382-967","Lurasidone hydrochloride","LURASIDONE HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","02/01/2023","N/A","ANDA","500 TABLET, COATED in 1 BOTTLE (68382-967-05)","Atypical Antipsychotic [EPC]","N/A","No","12/31/2024"
"Lurasidone hydrochloride","68382-967-06","80 mg/1","TABLET, COATED","ORAL","ANDA208052","Zydus Pharmaceuticals USA Inc.","68382-967","Lurasidone hydrochloride","LURASIDONE HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","02/01/2023","N/A","ANDA","30 TABLET, COATED in 1 BOTTLE (68382-967-06)","Atypical Antipsychotic [EPC]","N/A","No","12/31/2024"
"Lurasidone hydrochloride","68382-967-16","80 mg/1","TABLET, COATED","ORAL","ANDA208052","Zydus Pharmaceuticals USA Inc.","68382-967","Lurasidone hydrochloride","LURASIDONE HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","02/01/2023","N/A","ANDA","90 TABLET, COATED in 1 BOTTLE (68382-967-16)","Atypical Antipsychotic [EPC]","N/A","No","12/31/2024"
"Lurasidone hydrochloride","68382-967-77","80 mg/1","TABLET, COATED","ORAL","ANDA208052","Zydus Pharmaceuticals USA Inc.","68382-967","Lurasidone hydrochloride","LURASIDONE HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","02/01/2023","N/A","ANDA","100 BLISTER PACK in 1 CARTON (68382-967-77)  / 1 TABLET, COATED in 1 BLISTER PACK (68382-967-30)","Atypical Antipsychotic [EPC]","N/A","No","12/31/2024"
"LYVISPAH","64896-076-09","5 mg/1","GRANULE","ORAL","NDA215422","Amneal Pharmaceuticals LLC","64896-076","baclofen","BACLOFEN","HUMAN PRESCRIPTION DRUG","06/01/2023","N/A","NDA","90 PACKET in 1 CARTON (64896-076-09)  / 1 GRANULE in 1 PACKET","GABA A Agonists [MoA],  GABA B Agonists [MoA],  gamma-Aminobutyric Acid-ergic Agonist [EPC]","N/A","No","12/31/2024"
"Magnesium Oxide","0603-0209-22","400 mg/1","TABLET","ORAL","M001","PAR Pharmaceuticals","0603-0209","Magnesium Oxide","MAGNESIUM OXIDE","HUMAN OTC DRUG","07/01/2014","N/A","OTC MONOGRAPH DRUG","120 TABLET in 1 BOTTLE (0603-0209-22)","Calculi Dissolution Agent [EPC],  Increased Large Intestinal Motility [PE],  Inhibition Large Intestine Fluid/Electrolyte Absorption [PE],  Inhibition Small Intestine Fluid/Electrolyte Absorption [PE],  Magnesium Ion Exchange Activity [MoA],  Osmotic Activity [MoA],  Osmotic Laxative [EPC],  Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]","N/A","No","12/31/2024"
"Magnesium Sulfate in Water","44567-422-24","20 g/500mL","INJECTION","INTRAVENOUS","ANDA207350","WG Critical Care, LLC","44567-422","Magnesium Sulfate","MAGNESIUM SULFATE HEPTAHYDRATE","HUMAN PRESCRIPTION DRUG","01/09/2018","N/A","ANDA","24 BAG in 1 CARTON (44567-422-24)  / 500 mL in 1 BAG","Calculi Dissolution Agent [EPC],  Increased Large Intestinal Motility [PE],  Inhibition Large Intestine Fluid/Electrolyte Absorption [PE],  Inhibition Small Intestine Fluid/Electrolyte Absorption [PE],  Magnesium Ion Exchange Activity [MoA],  Osmotic Activity [MoA],  Osmotic Laxative [EPC],  Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]","N/A","No","12/31/2025"
"Maxim Assure","70542-701-41","1 g/L","SOAP","TOPICAL","505G(a)(3)","Midlab Incorporated","70542-701","PCMX, Dishwashing and Hand Soap","CHLOROXYLENOL","HUMAN OTC DRUG","01/12/2017","N/A","OTC MONOGRAPH DRUG","3.78 L in 1 BOTTLE, PLASTIC (70542-701-41)","N/A","N/A","No","12/31/2024"
"MAXOCAINE PAIN RELIEVING ROLL-ON","72188-170-03","40 mg/mL,                         10  mg/mL","LIQUID","TOPICAL","M017","Prime Commerce, LLC","72188-170","LIDOCAINE HYDROCHLORIDE, MENTHOL","LIDOCAINE HYDROCHLORIDE;  MENTHOL","HUMAN OTC DRUG","03/01/2018","N/A","OTC MONOGRAPH DRUG","88 mL in 1 BOTTLE, WITH APPLICATOR (72188-170-03)","Amide Local Anesthetic [EPC],  Amides [CS],  Antiarrhythmic [EPC],  Local Anesthesia [PE]","N/A","No","12/31/2024"
"Medi-First Alcohol Wipes","47682-222-33",".7 mL/1","SWAB","TOPICAL","M003","Unifirst First Aid Corporation","47682-222","Isopropyl Alcohol","ISOPROPYL ALCOHOL","HUMAN OTC DRUG","05/09/2017","N/A","OTC MONOGRAPH DRUG","100 PACKET in 1 BOX (47682-222-33)  / 1 SWAB in 1 PACKET","N/A","N/A","No","12/31/2025"
"Medi-First Alcohol Wipes","47682-222-50",".7 mL/1","SWAB","TOPICAL","M003","Unifirst First Aid Corporation","47682-222","Isopropyl Alcohol","ISOPROPYL ALCOHOL","HUMAN OTC DRUG","05/09/2017","N/A","OTC MONOGRAPH DRUG","50 PACKET in 1 BOX (47682-222-50)  / 1 SWAB in 1 PACKET","N/A","N/A","No","12/31/2025"
"Medi-First Alcohol Wipes","47682-222-12",".7 mL/1","SWAB","TOPICAL","M003","Unifirst First Aid Corporation","47682-222","Isopropyl Alcohol","ISOPROPYL ALCOHOL","HUMAN OTC DRUG","11/07/2016","N/A","OTC MONOGRAPH DRUG","10 PACKET in 1 BOX (47682-222-12)  / 1 SWAB in 1 PACKET (47682-222-99)","N/A","N/A","No","12/31/2025"
"Medi-First Antiseptic Wipes","47682-122-33","1.3 mg/1","CLOTH","TOPICAL","M003","Unifirst First Aid Corporation","47682-122","Benzalkonium chloride","BENZALKONIUM CHLORIDE","HUMAN OTC DRUG","02/01/2022","N/A","OTC MONOGRAPH DRUG","100 PACKET in 1 BOX (47682-122-33)  / 1 CLOTH in 1 PACKET (47682-122-99)","N/A","N/A","No","12/31/2025"
"Medi-First Antiseptic Wipes","47682-122-71","1.3 mg/1","CLOTH","TOPICAL","M003","Unifirst First Aid Corporation","47682-122","Benzalkonium chloride","BENZALKONIUM CHLORIDE","HUMAN OTC DRUG","02/01/2022","N/A","OTC MONOGRAPH DRUG","20 PACKET in 1 BOX (47682-122-71)  / 1 CLOTH in 1 PACKET (47682-122-99)","N/A","N/A","No","12/31/2025"
"Medi-First Plus Triple Antibiotic","47682-938-73","400 [USP'U]/g,                         3.5  mg/g,                         5000  [USP'U]/g","OINTMENT","TOPICAL","M004","Unifirst First Aid Corporation","47682-938","Bacitracin zinc, Neomycin sulfate, Polymyxin B sulfate","BACITRACIN ZINC;  NEOMYCIN SULFATE;  POLYMYXIN B SULFATE","HUMAN OTC DRUG","06/01/2021","04/30/2028","OTC MONOGRAPH DRUG","25 PACKET in 1 BOX (47682-938-73)  / .5 g in 1 PACKET","Aminoglycoside Antibacterial [EPC],  Aminoglycosides [CS],  Decreased Cell Wall Synthesis & Repair [PE],  Polymyxin-class Antibacterial [EPC],  Polymyxins [CS]","N/A","No","N/A"
"Medicated Corn Removers","56104-249-01","40 mg/91","PATCH","TOPICAL","M030","Premier Brands of America, Inc.","56104-249","Salicylic Acid","SALICYLIC ACID","HUMAN OTC DRUG","07/13/2022","N/A","OTC MONOGRAPH DRUG","9 PATCH in 1 PACKAGE (56104-249-01)","N/A","N/A","No","12/31/2025"
"Medline Alcohol Prep","53329-805-97","70 mL/100mL","SWAB","TOPICAL","part333A","Medline Industries, LP","53329-805","Isopropyl Alcohol","ISOPROPYL ALCOHOL","HUMAN OTC DRUG","01/01/2007","N/A","OTC MONOGRAPH NOT FINAL","3000 PACKET in 1 CASE (53329-805-97)  / 1 APPLICATOR in 1 PACKET / 5 mL in 1 APPLICATOR","N/A","N/A","No","12/31/2024"
"Medline Alcohol Prep","53329-805-09","70 mL/100mL","SWAB","TOPICAL","part333A","Medline Industries, LP","53329-805","Isopropyl Alcohol","ISOPROPYL ALCOHOL","HUMAN OTC DRUG","01/01/2007","N/A","OTC MONOGRAPH NOT FINAL","1 APPLICATOR in 1 PACKET (53329-805-09)  / 5 mL in 1 APPLICATOR","N/A","N/A","No","12/31/2024"
"Medline Alcohol Prep","53329-805-30","70 mL/100mL","SWAB","TOPICAL","part333A","Medline Industries, LP","53329-805","Isopropyl Alcohol","ISOPROPYL ALCOHOL","HUMAN OTC DRUG","01/01/2007","N/A","OTC MONOGRAPH NOT FINAL","100 PACKET in 1 BOX (53329-805-30)  / 1 APPLICATOR in 1 PACKET / 5 mL in 1 APPLICATOR","N/A","N/A","No","12/31/2024"
"Medline Alcohol Prep","53329-805-57","70 mL/100mL","SWAB","TOPICAL","part333A","Medline Industries, LP","53329-805","Isopropyl Alcohol","ISOPROPYL ALCOHOL","HUMAN OTC DRUG","09/22/2020","N/A","OTC MONOGRAPH NOT FINAL","12 PACKET in 1 PACKAGE (53329-805-57)  / 1 APPLICATOR in 1 PACKET / 5 mL in 1 APPLICATOR","N/A","N/A","No","12/31/2024"
"Medline Alcohol Prep","53329-805-60","70 mL/100mL","SWAB","TOPICAL","part333A","Medline Industries, LP","53329-805","Isopropyl Alcohol","ISOPROPYL ALCOHOL","HUMAN OTC DRUG","01/01/2007","N/A","OTC MONOGRAPH NOT FINAL","200 PACKET in 1 BOX (53329-805-60)  / 1 APPLICATOR in 1 PACKET / 5 mL in 1 APPLICATOR","N/A","N/A","No","12/31/2024"
"Medline Alcohol Prep","53329-805-86","70 mL/100mL","SWAB","TOPICAL","part333A","Medline Industries, LP","53329-805","Isopropyl Alcohol","ISOPROPYL ALCOHOL","HUMAN OTC DRUG","01/01/2007","N/A","OTC MONOGRAPH NOT FINAL","3984 PACKET in 1 CASE (53329-805-86)  / 1 APPLICATOR in 1 PACKET / 5 mL in 1 APPLICATOR","N/A","N/A","No","12/31/2024"
"Mejoralito","69729-068-02","160 mg/5mL","SUSPENSION","ORAL","part343","OPMX LLC","69729-068","Acetaminophen","ACETAMINOPHEN","HUMAN OTC DRUG","02/01/2021","N/A","OTC MONOGRAPH NOT FINAL","60 mL in 1 BOTTLE (69729-068-02)","N/A","N/A","No","12/31/2024"
"Meloxicam","68462-141-01","15 mg/1","TABLET","ORAL","ANDA077932","Glenmark Pharmaceuticals Inc., USA","68462-141","Meloxicam","MELOXICAM","HUMAN PRESCRIPTION DRUG","06/01/2021","N/A","ANDA","100 TABLET in 1 BOTTLE (68462-141-01)","Anti-Inflammatory Agents,  Non-Steroidal [CS],  Cyclooxygenase Inhibitors [MoA],  Nonsteroidal Anti-inflammatory Drug [EPC]","N/A","No","12/31/2025"
"Memantine hydrochloride","68180-229-07","5 mg/1","TABLET, FILM COATED","ORAL","ANDA090051","Lupin Pharmaceuticals, Inc.","68180-229","Memantine hydrochloride","MEMANTINE HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","07/13/2015","N/A","ANDA","60 TABLET, FILM COATED in 1 BOTTLE (68180-229-07)","N-methyl-D-aspartate Receptor Antagonist [EPC],  NMDA Receptor Antagonists [MoA]","N/A","No","12/31/2025"
"memantine hydrochloride","68180-246-06","7 mg/1","CAPSULE, EXTENDED RELEASE","ORAL","ANDA206028","Lupin Pharmaceuticals, Inc.","68180-246","memantine hydrochloride","MEMANTINE HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","02/20/2018","N/A","ANDA","30 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (68180-246-06)","N-methyl-D-aspartate Receptor Antagonist [EPC],  NMDA Receptor Antagonists [MoA]","N/A","No","12/31/2025"
"Menstrual Complete","69517-130-20","500 mg/1,                         60  mg/1,                         15  mg/1","TABLET, COATED","ORAL","M013","Healthlife of USA","69517-130","Menstrual Complete","ACETAMINOPHEN;  CAFFEINE;  PYRILAMINE MALEATE","HUMAN OTC DRUG","05/31/2017","N/A","OTC MONOGRAPH DRUG","1 BOTTLE in 1 CARTON (69517-130-20)  / 20 TABLET, COATED in 1 BOTTLE","Central Nervous System Stimulant [EPC],  Central Nervous System Stimulation [PE],  Methylxanthine [EPC],  Xanthines [CS]","N/A","No","12/31/2024"
"Menstrual Complete","69517-130-24","500 mg/1,                         60  mg/1,                         15  mg/1","TABLET, COATED","ORAL","M013","Healthlife of USA","69517-130","Menstrual Complete","ACETAMINOPHEN;  CAFFEINE;  PYRILAMINE MALEATE","HUMAN OTC DRUG","12/28/2017","N/A","OTC MONOGRAPH DRUG","24 TABLET, COATED in 1 BOTTLE (69517-130-24)","Central Nervous System Stimulant [EPC],  Central Nervous System Stimulation [PE],  Methylxanthine [EPC],  Xanthines [CS]","N/A","No","12/31/2024"
"Menstrual Complete","71679-127-00","500 mg/1,                         60  mg/1,                         15  mg/1","TABLET, COATED","ORAL","M013","Health Pharma USA LLC","71679-127","Menstrual Complete","ACETAMINOPHEN;  CAFFEINE;  PYRILAMINE MALEATE","HUMAN OTC DRUG","02/13/2021","N/A","OTC MONOGRAPH DRUG","1 BAG in 1 BOX (71679-127-00)  / 23357 TABLET, COATED in 1 BAG","Central Nervous System Stimulant [EPC],  Central Nervous System Stimulation [PE],  Methylxanthine [EPC],  Xanthines [CS]","N/A","No","12/31/2024"
"MENTHOL PAIN RELIEF Gel-Patch","73557-131-16",".05 g/g","PATCH","TOPICAL","M017","Shanghai Chuangshi Medical Technology (Group) Co., Ltd.","73557-131","Menthol","MENTHOL","HUMAN OTC DRUG","01/09/2024","N/A","OTC MONOGRAPH DRUG","15 PATCH in 1 BOX (73557-131-16)  / 11 g in 1 PATCH (73557-131-02)","N/A","N/A","No","12/31/2025"
"MENTHOL PAIN RELIEF Gel-Patch","73557-131-05",".05 g/g","PATCH","TOPICAL","M017","Shanghai Chuangshi Medical Technology (Group) Co., Ltd.","73557-131","Menthol","MENTHOL","HUMAN OTC DRUG","02/02/2024","N/A","OTC MONOGRAPH DRUG","5 PATCH in 1 BOX (73557-131-05)  / 11 g in 1 PATCH (73557-131-02)","N/A","N/A","No","12/31/2025"
"Methocarbamol","55700-990-30","500 mg/1","TABLET","ORAL","ANDA040489","Quality Care Products, LLC","55700-990","methocarbamol","METHOCARBAMOL","HUMAN PRESCRIPTION DRUG","12/15/2022","N/A","ANDA","30 TABLET in 1 BOTTLE (55700-990-30)","Centrally-mediated Muscle Relaxation [PE],  Muscle Relaxant [EPC]","N/A","No","12/31/2024"
"Methylphenidate Hydrochloride","63629-2461-1","36 mg/1","TABLET, EXTENDED RELEASE","ORAL","ANDA205327","Bryant Ranch Prepack","63629-2461","Methylphenidate hydrochloride","METHYLPHENIDATE HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","02/08/2022","N/A","ANDA","100 TABLET, EXTENDED RELEASE in 1 BOTTLE (63629-2461-1)","Central Nervous System Stimulant [EPC],  Central Nervous System Stimulation [PE]","CII","No","12/31/2024"
"metoprolol succinate","68788-8069-3","25 mg/1","TABLET, EXTENDED RELEASE","ORAL","ANDA203894","Preferred Pharmaceuticals Inc.","68788-8069","metoprolol succinate","METOPROLOL SUCCINATE","HUMAN PRESCRIPTION DRUG","08/23/2021","N/A","ANDA","30 TABLET, EXTENDED RELEASE in 1 BOTTLE (68788-8069-3)","Adrenergic beta-Antagonists [MoA],  beta-Adrenergic Blocker [EPC]","N/A","No","12/31/2024"
"metoprolol succinate","68788-8069-6","25 mg/1","TABLET, EXTENDED RELEASE","ORAL","ANDA203894","Preferred Pharmaceuticals Inc.","68788-8069","metoprolol succinate","METOPROLOL SUCCINATE","HUMAN PRESCRIPTION DRUG","08/23/2021","N/A","ANDA","60 TABLET, EXTENDED RELEASE in 1 BOTTLE (68788-8069-6)","Adrenergic beta-Antagonists [MoA],  beta-Adrenergic Blocker [EPC]","N/A","No","12/31/2024"
"metoprolol succinate","68788-8069-9","25 mg/1","TABLET, EXTENDED RELEASE","ORAL","ANDA203894","Preferred Pharmaceuticals Inc.","68788-8069","metoprolol succinate","METOPROLOL SUCCINATE","HUMAN PRESCRIPTION DRUG","08/23/2021","N/A","ANDA","90 TABLET, EXTENDED RELEASE in 1 BOTTLE (68788-8069-9)","Adrenergic beta-Antagonists [MoA],  beta-Adrenergic Blocker [EPC]","N/A","No","12/31/2024"
"Metoprolol Succinate","75834-291-00","50 mg/1","TABLET, EXTENDED RELEASE","ORAL","ANDA203028","Nivagen Pharmaceuticals, Inc.","75834-291","Metoprolol Succinate","METOPROLOL SUCCINATE","HUMAN PRESCRIPTION DRUG","02/23/2022","N/A","ANDA","1000 TABLET, EXTENDED RELEASE in 1 BOTTLE (75834-291-00)","Adrenergic beta-Antagonists [MoA],  beta-Adrenergic Blocker [EPC]","N/A","No","12/31/2024"
"Metoprolol Succinate","75834-291-01","50 mg/1","TABLET, EXTENDED RELEASE","ORAL","ANDA203028","Nivagen Pharmaceuticals, Inc.","75834-291","Metoprolol Succinate","METOPROLOL SUCCINATE","HUMAN PRESCRIPTION DRUG","02/23/2022","N/A","ANDA","100 TABLET, EXTENDED RELEASE in 1 BOTTLE (75834-291-01)","Adrenergic beta-Antagonists [MoA],  beta-Adrenergic Blocker [EPC]","N/A","No","12/31/2024"
"Metoprolol Succinate","75834-291-05","50 mg/1","TABLET, EXTENDED RELEASE","ORAL","ANDA203028","Nivagen Pharmaceuticals, Inc.","75834-291","Metoprolol Succinate","METOPROLOL SUCCINATE","HUMAN PRESCRIPTION DRUG","02/23/2022","N/A","ANDA","500 TABLET, EXTENDED RELEASE in 1 BOTTLE (75834-291-05)","Adrenergic beta-Antagonists [MoA],  beta-Adrenergic Blocker [EPC]","N/A","No","12/31/2024"
"Metoprolol Tartrate and Hydrochlorothiazide","62756-369-08","50 mg/1,                         100  mg/1","TABLET","ORAL","ANDA090654","Sun Pharmaceutical Industries, Inc.","62756-369","Metoprolol Tartrate and Hydrochlorothiazide","HYDROCHLOROTHIAZIDE;  METOPROLOL TARTRATE","HUMAN PRESCRIPTION DRUG","04/01/2022","N/A","ANDA","100 TABLET in 1 BOTTLE (62756-369-08)","Adrenergic beta-Antagonists [MoA],  Increased Diuresis [PE],  Thiazide Diuretic [EPC],  Thiazides [CS],  beta-Adrenergic Blocker [EPC]","N/A","No","12/31/2025"
"Metoprolol Tartrate and Hydrochlorothiazide","62756-369-18","50 mg/1,                         100  mg/1","TABLET","ORAL","ANDA090654","Sun Pharmaceutical Industries, Inc.","62756-369","Metoprolol Tartrate and Hydrochlorothiazide","HYDROCHLOROTHIAZIDE;  METOPROLOL TARTRATE","HUMAN PRESCRIPTION DRUG","04/01/2022","N/A","ANDA","1000 TABLET in 1 BOTTLE (62756-369-18)","Adrenergic beta-Antagonists [MoA],  Increased Diuresis [PE],  Thiazide Diuretic [EPC],  Thiazides [CS],  beta-Adrenergic Blocker [EPC]","N/A","No","12/31/2025"
"Metoprolol Tartrate and Hydrochlorothiazide","62756-369-83","50 mg/1,                         100  mg/1","TABLET","ORAL","ANDA090654","Sun Pharmaceutical Industries, Inc.","62756-369","Metoprolol Tartrate and Hydrochlorothiazide","HYDROCHLOROTHIAZIDE;  METOPROLOL TARTRATE","HUMAN PRESCRIPTION DRUG","04/01/2022","N/A","ANDA","30 TABLET in 1 BOTTLE (62756-369-83)","Adrenergic beta-Antagonists [MoA],  Increased Diuresis [PE],  Thiazide Diuretic [EPC],  Thiazides [CS],  beta-Adrenergic Blocker [EPC]","N/A","No","12/31/2025"
"Metoprolol Tartrate and Hydrochlorothiazide","62756-369-88","50 mg/1,                         100  mg/1","TABLET","ORAL","ANDA090654","Sun Pharmaceutical Industries, Inc.","62756-369","Metoprolol Tartrate and Hydrochlorothiazide","HYDROCHLOROTHIAZIDE;  METOPROLOL TARTRATE","HUMAN PRESCRIPTION DRUG","04/01/2022","N/A","ANDA","100 TABLET in 1 BOTTLE (62756-369-88)","Adrenergic beta-Antagonists [MoA],  Increased Diuresis [PE],  Thiazide Diuretic [EPC],  Thiazides [CS],  beta-Adrenergic Blocker [EPC]","N/A","No","12/31/2025"
"Metronidazole","68462-184-49","7.5 mg/g","GEL","VAGINAL","ANDA215794","GLENMARK PHARMACEUTICALS INC., USA","68462-184","Metronidazole","METRONIDAZOLE","HUMAN PRESCRIPTION DRUG","01/27/2022","N/A","ANDA","1 TUBE, WITH APPLICATOR in 1 CARTON (68462-184-49)  / 70 g in 1 TUBE, WITH APPLICATOR","Nitroimidazole Antimicrobial [EPC],  Nitroimidazoles [CS]","N/A","No","12/31/2025"
"Metronidazole","70518-0088-3","500 mg/1","TABLET, FILM COATED","ORAL","ANDA203458","REMEDYREPACK INC.","70518-0088","Metronidazole","METRONIDAZOLE","HUMAN PRESCRIPTION DRUG","12/30/2016","N/A","ANDA","4 TABLET, FILM COATED in 1 BOTTLE (70518-0088-3)","Nitroimidazole Antimicrobial [EPC],  Nitroimidazoles [CS]","N/A","No","12/31/2025"
"Metronidazole","70518-0088-4","500 mg/1","TABLET, FILM COATED","ORAL","ANDA203458","REMEDYREPACK INC.","70518-0088","Metronidazole","METRONIDAZOLE","HUMAN PRESCRIPTION DRUG","01/31/2017","N/A","ANDA","30 TABLET, FILM COATED in 1 BLISTER PACK (70518-0088-4)","Nitroimidazole Antimicrobial [EPC],  Nitroimidazoles [CS]","N/A","No","12/31/2025"
"Metronidazole","70518-0088-2","500 mg/1","TABLET, FILM COATED","ORAL","ANDA203458","REMEDYREPACK INC.","70518-0088","Metronidazole","METRONIDAZOLE","HUMAN PRESCRIPTION DRUG","12/30/2016","N/A","ANDA","14 TABLET, FILM COATED in 1 BOTTLE (70518-0088-2)","Nitroimidazole Antimicrobial [EPC],  Nitroimidazoles [CS]","N/A","No","12/31/2025"
"Metronidazole","70518-0088-5","500 mg/1","TABLET, FILM COATED","ORAL","ANDA203458","REMEDYREPACK INC.","70518-0088","Metronidazole","METRONIDAZOLE","HUMAN PRESCRIPTION DRUG","05/13/2019","N/A","ANDA","21 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (70518-0088-5)","Nitroimidazole Antimicrobial [EPC],  Nitroimidazoles [CS]","N/A","No","12/31/2025"
"Metronidazole","70518-0088-0","500 mg/1","TABLET, FILM COATED","ORAL","ANDA203458","REMEDYREPACK INC.","70518-0088","Metronidazole","METRONIDAZOLE","HUMAN PRESCRIPTION DRUG","12/28/2016","N/A","ANDA","14 TABLET, FILM COATED in 1 BLISTER PACK (70518-0088-0)","Nitroimidazole Antimicrobial [EPC],  Nitroimidazoles [CS]","N/A","No","12/31/2025"
"Metronidazole","53002-7340-1","7.5 mg/g","GEL","VAGINAL","ANDA077264","RPK Pharmaceuticals, Inc.","53002-7340","Metronidazole","METRONIDAZOLE","HUMAN PRESCRIPTION DRUG","10/01/2018","11/30/2024","ANDA","1 TUBE, WITH APPLICATOR in 1 CARTON (53002-7340-1)  / 70 g in 1 TUBE, WITH APPLICATOR","Nitroimidazole Antimicrobial [EPC],  Nitroimidazoles [CS]","N/A","No","N/A"
"Metronidazole","80830-2465-9","500 mg/100mL","INJECTION, SOLUTION","INTRAVENOUS","ANDA217665","Amneal Pharmaceuticals Private Limited","80830-2465","Metronidazole","METRONIDAZOLE","HUMAN PRESCRIPTION DRUG","06/17/2023","N/A","ANDA","24 POUCH in 1 CARTON (80830-2465-9)  / 1 BAG in 1 POUCH (80830-2465-1)  / 100 mL in 1 BAG","Nitroimidazole Antimicrobial [EPC],  Nitroimidazoles [CS]","N/A","No","12/31/2025"
"Micafungin","70710-1725-6","20 mg/mL","INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION","INTRAVENOUS","ANDA215241","Zydus Pharmaceuticals USA Inc.","70710-1725","Micafungin","MICAFUNGIN SODIUM","HUMAN PRESCRIPTION DRUG","04/10/2023","N/A","ANDA","10 VIAL in 1 CARTON (70710-1725-6)  / 5 mL in 1 VIAL (70710-1725-1)","Echinocandin Antifungal [EPC],  Lipopeptides [CS]","N/A","No","12/31/2024"
"MIGGY FOUNDATION 70% Hand Sanitizer","80781-094-60",".7 mL/mL","GEL","TOPICAL","505G(a)(3)","Miguel Cabrera Foundation, Inc.","80781-094","ALCOHOL","ALCOHOL","HUMAN OTC DRUG","09/17/2020","N/A","OTC MONOGRAPH DRUG","60 mL in 1 BOTTLE (80781-094-60)","N/A","N/A","No","12/31/2024"
"Mineral Sun Silk Moisturizer Sunscreen","79753-078-01","135 mg/mL","CREAM","TOPICAL","part352","COOLA LLC","79753-078","ZINC OXIDE 13.5%","ZINC OXIDE","HUMAN OTC DRUG","02/01/2023","N/A","OTC MONOGRAPH FINAL","1 JAR in 1 CARTON (79753-078-01)  / 44 mL in 1 JAR","N/A","N/A","No","12/31/2024"
"MINTOX MAXIMUM STRENGTH","71205-515-35","400 mg/5mL,                         40  mg/5mL,                         400  mg/5mL","SUSPENSION","ORAL","M001","Proficient Rx LP","71205-515","aluminum hydroxide, magnesium hydroxide, dimethicone","ALUMINUM HYDROXIDE;  DIMETHICONE;  MAGNESIUM HYDROXIDE","HUMAN OTC DRUG","12/16/2020","N/A","OTC MONOGRAPH DRUG","355 mL in 1 BOTTLE (71205-515-35)","Calculi Dissolution Agent [EPC],  Increased Large Intestinal Motility [PE],  Inhibition Large Intestine Fluid/Electrolyte Absorption [PE],  Inhibition Small Intestine Fluid/Electrolyte Absorption [PE],  Magnesium Ion Exchange Activity [MoA],  Osmotic Activity [MoA],  Osmotic Laxative [EPC],  Skin Barrier Activity [PE],  Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]","N/A","No","12/31/2024"
"Mirtazapine","70518-2819-2","7.5 mg/1","TABLET, FILM COATED","ORAL","ANDA076921","REMEDYREPACK INC.","70518-2819","Mirtazapine","MIRTAZAPINE","HUMAN PRESCRIPTION DRUG","07/12/2023","N/A","ANDA","30 TABLET, FILM COATED in 1 BLISTER PACK (70518-2819-2)","N/A","N/A","No","12/31/2025"
"Mirtazapine","57237-010-05","45 mg/1","TABLET, FILM COATED","ORAL","ANDA076921","Rising Pharma Holdings, Inc.","57237-010","Mirtazapine","MIRTAZAPINE","HUMAN PRESCRIPTION DRUG","10/22/2004","N/A","ANDA","500 TABLET, FILM COATED in 1 BOTTLE (57237-010-05)","N/A","N/A","No","12/31/2025"
"Mirtazapine","57237-010-30","45 mg/1","TABLET, FILM COATED","ORAL","ANDA076921","Rising Pharma Holdings, Inc.","57237-010","Mirtazapine","MIRTAZAPINE","HUMAN PRESCRIPTION DRUG","10/22/2004","N/A","ANDA","30 TABLET, FILM COATED in 1 BOTTLE (57237-010-30)","N/A","N/A","No","12/31/2025"
"Mometasone Furoate","68462-192-55","1 mg/g","CREAM","TOPICAL","ANDA078541","Glenmark Pharmaceuticals Inc., USA","68462-192","Mometasone Furoate","MOMETASONE FUROATE","HUMAN PRESCRIPTION DRUG","05/28/2008","N/A","ANDA","45 g in 1 TUBE (68462-192-55)","Corticosteroid Hormone Receptor Agonists [MoA],  Corticosteroid Hormone Receptor Agonists [MoA],  Corticosteroid [EPC]","N/A","No","12/31/2025"
"Mometasone Furoate","68462-192-17","1 mg/g","CREAM","TOPICAL","ANDA078541","Glenmark Pharmaceuticals Inc., USA","68462-192","Mometasone Furoate","MOMETASONE FUROATE","HUMAN PRESCRIPTION DRUG","05/28/2008","N/A","ANDA","15 g in 1 TUBE (68462-192-17)","Corticosteroid Hormone Receptor Agonists [MoA],  Corticosteroid Hormone Receptor Agonists [MoA],  Corticosteroid [EPC]","N/A","No","12/31/2025"
"MONPURIEL Hair loss care-shampoo","83472-411-01",".22 g/100mL,                         .33  g/100mL,                         .25  g/100mL","SHAMPOO","TOPICAL","","Y2K Co., Ltd.","83472-411","L-Menthol, Dexpanthenol, Salicylic Acid","DEXPANTHENOL;  LEVOMENTHOL;  SALICYLIC ACID","HUMAN OTC DRUG","05/01/2023","N/A","UNAPPROVED DRUG OTHER","500 mL in 1 BOTTLE, PUMP (83472-411-01)","N/A","N/A","No","12/31/2025"
"Montelukast","50090-6109-0","10 mg/1","TABLET, FILM COATED","ORAL","ANDA202843","A-S Medication Solutions","50090-6109","Montelukast","MONTELUKAST SODIUM","HUMAN PRESCRIPTION DRUG","09/28/2022","N/A","ANDA","90 TABLET, FILM COATED in 1 BOTTLE (50090-6109-0)","Leukotriene Receptor Antagonist [EPC],  Leukotriene Receptor Antagonists [MoA]","N/A","No","12/31/2024"
"montelukast sodium","29300-222-19","5 mg/1","TABLET, CHEWABLE","ORAL","ANDA208621","Unichem Pharmaceuticals (USA), Inc.","29300-222","montelukast sodium","MONTELUKAST SODIUM","HUMAN PRESCRIPTION DRUG","08/20/2018","N/A","ANDA","90 TABLET, CHEWABLE in 1 BOTTLE, PLASTIC (29300-222-19)","Leukotriene Receptor Antagonist [EPC],  Leukotriene Receptor Antagonists [MoA]","N/A","No","12/31/2024"
"montelukast sodium","29300-222-10","5 mg/1","TABLET, CHEWABLE","ORAL","ANDA208621","Unichem Pharmaceuticals (USA), Inc.","29300-222","montelukast sodium","MONTELUKAST SODIUM","HUMAN PRESCRIPTION DRUG","08/20/2018","N/A","ANDA","1000 TABLET, CHEWABLE in 1 BOTTLE, PLASTIC (29300-222-10)","Leukotriene Receptor Antagonist [EPC],  Leukotriene Receptor Antagonists [MoA]","N/A","No","12/31/2024"
"montelukast sodium","29300-222-13","5 mg/1","TABLET, CHEWABLE","ORAL","ANDA208621","Unichem Pharmaceuticals (USA), Inc.","29300-222","montelukast sodium","MONTELUKAST SODIUM","HUMAN PRESCRIPTION DRUG","08/20/2018","N/A","ANDA","30 TABLET, CHEWABLE in 1 BOTTLE, PLASTIC (29300-222-13)","Leukotriene Receptor Antagonist [EPC],  Leukotriene Receptor Antagonists [MoA]","N/A","No","12/31/2024"
"Morphine sulfate","0228-3116-11","45 mg/1","CAPSULE, EXTENDED RELEASE","ORAL","ANDA079040","Actavis Pharma, Inc.","0228-3116","Morphine sulfate","MORPHINE SULFATE","HUMAN PRESCRIPTION DRUG","02/04/2014","N/A","ANDA","100 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (0228-3116-11)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]","CII","No","12/31/2025"
"Morphine sulfate","0228-3117-11","75 mg/1","CAPSULE, EXTENDED RELEASE","ORAL","ANDA079040","Actavis Pharma, Inc.","0228-3117","Morphine sulfate","MORPHINE SULFATE","HUMAN PRESCRIPTION DRUG","02/04/2014","N/A","ANDA","100 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (0228-3117-11)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]","CII","No","12/31/2025"
"Morphine Sulfate","0641-6125-25","4 mg/mL","INJECTION","INTRAVENOUS","ANDA205758","Hikma Pharmaceuticals USA Inc.","0641-6125","Morphine Sulfate","MORPHINE SULFATE","HUMAN PRESCRIPTION DRUG","06/03/2015","N/A","ANDA","25 VIAL, SINGLE-DOSE in 1 PACKAGE (0641-6125-25)  / 1 mL in 1 VIAL, SINGLE-DOSE (0641-6125-01)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]","CII","No","12/31/2025"
"Mycophenolate Mofetil","54288-141-04","500 mg/20mL","INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION","INTRAVENOUS","ANDA214283","BPI Labs LLC","54288-141","Mycophenolate Mofetil hydrochloride","MYCOPHENOLATE MOFETIL HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","03/08/2023","N/A","ANDA","4 VIAL in 1 CARTON (54288-141-04)  / 20 mL in 1 VIAL","Antimetabolite Immunosuppressant [EPC]","N/A","No","12/31/2024"
"Mycophenolic Acid","16729-189-29","360 mg/1","TABLET, DELAYED RELEASE","ORAL","ANDA202555","Accord Healthcare Inc.","16729-189","Mycophenolic Acid","MYCOPHENOLATE SODIUM","HUMAN PRESCRIPTION DRUG","09/11/2017","N/A","ANDA","120 TABLET, DELAYED RELEASE in 1 BOTTLE (16729-189-29)","Antimetabolite Immunosuppressant [EPC]","N/A","No","12/31/2025"
"Nabumetone","80425-0104-1","750 mg/1","TABLET","ORAL","ANDA078420","Advanced Rx Pharmacy of Tennessee, LLC","80425-0104","Nabumetone","NABUMETONE","HUMAN PRESCRIPTION DRUG","06/26/2019","N/A","ANDA","30 TABLET in 1 BOTTLE (80425-0104-1)","Anti-Inflammatory Agents,  Non-Steroidal [CS],  Cyclooxygenase Inhibitors [MoA],  Nonsteroidal Anti-inflammatory Drug [EPC]","N/A","No","12/31/2024"
"Nabumetone","80425-0104-2","750 mg/1","TABLET","ORAL","ANDA078420","Advanced Rx Pharmacy of Tennessee, LLC","80425-0104","Nabumetone","NABUMETONE","HUMAN PRESCRIPTION DRUG","04/07/2023","N/A","ANDA","60 TABLET in 1 BOTTLE (80425-0104-2)","Anti-Inflammatory Agents,  Non-Steroidal [CS],  Cyclooxygenase Inhibitors [MoA],  Nonsteroidal Anti-inflammatory Drug [EPC]","N/A","No","12/31/2024"
"Nabumetone","80425-0104-3","750 mg/1","TABLET","ORAL","ANDA078420","Advanced Rx Pharmacy of Tennessee, LLC","80425-0104","Nabumetone","NABUMETONE","HUMAN PRESCRIPTION DRUG","04/07/2023","N/A","ANDA","90 TABLET in 1 BOTTLE (80425-0104-3)","Anti-Inflammatory Agents,  Non-Steroidal [CS],  Cyclooxygenase Inhibitors [MoA],  Nonsteroidal Anti-inflammatory Drug [EPC]","N/A","No","12/31/2024"
"Nanz Povidone","83254-750-21","7.5 g/100g","OINTMENT","TOPICAL","M005","1201258 Ontario Inc. O/A Nanz Pharma","83254-750","Povinanz 7.5%","POVIDONE-IODINE","HUMAN OTC DRUG","05/04/2023","N/A","OTC MONOGRAPH FINAL","2 g in 1 POUCH (83254-750-21)","N/A","N/A","No","12/31/2024"
"Nanz Povidone","83254-750-31","7.5 g/100g","OINTMENT","TOPICAL","M005","1201258 Ontario Inc. O/A Nanz Pharma","83254-750","Povinanz 7.5%","POVIDONE-IODINE","HUMAN OTC DRUG","05/04/2023","N/A","OTC MONOGRAPH FINAL","1 g in 1 POUCH (83254-750-31)","N/A","N/A","No","12/31/2024"
"Nanz Povidone","83254-750-55","7.5 g/100g","OINTMENT","TOPICAL","M005","1201258 Ontario Inc. O/A Nanz Pharma","83254-750","Povinanz 7.5%","POVIDONE-IODINE","HUMAN OTC DRUG","05/04/2023","N/A","OTC MONOGRAPH FINAL","5 g in 1 POUCH (83254-750-55)","N/A","N/A","No","12/31/2024"
"Nanz Povidone","83254-750-60","7.5 g/100g","OINTMENT","TOPICAL","M005","1201258 Ontario Inc. O/A Nanz Pharma","83254-750","Povinanz 7.5%","POVIDONE-IODINE","HUMAN OTC DRUG","05/04/2023","N/A","OTC MONOGRAPH FINAL","60 g in 1 TUBE (83254-750-60)","N/A","N/A","No","12/31/2024"
"Nanz Povidone","83254-750-90","7.5 g/100g","OINTMENT","TOPICAL","M005","1201258 Ontario Inc. O/A Nanz Pharma","83254-750","Povinanz 7.5%","POVIDONE-IODINE","HUMAN OTC DRUG","05/04/2023","N/A","OTC MONOGRAPH FINAL","90 g in 1 TUBE (83254-750-90)","N/A","N/A","No","12/31/2024"
"Nanz Povidone","83254-750-01","7.5 g/100g","OINTMENT","TOPICAL","M005","1201258 Ontario Inc. O/A Nanz Pharma","83254-750","Povinanz 7.5%","POVIDONE-IODINE","HUMAN OTC DRUG","05/04/2023","N/A","OTC MONOGRAPH FINAL","10 g in 1 TUBE (83254-750-01)","N/A","N/A","No","12/31/2024"
"Nanz Povidone","83254-750-05","7.5 g/100g","OINTMENT","TOPICAL","M005","1201258 Ontario Inc. O/A Nanz Pharma","83254-750","Povinanz 7.5%","POVIDONE-IODINE","HUMAN OTC DRUG","05/04/2023","N/A","OTC MONOGRAPH FINAL","5 g in 1 TUBE (83254-750-05)","N/A","N/A","No","12/31/2024"
"Nanz Povidone","83254-750-10","7.5 g/100g","OINTMENT","TOPICAL","M005","1201258 Ontario Inc. O/A Nanz Pharma","83254-750","Povinanz 7.5%","POVIDONE-IODINE","HUMAN OTC DRUG","05/04/2023","N/A","OTC MONOGRAPH FINAL","100 g in 1 TUBE (83254-750-10)","N/A","N/A","No","12/31/2024"
"Nanz Povidone","83254-750-15","7.5 g/100g","OINTMENT","TOPICAL","M005","1201258 Ontario Inc. O/A Nanz Pharma","83254-750","Povinanz 7.5%","POVIDONE-IODINE","HUMAN OTC DRUG","05/04/2023","N/A","OTC MONOGRAPH FINAL","15 g in 1 TUBE (83254-750-15)","N/A","N/A","No","12/31/2024"
"Nanz Povidone","83254-750-30","7.5 g/100g","OINTMENT","TOPICAL","M005","1201258 Ontario Inc. O/A Nanz Pharma","83254-750","Povinanz 7.5%","POVIDONE-IODINE","HUMAN OTC DRUG","05/04/2023","N/A","OTC MONOGRAPH FINAL","30 g in 1 TUBE (83254-750-30)","N/A","N/A","No","12/31/2024"
"Nanz Povidone","83254-750-50","7.5 g/100g","OINTMENT","TOPICAL","M005","1201258 Ontario Inc. O/A Nanz Pharma","83254-750","Povinanz 7.5%","POVIDONE-IODINE","HUMAN OTC DRUG","05/04/2023","N/A","OTC MONOGRAPH FINAL","150 g in 1 TUBE (83254-750-50)","N/A","N/A","No","12/31/2024"
"NasoClenz","81900-014-03","1.19 mg/mL","GEL","TOPICAL","505G(a)(3)","Silicon Valley Innovations, Inc.","81900-014","Benzalkonium Chloride 0.13%","BENZALKONIUM CHLORIDE","HUMAN OTC DRUG","09/25/2023","N/A","OTC MONOGRAPH DRUG","1 TUBE in 1 BOX (81900-014-03)  / 12 mL in 1 TUBE","N/A","N/A","No","12/31/2025"
"NasoClenz","81900-014-04","1.19 mg/mL","GEL","TOPICAL","505G(a)(3)","Silicon Valley Innovations, Inc.","81900-014","Benzalkonium Chloride 0.13%","BENZALKONIUM CHLORIDE","HUMAN OTC DRUG","09/25/2023","N/A","OTC MONOGRAPH DRUG","2 POUCH in 1 BOX (81900-014-04)  / 1 POUCH in 1 POUCH / 1 mL in 1 POUCH","N/A","N/A","No","12/31/2025"
"NasoClenz","81900-014-05","1.19 mg/mL","GEL","TOPICAL","505G(a)(3)","Silicon Valley Innovations, Inc.","81900-014","Benzalkonium Chloride 0.13%","BENZALKONIUM CHLORIDE","HUMAN OTC DRUG","09/25/2023","N/A","OTC MONOGRAPH DRUG","4 POUCH in 1 BOX (81900-014-05)  / 1 POUCH in 1 POUCH / 1 mL in 1 POUCH","N/A","N/A","No","12/31/2025"
"NasoClenz","81900-014-06","1.19 mg/mL","GEL","TOPICAL","505G(a)(3)","Silicon Valley Innovations, Inc.","81900-014","Benzalkonium Chloride 0.13%","BENZALKONIUM CHLORIDE","HUMAN OTC DRUG","02/16/2024","N/A","OTC MONOGRAPH DRUG","1 TUBE in 1 BOX (81900-014-06)  / 5 mL in 1 TUBE","N/A","N/A","No","12/31/2025"
"Nausia","43742-1663-1","12 [hp_X]/mL,                         12  [hp_X]/mL,                         12  [hp_X]/mL,                         12  [hp_X]/mL,                         12  [hp_X]/mL,                         12  [hp_X]/mL,                         8  [hp_X]/mL,                         24  [hp_X]/mL,                         3  [hp_X]/mL,                         6  [hp_X]/mL,                         6  [hp_X]/mL,                         12  [hp_X]/mL,                         8  [hp_X]/mL,                         6  [hp_X]/mL,                         12  [hp_X]/mL,                         12  [hp_X]/mL,                         6  [hp_X]/mL,                         12  [hp_X]/mL,                         12  [hp_X]/mL,                         8  [hp_X]/mL","LIQUID","ORAL","","Deseret Biologicals, Inc.","43742-1663","Zingiber Officinale, Ipecacuanha, Iris Versicolor, Lac Defloratum, Lacticum Acidum, Cyclamen Europaeum, Petroleum, Tabacum, Arsenicum Album, Bryonia (Alba), Cadmium Sulphuratum, Cocculus Indicus, Colchicum Autumnale, Conium Maculatum, Ferrum Metallicum, Nux Vomica, Pulsatilla (Pratensis), Sepia, Theridion, Euphorbia Corollata","ANAMIRTA COCCULUS SEED;  ARSENIC TRIOXIDE;  BRYONIA ALBA ROOT;  CADMIUM SULFIDE;  COLCHICUM AUTUMNALE BULB;  CONIUM MACULATUM FLOWERING TOP;  CYCLAMEN PURPURASCENS TUBER;  EUPHORBIA COROLLATA ROOT;  GINGER;  IPECAC;  IRIS VERSICOLOR ROOT;  IRON;  KEROSENE;  LACTIC ACID, DL-;  PULSATILLA PRATENSIS WHOLE;  SEPIA OFFICINALIS JUICE;  SKIM MILK;  STRYCHNOS NUX-VOMICA SEED;  THERIDION CURASSAVICUM;  TOBACCO LEAF","HUMAN OTC DRUG","08/17/2020","N/A","UNAPPROVED HOMEOPATHIC","30 mL in 1 BOTTLE, DROPPER (43742-1663-1)","Allergens [CS],  Allergens [CS],  Allergens [CS],  Cell-mediated Immunity [PE],  Cell-mediated Immunity [PE],  Cell-mediated Immunity [PE],  Dietary Proteins [CS],  Food Additives [CS],  Increased Histamine Release [PE],  Increased Histamine Release [PE],  Increased Histamine Release [PE],  Increased IgG Production [PE],  Increased IgG Production [PE],  Non-Standardized Food Allergenic Extract [EPC],  Non-Standardized Plant Allergenic Extract [EPC],  Non-Standardized Plant Allergenic Extract [EPC],  Non-Standardized Plant Allergenic Extract [EPC],  Plant Proteins [CS],  Plant Proteins [CS],  Plant Proteins [CS],  Seed Storage Proteins [CS]","N/A","No","12/31/2025"
"Nelarabine","70710-1726-1","5 mg/mL","INJECTION","INTRAVENOUS","ANDA215037","Zydus Pharmaceuticals USA Inc.","70710-1726","Nelarabine","NELARABINE","HUMAN PRESCRIPTION DRUG","11/17/2021","N/A","ANDA","1 VIAL, SINGLE-DOSE in 1 CARTON (70710-1726-1)  / 50 mL in 1 VIAL, SINGLE-DOSE","Nucleic Acid Synthesis Inhibitors [MoA],  Nucleoside Metabolic Inhibitor [EPC]","N/A","No","12/31/2024"
"Nelarabine","70710-1726-8","5 mg/mL","INJECTION","INTRAVENOUS","ANDA215037","Zydus Pharmaceuticals USA Inc.","70710-1726","Nelarabine","NELARABINE","HUMAN PRESCRIPTION DRUG","11/17/2021","N/A","ANDA","6 VIAL, SINGLE-DOSE in 1 CARTON (70710-1726-8)  / 50 mL in 1 VIAL, SINGLE-DOSE","Nucleic Acid Synthesis Inhibitors [MoA],  Nucleoside Metabolic Inhibitor [EPC]","N/A","No","12/31/2024"
"Neomycin Polymyxin B Sulfates and Dexamethasone","24208-830-60","1 mg/mL,                         3.5  mg/mL,                         10000  [USP'U]/mL","SUSPENSION/ DROPS","OPHTHALMIC","ANDA064135","Bausch & Lomb Incorporated","24208-830","Neomycin sulfate, Polymyxin B Sulfate and Dexamethasone","DEXAMETHASONE;  NEOMYCIN SULFATE;  POLYMYXIN B SULFATE","HUMAN PRESCRIPTION DRUG","09/13/1995","N/A","ANDA","1 BOTTLE, DROPPER in 1 CARTON (24208-830-60)  / 5 mL in 1 BOTTLE, DROPPER","Aminoglycoside Antibacterial [EPC],  Aminoglycosides [CS],  Corticosteroid Hormone Receptor Agonists [MoA],  Corticosteroid [EPC],  Polymyxin-class Antibacterial [EPC],  Polymyxins [CS]","N/A","No","12/31/2024"
"Neostigmine Methylsulfate","76045-383-30","1 mg/mL","INJECTION, SOLUTION","INTRAVENOUS","NDA203629","Fresenius Kabi USA, LLC","76045-383","Neostigmine Methylsulfate","NEOSTIGMINE METHYLSULFATE","HUMAN PRESCRIPTION DRUG","09/18/2018","N/A","NDA","10 BLISTER PACK in 1 CARTON (76045-383-30)  / 1 SYRINGE, GLASS in 1 BLISTER PACK (76045-383-13)  / 3 mL in 1 SYRINGE, GLASS","Cholinesterase Inhibitor [EPC],  Cholinesterase Inhibitors [MoA]","N/A","No","12/31/2025"
"Neostigmine Methylsulfate","0641-6240-10","1 mg/mL","INJECTION","INTRAVENOUS","ANDA216206","Hikma Pharmaceuticals USA Inc.","0641-6240","Neostigmine Methylsulfate","NEOSTIGMINE METHYLSULFATE","HUMAN PRESCRIPTION DRUG","07/13/2022","N/A","ANDA","10 SYRINGE, PLASTIC in 1 CARTON (0641-6240-10)  / 3 mL in 1 SYRINGE, PLASTIC","Cholinesterase Inhibitor [EPC],  Cholinesterase Inhibitors [MoA]","N/A","No","12/31/2025"
"Niobium Metallicum","37662-3206-1","12 [hp_C]/1","PELLET","ORAL","","Hahnemann Laboratories, INC.","37662-3206","Niobium Metallicum","NIOBIUM","HUMAN OTC DRUG","05/17/2023","N/A","UNAPPROVED HOMEOPATHIC","200 PELLET in 1 VIAL, GLASS (37662-3206-1)","N/A","N/A","No","12/31/2024"
"Niobium Metallicum","37662-3206-2","12 [hp_C]/1","PELLET","ORAL","","Hahnemann Laboratories, INC.","37662-3206","Niobium Metallicum","NIOBIUM","HUMAN OTC DRUG","05/17/2023","N/A","UNAPPROVED HOMEOPATHIC","1200 PELLET in 1 BOTTLE, GLASS (37662-3206-2)","N/A","N/A","No","12/31/2024"
"Niobium Metallicum","37662-3206-3","12 [hp_C]/1","PELLET","ORAL","","Hahnemann Laboratories, INC.","37662-3206","Niobium Metallicum","NIOBIUM","HUMAN OTC DRUG","05/17/2023","N/A","UNAPPROVED HOMEOPATHIC","4000 PELLET in 1 BOTTLE, GLASS (37662-3206-3)","N/A","N/A","No","12/31/2024"
"Niobium Metallicum","37662-3211-1","1 [hp_M]/1","PELLET","ORAL","","Hahnemann Laboratories, INC.","37662-3211","Niobium Metallicum","NIOBIUM","HUMAN OTC DRUG","05/17/2023","N/A","UNAPPROVED HOMEOPATHIC","200 PELLET in 1 VIAL, GLASS (37662-3211-1)","N/A","N/A","No","12/31/2024"
"Niobium Metallicum","37662-3211-2","1 [hp_M]/1","PELLET","ORAL","","Hahnemann Laboratories, INC.","37662-3211","Niobium Metallicum","NIOBIUM","HUMAN OTC DRUG","05/17/2023","N/A","UNAPPROVED HOMEOPATHIC","500 PELLET in 1 VIAL, GLASS (37662-3211-2)","N/A","N/A","No","12/31/2024"
"Niobium Metallicum","37662-3211-3","1 [hp_M]/1","PELLET","ORAL","","Hahnemann Laboratories, INC.","37662-3211","Niobium Metallicum","NIOBIUM","HUMAN OTC DRUG","05/17/2023","N/A","UNAPPROVED HOMEOPATHIC","3000 PELLET in 1 BOTTLE, GLASS (37662-3211-3)","N/A","N/A","No","12/31/2024"
"Niobium Metallicum","37662-3211-4","1 [hp_M]/1","PELLET","ORAL","","Hahnemann Laboratories, INC.","37662-3211","Niobium Metallicum","NIOBIUM","HUMAN OTC DRUG","05/17/2023","N/A","UNAPPROVED HOMEOPATHIC","10000 PELLET in 1 BOTTLE, GLASS (37662-3211-4)","N/A","N/A","No","12/31/2024"
"Niobium Metallicum","37662-3213-1","1 [hp_Q]/1","PELLET","ORAL","","Hahnemann Laboratories, INC.","37662-3213","Niobium Metallicum","NIOBIUM","HUMAN OTC DRUG","05/17/2023","N/A","UNAPPROVED HOMEOPATHIC","10000 PELLET in 1 BOTTLE, GLASS (37662-3213-1)","N/A","N/A","No","12/31/2024"
"Nitrofurantion Macrocrystals","70518-0103-2","100 mg/1","CAPSULE","ORAL","NDA016620","REMEDYREPACK INC.","70518-0103","Nitrofurantion Macrocrystals","NITROFURANTOIN","HUMAN PRESCRIPTION DRUG","04/26/2017","N/A","NDA","14 CAPSULE in 1 BOTTLE, PLASTIC (70518-0103-2)","Nitrofuran Antibacterial [EPC],  Nitrofurans [CS]","N/A","No","12/31/2025"
"Nitrofurantion Macrocrystals","70518-0103-0","100 mg/1","CAPSULE","ORAL","NDA016620","REMEDYREPACK INC.","70518-0103","Nitrofurantion Macrocrystals","NITROFURANTOIN","HUMAN PRESCRIPTION DRUG","01/05/2017","N/A","NDA","10 CAPSULE in 1 BOTTLE (70518-0103-0)","Nitrofuran Antibacterial [EPC],  Nitrofurans [CS]","N/A","No","12/31/2025"
"nitrofurantoin macrocrystals","68071-3460-8","100 mg/1","CAPSULE","ORAL","ANDA217272","NuCare Pharmaceuticals,Inc.","68071-3460","nitrofurantoin macrocrystals","NITROFURANTOIN","HUMAN PRESCRIPTION DRUG","07/18/2023","N/A","ANDA","28 CAPSULE in 1 BOTTLE (68071-3460-8)","Nitrofuran Antibacterial [EPC],  Nitrofurans [CS]","N/A","No","12/31/2024"
"nitrofurantoin macrocrystals","68071-3460-2","100 mg/1","CAPSULE","ORAL","ANDA217272","NuCare Pharmaceuticals,Inc.","68071-3460","nitrofurantoin macrocrystals","NITROFURANTOIN","HUMAN PRESCRIPTION DRUG","07/18/2023","N/A","ANDA","20 CAPSULE in 1 BOTTLE (68071-3460-2)","Nitrofuran Antibacterial [EPC],  Nitrofurans [CS]","N/A","No","12/31/2024"
"nitrofurantoin macrocrystals","68071-3460-7","100 mg/1","CAPSULE","ORAL","ANDA217272","NuCare Pharmaceuticals,Inc.","68071-3460","nitrofurantoin macrocrystals","NITROFURANTOIN","HUMAN PRESCRIPTION DRUG","07/18/2023","N/A","ANDA","14 CAPSULE in 1 BOTTLE (68071-3460-7)","Nitrofuran Antibacterial [EPC],  Nitrofurans [CS]","N/A","No","12/31/2024"
"Norethindrone Acetate","68462-304-05","5 mg/1","TABLET","ORAL","ANDA091090","Glenmark Pharmaceuticals Inc., USA","68462-304","Norethindrone Acetate","NORETHINDRONE ACETATE","HUMAN PRESCRIPTION DRUG","07/21/2010","N/A","ANDA","500 TABLET in 1 BOTTLE (68462-304-05)","Progesterone Congeners [CS],  Progestin [EPC]","N/A","No","12/31/2025"
"Norethindrone Acetate","68462-304-50","5 mg/1","TABLET","ORAL","ANDA091090","Glenmark Pharmaceuticals Inc., USA","68462-304","Norethindrone Acetate","NORETHINDRONE ACETATE","HUMAN PRESCRIPTION DRUG","07/21/2010","N/A","ANDA","50 TABLET in 1 BOTTLE (68462-304-50)","Progesterone Congeners [CS],  Progestin [EPC]","N/A","No","12/31/2025"
"norethindrone acetate and ethinyl estradiol and ferrous fumarate","68462-376-29","","KIT","","ANDA210369","Glenmark Pharmaceuticals Inc., USA","68462-376","norethindrone acetate and ethinyl estradiol and ferrous fumarate","","HUMAN PRESCRIPTION DRUG","12/26/2017","N/A","ANDA","3 BLISTER PACK in 1 CARTON (68462-376-29)  / 1 KIT in 1 BLISTER PACK","N/A","N/A","No","12/31/2025"
"Nufabrx Medicine Infused Socks","72490-037-10",".12 g/100g","CLOTH","TOPICAL","M017","Nufabrx LLC","72490-037","Capsaicin","CAPSAICIN","HUMAN OTC DRUG","07/19/2023","N/A","OTC MONOGRAPH DRUG","1 g in 1 BOX (72490-037-10)","N/A","N/A","No","12/31/2024"
"Nystatin","82804-045-15","100000 U/g","CREAM","TOPICAL","ANDA212557","Proficient Rx LP","82804-045","Nystatin","NYSTATIN","HUMAN PRESCRIPTION DRUG","12/08/2023","N/A","ANDA","15 g in 1 TUBE (82804-045-15)","Polyene Antifungal [EPC],  Polyenes [CS]","N/A","No","12/31/2024"
"Nystatin","82804-045-30","100000 U/g","CREAM","TOPICAL","ANDA212557","Proficient Rx LP","82804-045","Nystatin","NYSTATIN","HUMAN PRESCRIPTION DRUG","12/08/2023","N/A","ANDA","30 g in 1 TUBE (82804-045-30)","Polyene Antifungal [EPC],  Polyenes [CS]","N/A","No","12/31/2024"
"Nystatin and Triamcinolone Acetonide","53002-9360-1","100000 [USP'U]/g,                         1  mg/g","CREAM","TOPICAL","ANDA062364","RPK Pharmaceuticals, Inc.","53002-9360","Nystatin and Triamcinolone Acetonide","NYSTATIN;  TRIAMCINOLONE ACETONIDE","HUMAN PRESCRIPTION DRUG","01/01/2021","N/A","ANDA","15 g in 1 TUBE (53002-9360-1)","Corticosteroid Hormone Receptor Agonists [MoA],  Corticosteroid [EPC],  Polyene Antifungal [EPC],  Polyenes [CS]","N/A","No","12/31/2024"
"Nystatin and Triamcinolone Acetonide","53002-9360-2","100000 [USP'U]/g,                         1  mg/g","CREAM","TOPICAL","ANDA062364","RPK Pharmaceuticals, Inc.","53002-9360","Nystatin and Triamcinolone Acetonide","NYSTATIN;  TRIAMCINOLONE ACETONIDE","HUMAN PRESCRIPTION DRUG","01/01/2021","N/A","ANDA","30 g in 1 TUBE (53002-9360-2)","Corticosteroid Hormone Receptor Agonists [MoA],  Corticosteroid [EPC],  Polyene Antifungal [EPC],  Polyenes [CS]","N/A","No","12/31/2024"
"O24 Pain Neutralizer","58265-006-30","2 [hp_X]/30g","SPRAY","TOPICAL","","O24 Naturals, LLC","58265-006","Arnica montana","ARNICA MONTANA","HUMAN OTC DRUG","01/17/2023","N/A","UNAPPROVED HOMEOPATHIC","1 BOTTLE, SPRAY in 1 CARTON (58265-006-30)  / 30 g in 1 BOTTLE, SPRAY","N/A","N/A","No","12/31/2024"
"Odactra","52709-1701-3","6 [arb'U]/1,                         6  [arb'U]/1","TABLET","SUBLINGUAL","BLA125592","ALK-Abello A S","52709-1701","DERMATOPHAGOIDES PTERONYSSINUS and DERMATOPHAGOIDES FARINAE","DERMATOPHAGOIDES FARINAE;  DERMATOPHAGOIDES PTERONYSSINUS","STANDARDIZED ALLERGENIC","01/01/2018","N/A","BLA","3 BLISTER PACK in 1 CARTON (52709-1701-3)  / 10 TABLET in 1 BLISTER PACK (52709-1701-1)","Allergens [CS],  Allergens [CS],  Antigens,  Dermatophagoides [CS],  Antigens,  Dermatophagoides [CS],  Cell-mediated Immunity [PE],  Cell-mediated Immunity [PE],  Increased Histamine Release [PE],  Increased Histamine Release [PE],  Increased IgG Production [PE],  Increased IgG Production [PE],  Insect Proteins [CS],  Insect Proteins [CS],  Standardized Insect Allergenic Extract [EPC],  Standardized Insect Allergenic Extract [EPC]","N/A","No","12/31/2024"
"Odactra","52709-1701-5","6 [arb'U]/1,                         6  [arb'U]/1","TABLET","SUBLINGUAL","BLA125592","ALK-Abello A S","52709-1701","DERMATOPHAGOIDES PTERONYSSINUS and DERMATOPHAGOIDES FARINAE","DERMATOPHAGOIDES FARINAE;  DERMATOPHAGOIDES PTERONYSSINUS","STANDARDIZED ALLERGENIC","01/01/2018","N/A","BLA","1 BLISTER PACK in 1 CARTON (52709-1701-5)  / 5 TABLET in 1 BLISTER PACK","Allergens [CS],  Allergens [CS],  Antigens,  Dermatophagoides [CS],  Antigens,  Dermatophagoides [CS],  Cell-mediated Immunity [PE],  Cell-mediated Immunity [PE],  Increased Histamine Release [PE],  Increased Histamine Release [PE],  Increased IgG Production [PE],  Increased IgG Production [PE],  Insect Proteins [CS],  Insect Proteins [CS],  Standardized Insect Allergenic Extract [EPC],  Standardized Insect Allergenic Extract [EPC]","N/A","No","12/31/2024"
"Ofloxacin","53002-3324-1","3 mg/mL","SOLUTION/ DROPS","OPHTHALMIC","ANDA076622","RPK Pharmaceuticals, Inc.","53002-3324","Ofloxacin","OFLOXACIN","HUMAN PRESCRIPTION DRUG","01/01/2024","N/A","ANDA","1 BOTTLE, DROPPER in 1 CARTON (53002-3324-1)  / 5 mL in 1 BOTTLE, DROPPER","Quinolone Antimicrobial [EPC],  Quinolones [CS]","N/A","No","12/31/2025"
"Ofloxacin","53002-3324-2","3 mg/mL","SOLUTION/ DROPS","OPHTHALMIC","ANDA076622","RPK Pharmaceuticals, Inc.","53002-3324","Ofloxacin","OFLOXACIN","HUMAN PRESCRIPTION DRUG","01/01/2024","N/A","ANDA","1 BOTTLE, DROPPER in 1 CARTON (53002-3324-2)  / 10 mL in 1 BOTTLE, DROPPER","Quinolone Antimicrobial [EPC],  Quinolones [CS]","N/A","No","12/31/2025"
"ofloxacin","50090-6795-0","3 mg/mL","SOLUTION/ DROPS","OPHTHALMIC","ANDA215886","A-S Medication Solutions","50090-6795","ofloxacin","OFLOXACIN","HUMAN PRESCRIPTION DRUG","11/01/2023","N/A","ANDA","144 BOTTLE, DROPPER in 1 CARTON (50090-6795-0)  / 5 mL in 1 BOTTLE, DROPPER","Quinolone Antimicrobial [EPC],  Quinolones [CS]","N/A","No","12/31/2024"
"OFLOXACIN","69315-320-05","3 mg/mL","SOLUTION","AURICULAR (OTIC)","ANDA217903","Leading Pharma, LLC","69315-320","OFLOXACIN","OFLOXACIN","HUMAN PRESCRIPTION DRUG","03/01/2024","N/A","ANDA","5 mL in 1 BOTTLE, DROPPER (69315-320-05)","Quinolone Antimicrobial [EPC],  Quinolones [CS]","N/A","No","12/31/2025"
"OFLOXACIN","69315-320-10","3 mg/mL","SOLUTION","AURICULAR (OTIC)","ANDA217903","Leading Pharma, LLC","69315-320","OFLOXACIN","OFLOXACIN","HUMAN PRESCRIPTION DRUG","03/01/2024","N/A","ANDA","10 mL in 1 BOTTLE, DROPPER (69315-320-10)","Quinolone Antimicrobial [EPC],  Quinolones [CS]","N/A","No","12/31/2025"
"Oleum Santali","37662-3407-1","6 [hp_C]/1","PELLET","ORAL","","Hahnemann Laboratories, INC.","37662-3407","Oleum Santali","SANDALWOOD OIL","HUMAN OTC DRUG","06/23/2023","N/A","UNAPPROVED HOMEOPATHIC","200 PELLET in 1 VIAL, GLASS (37662-3407-1)","N/A","N/A","No","12/31/2024"
"Oleum Santali","37662-3407-2","6 [hp_C]/1","PELLET","ORAL","","Hahnemann Laboratories, INC.","37662-3407","Oleum Santali","SANDALWOOD OIL","HUMAN OTC DRUG","06/23/2023","N/A","UNAPPROVED HOMEOPATHIC","1200 PELLET in 1 BOTTLE, GLASS (37662-3407-2)","N/A","N/A","No","12/31/2024"
"Oleum Santali","37662-3407-3","6 [hp_C]/1","PELLET","ORAL","","Hahnemann Laboratories, INC.","37662-3407","Oleum Santali","SANDALWOOD OIL","HUMAN OTC DRUG","06/23/2023","N/A","UNAPPROVED HOMEOPATHIC","4000 PELLET in 1 BOTTLE, GLASS (37662-3407-3)","N/A","N/A","No","12/31/2024"
"Omeprazole","60687-608-01","40 mg/1","CAPSULE, DELAYED RELEASE","ORAL","ANDA078490","American Health Packaging","60687-608","Omeprazole","OMEPRAZOLE","HUMAN PRESCRIPTION DRUG","08/04/2021","N/A","ANDA","100 BLISTER PACK in 1 CARTON (60687-608-01)  / 1 CAPSULE, DELAYED RELEASE in 1 BLISTER PACK (60687-608-11)","Cytochrome P450 2C19 Inhibitors [MoA],  Proton Pump Inhibitor [EPC],  Proton Pump Inhibitors [MoA]","N/A","No","12/31/2025"
"Omeprazole and Sodium Bicarbonate","27241-029-31","20 mg/1,                         1680  mg/1","FOR SUSPENSION","ORAL","ANDA205545","Ajanta Pharma USA Inc.","27241-029","Omeprazole and Sodium Bicarbonate","OMEPRAZOLE;  SODIUM BICARBONATE","HUMAN PRESCRIPTION DRUG","07/27/2016","N/A","ANDA","30 FOR SUSPENSION in 1 CARTON (27241-029-31)","Alkalinizing Activity [MoA],  Cytochrome P450 2C19 Inhibitors [MoA],  Proton Pump Inhibitor [EPC],  Proton Pump Inhibitors [MoA]","N/A","No","12/31/2024"
"Omeprazole and Sodium Bicarbonate","27241-029-62","20 mg/1,                         1680  mg/1","FOR SUSPENSION","ORAL","ANDA205545","Ajanta Pharma USA Inc.","27241-029","Omeprazole and Sodium Bicarbonate","OMEPRAZOLE;  SODIUM BICARBONATE","HUMAN PRESCRIPTION DRUG","07/27/2016","N/A","ANDA","1 FOR SUSPENSION in 1 PACKET (27241-029-62)","Alkalinizing Activity [MoA],  Cytochrome P450 2C19 Inhibitors [MoA],  Proton Pump Inhibitor [EPC],  Proton Pump Inhibitors [MoA]","N/A","No","12/31/2024"
"Omeprazole and Sodium Bicarbonate","27241-030-31","40 mg/1,                         1680  mg/1","FOR SUSPENSION","ORAL","ANDA205545","Ajanta Pharma USA Inc.","27241-030","Omeprazole and Sodium Bicarbonate","OMEPRAZOLE;  SODIUM BICARBONATE","HUMAN PRESCRIPTION DRUG","07/27/2016","N/A","ANDA","30 FOR SUSPENSION in 1 CARTON (27241-030-31)","Alkalinizing Activity [MoA],  Cytochrome P450 2C19 Inhibitors [MoA],  Proton Pump Inhibitor [EPC],  Proton Pump Inhibitors [MoA]","N/A","No","12/31/2024"
"Omeprazole and Sodium Bicarbonate","27241-030-62","40 mg/1,                         1680  mg/1","FOR SUSPENSION","ORAL","ANDA205545","Ajanta Pharma USA Inc.","27241-030","Omeprazole and Sodium Bicarbonate","OMEPRAZOLE;  SODIUM BICARBONATE","HUMAN PRESCRIPTION DRUG","07/27/2016","N/A","ANDA","1 FOR SUSPENSION in 1 PACKET (27241-030-62)","Alkalinizing Activity [MoA],  Cytochrome P450 2C19 Inhibitors [MoA],  Proton Pump Inhibitor [EPC],  Proton Pump Inhibitors [MoA]","N/A","No","12/31/2024"
"Ondansetron","68462-158-11","8 mg/1","TABLET, ORALLY DISINTEGRATING","ORAL","ANDA078152","Glenmark Pharmaceuticals Inc., USA","68462-158","Ondansetron","ONDANSETRON","HUMAN PRESCRIPTION DRUG","06/27/2007","N/A","ANDA","10 TABLET, ORALLY DISINTEGRATING in 1 BOX, UNIT-DOSE (68462-158-11)","Serotonin 3 Receptor Antagonists [MoA],  Serotonin-3 Receptor Antagonist [EPC]","N/A","No","12/31/2025"
"Ondansetron","68462-158-13","8 mg/1","TABLET, ORALLY DISINTEGRATING","ORAL","ANDA078152","Glenmark Pharmaceuticals Inc., USA","68462-158","Ondansetron","ONDANSETRON","HUMAN PRESCRIPTION DRUG","06/27/2007","N/A","ANDA","30 TABLET, ORALLY DISINTEGRATING in 1 BOX, UNIT-DOSE (68462-158-13)","Serotonin 3 Receptor Antagonists [MoA],  Serotonin-3 Receptor Antagonist [EPC]","N/A","No","12/31/2025"
"Ondansetron","71335-9726-0","4 mg/1","TABLET, ORALLY DISINTEGRATING","ORAL","ANDA078152","Bryant Ranch Prepack","71335-9726","Ondansetron","ONDANSETRON","HUMAN PRESCRIPTION DRUG","05/30/2023","N/A","ANDA","90 TABLET, ORALLY DISINTEGRATING in 1 BLISTER PACK (71335-9726-0)","Serotonin 3 Receptor Antagonists [MoA],  Serotonin-3 Receptor Antagonist [EPC]","N/A","No","12/31/2024"
"Ondansetron","71335-9726-1","4 mg/1","TABLET, ORALLY DISINTEGRATING","ORAL","ANDA078152","Bryant Ranch Prepack","71335-9726","Ondansetron","ONDANSETRON","HUMAN PRESCRIPTION DRUG","05/30/2023","N/A","ANDA","30 TABLET, ORALLY DISINTEGRATING in 1 BLISTER PACK (71335-9726-1)","Serotonin 3 Receptor Antagonists [MoA],  Serotonin-3 Receptor Antagonist [EPC]","N/A","No","12/31/2024"
"Ondansetron","71335-9726-2","4 mg/1","TABLET, ORALLY DISINTEGRATING","ORAL","ANDA078152","Bryant Ranch Prepack","71335-9726","Ondansetron","ONDANSETRON","HUMAN PRESCRIPTION DRUG","05/30/2023","N/A","ANDA","20 TABLET, ORALLY DISINTEGRATING in 1 BLISTER PACK (71335-9726-2)","Serotonin 3 Receptor Antagonists [MoA],  Serotonin-3 Receptor Antagonist [EPC]","N/A","No","12/31/2024"
"Ondansetron","71335-9726-3","4 mg/1","TABLET, ORALLY DISINTEGRATING","ORAL","ANDA078152","Bryant Ranch Prepack","71335-9726","Ondansetron","ONDANSETRON","HUMAN PRESCRIPTION DRUG","05/30/2023","N/A","ANDA","10 TABLET, ORALLY DISINTEGRATING in 1 BLISTER PACK (71335-9726-3)","Serotonin 3 Receptor Antagonists [MoA],  Serotonin-3 Receptor Antagonist [EPC]","N/A","No","12/31/2024"
"Ondansetron","71335-9726-4","4 mg/1","TABLET, ORALLY DISINTEGRATING","ORAL","ANDA078152","Bryant Ranch Prepack","71335-9726","Ondansetron","ONDANSETRON","HUMAN PRESCRIPTION DRUG","05/30/2023","N/A","ANDA","6 TABLET, ORALLY DISINTEGRATING in 1 BLISTER PACK (71335-9726-4)","Serotonin 3 Receptor Antagonists [MoA],  Serotonin-3 Receptor Antagonist [EPC]","N/A","No","12/31/2024"
"Ondansetron","71335-9726-5","4 mg/1","TABLET, ORALLY DISINTEGRATING","ORAL","ANDA078152","Bryant Ranch Prepack","71335-9726","Ondansetron","ONDANSETRON","HUMAN PRESCRIPTION DRUG","05/30/2023","N/A","ANDA","60 TABLET, ORALLY DISINTEGRATING in 1 BLISTER PACK (71335-9726-5)","Serotonin 3 Receptor Antagonists [MoA],  Serotonin-3 Receptor Antagonist [EPC]","N/A","No","12/31/2024"
"Ondansetron","71335-9726-6","4 mg/1","TABLET, ORALLY DISINTEGRATING","ORAL","ANDA078152","Bryant Ranch Prepack","71335-9726","Ondansetron","ONDANSETRON","HUMAN PRESCRIPTION DRUG","05/30/2023","N/A","ANDA","9 TABLET, ORALLY DISINTEGRATING in 1 BLISTER PACK (71335-9726-6)","Serotonin 3 Receptor Antagonists [MoA],  Serotonin-3 Receptor Antagonist [EPC]","N/A","No","12/31/2024"
"Ondansetron","71335-9726-7","4 mg/1","TABLET, ORALLY DISINTEGRATING","ORAL","ANDA078152","Bryant Ranch Prepack","71335-9726","Ondansetron","ONDANSETRON","HUMAN PRESCRIPTION DRUG","05/30/2023","N/A","ANDA","5 TABLET, ORALLY DISINTEGRATING in 1 BLISTER PACK (71335-9726-7)","Serotonin 3 Receptor Antagonists [MoA],  Serotonin-3 Receptor Antagonist [EPC]","N/A","No","12/31/2024"
"Ondansetron","71335-9726-8","4 mg/1","TABLET, ORALLY DISINTEGRATING","ORAL","ANDA078152","Bryant Ranch Prepack","71335-9726","Ondansetron","ONDANSETRON","HUMAN PRESCRIPTION DRUG","05/30/2023","N/A","ANDA","15 TABLET, ORALLY DISINTEGRATING in 1 BLISTER PACK (71335-9726-8)","Serotonin 3 Receptor Antagonists [MoA],  Serotonin-3 Receptor Antagonist [EPC]","N/A","No","12/31/2024"
"Ondansetron","71335-9726-9","4 mg/1","TABLET, ORALLY DISINTEGRATING","ORAL","ANDA078152","Bryant Ranch Prepack","71335-9726","Ondansetron","ONDANSETRON","HUMAN PRESCRIPTION DRUG","05/30/2023","N/A","ANDA","3 TABLET, ORALLY DISINTEGRATING in 1 BLISTER PACK (71335-9726-9)","Serotonin 3 Receptor Antagonists [MoA],  Serotonin-3 Receptor Antagonist [EPC]","N/A","No","12/31/2024"
"Ondansetron Hydrochloride","68084-221-01","8 mg/1","TABLET, FILM COATED","ORAL","ANDA078539","American Health Packaging","68084-221","Ondansetron Hydrochloride","ONDANSETRON HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","08/01/2023","N/A","ANDA","100 BLISTER PACK in 1 BOX, UNIT-DOSE (68084-221-01)  / 1 TABLET, FILM COATED in 1 BLISTER PACK (68084-221-11)","Serotonin 3 Receptor Antagonists [MoA],  Serotonin-3 Receptor Antagonist [EPC]","N/A","No","12/31/2024"
"Ondansetron Hydrochloride","68788-9402-2","8 mg/1","TABLET, FILM COATED","ORAL","ANDA078539","Preferred Pharmaceuticals, Inc.","68788-9402","Ondansetron Hydrochloride","ONDANSETRON HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","06/23/2017","N/A","ANDA","12 TABLET, FILM COATED in 1 BOTTLE (68788-9402-2)","Serotonin 3 Receptor Antagonists [MoA],  Serotonin-3 Receptor Antagonist [EPC]","N/A","No","12/31/2024"
"Ondansetron Hydrochloride","68788-9402-5","8 mg/1","TABLET, FILM COATED","ORAL","ANDA078539","Preferred Pharmaceuticals, Inc.","68788-9402","Ondansetron Hydrochloride","ONDANSETRON HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","06/23/2017","N/A","ANDA","15 TABLET, FILM COATED in 1 BOTTLE (68788-9402-5)","Serotonin 3 Receptor Antagonists [MoA],  Serotonin-3 Receptor Antagonist [EPC]","N/A","No","12/31/2024"
"Ondansetron Hydrochloride","68788-9402-1","8 mg/1","TABLET, FILM COATED","ORAL","ANDA078539","Preferred Pharmaceuticals, Inc.","68788-9402","Ondansetron Hydrochloride","ONDANSETRON HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","06/12/2012","N/A","ANDA","10 TABLET, FILM COATED in 1 BOTTLE (68788-9402-1)","Serotonin 3 Receptor Antagonists [MoA],  Serotonin-3 Receptor Antagonist [EPC]","N/A","No","12/31/2024"
"Ondansetron Hydrochloride","68788-9402-6","8 mg/1","TABLET, FILM COATED","ORAL","ANDA078539","Preferred Pharmaceuticals, Inc.","68788-9402","Ondansetron Hydrochloride","ONDANSETRON HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","06/23/2017","N/A","ANDA","6 TABLET, FILM COATED in 1 BOTTLE (68788-9402-6)","Serotonin 3 Receptor Antagonists [MoA],  Serotonin-3 Receptor Antagonist [EPC]","N/A","No","12/31/2024"
"Ondansetron Hydrochloride","68788-9402-3","8 mg/1","TABLET, FILM COATED","ORAL","ANDA078539","Preferred Pharmaceuticals, Inc.","68788-9402","Ondansetron Hydrochloride","ONDANSETRON HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","06/12/2012","N/A","ANDA","30 TABLET, FILM COATED in 1 BOTTLE (68788-9402-3)","Serotonin 3 Receptor Antagonists [MoA],  Serotonin-3 Receptor Antagonist [EPC]","N/A","No","12/31/2024"
"Pain Relief PM","55910-655-10","500 mg/1,                         25  mg/1","TABLET, COATED","ORAL","M013","DOLGENCORP, LLC","55910-655","Acetaminophen and Diphenhydramine HCl","ACETAMINOPHEN;  DIPHENHYDRAMINE HYDROCHLORIDE","HUMAN OTC DRUG","12/17/2007","N/A","OTC MONOGRAPH DRUG","1 BOTTLE, PLASTIC in 1 CARTON (55910-655-10)  / 40 TABLET, COATED in 1 BOTTLE, PLASTIC","Histamine H1 Receptor Antagonists [MoA],  Histamine-1 Receptor Antagonist [EPC]","N/A","No","12/31/2024"
"Pain Relief PM","55910-655-31","500 mg/1,                         25  mg/1","TABLET, COATED","ORAL","M013","DOLGENCORP, LLC","55910-655","Acetaminophen and Diphenhydramine HCl","ACETAMINOPHEN;  DIPHENHYDRAMINE HYDROCHLORIDE","HUMAN OTC DRUG","12/17/2007","N/A","OTC MONOGRAPH DRUG","1 BOTTLE, PLASTIC in 1 CARTON (55910-655-31)  / 80 TABLET, COATED in 1 BOTTLE, PLASTIC","Histamine H1 Receptor Antagonists [MoA],  Histamine-1 Receptor Antagonist [EPC]","N/A","No","12/31/2024"
"Pain Reliever","68210-4178-5","325 mg/1","TABLET, COATED","ORAL","M013","Spirit Pharmaceuticals LLC","68210-4178","Aspirin","ASPIRIN","HUMAN OTC DRUG","11/23/2021","N/A","OTC MONOGRAPH DRUG","50 TABLET, COATED in 1 POUCH (68210-4178-5)","Anti-Inflammatory Agents,  Non-Steroidal [CS],  Cyclooxygenase Inhibitors [MoA],  Decreased Platelet Aggregation [PE],  Decreased Prostaglandin Production [PE],  Nonsteroidal Anti-inflammatory Drug [EPC],  Platelet Aggregation Inhibitor [EPC]","N/A","No","12/31/2024"
"Pain Reliever","0363-0175-03","500 mg/1","TABLET, FILM COATED","ORAL","M013","Walgreen Company","0363-0175","Acetaminophen","ACETAMINOPHEN","HUMAN OTC DRUG","04/02/1993","N/A","OTC MONOGRAPH DRUG","10 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (0363-0175-03)","N/A","N/A","No","12/31/2025"
"Pain Reliever","0363-0175-12","500 mg/1","TABLET, FILM COATED","ORAL","M013","Walgreen Company","0363-0175","Acetaminophen","ACETAMINOPHEN","HUMAN OTC DRUG","04/02/1993","12/09/2024","OTC MONOGRAPH DRUG","1 BOTTLE, PLASTIC in 1 CARTON (0363-0175-12)  / 100 TABLET, FILM COATED in 1 BOTTLE, PLASTIC","N/A","N/A","No","12/31/2025"
"Pain Reliever","0363-0175-29","500 mg/1","TABLET, FILM COATED","ORAL","M013","Walgreen Company","0363-0175","Acetaminophen","ACETAMINOPHEN","HUMAN OTC DRUG","04/02/1993","07/21/2024","OTC MONOGRAPH DRUG","150 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (0363-0175-29)","N/A","N/A","No","12/31/2025"
"Pain Reliever and Sleep Aid","68210-4236-1","500 mg/1,                         25  mg/1","TABLET, FILM COATED","ORAL","M013","Spirit Pharmaceuticals LLC","68210-4236","Acetaminophen, and Diphenhydramine hydrochloride","ACETAMINOPHEN;  DIPHENHYDRAMINE HYDROCHLORIDE","HUMAN OTC DRUG","11/17/2022","N/A","OTC MONOGRAPH DRUG","120 TABLET, FILM COATED in 1 POUCH (68210-4236-1)","Histamine H1 Receptor Antagonists [MoA],  Histamine-1 Receptor Antagonist [EPC]","N/A","No","12/31/2024"
"Pain Reliever Cream","69396-151-01","10 g/100g,                         15  g/100g","CREAM","TOPICAL","M017","Trifecta Pharmaceuticals USA, LLC.","69396-151","Menthol 10%, Methyl Salicylate 15%","MENTHOL;  METHYL SALICYLATE","HUMAN OTC DRUG","03/06/2024","N/A","OTC MONOGRAPH DRUG","1 TUBE in 1 BOX (69396-151-01)  / 114 g in 1 TUBE","N/A","N/A","No","12/31/2025"
"Pain Reliever PM","71679-143-00","500 mg/1,                         25  mg/1","TABLET","ORAL","M013","Health Pharma USA LLC","71679-143","Acetaminophen and Diphenhydramine Hydrochloride","ACETAMINOPHEN;  DIPHENHYDRAMINE HYDROCHLORIDE","HUMAN OTC DRUG","02/01/2021","N/A","OTC MONOGRAPH DRUG","1 BAG in 1 BOX (71679-143-00)  / 25000 TABLET in 1 BAG","Histamine H1 Receptor Antagonists [MoA],  Histamine-1 Receptor Antagonist [EPC]","N/A","No","12/31/2024"
"PANTOPRAZOLE SODIUM","31722-712-31","20 mg/1","TABLET, DELAYED RELEASE","ORAL","ANDA202882","Camber Pharmaceuticals, Inc.","31722-712","PANTOPRAZOLE","PANTOPRAZOLE SODIUM","HUMAN PRESCRIPTION DRUG","09/10/2014","N/A","ANDA","10 TABLET, DELAYED RELEASE in 1 BLISTER PACK (31722-712-31)","Proton Pump Inhibitor [EPC],  Proton Pump Inhibitors [MoA]","N/A","No","12/31/2025"
"PANTOPRAZOLE SODIUM","31722-712-32","20 mg/1","TABLET, DELAYED RELEASE","ORAL","ANDA202882","Camber Pharmaceuticals, Inc.","31722-712","PANTOPRAZOLE","PANTOPRAZOLE SODIUM","HUMAN PRESCRIPTION DRUG","09/10/2014","N/A","ANDA","10 TABLET, DELAYED RELEASE in 1 CARTON (31722-712-32)","Proton Pump Inhibitor [EPC],  Proton Pump Inhibitors [MoA]","N/A","No","12/31/2025"
"PANTOPRAZOLE SODIUM","31722-712-90","20 mg/1","TABLET, DELAYED RELEASE","ORAL","ANDA202882","Camber Pharmaceuticals, Inc.","31722-712","PANTOPRAZOLE","PANTOPRAZOLE SODIUM","HUMAN PRESCRIPTION DRUG","09/10/2014","N/A","ANDA","90 TABLET, DELAYED RELEASE in 1 BOTTLE (31722-712-90)","Proton Pump Inhibitor [EPC],  Proton Pump Inhibitors [MoA]","N/A","No","12/31/2025"
"Paroxetine","70518-3988-0","30 mg/1","TABLET, FILM COATED","ORAL","ANDA078406","REMEDYREPACK INC.","70518-3988","Paroxetine","PAROXETINE HYDROCHLORIDE HEMIHYDRATE","HUMAN PRESCRIPTION DRUG","01/19/2024","N/A","ANDA","30 TABLET, FILM COATED in 1 BLISTER PACK (70518-3988-0)","Serotonin Reuptake Inhibitor [EPC],  Serotonin Uptake Inhibitors [MoA]","N/A","No","12/31/2025"
"Personalized Day Moisturizer with SPF 50","73572-007-01","120 mg/mL","CREAM","TOPICAL","M020","Proven Skincare","73572-007","ZINC OXIDE","ZINC OXIDE","HUMAN OTC DRUG","03/01/2022","N/A","OTC MONOGRAPH DRUG","30 mL in 1 BOTTLE (73572-007-01)","Copper Absorption Inhibitor [EPC],  Decreased Copper Ion Absorption [PE]","N/A","No","12/31/2024"
"PHARBINEX-DM","16103-381-04","20 mg/1,                         400  mg/1","TABLET","ORAL","M","Pharbest Pharmaceuticals, Inc.","16103-381","GUAIFENESIN 400mg and DEXTROMETHORPHAN HBR 20MG","DEXTROMETHORPHAN HYDROBROMIDE;  GUAIFENESIN","HUMAN OTC DRUG","04/02/2018","N/A","OTC MONOGRAPH DRUG","1 BOTTLE, PLASTIC in 1 CARTON (16103-381-04)  / 30 TABLET in 1 BOTTLE, PLASTIC","Decreased Respiratory Secretion Viscosity [PE],  Expectorant [EPC],  Increased Respiratory Secretions [PE],  Sigma-1 Agonist [EPC],  Sigma-1 Receptor Agonists [MoA],  Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC],  Uncompetitive NMDA Receptor Antagonists [MoA]","N/A","No","12/31/2025"
"Phenazopyridine Hydrochloride","71205-836-55","200 mg/1","TABLET","ORAL","","Proficient Rx LP","71205-836","Phenazopyridine Hydrochloride","PHENAZOPYRIDINE HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","06/06/2023","N/A","UNAPPROVED DRUG OTHER","500 TABLET in 1 BOTTLE (71205-836-55)","N/A","N/A","No","12/31/2024"
"Phenazopyridine Hydrochloride","71205-836-90","200 mg/1","TABLET","ORAL","","Proficient Rx LP","71205-836","Phenazopyridine Hydrochloride","PHENAZOPYRIDINE HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","06/06/2023","N/A","UNAPPROVED DRUG OTHER","90 TABLET in 1 BOTTLE (71205-836-90)","N/A","N/A","No","12/31/2024"
"Phenazopyridine Hydrochloride","71205-836-96","200 mg/1","TABLET","ORAL","","Proficient Rx LP","71205-836","Phenazopyridine Hydrochloride","PHENAZOPYRIDINE HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","06/06/2023","N/A","UNAPPROVED DRUG OTHER","96 TABLET in 1 BOTTLE (71205-836-96)","N/A","N/A","No","12/31/2024"
"Phenazopyridine Hydrochloride","71205-836-00","200 mg/1","TABLET","ORAL","","Proficient Rx LP","71205-836","Phenazopyridine Hydrochloride","PHENAZOPYRIDINE HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","06/06/2023","N/A","UNAPPROVED DRUG OTHER","100 TABLET in 1 BOTTLE (71205-836-00)","N/A","N/A","No","12/31/2024"
"Phenazopyridine Hydrochloride","71205-836-06","200 mg/1","TABLET","ORAL","","Proficient Rx LP","71205-836","Phenazopyridine Hydrochloride","PHENAZOPYRIDINE HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","06/06/2023","N/A","UNAPPROVED DRUG OTHER","6 TABLET in 1 BOTTLE (71205-836-06)","N/A","N/A","No","12/31/2024"
"Phenazopyridine Hydrochloride","71205-836-10","200 mg/1","TABLET","ORAL","","Proficient Rx LP","71205-836","Phenazopyridine Hydrochloride","PHENAZOPYRIDINE HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","06/06/2023","N/A","UNAPPROVED DRUG OTHER","10 TABLET in 1 BOTTLE (71205-836-10)","N/A","N/A","No","12/31/2024"
"Phenazopyridine Hydrochloride","71205-836-12","200 mg/1","TABLET","ORAL","","Proficient Rx LP","71205-836","Phenazopyridine Hydrochloride","PHENAZOPYRIDINE HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","06/06/2023","N/A","UNAPPROVED DRUG OTHER","12 TABLET in 1 BOTTLE (71205-836-12)","N/A","N/A","No","12/31/2024"
"Phenazopyridine Hydrochloride","71205-836-20","200 mg/1","TABLET","ORAL","","Proficient Rx LP","71205-836","Phenazopyridine Hydrochloride","PHENAZOPYRIDINE HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","06/06/2023","N/A","UNAPPROVED DRUG OTHER","20 TABLET in 1 BOTTLE (71205-836-20)","N/A","N/A","No","12/31/2024"
"Phenazopyridine Hydrochloride","71205-836-24","200 mg/1","TABLET","ORAL","","Proficient Rx LP","71205-836","Phenazopyridine Hydrochloride","PHENAZOPYRIDINE HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","06/06/2023","N/A","UNAPPROVED DRUG OTHER","24 TABLET in 1 BOTTLE (71205-836-24)","N/A","N/A","No","12/31/2024"
"Phenobarbital","13517-693-01","60 mg/1","TABLET","ORAL","","e5 Pharma, LLC","13517-693","phenobarbital","PHENOBARBITAL","HUMAN PRESCRIPTION DRUG","11/30/2022","N/A","UNAPPROVED DRUG OTHER","100 TABLET in 1 BOTTLE, PLASTIC (13517-693-01)","N/A","CIV","No","12/31/2025"
"Phenobarbital","13517-693-05","60 mg/1","TABLET","ORAL","","e5 Pharma, LLC","13517-693","phenobarbital","PHENOBARBITAL","HUMAN PRESCRIPTION DRUG","11/30/2022","N/A","UNAPPROVED DRUG OTHER","500 TABLET in 1 BOTTLE, PLASTIC (13517-693-05)","N/A","CIV","No","12/31/2025"
"Phenobarbital","13517-628-01","97.2 mg/1","TABLET","ORAL","","e5 Pharma, LLC","13517-628","phenobarbital","PHENOBARBITAL","HUMAN PRESCRIPTION DRUG","11/30/2022","N/A","UNAPPROVED DRUG OTHER","100 TABLET in 1 BOTTLE, PLASTIC (13517-628-01)","N/A","CIV","No","12/31/2025"
"Phenobarbital","13517-628-10","97.2 mg/1","TABLET","ORAL","","e5 Pharma, LLC","13517-628","phenobarbital","PHENOBARBITAL","HUMAN PRESCRIPTION DRUG","11/30/2022","N/A","UNAPPROVED DRUG OTHER","1000 TABLET in 1 BOTTLE, PLASTIC (13517-628-10)","N/A","CIV","No","12/31/2025"
"Phenobarbital","72162-1573-0","64.8 mg/1","TABLET","ORAL","","Bryant Ranch Prepack","72162-1573","phenobarbital","PHENOBARBITAL","HUMAN PRESCRIPTION DRUG","02/07/2024","N/A","UNAPPROVED DRUG OTHER","1000 TABLET in 1 BOTTLE, PLASTIC (72162-1573-0)","N/A","CIV","No","12/31/2025"
"Phenobarbital","72162-1573-1","64.8 mg/1","TABLET","ORAL","","Bryant Ranch Prepack","72162-1573","phenobarbital","PHENOBARBITAL","HUMAN PRESCRIPTION DRUG","02/07/2024","N/A","UNAPPROVED DRUG OTHER","100 TABLET in 1 BOTTLE, PLASTIC (72162-1573-1)","N/A","CIV","No","12/31/2025"
"PIOGLITAZONE HYDROCHLORIDE","82009-105-05","45 mg/1","TABLET","ORAL","ANDA200268","QUALLENT PHARMACEUTICALS HEALTH LLC","82009-105","pioglitazone hydrochloride","PIOGLITAZONE HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","08/01/2023","N/A","ANDA","500 TABLET in 1 BOTTLE (82009-105-05)","Peroxisome Proliferator Receptor alpha Agonist [EPC],  Peroxisome Proliferator Receptor gamma Agonist [EPC],  Peroxisome Proliferator-activated Receptor alpha Agonists [MoA],  Peroxisome Proliferator-activated Receptor gamma Agonists [MoA],  Thiazolidinedione [EPC],  Thiazolidinediones [CS]","N/A","No","12/31/2024"
"Polymyxin B Sulfate and Trimethoprim","53002-8620-1","10000 [USP'U]/mL,                         1  mg/mL","SOLUTION/ DROPS","OPHTHALMIC","ANDA064120","RPK Pharmaceuticals, Inc.","53002-8620","Polymyxin B Sulfate and Trimethoprim Sulfate","POLYMYXIN B SULFATE;  TRIMETHOPRIM SULFATE","HUMAN PRESCRIPTION DRUG","10/01/2017","N/A","ANDA","10 mL in 1 BOTTLE, DROPPER (53002-8620-1)","Cytochrome P450 2C8 Inhibitors [MoA],  Dihydrofolate Reductase Inhibitor Antibacterial [EPC],  Dihydrofolate Reductase Inhibitors [MoA],  Organic Cation Transporter 2 Inhibitors [MoA],  Polymyxin-class Antibacterial [EPC],  Polymyxins [CS]","N/A","No","12/31/2024"
"Potassium Chloride","50090-5665-0","1500 mg/1","TABLET, EXTENDED RELEASE","ORAL","ANDA212861","A-S Medication Solutions","50090-5665","Potassium Chloride","POTASSIUM CHLORIDE","HUMAN PRESCRIPTION DRUG","09/15/2021","N/A","ANDA","30 TABLET, EXTENDED RELEASE in 1 BOTTLE (50090-5665-0)","Increased Large Intestinal Motility [PE],  Inhibition Large Intestine Fluid/Electrolyte Absorption [PE],  Osmotic Activity [MoA],  Osmotic Laxative [EPC],  Potassium Compounds [CS],  Potassium Salt [EPC]","N/A","No","12/31/2024"
"Potassium Chloride","50090-5665-1","1500 mg/1","TABLET, EXTENDED RELEASE","ORAL","ANDA212861","A-S Medication Solutions","50090-5665","Potassium Chloride","POTASSIUM CHLORIDE","HUMAN PRESCRIPTION DRUG","09/15/2021","N/A","ANDA","60 TABLET, EXTENDED RELEASE in 1 BOTTLE (50090-5665-1)","Increased Large Intestinal Motility [PE],  Inhibition Large Intestine Fluid/Electrolyte Absorption [PE],  Osmotic Activity [MoA],  Osmotic Laxative [EPC],  Potassium Compounds [CS],  Potassium Salt [EPC]","N/A","No","12/31/2024"
"Potassium Chloride","50090-5665-2","1500 mg/1","TABLET, EXTENDED RELEASE","ORAL","ANDA212861","A-S Medication Solutions","50090-5665","Potassium Chloride","POTASSIUM CHLORIDE","HUMAN PRESCRIPTION DRUG","09/15/2021","N/A","ANDA","90 TABLET, EXTENDED RELEASE in 1 BOTTLE (50090-5665-2)","Increased Large Intestinal Motility [PE],  Inhibition Large Intestine Fluid/Electrolyte Absorption [PE],  Osmotic Activity [MoA],  Osmotic Laxative [EPC],  Potassium Compounds [CS],  Potassium Salt [EPC]","N/A","No","12/31/2024"
"Potassium Chloride","62037-710-01","10 meq/1","TABLET, EXTENDED RELEASE","ORAL","ANDA075604","Actavis Pharma, Inc.","62037-710","Potassium Chloride","POTASSIUM CHLORIDE","HUMAN PRESCRIPTION DRUG","04/10/2002","N/A","ANDA","100 TABLET, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (62037-710-01)","Increased Large Intestinal Motility [PE],  Inhibition Large Intestine Fluid/Electrolyte Absorption [PE],  Osmotic Activity [MoA],  Osmotic Laxative [EPC],  Potassium Compounds [CS],  Potassium Salt [EPC]","N/A","No","12/31/2024"
"Povidone-lodine Swabsticks Triple","59050-261-03","100 mg/g","LIQUID","TOPICAL","M003","Changzhou Maokang Medical Products Co., Ltd","59050-261","POVIDONE-IODINE","POVIDONE-IODINE","HUMAN OTC DRUG","11/30/2021","N/A","OTC MONOGRAPH DRUG","3 POUCH in 1 POUCH (59050-261-03)  / 6 g in 1 POUCH","N/A","N/A","No","12/31/2024"
"Prazosin Hydrochloride","70518-3186-0","2 mg/1","CAPSULE","ORAL","ANDA071745","REMEDYREPACK INC.","70518-3186","Prazosin Hydrochloride","PRAZOSIN HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","08/10/2021","N/A","ANDA","30 CAPSULE in 1 BLISTER PACK (70518-3186-0)","Adrenergic alpha-Antagonists [MoA],  alpha-Adrenergic Blocker [EPC]","N/A","No","12/31/2025"
"Prazosin Hydrochloride","70518-3186-1","2 mg/1","CAPSULE","ORAL","ANDA071745","REMEDYREPACK INC.","70518-3186","Prazosin Hydrochloride","PRAZOSIN HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","01/31/2022","N/A","ANDA","100 POUCH in 1 BOX (70518-3186-1)  / 1 CAPSULE in 1 POUCH (70518-3186-2)","Adrenergic alpha-Antagonists [MoA],  alpha-Adrenergic Blocker [EPC]","N/A","No","12/31/2025"
"Prazosin Hydrochloride","70518-3271-2","1 mg/1","CAPSULE","ORAL","NDA017442","REMEDYREPACK INC.","70518-3271","prazosin hydrochloride","PRAZOSIN HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","12/07/2023","N/A","NDA AUTHORIZED GENERIC","30 CAPSULE in 1 BLISTER PACK (70518-3271-2)","Adrenergic alpha-Antagonists [MoA],  alpha-Adrenergic Blocker [EPC]","N/A","No","12/31/2025"
"Prazosin Hydrochloride","70518-3271-0","1 mg/1","CAPSULE","ORAL","NDA017442","REMEDYREPACK INC.","70518-3271","prazosin hydrochloride","PRAZOSIN HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","11/17/2021","N/A","NDA AUTHORIZED GENERIC","30 POUCH in 1 BOX (70518-3271-0)  / 1 CAPSULE in 1 POUCH (70518-3271-1)","Adrenergic alpha-Antagonists [MoA],  alpha-Adrenergic Blocker [EPC]","N/A","No","12/31/2025"
"Pregabalin","60219-1312-9","75 mg/1","CAPSULE","ORAL","ANDA209743","Amneal Pharmaceuticals NY LLC","60219-1312","Pregabalin","PREGABALIN","HUMAN PRESCRIPTION DRUG","07/19/2019","N/A","ANDA","90 CAPSULE in 1 BOTTLE (60219-1312-9)","N/A","CV","No","12/31/2025"
"Pregabalin","72162-2028-9","225 mg/1","CAPSULE","ORAL","ANDA211685","Bryant Ranch Prepack","72162-2028","Pregabalin","PREGABALIN","HUMAN PRESCRIPTION DRUG","05/26/2023","N/A","ANDA","90 CAPSULE in 1 BOTTLE (72162-2028-9)","N/A","CV","No","12/31/2024"
"PREGABALIN","80425-0185-2","150 mg/1","CAPSULE","ORAL","ANDA207799","Advanced Rx Pharmacy of Tennessee, LLC","80425-0185","PREGABALIN","PREGABALIN","HUMAN PRESCRIPTION DRUG","07/21/2019","N/A","ANDA","60 CAPSULE in 1 BOTTLE (80425-0185-2)","N/A","CV","No","12/31/2024"
"PREGABALIN","80425-0185-1","150 mg/1","CAPSULE","ORAL","ANDA207799","Advanced Rx Pharmacy of Tennessee, LLC","80425-0185","PREGABALIN","PREGABALIN","HUMAN PRESCRIPTION DRUG","05/17/2023","N/A","ANDA","30 CAPSULE in 1 BOTTLE (80425-0185-1)","N/A","CV","No","12/31/2024"
"PREGABALIN","80425-0185-3","150 mg/1","CAPSULE","ORAL","ANDA207799","Advanced Rx Pharmacy of Tennessee, LLC","80425-0185","PREGABALIN","PREGABALIN","HUMAN PRESCRIPTION DRUG","07/21/2019","N/A","ANDA","90 CAPSULE in 1 BOTTLE (80425-0185-3)","N/A","CV","No","12/31/2024"
"Premier Value","61658-883-30","5.8 mg/1","LOZENGE","ORAL","part341","YUNNAN BAIYAO GROUP CO., LTD","61658-883","Cough Drops Cherry","MENTHOL","HUMAN OTC DRUG","07/31/2023","N/A","OTC MONOGRAPH FINAL","30 LOZENGE in 1 BAG (61658-883-30)","N/A","N/A","No","12/31/2024"
"Prenatal Vitamins Plus Low Iron","50090-0616-0","10 mg/1,                         276  ug/1,                         120  mg/1,                         200  mg/1,                         10  ug/1,                         2  mg/1,                         12  ug/1,                         27  mg/1,                         1667  ug/1,                         20  mg/1,                         10  mg/1,                         3  mg/1,                         1.84  mg/1,                         924  ug/1,                         25  mg/1","TABLET","ORAL","","A-S Medication Solutions","50090-0616","prenatal with ferrous fumarate and folic acid",".ALPHA.-TOCOPHEROL ACETATE, DL-;  .BETA.-CAROTENE;  ASCORBIC ACID;  CALCIUM CARBONATE;  CHOLECALCIFEROL;  CUPRIC OXIDE;  CYANOCOBALAMIN;  FERROUS FUMARATE;  FOLIC ACID;  NIACINAMIDE;  PYRIDOXINE HYDROCHLORIDE;  RIBOFLAVIN;  THIAMINE MONONITRATE;  VITAMIN A ACETATE;  ZINC OXIDE","HUMAN PRESCRIPTION DRUG","11/28/2014","N/A","UNAPPROVED DRUG OTHER","100 TABLET in 1 BOTTLE, PLASTIC (50090-0616-0)","Analogs/Derivatives [Chemical/Ingredient],  Ascorbic Acid [CS],  Blood Coagulation Factor [EPC],  Calcium [CS],  Cations,  Divalent [CS],  Increased Coagulation Factor Activity [PE],  Phosphate Binder [EPC],  Phosphate Chelating Activity [MoA],  Vitamin A [CS],  Vitamin A [EPC],  Vitamin B 12 [CS],  Vitamin B 6 [Chemical/Ingredient],  Vitamin B12 [EPC],  Vitamin B6 Analog [EPC],  Vitamin C [EPC],  Vitamin D [CS],  Vitamin D [EPC]","N/A","No","12/31/2024"
"Prenatal Vitamins Plus Low Iron","50090-0616-1","10 mg/1,                         276  ug/1,                         120  mg/1,                         200  mg/1,                         10  ug/1,                         2  mg/1,                         12  ug/1,                         27  mg/1,                         1667  ug/1,                         20  mg/1,                         10  mg/1,                         3  mg/1,                         1.84  mg/1,                         924  ug/1,                         25  mg/1","TABLET","ORAL","","A-S Medication Solutions","50090-0616","prenatal with ferrous fumarate and folic acid",".ALPHA.-TOCOPHEROL ACETATE, DL-;  .BETA.-CAROTENE;  ASCORBIC ACID;  CALCIUM CARBONATE;  CHOLECALCIFEROL;  CUPRIC OXIDE;  CYANOCOBALAMIN;  FERROUS FUMARATE;  FOLIC ACID;  NIACINAMIDE;  PYRIDOXINE HYDROCHLORIDE;  RIBOFLAVIN;  THIAMINE MONONITRATE;  VITAMIN A ACETATE;  ZINC OXIDE","HUMAN PRESCRIPTION DRUG","11/28/2014","N/A","UNAPPROVED DRUG OTHER","30 TABLET in 1 BOTTLE (50090-0616-1)","Analogs/Derivatives [Chemical/Ingredient],  Ascorbic Acid [CS],  Blood Coagulation Factor [EPC],  Calcium [CS],  Cations,  Divalent [CS],  Increased Coagulation Factor Activity [PE],  Phosphate Binder [EPC],  Phosphate Chelating Activity [MoA],  Vitamin A [CS],  Vitamin A [EPC],  Vitamin B 12 [CS],  Vitamin B 6 [Chemical/Ingredient],  Vitamin B12 [EPC],  Vitamin B6 Analog [EPC],  Vitamin C [EPC],  Vitamin D [CS],  Vitamin D [EPC]","N/A","No","12/31/2024"
"Prep Pad Sterile","59050-456-11","10 g/100g","PATCH","TOPICAL","M003","Changzhou Maokang Medical Products Co., Ltd","59050-456","POVIDONE-IODINE","POVIDONE-IODINE","HUMAN OTC DRUG","06/29/2018","N/A","OTC MONOGRAPH DRUG","5.5 g in 1 POUCH (59050-456-11)","N/A","N/A","No","12/31/2024"
"Professional Weight Support","43742-2048-1","30 [hp_X]/1,                         30  [hp_X]/1,                         6  [hp_X]/1,                         12  [hp_X]/1,                         12  [hp_X]/1,                         30  [hp_X]/1,                         30  [hp_X]/1,                         8  [hp_X]/1,                         12  [hp_X]/1,                         8  [hp_X]/1,                         8  [hp_X]/1,                         30  [hp_C]/1,                         12  [hp_X]/1,                         6  [hp_X]/1,                         30  [hp_X]/1,                         6  [hp_X]/1","TABLET","ORAL","","Deseret Biologicals","43742-2048","Asclepias Vincetoxicum, Echinacea (Angustifolia), Hypothalamus (Suis), Hepar Suis, Kidney (Suis), Methylcobalamin, Gambogia, Graphites, Nux Vomica, Phytolacca Decandra, 7-Oxo-Dehydroepiandrosterone 3B-Acetate, Adenosinum Triphosphoricum Dinatrum, Insulinum (human), Pancreas Suis, Sarcolacticum Acidum, Proteus (Vulgaris)","7-KETO-DEHYDROEPIANDROSTERONE;  ADENOSINE TRIPHOSPHATE DISODIUM;  ECHINACEA, UNSPECIFIED;  GAMBOGE;  GRAPHITE;  INSULIN HUMAN;  LACTIC ACID, L-;  METHYLCOBALAMIN;  PHYTOLACCA AMERICANA ROOT;  PORK KIDNEY;  PORK LIVER;  PROTEUS VULGARIS;  STRYCHNOS NUX-VOMICA SEED;  SUS SCROFA HYPOTHALAMUS;  SUS SCROFA PANCREAS;  VINCETOXICUM HIRUNDINARIA ROOT","HUMAN OTC DRUG","03/11/2022","N/A","UNAPPROVED HOMEOPATHIC","90 TABLET in 1 BOTTLE, PLASTIC (43742-2048-1)","Allergens [CS],  Cell-mediated Immunity [PE],  Increased Histamine Release [PE],  Increased IgG Production [PE],  Insulin [CS],  Insulin [EPC],  Non-Standardized Plant Allergenic Extract [EPC],  Plant Proteins [CS],  Seed Storage Proteins [CS]","N/A","No","12/31/2025"
"propafenone hydrochloride","68462-410-60","425 mg/1","CAPSULE, EXTENDED RELEASE","ORAL","ANDA205268","Glenmark Pharmaceuticals Inc., USA","68462-410","propafenone hydrochloride","PROPAFENONE HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","09/08/2017","N/A","ANDA","60 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (68462-410-60)","Antiarrhythmic [EPC]","N/A","No","12/31/2025"
"Protopam Chloride","60977-141-01","1 g/20mL","INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION","INTRAMUSCULAR; INTRAVENOUS; SUBCUTANEOUS","NDA014134","Baxter Healthcare Corporation","60977-141","pralidoxime chloride","PRALIDOXIME CHLORIDE","HUMAN PRESCRIPTION DRUG","03/10/1965","N/A","NDA","6 VIAL, SINGLE-DOSE in 1 PACKAGE (60977-141-01)  / 20 mL in 1 VIAL, SINGLE-DOSE (60977-141-27)","Cholinesterase Reactivator [EPC],  Cholinesterase Reactivators [MoA]","N/A","No","12/31/2025"
"Quetiapine","16729-146-01","50 mg/1","TABLET, FILM COATED","ORAL","ANDA202152","Accord Healthcare Inc.","16729-146","Quetiapine","QUETIAPINE FUMARATE","HUMAN PRESCRIPTION DRUG","03/28/2012","N/A","ANDA","100 TABLET, FILM COATED in 1 BOTTLE (16729-146-01)","Atypical Antipsychotic [EPC]","N/A","No","12/31/2024"
"Quetiapine","16729-146-17","50 mg/1","TABLET, FILM COATED","ORAL","ANDA202152","Accord Healthcare Inc.","16729-146","Quetiapine","QUETIAPINE FUMARATE","HUMAN PRESCRIPTION DRUG","03/28/2012","N/A","ANDA","1000 TABLET, FILM COATED in 1 BOTTLE (16729-146-17)","Atypical Antipsychotic [EPC]","N/A","No","12/31/2024"
"Quetiapine","16729-149-01","300 mg/1","TABLET, FILM COATED","ORAL","ANDA202152","Accord Healthcare Inc.","16729-149","Quetiapine","QUETIAPINE FUMARATE","HUMAN PRESCRIPTION DRUG","11/02/2015","N/A","ANDA","100 TABLET, FILM COATED in 1 BOTTLE (16729-149-01)","Atypical Antipsychotic [EPC]","N/A","No","12/31/2024"
"Quetiapine","16729-149-10","300 mg/1","TABLET, FILM COATED","ORAL","ANDA202152","Accord Healthcare Inc.","16729-149","Quetiapine","QUETIAPINE FUMARATE","HUMAN PRESCRIPTION DRUG","03/28/2012","N/A","ANDA","30 TABLET, FILM COATED in 1 BOTTLE (16729-149-10)","Atypical Antipsychotic [EPC]","N/A","No","12/31/2024"
"Quetiapine","16729-149-12","300 mg/1","TABLET, FILM COATED","ORAL","ANDA202152","Accord Healthcare Inc.","16729-149","Quetiapine","QUETIAPINE FUMARATE","HUMAN PRESCRIPTION DRUG","03/28/2012","N/A","ANDA","60 TABLET, FILM COATED in 1 BOTTLE (16729-149-12)","Atypical Antipsychotic [EPC]","N/A","No","12/31/2024"
"Quetiapine","16729-149-17","300 mg/1","TABLET, FILM COATED","ORAL","ANDA202152","Accord Healthcare Inc.","16729-149","Quetiapine","QUETIAPINE FUMARATE","HUMAN PRESCRIPTION DRUG","03/28/2012","N/A","ANDA","1000 TABLET, FILM COATED in 1 BOTTLE (16729-149-17)","Atypical Antipsychotic [EPC]","N/A","No","12/31/2024"
"QUETIAPINE","33342-136-09","300 mg/1","TABLET, EXTENDED RELEASE","ORAL","ANDA204253","Macleods Pharmaceuticals Limited","33342-136","QUETIAPINE","QUETIAPINE FUMARATE","HUMAN PRESCRIPTION DRUG","11/01/2017","N/A","ANDA","60 TABLET, EXTENDED RELEASE in 1 BOTTLE (33342-136-09)","Atypical Antipsychotic [EPC]","N/A","No","12/31/2024"
"QUETIAPINE","33342-136-15","300 mg/1","TABLET, EXTENDED RELEASE","ORAL","ANDA204253","Macleods Pharmaceuticals Limited","33342-136","QUETIAPINE","QUETIAPINE FUMARATE","HUMAN PRESCRIPTION DRUG","11/01/2017","N/A","ANDA","500 TABLET, EXTENDED RELEASE in 1 BOTTLE (33342-136-15)","Atypical Antipsychotic [EPC]","N/A","No","12/31/2024"
"QUETIAPINE FUMARATE","16729-097-12","400 mg/1","TABLET, EXTENDED RELEASE","ORAL","ANDA090681","Accord Healthcare Inc.","16729-097","QUETIAPINE FUMARATE","QUETIAPINE FUMARATE","HUMAN PRESCRIPTION DRUG","11/01/2016","N/A","ANDA","60 TABLET, EXTENDED RELEASE in 1 BOTTLE (16729-097-12)","Atypical Antipsychotic [EPC]","N/A","No","12/31/2025"
"Quetiapine fumarate","47335-905-88","200 mg/1","TABLET, FILM COATED","ORAL","ANDA201190","Sun Pharmaceutical Industries, Inc.","47335-905","Quetiapine fumarate","QUETIAPINE FUMARATE","HUMAN PRESCRIPTION DRUG","03/28/2012","N/A","ANDA","100 TABLET, FILM COATED in 1 BOTTLE (47335-905-88)","Atypical Antipsychotic [EPC]","N/A","No","12/31/2024"
"Quetiapine fumarate","47335-905-83","200 mg/1","TABLET, FILM COATED","ORAL","ANDA201190","Sun Pharmaceutical Industries, Inc.","47335-905","Quetiapine fumarate","QUETIAPINE FUMARATE","HUMAN PRESCRIPTION DRUG","03/28/2012","N/A","ANDA","30 TABLET, FILM COATED in 1 BOTTLE (47335-905-83)","Atypical Antipsychotic [EPC]","N/A","No","12/31/2024"
"Quetiapine fumarate","47335-905-61","200 mg/1","TABLET, FILM COATED","ORAL","ANDA201190","Sun Pharmaceutical Industries, Inc.","47335-905","Quetiapine fumarate","QUETIAPINE FUMARATE","HUMAN PRESCRIPTION DRUG","03/28/2012","N/A","ANDA","10 BLISTER PACK in 1 BOX, UNIT-DOSE (47335-905-61)  / 10 TABLET, FILM COATED in 1 BLISTER PACK","Atypical Antipsychotic [EPC]","N/A","No","12/31/2024"
"Quetiapine fumarate","47335-905-18","200 mg/1","TABLET, FILM COATED","ORAL","ANDA201190","Sun Pharmaceutical Industries, Inc.","47335-905","Quetiapine fumarate","QUETIAPINE FUMARATE","HUMAN PRESCRIPTION DRUG","03/28/2012","N/A","ANDA","1000 TABLET, FILM COATED in 1 BOTTLE (47335-905-18)","Atypical Antipsychotic [EPC]","N/A","No","12/31/2024"
"Ranolazine","72578-064-01","500 mg/1","TABLET, EXTENDED RELEASE","ORAL","ANDA210188","Viona Pharmaceuticals Inc","72578-064","Ranolazine","RANOLAZINE","HUMAN PRESCRIPTION DRUG","09/10/2019","N/A","ANDA","100 TABLET, EXTENDED RELEASE in 1 BOTTLE (72578-064-01)","Anti-anginal [EPC],  Cytochrome P450 2D6 Inhibitors [MoA],  Cytochrome P450 3A Inhibitors [MoA],  Organic Cation Transporter 2 Inhibitors [MoA],  P-Glycoprotein Inhibitors [MoA]","N/A","No","12/31/2024"
"Ranolazine","72578-064-05","500 mg/1","TABLET, EXTENDED RELEASE","ORAL","ANDA210188","Viona Pharmaceuticals Inc","72578-064","Ranolazine","RANOLAZINE","HUMAN PRESCRIPTION DRUG","09/10/2019","N/A","ANDA","500 TABLET, EXTENDED RELEASE in 1 BOTTLE (72578-064-05)","Anti-anginal [EPC],  Cytochrome P450 2D6 Inhibitors [MoA],  Cytochrome P450 3A Inhibitors [MoA],  Organic Cation Transporter 2 Inhibitors [MoA],  P-Glycoprotein Inhibitors [MoA]","N/A","No","12/31/2024"
"Ranolazine","72578-064-14","500 mg/1","TABLET, EXTENDED RELEASE","ORAL","ANDA210188","Viona Pharmaceuticals Inc","72578-064","Ranolazine","RANOLAZINE","HUMAN PRESCRIPTION DRUG","09/10/2019","N/A","ANDA","60 TABLET, EXTENDED RELEASE in 1 BOTTLE (72578-064-14)","Anti-anginal [EPC],  Cytochrome P450 2D6 Inhibitors [MoA],  Cytochrome P450 3A Inhibitors [MoA],  Organic Cation Transporter 2 Inhibitors [MoA],  P-Glycoprotein Inhibitors [MoA]","N/A","No","12/31/2024"
"Ranolazine","72578-064-77","500 mg/1","TABLET, EXTENDED RELEASE","ORAL","ANDA210188","Viona Pharmaceuticals Inc","72578-064","Ranolazine","RANOLAZINE","HUMAN PRESCRIPTION DRUG","09/10/2019","N/A","ANDA","10 BLISTER PACK in 1 CARTON (72578-064-77)  / 10 TABLET, EXTENDED RELEASE in 1 BLISTER PACK (72578-064-30)","Anti-anginal [EPC],  Cytochrome P450 2D6 Inhibitors [MoA],  Cytochrome P450 3A Inhibitors [MoA],  Organic Cation Transporter 2 Inhibitors [MoA],  P-Glycoprotein Inhibitors [MoA]","N/A","No","12/31/2024"
"RAYO ACTIVE ICE SACHET","83033-1609-1","1 g/g,                         1  g/g","CREAM","TOPICAL","M012","Quimicas Handal de Centroamerica SA de CV","83033-1609","MENTHOL, CAMPHOR","CAMPHOR (SYNTHETIC);  MENTHOL","HUMAN OTC DRUG","11/01/2023","N/A","OTC MONOGRAPH DRUG","1 POUCH in 1 BOX (83033-1609-1)  / 4 g in 1 POUCH","N/A","N/A","No","12/31/2024"
"REGRANEX","50484-810-15","100 ug/g","GEL","TOPICAL","BLA103691","Smith & Nephew, Inc.","50484-810","becaplermin","BECAPLERMIN","HUMAN PRESCRIPTION DRUG","08/01/2014","N/A","BLA","1 TUBE in 1 CARTON (50484-810-15)  / 15 g in 1 TUBE","Human Platelet-derived Growth Factor [EPC],  Platelet-Derived Growth Factor [CS]","N/A","No","12/31/2024"
"Ring Relief PM Nighttime Formula","17312-175-15","6 [hp_X]/mL,                         6  [hp_X]/mL,                         13  [hp_X]/mL,                         6  [hp_X]/mL,                         12  [hp_X]/mL,                         12  [hp_X]/mL,                         5  [hp_X]/mL,                         6  [hp_X]/mL,                         13  [hp_X]/mL,                         6  [hp_X]/mL","LIQUID","AURICULAR (OTIC)","","TRP Company","17312-175","Arnica Montana, Calcium Sulfide, Hypericum Perforatum, Lycopodium Clavatum Spore, Thiosinaminum, Mercurius Solubilis, Salicylic Acid, Silicon Dioxide, Allylthiourea","ALLYLTHIOUREA;  ARNICA MONTANA;  CALCIUM SULFIDE;  HYPERICUM PERFORATUM;  LYCOPODIUM CLAVATUM SPORE;  MATRICARIA CHAMOMILLA;  PASSIFLORA INCARNATA FLOWER;  SALICYLIC ACID;  SILICON DIOXIDE;  VALERIAN","HUMAN OTC DRUG","09/19/2019","N/A","UNAPPROVED HOMEOPATHIC","1 BOTTLE, DROPPER in 1 PACKAGE (17312-175-15)  / 10 mL in 1 BOTTLE, DROPPER","N/A","N/A","No","12/31/2025"
"Risedronate Sodium","33342-107-06","5 mg/1","TABLET, FILM COATED","ORAL","ANDA203533","Macleods Pharmaceuticals Limited","33342-107","Risedronate Sodium","RISEDRONATE SODIUM","HUMAN PRESCRIPTION DRUG","12/09/2015","N/A","ANDA","3 BLISTER PACK in 1 CARTON (33342-107-06)  / 10 TABLET, FILM COATED in 1 BLISTER PACK","Bisphosphonate [EPC],  Diphosphonates [CS]","N/A","No","12/31/2024"
"Risedronate Sodium","33342-107-07","5 mg/1","TABLET, FILM COATED","ORAL","ANDA203533","Macleods Pharmaceuticals Limited","33342-107","Risedronate Sodium","RISEDRONATE SODIUM","HUMAN PRESCRIPTION DRUG","12/09/2015","N/A","ANDA","30 TABLET, FILM COATED in 1 CONTAINER (33342-107-07)","Bisphosphonate [EPC],  Diphosphonates [CS]","N/A","No","12/31/2024"
"Risedronate Sodium","33342-107-49","5 mg/1","TABLET, FILM COATED","ORAL","ANDA203533","Macleods Pharmaceuticals Limited","33342-107","Risedronate Sodium","RISEDRONATE SODIUM","HUMAN PRESCRIPTION DRUG","12/09/2015","N/A","ANDA","2000 TABLET, FILM COATED in 1 CONTAINER (33342-107-49)","Bisphosphonate [EPC],  Diphosphonates [CS]","N/A","No","12/31/2024"
"Rite Aid Digestive Relief","11822-1254-0","262 mg/1","TABLET, FILM COATED","ORAL","M008","RITE AID CORPORATION","11822-1254","Bismuth Subsalicylate","BISMUTH SUBSALICYLATE","HUMAN OTC DRUG","03/31/2020","N/A","OTC MONOGRAPH DRUG","1 BOTTLE in 1 CARTON (11822-1254-0)  / 40 TABLET, FILM COATED in 1 BOTTLE","N/A","N/A","No","12/31/2024"
"RITE AID Maximum strength","11822-7220-5",".13 g/100mL,                         4  g/100mL","LIQUID","TOPICAL","M003","RITE AID","11822-7220","benzalkonium chloride and lidocaine hydrochloride","BENZALKONIUM CHLORIDE;  LIDOCAINE HYDROCHLORIDE","HUMAN OTC DRUG","01/23/2020","N/A","OTC MONOGRAPH DRUG","148 mL in 1 BOTTLE (11822-7220-5)","Amide Local Anesthetic [EPC],  Amides [CS],  Antiarrhythmic [EPC],  Local Anesthesia [PE]","N/A","No","12/31/2024"
"Rite Aid Ryshi Sunscreen with Hyaluronic Acid and Collagen Broad Spectrum SPF 50","11822-0027-1","30 mg/g,                         100  mg/g,                         50  mg/g,                         40  mg/g","SPRAY","TOPICAL","M020","Rite Aid","11822-0027","AVOBENZONE, HOMOSALATE, OCTISALATE, OCTOCRYLENE","AVOBENZONE;  HOMOSALATE;  OCTISALATE;  OCTOCRYLENE","HUMAN OTC DRUG","12/23/2022","N/A","OTC MONOGRAPH DRUG","156 g in 1 CAN (11822-0027-1)","N/A","N/A","No","12/31/2024"
"Rite Aid Zinc Cold Therapy","11822-1183-5","1 [hp_X]/1","TABLET","ORAL","","RITE AID CORPORATION","11822-1183","Zincum Gluconicum","ZINC GLUCONATE","HUMAN OTC DRUG","04/13/2020","N/A","UNAPPROVED HOMEOPATHIC","25 TABLET in 1 BOTTLE, PLASTIC (11822-1183-5)","Copper Absorption Inhibitor [EPC],  Decreased Copper Ion Absorption [PE]","N/A","No","12/31/2024"
"rizatriptan benzoate","68462-467-06","5 mg/1","TABLET, ORALLY DISINTEGRATING","ORAL","ANDA201914","Glenmark Pharmaceuticals Inc., USA","68462-467","rizatriptan benzoate","RIZATRIPTAN BENZOATE","HUMAN PRESCRIPTION DRUG","07/01/2013","N/A","ANDA","6 BOX in 1 CARTON (68462-467-06)  / 3 POUCH in 1 BOX (68462-467-46)  / 1 BLISTER PACK in 1 POUCH / 1 TABLET, ORALLY DISINTEGRATING in 1 BLISTER PACK","Serotonin 1b Receptor Agonists [MoA],  Serotonin 1d Receptor Agonists [MoA],  Serotonin-1b and Serotonin-1d Receptor Agonist [EPC]","N/A","No","12/31/2025"
"rizatriptan benzoate","68462-467-74","5 mg/1","TABLET, ORALLY DISINTEGRATING","ORAL","ANDA201914","Glenmark Pharmaceuticals Inc., USA","68462-467","rizatriptan benzoate","RIZATRIPTAN BENZOATE","HUMAN PRESCRIPTION DRUG","07/01/2013","N/A","ANDA","4 BOX in 1 CARTON (68462-467-74)  / 3 POUCH in 1 BOX / 1 BLISTER PACK in 1 POUCH / 1 TABLET, ORALLY DISINTEGRATING in 1 BLISTER PACK","Serotonin 1b Receptor Agonists [MoA],  Serotonin 1d Receptor Agonists [MoA],  Serotonin-1b and Serotonin-1d Receptor Agonist [EPC]","N/A","No","12/31/2025"
"Rubraca","82154-0785-1","300 mg/1","TABLET, FILM COATED","ORAL","NDA209115","pharmaand GmbH","82154-0785","rucaparib","RUCAPARIB CAMSYLATE","HUMAN PRESCRIPTION DRUG","12/19/2016","N/A","NDA","60 TABLET, FILM COATED in 1 BOTTLE (82154-0785-1)","Poly(ADP-Ribose) Polymerase Inhibitor [EPC],  Poly(ADP-Ribose) Polymerase Inhibitors [MoA]","N/A","No","12/31/2024"
"rufinamide","68462-713-08","200 mg/1","TABLET, FILM COATED","ORAL","ANDA205075","Glenmark Pharmaceuticals Inc., USA","68462-713","rufinamide","RUFINAMIDE","HUMAN PRESCRIPTION DRUG","05/16/2016","N/A","ANDA","120 TABLET, FILM COATED in 1 BOTTLE (68462-713-08)","N/A","N/A","No","12/31/2025"
"rufinamide","68462-713-30","200 mg/1","TABLET, FILM COATED","ORAL","ANDA205075","Glenmark Pharmaceuticals Inc., USA","68462-713","rufinamide","RUFINAMIDE","HUMAN PRESCRIPTION DRUG","05/16/2016","N/A","ANDA","30 TABLET, FILM COATED in 1 BOTTLE (68462-713-30)","N/A","N/A","No","12/31/2025"
"rufinamide","68462-713-05","200 mg/1","TABLET, FILM COATED","ORAL","ANDA205075","Glenmark Pharmaceuticals Inc., USA","68462-713","rufinamide","RUFINAMIDE","HUMAN PRESCRIPTION DRUG","05/16/2016","N/A","ANDA","500 TABLET, FILM COATED in 1 BOTTLE (68462-713-05)","N/A","N/A","No","12/31/2025"
"Rugby Lubricating Drops","50090-5996-0","14 mg/mL","SOLUTION/ DROPS","OPHTHALMIC","M018","A-S Medication Solutions","50090-5996","Polyvinyl Alcohol","POLYVINYL ALCOHOL","HUMAN OTC DRUG","06/16/2022","N/A","OTC MONOGRAPH DRUG","15 mL in 1 BOTTLE (50090-5996-0)","N/A","N/A","No","12/31/2024"
"Ruta graveolens","68428-609-03","30 [hp_C]/1","PELLET","ORAL","","Washington Homeopathic Products","68428-609","Ruta Graveolens Flowering Top","RUTA GRAVEOLENS FLOWERING TOP","HUMAN OTC DRUG","12/31/2009","N/A","UNAPPROVED HOMEOPATHIC","75 PELLET in 1 VIAL, GLASS (68428-609-03)","N/A","N/A","No","12/31/2024"
"Ruta graveolens","68428-609-05","30 [hp_C]/1","PELLET","ORAL","","Washington Homeopathic Products","68428-609","Ruta Graveolens Flowering Top","RUTA GRAVEOLENS FLOWERING TOP","HUMAN OTC DRUG","12/31/2009","N/A","UNAPPROVED HOMEOPATHIC","150 PELLET in 1 VIAL, GLASS (68428-609-05)","N/A","N/A","No","12/31/2024"
"Ruta graveolens","68428-609-06","30 [hp_C]/1","PELLET","ORAL","","Washington Homeopathic Products","68428-609","Ruta Graveolens Flowering Top","RUTA GRAVEOLENS FLOWERING TOP","HUMAN OTC DRUG","12/31/2009","N/A","UNAPPROVED HOMEOPATHIC","1200 PELLET in 1 BOTTLE, GLASS (68428-609-06)","N/A","N/A","No","12/31/2024"
"Ruta graveolens","68428-609-11","30 [hp_C]/1","PELLET","ORAL","","Washington Homeopathic Products","68428-609","Ruta Graveolens Flowering Top","RUTA GRAVEOLENS FLOWERING TOP","HUMAN OTC DRUG","12/31/2009","N/A","UNAPPROVED HOMEOPATHIC","300 PELLET in 1 BOTTLE, GLASS (68428-609-11)","N/A","N/A","No","12/31/2024"
"Ruta graveolens","68428-609-12","30 [hp_C]/1","PELLET","ORAL","","Washington Homeopathic Products","68428-609","Ruta Graveolens Flowering Top","RUTA GRAVEOLENS FLOWERING TOP","HUMAN OTC DRUG","12/31/2009","N/A","UNAPPROVED HOMEOPATHIC","600 PELLET in 1 BOTTLE, GLASS (68428-609-12)","N/A","N/A","No","12/31/2024"
"Saie Slip Cover Broad Spectrum SPF 35 Sunscreen Tinted Moisturizer Two","90086-003-01","150 mg/mL","CREAM","TOPICAL","M020","Clean Beauty For All, Inc","90086-003","ZINC OXIDE","ZINC OXIDE","HUMAN OTC DRUG","09/07/2020","N/A","OTC MONOGRAPH DRUG","1 TUBE in 1 BOX (90086-003-01)  / 40 mL in 1 TUBE","Copper Absorption Inhibitor [EPC],  Decreased Copper Ion Absorption [PE]","N/A","No","12/31/2024"
"Salicylic Acid","53943-009-09",".17 mg/9mL","LIQUID","TOPICAL","M028","Discount Drug Mart","53943-009","Wart Remover Liquid","SALICYLIC ACID","HUMAN OTC DRUG","12/19/2017","N/A","OTC MONOGRAPH DRUG","9 mL in 1 BOTTLE, WITH APPLICATOR (53943-009-09)","N/A","N/A","No","12/31/2025"
"Salicylic Acid","37808-523-04","40 mg/41","PATCH","TOPICAL","M030","HEB","37808-523","Medicated Callus Removers","SALICYLIC ACID","HUMAN OTC DRUG","12/22/2017","N/A","OTC MONOGRAPH DRUG","4 PATCH in 1 PACKAGE (37808-523-04)","N/A","N/A","No","12/31/2025"
"Sambucus nigra","0220-4536-41","6 [hp_C]/6[hp_C]","PELLET","ORAL","","Boiron","0220-4536","SAMBUCUS NIGRA FLOWERING TOP","SAMBUCUS NIGRA FLOWERING TOP","HUMAN OTC DRUG","03/03/1983","N/A","UNAPPROVED HOMEOPATHIC","6 [hp_C] in 1 TUBE (0220-4536-41)","N/A","N/A","No","12/31/2024"
"Sambucus nigra","0220-4536-43","6 [hp_C]/6[hp_C]","PELLET","ORAL","","Boiron","0220-4536","SAMBUCUS NIGRA FLOWERING TOP","SAMBUCUS NIGRA FLOWERING TOP","HUMAN OTC DRUG","09/01/2020","N/A","UNAPPROVED HOMEOPATHIC","3 TUBE in 1 BOX (0220-4536-43)  / 6 [hp_C] in 1 TUBE","N/A","N/A","No","12/31/2024"
"Sarsaparilla","68428-625-06","30 [hp_C]/1","PELLET","ORAL","","Washington Homeopathic Products","68428-625","SARSAPARILLA ROOT","SARSAPARILLA ROOT","HUMAN OTC DRUG","05/04/2010","N/A","UNAPPROVED HOMEOPATHIC","1200 PELLET in 1 BOTTLE, GLASS (68428-625-06)","N/A","N/A","No","12/31/2024"
"Sarsaparilla","68428-625-03","30 [hp_C]/1","PELLET","ORAL","","Washington Homeopathic Products","68428-625","SARSAPARILLA ROOT","SARSAPARILLA ROOT","HUMAN OTC DRUG","05/04/2010","N/A","UNAPPROVED HOMEOPATHIC","75 PELLET in 1 VIAL, GLASS (68428-625-03)","N/A","N/A","No","12/31/2024"
"Sarsaparilla","68428-625-12","30 [hp_C]/1","PELLET","ORAL","","Washington Homeopathic Products","68428-625","SARSAPARILLA ROOT","SARSAPARILLA ROOT","HUMAN OTC DRUG","05/04/2010","N/A","UNAPPROVED HOMEOPATHIC","600 PELLET in 1 BOTTLE, GLASS (68428-625-12)","N/A","N/A","No","12/31/2024"
"Sarsaparilla","68428-625-05","30 [hp_C]/1","PELLET","ORAL","","Washington Homeopathic Products","68428-625","SARSAPARILLA ROOT","SARSAPARILLA ROOT","HUMAN OTC DRUG","05/04/2010","N/A","UNAPPROVED HOMEOPATHIC","150 PELLET in 1 VIAL, GLASS (68428-625-05)","N/A","N/A","No","12/31/2024"
"Sarsaparilla","68428-625-11","30 [hp_C]/1","PELLET","ORAL","","Washington Homeopathic Products","68428-625","SARSAPARILLA ROOT","SARSAPARILLA ROOT","HUMAN OTC DRUG","05/04/2010","N/A","UNAPPROVED HOMEOPATHIC","300 PELLET in 1 BOTTLE, GLASS (68428-625-11)","N/A","N/A","No","12/31/2024"
"Secret Clinical Stress Response Soft","69423-710-45","20 g/100g","CREAM","TOPICAL","M019","The Procter & Gamble Manufacturing Company","69423-710","Aluminum Zirconium Trichlorohydrex Gly","ALUMINUM ZIRCONIUM TRICHLOROHYDREX GLY","HUMAN OTC DRUG","03/01/2023","N/A","OTC MONOGRAPH FINAL","1 CYLINDER in 1 CARTON (69423-710-45)  / 45 g in 1 CYLINDER","N/A","N/A","No","12/31/2024"
"SENSODYNE PRONAMEL","0135-0520-01","50 mg/g,                         1.15  mg/g","PASTE","ORAL","M022","Haleon US Holdings LLC","0135-0520","potassium nitrate and sodium fluoride","POTASSIUM NITRATE;  SODIUM FLUORIDE","HUMAN OTC DRUG","04/14/2011","N/A","OTC MONOGRAPH DRUG","1 TUBE in 1 CARTON (0135-0520-01)  / 113 g in 1 TUBE","N/A","N/A","No","12/31/2025"
"SENSODYNE PRONAMEL","0135-0520-02","50 mg/g,                         1.15  mg/g","PASTE","ORAL","M022","Haleon US Holdings LLC","0135-0520","potassium nitrate and sodium fluoride","POTASSIUM NITRATE;  SODIUM FLUORIDE","HUMAN OTC DRUG","04/14/2011","N/A","OTC MONOGRAPH DRUG","23 g in 1 TUBE (0135-0520-02)","N/A","N/A","No","12/31/2025"
"SENSODYNE PRONAMEL","0135-0520-05","50 mg/g,                         1.15  mg/g","PASTE","ORAL","M022","Haleon US Holdings LLC","0135-0520","potassium nitrate and sodium fluoride","POTASSIUM NITRATE;  SODIUM FLUORIDE","HUMAN OTC DRUG","04/14/2011","N/A","OTC MONOGRAPH DRUG","2 TUBE in 1 CARTON (0135-0520-05)  / 113 g in 1 TUBE","N/A","N/A","No","12/31/2025"
"SENSODYNE PRONAMEL","0135-0520-06","50 mg/g,                         1.15  mg/g","PASTE","ORAL","M022","Haleon US Holdings LLC","0135-0520","potassium nitrate and sodium fluoride","POTASSIUM NITRATE;  SODIUM FLUORIDE","HUMAN OTC DRUG","03/20/2015","N/A","OTC MONOGRAPH DRUG","1 TUBE in 1 CARTON (0135-0520-06)  / 77 g in 1 TUBE","N/A","N/A","No","12/31/2025"
"SEVEN MINERALS Skin Friendly SPF 50","73609-221-08","30 mg/mL,                         100  mg/mL,                         50  mg/mL,                         100  mg/mL","LOTION","TOPICAL","M020","Seven Minerals NA LLC","73609-221","AVOBENZONE, HOMOSALATE, OCTISALATE, OCTOCRYLENE","AVOBENZONE;  HOMOSALATE;  OCTISALATE;  OCTOCRYLENE","HUMAN OTC DRUG","02/03/2020","N/A","OTC MONOGRAPH DRUG","237 mL in 1 BOTTLE (73609-221-08)","N/A","N/A","No","12/31/2024"
"Severe Allergy Plus Sinus Headache","49035-543-41","325 mg/1,                         25  mg/1,                         5  mg/1","TABLET, FILM COATED","ORAL","M012","Wal-Mart Stores Inc","49035-543","Acetaminophen, Diphenhydramine HCl, Phenylephrine HCl","ACETAMINOPHEN;  DIPHENHYDRAMINE HYDROCHLORIDE;  PHENYLEPHRINE HYDROCHLORIDE","HUMAN OTC DRUG","06/27/2007","N/A","OTC MONOGRAPH DRUG","10 TABLET, FILM COATED in 1 BLISTER PACK (49035-543-41)","Adrenergic alpha1-Agonists [MoA],  Histamine H1 Receptor Antagonists [MoA],  Histamine-1 Receptor Antagonist [EPC],  alpha-1 Adrenergic Agonist [EPC]","N/A","No","12/31/2024"
"Severe Allergy Plus Sinus Headache","49035-543-09","325 mg/1,                         25  mg/1,                         5  mg/1","TABLET, FILM COATED","ORAL","M012","Wal-Mart Stores Inc","49035-543","Acetaminophen, Diphenhydramine HCl, Phenylephrine HCl","ACETAMINOPHEN;  DIPHENHYDRAMINE HYDROCHLORIDE;  PHENYLEPHRINE HYDROCHLORIDE","HUMAN OTC DRUG","06/27/2007","N/A","OTC MONOGRAPH DRUG","2 BLISTER PACK in 1 CARTON (49035-543-09)  / 10 TABLET, FILM COATED in 1 BLISTER PACK","Adrenergic alpha1-Agonists [MoA],  Histamine H1 Receptor Antagonists [MoA],  Histamine-1 Receptor Antagonist [EPC],  alpha-1 Adrenergic Agonist [EPC]","N/A","No","12/31/2024"
"Seysara","16110-245-30","60 mg/1","TABLET, COATED","ORAL","NDA209521","Almirall, LLC","16110-245","sarecycline hydrochloride","SARECYCLINE HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","01/04/2019","N/A","NDA","30 TABLET, COATED in 1 BOTTLE (16110-245-30)","P-Glycoprotein Inhibitors [MoA],  Tetracycline-class Drug [EPC],  Tetracyclines [CS]","N/A","No","12/31/2024"
"SHISEIDO REVITALESSENCE SKIN GLOW FOUNDATION","58411-874-40","2.30805 g/30mL","EMULSION","TOPICAL","part352","SHISEIDO AMERICAS CORPORATION","58411-874","OCTINOXATE","OCTINOXATE","HUMAN OTC DRUG","08/01/2023","N/A","OTC MONOGRAPH NOT FINAL","1 CONTAINER in 1 CARTON (58411-874-40)  / 30 mL in 1 CONTAINER","N/A","N/A","No","12/31/2024"
"Signature Care Eye Drops Redness and Dry Eye Relief","21130-703-01",".25 g/100mL,                         .012  g/100mL","SOLUTION/ DROPS","OPHTHALMIC","M018","Better Living Brands LLC","21130-703","Glycerin, Naphazoline hydrochloride","GLYCERIN;  NAPHAZOLINE HYDROCHLORIDE","HUMAN OTC DRUG","10/05/2018","N/A","OTC MONOGRAPH DRUG","1 BOTTLE, PLASTIC in 1 CARTON (21130-703-01)  / 15 mL in 1 BOTTLE, PLASTIC","Allergens [CS],  Cell-mediated Immunity [PE],  Glycerol [CS],  Increased Histamine Release [PE],  Increased IgG Production [PE],  Non-Standardized Chemical Allergen [EPC]","N/A","No","12/31/2024"
"Signature Care Lidocaine Cream","21130-544-27","40 mg/g","CREAM","TOPICAL","part348","Better Living Brands LLC","21130-544","Lidocaine","LIDOCAINE HYDROCHLORIDE","HUMAN OTC DRUG","08/03/2020","N/A","OTC MONOGRAPH NOT FINAL","1 BOTTLE in 1 CARTON (21130-544-27)  / 76 g in 1 BOTTLE","Amide Local Anesthetic [EPC],  Amides [CS],  Antiarrhythmic [EPC],  Local Anesthesia [PE]","N/A","No","12/31/2024"
"Sildenafil","0093-5341-56","25 mg/1","TABLET, FILM COATED","ORAL","ANDA077342","Teva Pharmaceuticals USA, Inc.","0093-5341","Sildenafil","SILDENAFIL CITRATE","HUMAN PRESCRIPTION DRUG","12/11/2017","N/A","ANDA","30 TABLET, FILM COATED in 1 BOTTLE (0093-5341-56)","Phosphodiesterase 5 Inhibitor [EPC],  Phosphodiesterase 5 Inhibitors [MoA]","N/A","No","12/31/2025"
"Silica comp.","48951-8327-4","9 [hp_X]/g,                         11  [hp_X]/g,                         5  [hp_X]/g,                         9  [hp_X]/g,                         9  [hp_X]/g,                         9  [hp_X]/g,                         9  [hp_X]/g,                         9  [hp_X]/g","POWDER","ORAL","","Uriel Pharmacy Inc.","48951-8327","Silica comp.","BEEF HEART;  BOS TAURUS CARTILAGE;  EQUISETUM ARVENSE TOP;  MAMMAL LIVER;  PORK KIDNEY;  QUERCUS ROBUR WHOLE;  SUS SCROFA LUNG;  SUS SCROFA PANCREAS","HUMAN OTC DRUG","09/01/2009","N/A","UNAPPROVED HOMEOPATHIC","100 g in 1 BOTTLE, GLASS (48951-8327-4)","N/A","N/A","No","12/31/2025"
"simethicone gas relief","71444-788-01","20 mg/.3mL","SUSPENSION/ DROPS","ORAL","M002","MOM Enterprises, LCC","71444-788","simethicone","DIMETHICONE","HUMAN OTC DRUG","08/01/2017","N/A","OTC MONOGRAPH DRUG","1 BOTTLE, DROPPER in 1 CARTON (71444-788-01)  / 30 mL in 1 BOTTLE, DROPPER","Skin Barrier Activity [PE]","N/A","No","12/31/2025"
"SIMPLY BODYCARE ANTIPERSPIRANT DEODORANT CHERRY BLOSSOM","58037-203-01","20 g/100g","STICK","TOPICAL","M019","New Pride Corp","58037-203","aluminum chlorohydrate","ALUMINUM CHLOROHYDRATE","HUMAN OTC DRUG","04/01/2023","N/A","OTC MONOGRAPH FINAL","57 g in 1 APPLICATOR (58037-203-01)","N/A","N/A","No","12/31/2024"
"SIMPLY BODYCARE ANTIPERSPIRANT DEODORANT FRESH","58037-202-01","20 g/100g","STICK","TOPICAL","M019","New Pride Corp","58037-202","aluminum chlorohydrate","ALUMINUM CHLOROHYDRATE","HUMAN OTC DRUG","04/01/2023","N/A","OTC MONOGRAPH FINAL","57 g in 1 APPLICATOR (58037-202-01)","N/A","N/A","No","12/31/2024"
"Sinus and Headache","55910-466-08","325 mg/1,                         5  mg/1","TABLET, FILM COATED","ORAL","M012","DOLGENCORP, LLC","55910-466","Acetaminophen, Phenylephrine HCl","ACETAMINOPHEN;  PHENYLEPHRINE HYDROCHLORIDE","HUMAN OTC DRUG","07/26/2005","N/A","OTC MONOGRAPH DRUG","2 BLISTER PACK in 1 CARTON (55910-466-08)  / 12 TABLET, FILM COATED in 1 BLISTER PACK","Adrenergic alpha1-Agonists [MoA],  alpha-1 Adrenergic Agonist [EPC]","N/A","No","12/31/2025"
"Sinus Wash Packet","11822-0484-0","700 mg/3000mg,                         2300  mg/3000mg","POWDER","NASAL","","RITE AID CORPORATION","11822-0484","SODIUM BICARBONATE, SODIUM CHLORIDE","SODIUM BICARBONATE;  SODIUM CHLORIDE","HUMAN OTC DRUG","01/16/2022","N/A","UNAPPROVED DRUG OTHER","100 PACKET in 1 CARTON (11822-0484-0)  / 3000 mg in 1 PACKET (11822-0484-1)","Increased Large Intestinal Motility [PE],  Inhibition Large Intestine Fluid/Electrolyte Absorption [PE],  Osmotic Activity [MoA],  Osmotic Laxative [EPC]","N/A","No","12/31/2025"
"SkinCeuticals Silymarin CF Acne Treatment","49967-068-01","5 mg/mL","SOLUTION","TOPICAL","M006","L'Oreal USA Products Inc","49967-068","Salicylic Acid","SALICYLIC ACID","HUMAN OTC DRUG","01/01/2021","N/A","OTC MONOGRAPH DRUG","1 BOTTLE in 1 CARTON (49967-068-01)  / 30 mL in 1 BOTTLE","N/A","N/A","No","12/31/2024"
"SkinCeuticals Silymarin CF Acne Treatment","49967-068-02","5 mg/mL","SOLUTION","TOPICAL","M006","L'Oreal USA Products Inc","49967-068","Salicylic Acid","SALICYLIC ACID","HUMAN OTC DRUG","01/01/2021","N/A","OTC MONOGRAPH DRUG","1 BOTTLE in 1 CARTON (49967-068-02)  / 55 mL in 1 BOTTLE","N/A","N/A","No","12/31/2024"
"SkinCeuticals Silymarin CF Acne Treatment","49967-068-03","5 mg/mL","SOLUTION","TOPICAL","M006","L'Oreal USA Products Inc","49967-068","Salicylic Acid","SALICYLIC ACID","HUMAN OTC DRUG","01/01/2021","N/A","OTC MONOGRAPH DRUG","1 BOTTLE in 1 CARTON (49967-068-03)  / 15 mL in 1 BOTTLE","N/A","N/A","No","12/31/2024"
"SkinCeuticals Silymarin CF Acne Treatment","49967-068-04","5 mg/mL","SOLUTION","TOPICAL","M006","L'Oreal USA Products Inc","49967-068","Salicylic Acid","SALICYLIC ACID","HUMAN OTC DRUG","01/01/2021","N/A","OTC MONOGRAPH DRUG","10 VIAL in 1 CARTON (49967-068-04)  / 4 mL in 1 VIAL","N/A","N/A","No","12/31/2024"
"SMOOTH GATOR 60-second Pain Relief","70673-298-08","30 mg/g,                         12.5  mg/g","CREAM","TOPICAL","M017","Smooth Gator LLC","70673-298","CAMPHOR (SYNTHETIC), MENTHOL","CAMPHOR (SYNTHETIC);  MENTHOL","HUMAN OTC DRUG","06/01/2022","N/A","OTC MONOGRAPH DRUG","227 g in 1 BOTTLE (70673-298-08)","N/A","N/A","No","12/31/2024"
"SMOOTH GATOR 60-second Pain Relief","70673-298-16","30 mg/g,                         12.5  mg/g","CREAM","TOPICAL","M017","Smooth Gator LLC","70673-298","CAMPHOR (SYNTHETIC), MENTHOL","CAMPHOR (SYNTHETIC);  MENTHOL","HUMAN OTC DRUG","06/01/2022","N/A","OTC MONOGRAPH DRUG","454 g in 1 BOTTLE (70673-298-16)","N/A","N/A","No","12/31/2024"
"Sodium Sulfacetamide 10% and Sulfur 5% Cleanser","71399-0488-6","100 mg/g,                         50  mg/g","LIQUID","TOPICAL","","Akron Pharma Inc.","71399-0488","SULFACETAMIDE SODIUM, SULFUR","SULFACETAMIDE SODIUM;  SULFUR","HUMAN PRESCRIPTION DRUG","11/09/2020","N/A","UNAPPROVED DRUG OTHER","170.3 g in 1 BOTTLE, PLASTIC (71399-0488-6)","Sulfonamide Antibacterial [EPC],  Sulfonamides [CS]","N/A","No","12/31/2025"
"Sodium Sulfacetamide 9.8% and Sulfur 4.8% Cleanser","82429-109-10","98 mg/g,                         48  mg/g","RINSE","TOPICAL","","Gabar Health Sciences Corp.","82429-109","Sodium Sulfacetamide, Sulfur","SULFACETAMIDE SODIUM;  SULFUR","HUMAN PRESCRIPTION DRUG","10/10/2022","N/A","UNAPPROVED DRUG OTHER","1 BOTTLE in 1 CARTON (82429-109-10)  / 285 g in 1 BOTTLE","Sulfonamide Antibacterial [EPC],  Sulfonamides [CS]","N/A","No","12/31/2024"
"Soft Tip Neti Pot Easy to use Sinus Relief","68016-451-01","","KIT","NASAL","","Premier Value","68016-451","SODIUM BICARBONATE, SODIUM CHLORIDE","","HUMAN OTC DRUG","01/09/2022","N/A","UNAPPROVED DRUG OTHER","1 KIT in 1 KIT (68016-451-01)  *  3000 mg in 1 PACKET (68016-251-01)  *  3000 mg in 1 PACKET (42829-998-00)","N/A","N/A","No","12/31/2025"
"Soft Tip Neti Pot Sinus wash","41520-929-30","","KIT","NASAL","","FOODHOLD U.S.A.","41520-929","SODIUM BICARBONATE, SODIUM CHLORIDE","","HUMAN OTC DRUG","01/09/2022","N/A","UNAPPROVED DRUG OTHER","1 KIT in 1 KIT (41520-929-30)  *  3000 mg in 1 PACKET (42829-998-00)","N/A","N/A","No","12/31/2025"
"Soft Tip Squeeze bottle Sinus Wash","79481-0501-1","","KIT","NASAL","","Meijer, Inc.","79481-0501","SODIUM BICARBONATE, SODIUM CHLORIDE","","HUMAN OTC DRUG","01/09/2022","N/A","UNAPPROVED DRUG OTHER","1 KIT in 1 KIT (79481-0501-1)  *  3000 mg in 1 PACKET (42829-998-00)","N/A","N/A","No","12/31/2025"
"SOLIDAGO VIRGAUREA","0220-4703-41","30 [hp_C]/30[hp_C]","PELLET","ORAL","","Boiron","0220-4703","SOLIDAGO VIRGAUREA FLOWERING TOP","SOLIDAGO VIRGAUREA FLOWERING TOP","HUMAN OTC DRUG","03/03/1983","N/A","UNAPPROVED HOMEOPATHIC","30 [hp_C] in 1 TUBE (0220-4703-41)","N/A","N/A","No","12/31/2024"
"Sotalol Hydrochloride","63629-2423-1","120 mg/1","TABLET","ORAL","ANDA075563","Bryant Ranch Prepack","63629-2423","Sotalol Hydrochloride","SOTALOL HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","07/24/2020","N/A","ANDA","100 TABLET in 1 BOTTLE (63629-2423-1)","Adrenergic beta-Antagonists [MoA],  Antiarrhythmic [EPC],  Cardiac Rhythm Alteration [PE]","N/A","No","12/31/2024"
"Southern Ragweed","22840-1392-1",".001 g/mL","SOLUTION","INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS","BLA101833","Greer Laboratories, Inc.","22840-1392","Ambrosia bidentata","AMBROSIA BIDENTATA POLLEN","NON-STANDARDIZED ALLERGENIC","09/15/1981","N/A","BLA","5 mL in 1 VIAL, MULTI-DOSE (22840-1392-1)","Allergens [CS],  Cell-mediated Immunity [PE],  Increased Histamine Release [PE],  Non-Standardized Pollen Allergenic Extract [EPC],  Pollen [CS]","N/A","No","12/31/2024"
"SPIRONOLACTONE","71205-830-30","50 mg/1","TABLET, FILM COATED","ORAL","ANDA089424","Proficient Rx LP","71205-830","SPIRONOLACTONE","SPIRONOLACTONE","HUMAN PRESCRIPTION DRUG","08/18/2023","N/A","ANDA","30 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (71205-830-30)","Aldosterone Antagonist [EPC],  Aldosterone Antagonists [MoA]","N/A","No","12/31/2024"
"SPIRONOLACTONE","71205-830-60","50 mg/1","TABLET, FILM COATED","ORAL","ANDA089424","Proficient Rx LP","71205-830","SPIRONOLACTONE","SPIRONOLACTONE","HUMAN PRESCRIPTION DRUG","08/18/2023","N/A","ANDA","60 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (71205-830-60)","Aldosterone Antagonist [EPC],  Aldosterone Antagonists [MoA]","N/A","No","12/31/2024"
"SPIRONOLACTONE","71205-830-90","50 mg/1","TABLET, FILM COATED","ORAL","ANDA089424","Proficient Rx LP","71205-830","SPIRONOLACTONE","SPIRONOLACTONE","HUMAN PRESCRIPTION DRUG","08/18/2023","N/A","ANDA","90 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (71205-830-90)","Aldosterone Antagonist [EPC],  Aldosterone Antagonists [MoA]","N/A","No","12/31/2024"
"SprayPain Away","75249-006-01",".025 g/100g","SPRAY","TOPICAL","M017","SOLITEINT Kozmetikum gyarto es forgalmazo, termelo es kereskedelmi Korlatolt Felelossegu Tarsasag","75249-006","Capsaicin","CAPSAICIN","HUMAN OTC DRUG","06/30/2021","N/A","OTC MONOGRAPH DRUG","118 g in 1 BOTTLE, SPRAY (75249-006-01)","N/A","N/A","No","12/31/2024"
"SprayPain Away","72683-006-01",".025 g/100g","SPRAY","TOPICAL","M017","Proximity Capital Partners LLC dba Asutra","72683-006","Capsaicin","CAPSAICIN","HUMAN OTC DRUG","06/30/2021","N/A","OTC MONOGRAPH DRUG","118 g in 1 BOTTLE, SPRAY (72683-006-01)","N/A","N/A","No","12/31/2024"
"STAY HOT BURN NOT Broad Spectrum SPF 25 Sunscreen","82704-2650-2","7 g/100mL,                         6  g/100mL","LOTION","TOPICAL","M020","SKNVCARE,LLC","82704-2650","Octinoxate and Zinc Oxide","OCTINOXATE;  ZINC OXIDE","HUMAN OTC DRUG","08/01/2022","N/A","OTC MONOGRAPH DRUG","50 mL in 1 BOTTLE, PUMP (82704-2650-2)","N/A","N/A","No","12/31/2025"
"Stick Foundation SPF","59735-430-01","7.5 g/100g,                         5  g/100g,                         2  g/100g","CREAM","TOPICAL","M020","MANA PRODUCTS, INC.","59735-430","Stick Foundation","OCTINOXATE;  OCTISALATE;  TITANIUM DIOXIDE","HUMAN OTC DRUG","12/12/2013","N/A","OTC MONOGRAPH DRUG","1 TUBE in 1 CARTON (59735-430-01)  / 14 g in 1 TUBE","N/A","N/A","No","12/31/2025"
"STING MASTER","80324-078-00","40 mg/g","CREAM","TOPICAL","M017","Les Technologies Ptero, Inc","80324-078","LIDOCAINE HYDROCHLORIDE","LIDOCAINE HYDROCHLORIDE","HUMAN OTC DRUG","08/20/2020","N/A","OTC MONOGRAPH DRUG","1 JAR in 1 BOX (80324-078-00)  / 28.35 g in 1 JAR","Amide Local Anesthetic [EPC],  Amides [CS],  Antiarrhythmic [EPC],  Local Anesthesia [PE]","N/A","No","12/31/2024"
"Stomach Relief","0363-7024-16","525 mg/30mL","LIQUID","ORAL","M008","Walgreens","0363-7024","Bismuth subsalicylate","BISMUTH SUBSALICYLATE","HUMAN OTC DRUG","11/30/2023","N/A","OTC MONOGRAPH DRUG","473 mL in 1 BOTTLE, PLASTIC (0363-7024-16)","Bismuth [CS],  Bismuth [EPC]","N/A","No","12/31/2025"
"Stomach Relief","0363-7024-32","525 mg/30mL","LIQUID","ORAL","M008","Walgreens","0363-7024","Bismuth subsalicylate","BISMUTH SUBSALICYLATE","HUMAN OTC DRUG","11/30/2023","N/A","OTC MONOGRAPH DRUG","2 BOTTLE, PLASTIC in 1 PACKAGE (0363-7024-32)  / 473 mL in 1 BOTTLE, PLASTIC","Bismuth [CS],  Bismuth [EPC]","N/A","No","12/31/2025"
"Stool Softener with Laxative","57896-304-01","50 mg/1,                         8.6  mg/1","TABLET, FILM COATED","ORAL","505G(a)(3)","Geri-Care Pharmaceutical Corp","57896-304","Docusate Sodium and Sennosides","DOCUSATE SODIUM;  SENNOSIDES","HUMAN OTC DRUG","12/01/2019","N/A","OTC MONOGRAPH DRUG","100 TABLET, FILM COATED in 1 BOTTLE (57896-304-01)","N/A","N/A","No","12/31/2024"
"Stool Softener with Laxative","57896-304-10","50 mg/1,                         8.6  mg/1","TABLET, FILM COATED","ORAL","505G(a)(3)","Geri-Care Pharmaceutical Corp","57896-304","Docusate Sodium and Sennosides","DOCUSATE SODIUM;  SENNOSIDES","HUMAN OTC DRUG","12/01/2019","N/A","OTC MONOGRAPH DRUG","1000 TABLET, FILM COATED in 1 BOTTLE (57896-304-10)","N/A","N/A","No","12/31/2024"
"Suave","64942-2144-1","1 g/100mL","SHAMPOO","TOPICAL","part358H","Conopco, Inc. d/b/a/ Unilever","64942-2144","Essentials Scalp Control Anti-Dandruff 2 IN 1 Shampoo plus Conditioner","PYRITHIONE ZINC","HUMAN OTC DRUG","08/04/2023","N/A","OTC MONOGRAPH FINAL","373 mL in 1 CONTAINER (64942-2144-1)","N/A","N/A","No","12/31/2024"
"Sucralfate","51407-881-90","1 g/1","TABLET","ORAL","ANDA074415","Golden State Medical Supply, Inc.","51407-881","Sucralfate","SUCRALFATE","HUMAN PRESCRIPTION DRUG","03/16/2024","N/A","ANDA","90 TABLET in 1 BOTTLE, PLASTIC (51407-881-90)","Aluminum Complex [EPC],  Organometallic Compounds [CS]","N/A","No","12/31/2025"
"sugar free honey lemon cough drops","55910-062-30","7.6 mg/1","LOZENGE","ORAL","M012","Dollar General Corporation","55910-062","menthol","MENTHOL","HUMAN OTC DRUG","03/22/2016","N/A","OTC MONOGRAPH DRUG","30 LOZENGE in 1 BAG (55910-062-30)","N/A","N/A","No","12/31/2024"
"Sulfacetamide Sodium and Prednisolone Sodium Phosphate","53002-8690-1","2.3 mg/mL,                         100  mg/mL","SOLUTION/ DROPS","OPHTHALMIC","ANDA074449","RPK Pharmaceuticals, Inc.","53002-8690","Sulfacetamide Sodium and Prednisolone Sodium Phosphate","PREDNISOLONE SODIUM PHOSPHATE;  SULFACETAMIDE SODIUM","HUMAN PRESCRIPTION DRUG","10/01/2018","N/A","ANDA","5 mL in 1 BOTTLE, DROPPER (53002-8690-1)","Corticosteroid Hormone Receptor Agonists [MoA],  Corticosteroid [EPC],  Sulfonamide Antibacterial [EPC],  Sulfonamides [CS]","N/A","No","12/31/2024"
"Sulfacetamide Sodium and Prednisolone Sodium Phosphate","53002-8690-2","2.3 mg/mL,                         100  mg/mL","SOLUTION/ DROPS","OPHTHALMIC","ANDA074449","RPK Pharmaceuticals, Inc.","53002-8690","Sulfacetamide Sodium and Prednisolone Sodium Phosphate","PREDNISOLONE SODIUM PHOSPHATE;  SULFACETAMIDE SODIUM","HUMAN PRESCRIPTION DRUG","10/01/2018","N/A","ANDA","10 mL in 1 BOTTLE, DROPPER (53002-8690-2)","Corticosteroid Hormone Receptor Agonists [MoA],  Corticosteroid [EPC],  Sulfonamide Antibacterial [EPC],  Sulfonamides [CS]","N/A","No","12/31/2024"
"Sulur 8 Kids Anti-Dandruff Hair and Scalp Conditioner","12022-022-00","20 mg/g","OINTMENT","TOPICAL","M032","J. Strickland & Co.","12022-022","Sulfur","SULFUR","HUMAN OTC DRUG","08/20/1997","N/A","OTC MONOGRAPH DRUG","113 g in 1 JAR (12022-022-00)","N/A","N/A","No","12/31/2024"
"Sumatriptan Succinate","0378-5631-59","50 mg/1","TABLET, FILM COATED","ORAL","ANDA077744","Mylan Pharmaceuticals Inc.","0378-5631","sumatriptan succinate","SUMATRIPTAN SUCCINATE","HUMAN PRESCRIPTION DRUG","08/10/2009","N/A","ANDA","9 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (0378-5631-59)","Serotonin 1b Receptor Agonists [MoA],  Serotonin 1d Receptor Agonists [MoA],  Serotonin-1b and Serotonin-1d Receptor Agonist [EPC]","N/A","No","12/31/2024"
"Sumatriptan Succinate","0378-5632-59","100 mg/1","TABLET, FILM COATED","ORAL","ANDA077744","Mylan Pharmaceuticals Inc.","0378-5632","sumatriptan succinate","SUMATRIPTAN SUCCINATE","HUMAN PRESCRIPTION DRUG","08/10/2009","N/A","ANDA","9 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (0378-5632-59)","Serotonin 1b Receptor Agonists [MoA],  Serotonin 1d Receptor Agonists [MoA],  Serotonin-1b and Serotonin-1d Receptor Agonist [EPC]","N/A","No","12/31/2024"
"Synjardy","0597-0290-20","5 mg/1,                         1000  mg/1","TABLET, EXTENDED RELEASE","ORAL","NDA208658","Boehringer Ingelheim Pharmaceuticals, Inc.","0597-0290","empagliflozin, metformin hydrochloride","EMPAGLIFLOZIN;  METFORMIN HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","12/10/2016","03/31/2025","NDA","1 BOTTLE in 1 CARTON (0597-0290-20)  / 14 TABLET, EXTENDED RELEASE in 1 BOTTLE","Biguanide [EPC],  Biguanides [CS],  Sodium-Glucose Cotransporter 2 Inhibitor [EPC],  Sodium-Glucose Transporter 2 Inhibitors [MoA]","N/A","No","12/31/2024"
"Synjardy","0597-0290-59","5 mg/1,                         1000  mg/1","TABLET, EXTENDED RELEASE","ORAL","NDA208658","Boehringer Ingelheim Pharmaceuticals, Inc.","0597-0290","empagliflozin, metformin hydrochloride","EMPAGLIFLOZIN;  METFORMIN HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","12/10/2016","N/A","NDA","180 TABLET, EXTENDED RELEASE in 1 BOTTLE (0597-0290-59)","Biguanide [EPC],  Biguanides [CS],  Sodium-Glucose Cotransporter 2 Inhibitor [EPC],  Sodium-Glucose Transporter 2 Inhibitors [MoA]","N/A","No","12/31/2024"
"Synjardy","0597-0290-74","5 mg/1,                         1000  mg/1","TABLET, EXTENDED RELEASE","ORAL","NDA208658","Boehringer Ingelheim Pharmaceuticals, Inc.","0597-0290","empagliflozin, metformin hydrochloride","EMPAGLIFLOZIN;  METFORMIN HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","12/10/2016","N/A","NDA","60 TABLET, EXTENDED RELEASE in 1 BOTTLE (0597-0290-74)","Biguanide [EPC],  Biguanides [CS],  Sodium-Glucose Cotransporter 2 Inhibitor [EPC],  Sodium-Glucose Transporter 2 Inhibitors [MoA]","N/A","No","12/31/2024"
"SYSTANE HYDRATION PF PRESERVATIVE FREE","0065-1510-00","4 mg/mL,                         3  mg/mL","SOLUTION/ DROPS","OPHTHALMIC","M018","Alcon Laboratories, Inc.","0065-1510","Polyethylene Glycol 400 and Propylene Glycol","POLYETHYLENE GLYCOL 400;  PROPYLENE GLYCOL","HUMAN OTC DRUG","01/11/2023","N/A","OTC MONOGRAPH DRUG","2 BOTTLE in 1 CARTON (0065-1510-00)  / 10 mL in 1 BOTTLE","N/A","N/A","No","12/31/2024"
"SYSTANE HYDRATION PF PRESERVATIVE FREE","0065-1510-06","4 mg/mL,                         3  mg/mL","SOLUTION/ DROPS","OPHTHALMIC","M018","Alcon Laboratories, Inc.","0065-1510","Polyethylene Glycol 400 and Propylene Glycol","POLYETHYLENE GLYCOL 400;  PROPYLENE GLYCOL","HUMAN OTC DRUG","02/01/2021","N/A","OTC MONOGRAPH DRUG","1 BOTTLE in 1 CARTON (0065-1510-06)  / 10 mL in 1 BOTTLE","N/A","N/A","No","12/31/2024"
"Tadalafil","0093-3016-65","2.5 mg/1","TABLET, FILM COATED","ORAL","ANDA090141","Teva Pharmaceuticals USA, Inc.","0093-3016","Tadalafil","TADALAFIL","HUMAN PRESCRIPTION DRUG","09/27/2018","N/A","ANDA","2 BLISTER PACK in 1 BOX (0093-3016-65)  / 15 TABLET, FILM COATED in 1 BLISTER PACK (0093-3016-30)","Phosphodiesterase 5 Inhibitor [EPC],  Phosphodiesterase 5 Inhibitors [MoA]","N/A","No","12/31/2025"
"Tadalafil","0093-3017-65","5 mg/1","TABLET, FILM COATED","ORAL","ANDA090141","Teva Pharmaceuticals USA, Inc.","0093-3017","Tadalafil","TADALAFIL","HUMAN PRESCRIPTION DRUG","09/27/2018","N/A","ANDA","2 BLISTER PACK in 1 BOX (0093-3017-65)  / 15 TABLET, FILM COATED in 1 BLISTER PACK (0093-3017-30)","Phosphodiesterase 5 Inhibitor [EPC],  Phosphodiesterase 5 Inhibitors [MoA]","N/A","No","12/31/2025"
"Tadalafil","0093-3017-56","5 mg/1","TABLET, FILM COATED","ORAL","ANDA090141","Teva Pharmaceuticals USA, Inc.","0093-3017","Tadalafil","TADALAFIL","HUMAN PRESCRIPTION DRUG","09/27/2018","01/31/2025","ANDA","30 TABLET, FILM COATED in 1 BOTTLE (0093-3017-56)","Phosphodiesterase 5 Inhibitor [EPC],  Phosphodiesterase 5 Inhibitors [MoA]","N/A","No","12/31/2025"
"Tadalafil","71335-1491-1","20 mg/1","TABLET","ORAL","ANDA209654","Bryant Ranch Prepack","71335-1491","Tadalafil","TADALAFIL","HUMAN PRESCRIPTION DRUG","01/29/2020","N/A","ANDA","30 TABLET in 1 BOTTLE (71335-1491-1)","Phosphodiesterase 5 Inhibitor [EPC],  Phosphodiesterase 5 Inhibitors [MoA]","N/A","No","12/31/2024"
"Tadalafil","71335-1491-2","20 mg/1","TABLET","ORAL","ANDA209654","Bryant Ranch Prepack","71335-1491","Tadalafil","TADALAFIL","HUMAN PRESCRIPTION DRUG","02/25/2020","N/A","ANDA","10 TABLET in 1 BOTTLE (71335-1491-2)","Phosphodiesterase 5 Inhibitor [EPC],  Phosphodiesterase 5 Inhibitors [MoA]","N/A","No","12/31/2024"
"Tadalafil","71335-1491-3","20 mg/1","TABLET","ORAL","ANDA209654","Bryant Ranch Prepack","71335-1491","Tadalafil","TADALAFIL","HUMAN PRESCRIPTION DRUG","06/03/2020","N/A","ANDA","90 TABLET in 1 BOTTLE (71335-1491-3)","Phosphodiesterase 5 Inhibitor [EPC],  Phosphodiesterase 5 Inhibitors [MoA]","N/A","No","12/31/2024"
"Tadalafil","71335-1491-4","20 mg/1","TABLET","ORAL","ANDA209654","Bryant Ranch Prepack","71335-1491","Tadalafil","TADALAFIL","HUMAN PRESCRIPTION DRUG","08/30/2021","N/A","ANDA","5 TABLET in 1 BOTTLE (71335-1491-4)","Phosphodiesterase 5 Inhibitor [EPC],  Phosphodiesterase 5 Inhibitors [MoA]","N/A","No","12/31/2024"
"Tadalafil","71335-1491-5","20 mg/1","TABLET","ORAL","ANDA209654","Bryant Ranch Prepack","71335-1491","Tadalafil","TADALAFIL","HUMAN PRESCRIPTION DRUG","12/28/2021","N/A","ANDA","60 TABLET in 1 BOTTLE (71335-1491-5)","Phosphodiesterase 5 Inhibitor [EPC],  Phosphodiesterase 5 Inhibitors [MoA]","N/A","No","12/31/2024"
"Tadalafil","71335-1491-6","20 mg/1","TABLET","ORAL","ANDA209654","Bryant Ranch Prepack","71335-1491","Tadalafil","TADALAFIL","HUMAN PRESCRIPTION DRUG","09/23/2021","N/A","ANDA","20 TABLET in 1 BOTTLE (71335-1491-6)","Phosphodiesterase 5 Inhibitor [EPC],  Phosphodiesterase 5 Inhibitors [MoA]","N/A","No","12/31/2024"
"Tadalafil","71335-1491-7","20 mg/1","TABLET","ORAL","ANDA209654","Bryant Ranch Prepack","71335-1491","Tadalafil","TADALAFIL","HUMAN PRESCRIPTION DRUG","03/29/2021","N/A","ANDA","15 TABLET in 1 BOTTLE (71335-1491-7)","Phosphodiesterase 5 Inhibitor [EPC],  Phosphodiesterase 5 Inhibitors [MoA]","N/A","No","12/31/2024"
"Tamsulosin hydrochloride","76282-744-05",".4 mg/1","CAPSULE","ORAL","ANDA078801","EXELAN PHARMACEUTICALS, INC.","76282-744","Tamsulosin hydrochloride","TAMSULOSIN HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","03/01/2024","N/A","ANDA","500 CAPSULE in 1 BOTTLE (76282-744-05)","Adrenergic alpha-Antagonists [MoA],  alpha-Adrenergic Blocker [EPC]","N/A","No","12/31/2025"
"TARINA 24 FE","50102-224-23","","KIT","","ANDA207504","Afaxys Pharma, LLC","50102-224","Norethindrone Acetate and Ethinyl Estradiol and Ferrous Fumarate","","HUMAN PRESCRIPTION DRUG","06/15/2017","N/A","ANDA","3 POUCH in 1 CARTON (50102-224-23)  / 1 BLISTER PACK in 1 POUCH (50102-224-21)  / 1 KIT in 1 BLISTER PACK","N/A","N/A","No","12/31/2025"
"Tazza Antiseptic Hand Sanitizing Wipes","76370-0016-0",".13 g/100mL","CLOTH","TOPICAL","505G(a)(3)","Tazza Brands East, Inc.","76370-0016","Benzalkonium Chloride","BENZALKONIUM CHLORIDE","HUMAN OTC DRUG","02/11/2022","N/A","OTC MONOGRAPH DRUG","1400 APPLICATOR in 1 POUCH (76370-0016-0)  / 1.3 mL in 1 APPLICATOR","N/A","N/A","No","12/31/2025"
"Tazza Hand Sanitizer","76370-0017-0",".13 g/100mL","CLOTH","TOPICAL","505G(a)(3)","Tazza Brands East Inc.","76370-0017","Benzalkonium Chloride","BENZALKONIUM CHLORIDE","HUMAN OTC DRUG","06/10/2022","N/A","OTC MONOGRAPH DRUG","1500 APPLICATOR in 1 BAG (76370-0017-0)  / 1.1 mL in 1 APPLICATOR","N/A","N/A","No","12/31/2025"
"Tazza-X Extreme Hand Sanitizing Wipes","76370-0010-0","70 mL/100mL","CLOTH","TOPICAL","505G(a)(3)","Tazza Brands East Inc.","76370-0010","Ethanol","ALCOHOL","HUMAN OTC DRUG","11/27/2020","N/A","OTC MONOGRAPH DRUG","50 POUCH in 1 CARTON (76370-0010-0)  / 1 APPLICATOR in 1 POUCH / 3.2 mL in 1 APPLICATOR","N/A","N/A","No","12/31/2025"
"Telmisartan","68462-200-30","40 mg/1","TABLET","ORAL","ANDA090032","Glenmark Pharmaceuticals Inc., USA","68462-200","Telmisartan","TELMISARTAN","HUMAN PRESCRIPTION DRUG","12/14/2020","N/A","ANDA","30 TABLET in 1 BOTTLE (68462-200-30)","Angiotensin 2 Receptor Antagonists [MoA],  Angiotensin 2 Receptor Blocker [EPC]","N/A","No","12/31/2025"
"Telmisartan","68462-200-82","40 mg/1","TABLET","ORAL","ANDA090032","Glenmark Pharmaceuticals Inc., USA","68462-200","Telmisartan","TELMISARTAN","HUMAN PRESCRIPTION DRUG","12/14/2020","N/A","ANDA","5 BLISTER PACK in 1 CARTON (68462-200-82)  / 10 TABLET in 1 BLISTER PACK","Angiotensin 2 Receptor Antagonists [MoA],  Angiotensin 2 Receptor Blocker [EPC]","N/A","No","12/31/2025"
"Telmisartan","68462-200-01","40 mg/1","TABLET","ORAL","ANDA090032","Glenmark Pharmaceuticals Inc., USA","68462-200","Telmisartan","TELMISARTAN","HUMAN PRESCRIPTION DRUG","07/07/2014","N/A","ANDA","100 TABLET in 1 BOTTLE (68462-200-01)","Angiotensin 2 Receptor Antagonists [MoA],  Angiotensin 2 Receptor Blocker [EPC]","N/A","No","12/31/2025"
"Telmisartan","68462-200-13","40 mg/1","TABLET","ORAL","ANDA090032","Glenmark Pharmaceuticals Inc., USA","68462-200","Telmisartan","TELMISARTAN","HUMAN PRESCRIPTION DRUG","07/07/2014","N/A","ANDA","3 BLISTER PACK in 1 CARTON (68462-200-13)  / 10 TABLET in 1 BLISTER PACK","Angiotensin 2 Receptor Antagonists [MoA],  Angiotensin 2 Receptor Blocker [EPC]","N/A","No","12/31/2025"
"Telmisartan","68462-200-90","40 mg/1","TABLET","ORAL","ANDA090032","Glenmark Pharmaceuticals Inc., USA","68462-200","Telmisartan","TELMISARTAN","HUMAN PRESCRIPTION DRUG","03/07/2024","N/A","ANDA","90 TABLET in 1 BOTTLE (68462-200-90)","Angiotensin 2 Receptor Antagonists [MoA],  Angiotensin 2 Receptor Blocker [EPC]","N/A","No","12/31/2025"
"Telmisartan and Hydrochlorothiazide","68180-195-06","25 mg/1,                         80  mg/1","TABLET","ORAL","ANDA091351","Lupin Pharmaceuticals, Inc.","68180-195","Telmisartan and Hydrochlorothiazide","HYDROCHLOROTHIAZIDE;  TELMISARTAN","HUMAN PRESCRIPTION DRUG","04/28/2015","01/31/2025","ANDA","30 TABLET in 1 BOTTLE (68180-195-06)","Angiotensin 2 Receptor Antagonists [MoA],  Angiotensin 2 Receptor Blocker [EPC],  Increased Diuresis [PE],  Thiazide Diuretic [EPC],  Thiazides [CS]","N/A","No","12/31/2025"
"TENA Proskin protective cream","59608-017-01","130 mg/g","CREAM","TOPICAL","M016","Essity HMS North America Inc","59608-017","Zinc oxide","ZINC OXIDE","HUMAN OTC DRUG","10/25/2022","N/A","OTC MONOGRAPH DRUG","1 TUBE in 1 CARTON (59608-017-01)  / 113 g in 1 TUBE","Copper Absorption Inhibitor [EPC],  Decreased Copper Ion Absorption [PE]","N/A","No","12/31/2025"
"Tenofovir disoproxil fumarate","69097-533-02","300 mg/1","TABLET","ORAL","ANDA078800","Cipla USA Inc.","69097-533","Tenofovir disoproxil fumarate","TENOFOVIR DISOPROXIL FUMARATE","HUMAN PRESCRIPTION DRUG","01/26/2018","N/A","ANDA","30 TABLET in 1 BOTTLE (69097-533-02)","Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC],  Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC],  Nucleoside Reverse Transcriptase Inhibitors [MoA],  Nucleosides [CS]","N/A","No","12/31/2025"
"Tenofovir disoproxil fumarate","69097-533-15","300 mg/1","TABLET","ORAL","ANDA078800","Cipla USA Inc.","69097-533","Tenofovir disoproxil fumarate","TENOFOVIR DISOPROXIL FUMARATE","HUMAN PRESCRIPTION DRUG","01/26/2018","N/A","ANDA","1000 TABLET in 1 BOTTLE (69097-533-15)","Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC],  Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC],  Nucleoside Reverse Transcriptase Inhibitors [MoA],  Nucleosides [CS]","N/A","No","12/31/2025"
"Terbinafine Hydrochloride","72162-1595-1","250 mg/1","TABLET","ORAL","ANDA077714","Bryant Ranch Prepack","72162-1595","Terbinafine Hydrochloride","TERBINAFINE HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","02/07/2024","N/A","ANDA","100 TABLET in 1 BOTTLE (72162-1595-1)","Allylamine Antifungal [EPC],  Allylamine [CS]","N/A","No","12/31/2025"
"Terbium Metallicum","37662-3643-1","100 [hp_C]/1","PELLET","ORAL","","Hahnemann Laboratories, INC.","37662-3643","Terbium Metallicum","TERBIUM","HUMAN OTC DRUG","07/27/2023","N/A","UNAPPROVED HOMEOPATHIC","200 PELLET in 1 VIAL, GLASS (37662-3643-1)","N/A","N/A","No","12/31/2024"
"Terbium Metallicum","37662-3643-2","100 [hp_C]/1","PELLET","ORAL","","Hahnemann Laboratories, INC.","37662-3643","Terbium Metallicum","TERBIUM","HUMAN OTC DRUG","07/27/2023","N/A","UNAPPROVED HOMEOPATHIC","500 PELLET in 1 VIAL, GLASS (37662-3643-2)","N/A","N/A","No","12/31/2024"
"Terbium Metallicum","37662-3643-3","100 [hp_C]/1","PELLET","ORAL","","Hahnemann Laboratories, INC.","37662-3643","Terbium Metallicum","TERBIUM","HUMAN OTC DRUG","07/27/2023","N/A","UNAPPROVED HOMEOPATHIC","3000 PELLET in 1 BOTTLE, GLASS (37662-3643-3)","N/A","N/A","No","12/31/2024"
"Terbium Metallicum","37662-3643-4","100 [hp_C]/1","PELLET","ORAL","","Hahnemann Laboratories, INC.","37662-3643","Terbium Metallicum","TERBIUM","HUMAN OTC DRUG","07/27/2023","N/A","UNAPPROVED HOMEOPATHIC","10000 PELLET in 1 BOTTLE, GLASS (37662-3643-4)","N/A","N/A","No","12/31/2024"
"Thai Duong Hand Sanitizer Antiseptic Hand Rub","81379-001-00","70 mL/100mL","GEL","TOPICAL","505G(a)(3)","SAO THAI DUONG JOINT STOCK COMPANY - BRANCH","81379-001","ALCOHOL","ALCOHOL","HUMAN OTC DRUG","04/27/2021","N/A","OTC MONOGRAPH DRUG","480 mL in 1 BOTTLE (81379-001-00)","N/A","N/A","No","12/31/2024"
"The Pearl Sun Defender Sunscreen Broad Spectrum SPF 25","83551-2650-2","7 g/100mL,                         6  g/100mL","LOTION","TOPICAL","part352","CARL B. PEARL, M.D., P.C","83551-2650","Octinoxate and Zinc Oxide","OCTINOXATE;  ZINC OXIDE","HUMAN OTC DRUG","04/01/2023","N/A","OTC MONOGRAPH NOT FINAL","50 mL in 1 BOTTLE, PUMP (83551-2650-2)","N/A","N/A","No","12/31/2024"
"The Pharma C Company Triple Action Hemorrhoidal Pads","55239-459-00","50 mg/g,                         2.5  mg/g,                         500  mg/g","CLOTH","TOPICAL","M015","Kleen Test Products Corporation","55239-459","WITCH HAZEL, LIDOCAINE, PHENYLEPHRINE HYDROCHLORIDE","LIDOCAINE;  PHENYLEPHRINE HYDROCHLORIDE;  WITCH HAZEL","HUMAN OTC DRUG","01/15/2024","N/A","OTC MONOGRAPH DRUG","100 PATCH in 1 JAR (55239-459-00)  / 2 g in 1 PATCH","Adrenergic alpha1-Agonists [MoA],  Amide Local Anesthetic [EPC],  Amides [CS],  Antiarrhythmic [EPC],  Local Anesthesia [PE],  alpha-1 Adrenergic Agonist [EPC]","N/A","No","12/31/2025"
"Tizanidine","70518-0133-0","4 mg/1","TABLET","ORAL","ANDA076286","REMEDYREPACK INC.","70518-0133","Tizanidine","TIZANIDINE HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","01/07/2017","N/A","ANDA","60 TABLET in 1 BOTTLE (70518-0133-0)","Adrenergic alpha2-Agonists [MoA],  Central alpha-2 Adrenergic Agonist [EPC]","N/A","No","12/31/2025"
"Tizanidine","70518-0133-1","4 mg/1","TABLET","ORAL","ANDA076286","REMEDYREPACK INC.","70518-0133","Tizanidine","TIZANIDINE HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","04/05/2017","N/A","ANDA","90 TABLET in 1 BOTTLE, PLASTIC (70518-0133-1)","Adrenergic alpha2-Agonists [MoA],  Central alpha-2 Adrenergic Agonist [EPC]","N/A","No","12/31/2025"
"Tizanidine","70518-0133-3","4 mg/1","TABLET","ORAL","ANDA076286","REMEDYREPACK INC.","70518-0133","Tizanidine","TIZANIDINE HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","01/07/2021","N/A","ANDA","30 TABLET in 1 BOTTLE, PLASTIC (70518-0133-3)","Adrenergic alpha2-Agonists [MoA],  Central alpha-2 Adrenergic Agonist [EPC]","N/A","No","12/31/2025"
"Tizanidine","70518-0133-2","4 mg/1","TABLET","ORAL","ANDA076286","REMEDYREPACK INC.","70518-0133","Tizanidine","TIZANIDINE HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","08/30/2017","N/A","ANDA","15 TABLET in 1 BOTTLE, PLASTIC (70518-0133-2)","Adrenergic alpha2-Agonists [MoA],  Central alpha-2 Adrenergic Agonist [EPC]","N/A","No","12/31/2025"
"Tizanidine","70518-3181-0","2 mg/1","TABLET","ORAL","ANDA076416","REMEDYREPACK INC.","70518-3181","Tizanidine","TIZANIDINE HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","08/05/2021","N/A","ANDA","60 TABLET in 1 BOTTLE, PLASTIC (70518-3181-0)","Adrenergic alpha2-Agonists [MoA],  Central alpha-2 Adrenergic Agonist [EPC]","N/A","No","12/31/2025"
"Tizanidine","70518-3181-1","2 mg/1","TABLET","ORAL","ANDA076416","REMEDYREPACK INC.","70518-3181","Tizanidine","TIZANIDINE HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","03/22/2022","N/A","ANDA","30 TABLET in 1 BOTTLE, PLASTIC (70518-3181-1)","Adrenergic alpha2-Agonists [MoA],  Central alpha-2 Adrenergic Agonist [EPC]","N/A","No","12/31/2025"
"Tobramycin","53002-9230-1","3 mg/mL","SOLUTION","OPHTHALMIC","ANDA064052","RPK Pharmaceuticals, Inc.","53002-9230","Tobramycin","TOBRAMYCIN","HUMAN PRESCRIPTION DRUG","10/01/2017","N/A","ANDA","5 mL in 1 BOTTLE, DROPPER (53002-9230-1)","Aminoglycoside Antibacterial [EPC],  Aminoglycosides [CS]","N/A","No","12/31/2024"
"Tolnaftate","21130-213-00","1.5 g/150g","AEROSOL, SPRAY","TOPICAL","M005","Better Living Brands LLC","21130-213","Antifungal Liquid Spray","TOLNAFTATE","HUMAN OTC DRUG","09/27/2021","N/A","OTC MONOGRAPH DRUG","150 g in 1 CANISTER (21130-213-00)","N/A","N/A","No","12/31/2025"
"Tolnaftate","56104-036-46","1.3 g/130g","AEROSOL, SPRAY","TOPICAL","M005","Premier Brands of America Inc.","56104-036","Tolnaftate Powder Spray Talc Free","TOLNAFTATE","HUMAN OTC DRUG","05/22/2017","N/A","OTC MONOGRAPH DRUG","130 g in 1 CAN (56104-036-46)","N/A","N/A","No","12/31/2025"
"Tolnaftate","56104-037-46","1.3 g/130g","AEROSOL, SPRAY","TOPICAL","M005","Premier Brands of America Inc.","56104-037","Tolnaftate Jock Itch Powder Spray - Talc Free","TOLNAFTATE","HUMAN OTC DRUG","10/31/2017","N/A","OTC MONOGRAPH DRUG","130 g in 1 CAN (56104-037-46)","N/A","N/A","No","12/31/2025"
"Topcare Antacid Calcium","36800-489-83","750 mg/1","TABLET, CHEWABLE","ORAL","M001","Topco Associates LLC","36800-489","Calcium carbonate","CALCIUM CARBONATE","HUMAN OTC DRUG","12/15/2018","N/A","OTC MONOGRAPH DRUG","200 TABLET, CHEWABLE in 1 BOTTLE (36800-489-83)","N/A","N/A","No","12/31/2024"
"TopCare Ibuprofen","36800-604-62","200 mg/1","TABLET, FILM COATED","ORAL","ANDA072096","Topco Associates LLC","36800-604","Ibuprofen","IBUPROFEN","HUMAN OTC DRUG","06/15/1991","N/A","ANDA","1 BOTTLE in 1 CARTON (36800-604-62)  / 24 TABLET, FILM COATED in 1 BOTTLE","Anti-Inflammatory Agents,  Non-Steroidal [CS],  Cyclooxygenase Inhibitors [MoA],  Nonsteroidal Anti-inflammatory Drug [EPC]","N/A","No","12/31/2024"
"TopCare Ibuprofen","36800-604-71","200 mg/1","TABLET, FILM COATED","ORAL","ANDA072096","Topco Associates LLC","36800-604","Ibuprofen","IBUPROFEN","HUMAN OTC DRUG","02/15/1988","N/A","ANDA","1 BOTTLE in 1 CARTON (36800-604-71)  / 50 TABLET, FILM COATED in 1 BOTTLE","Anti-Inflammatory Agents,  Non-Steroidal [CS],  Cyclooxygenase Inhibitors [MoA],  Nonsteroidal Anti-inflammatory Drug [EPC]","N/A","No","12/31/2024"
"TopCare Ibuprofen","36800-604-76","200 mg/1","TABLET, FILM COATED","ORAL","ANDA072096","Topco Associates LLC","36800-604","Ibuprofen","IBUPROFEN","HUMAN OTC DRUG","09/27/1993","N/A","ANDA","1 BOTTLE in 1 CARTON (36800-604-76)  / 120 TABLET, FILM COATED in 1 BOTTLE","Anti-Inflammatory Agents,  Non-Steroidal [CS],  Cyclooxygenase Inhibitors [MoA],  Nonsteroidal Anti-inflammatory Drug [EPC]","N/A","No","12/31/2024"
"TopCare Ibuprofen","36800-604-78","200 mg/1","TABLET, FILM COATED","ORAL","ANDA072096","Topco Associates LLC","36800-604","Ibuprofen","IBUPROFEN","HUMAN OTC DRUG","03/15/1988","N/A","ANDA","1 BOTTLE in 1 CARTON (36800-604-78)  / 100 TABLET, FILM COATED in 1 BOTTLE","Anti-Inflammatory Agents,  Non-Steroidal [CS],  Cyclooxygenase Inhibitors [MoA],  Nonsteroidal Anti-inflammatory Drug [EPC]","N/A","No","12/31/2024"
"TopCare Ibuprofen","36800-604-82","200 mg/1","TABLET, FILM COATED","ORAL","ANDA072096","Topco Associates LLC","36800-604","Ibuprofen","IBUPROFEN","HUMAN OTC DRUG","02/15/1988","N/A","ANDA","2 BOTTLE in 1 CARTON (36800-604-82)  / 100 TABLET, FILM COATED in 1 BOTTLE","Anti-Inflammatory Agents,  Non-Steroidal [CS],  Cyclooxygenase Inhibitors [MoA],  Nonsteroidal Anti-inflammatory Drug [EPC]","N/A","No","12/31/2024"
"TopCare Ibuprofen","36800-604-85","200 mg/1","TABLET, FILM COATED","ORAL","ANDA072096","Topco Associates LLC","36800-604","Ibuprofen","IBUPROFEN","HUMAN OTC DRUG","07/30/1991","N/A","ANDA","1 BOTTLE in 1 CARTON (36800-604-85)  / 250 TABLET, FILM COATED in 1 BOTTLE","Anti-Inflammatory Agents,  Non-Steroidal [CS],  Cyclooxygenase Inhibitors [MoA],  Nonsteroidal Anti-inflammatory Drug [EPC]","N/A","No","12/31/2024"
"TopCare Ibuprofen","36800-604-90","200 mg/1","TABLET, FILM COATED","ORAL","ANDA072096","Topco Associates LLC","36800-604","Ibuprofen","IBUPROFEN","HUMAN OTC DRUG","07/29/1993","N/A","ANDA","500 TABLET, FILM COATED in 1 BOTTLE (36800-604-90)","Anti-Inflammatory Agents,  Non-Steroidal [CS],  Cyclooxygenase Inhibitors [MoA],  Nonsteroidal Anti-inflammatory Drug [EPC]","N/A","No","12/31/2024"
"Topiramate","24979-211-04","25 mg/1","CAPSULE","ORAL","ANDA217694","TWi Pharmaceuticals, Inc.","24979-211","Topiramate","TOPIRAMATE","HUMAN PRESCRIPTION DRUG","12/05/2023","N/A","ANDA","60 CAPSULE in 1 PACKAGE (24979-211-04)","Cytochrome P450 2C19 Inhibitors [MoA],  Cytochrome P450 3A4 Inducers [MoA],  Decreased Central Nervous System Disorganized Electrical Activity [PE]","N/A","No","12/31/2024"
"Topix Mineral Mattifying Tinted Sunscreen","51326-130-01","32 mg/g,                         162  mg/g","CREAM","TOPICAL","part352","Topiderm, Inc.","51326-130","Zinc Oxide","TITANIUM DIOXIDE;  ZINC OXIDE","HUMAN OTC DRUG","02/21/2023","N/A","OTC MONOGRAPH FINAL","54 g in 1 BOTTLE (51326-130-01)","N/A","N/A","No","12/31/2024"
"Totally Fun After Sun","72085-145-08","15 mg/mL","GEL","TOPICAL","M017","MJ Products Association, LLC","72085-145","Lidocaine HCL","LIDOCAINE HYDROCHLORIDE","HUMAN OTC DRUG","03/01/2018","N/A","OTC MONOGRAPH DRUG","236 mL in 1 BOTTLE (72085-145-08)","Amide Local Anesthetic [EPC],  Amides [CS],  Antiarrhythmic [EPC],  Local Anesthesia [PE]","N/A","No","12/31/2024"
"TOUCH Sanitizing Germ Block, Mint Green Tea Aloe, 1oz (28.35g)","69744-0202-1",".13 g/100g","AEROSOL, SPRAY","TOPICAL","part333A","Relevo, Inc.","69744-0202","benzalkonium chloride","BENZALKONIUM CHLORIDE","HUMAN OTC DRUG","05/07/2021","05/01/2027","OTC MONOGRAPH NOT FINAL","43 g in 1 BOTTLE, SPRAY (69744-0202-1)","N/A","N/A","No","N/A"
"Tranexamic Acid","70860-400-10","100 mg/mL","INJECTION, SOLUTION","INTRAVENOUS","ANDA207239","Athenex Pharmaceutical Division, LLC.","70860-400","tranexamic acid","TRANEXAMIC ACID","HUMAN PRESCRIPTION DRUG","03/27/2017","08/31/2024","ANDA","10 VIAL in 1 CARTON (70860-400-10)  / 10 mL in 1 VIAL (70860-400-41)","Antifibrinolytic Agent [EPC],  Decreased Fibrinolysis [PE]","N/A","No","N/A"
"Triamcinolone Acetonide","68462-798-17","5 mg/g","OINTMENT","TOPICAL","ANDA206379","Glenmark Pharmaceuticals Inc., USA","68462-798","Triamcinolone Acetonide","TRIAMCINOLONE ACETONIDE","HUMAN PRESCRIPTION DRUG","07/22/2016","N/A","ANDA","1 TUBE in 1 CARTON (68462-798-17)  / 15 g in 1 TUBE","Corticosteroid Hormone Receptor Agonists [MoA],  Corticosteroid [EPC]","N/A","No","12/31/2025"
"Triamcinolone Acetonide","81298-5781-5","40 mg/mL","SUSPENSION","INTRA-ARTERIAL; INTRAMUSCULAR","ANDA213543","Long Grove Pharmaceuticals, LLC","81298-5781","Triamcinolone Acetonide","TRIAMCINOLONE ACETONIDE","HUMAN PRESCRIPTION DRUG","05/02/2022","N/A","ANDA","25 VIAL, SINGLE-USE in 1 CARTON (81298-5781-5)  / 1 mL in 1 VIAL, SINGLE-USE (81298-5781-1)","Corticosteroid Hormone Receptor Agonists [MoA],  Corticosteroid [EPC]","N/A","No","12/31/2024"
"Tricalm Hydrogel","71207-221-02",".2 g/100g","GEL","TOPICAL","M016","MODULAR THERMAL TECHNOLOGIES LLC DBA LIFE WEAR TECHNOLOGIES","71207-221","Aluminum acetate","ALUMINUM ACETATE","HUMAN OTC DRUG","01/02/2023","N/A","OTC MONOGRAPH DRUG","1 TUBE in 1 CARTON (71207-221-02)  / 57 g in 1 TUBE","N/A","N/A","No","12/31/2024"
"Triple Antibiotic","82942-1002-1","400 [CFU]/g,                         3.5  mg/g,                         5000  [CFU]/g","CREAM","TOPICAL","M004","J&A Digital Inc.","82942-1002","BACITRACIN ZINC, NEOMYCIN SULFATE, POLYMYXIN B SULFATE, POLYMYXIN B","BACITRACIN ZINC;  NEOMYCIN SULFATE;  POLYMYXIN B SULFATE","HUMAN OTC DRUG","10/01/2022","N/A","OTC MONOGRAPH DRUG",".9 g in 1 PACKET (82942-1002-1)","Aminoglycoside Antibacterial [EPC],  Aminoglycosides [CS],  Decreased Cell Wall Synthesis & Repair [PE],  Polymyxin-class Antibacterial [EPC],  Polymyxins [CS]","N/A","No","12/31/2025"
"Triple Antibiotic plus Pain Relief","70677-1219-1","500 [USP'U]/g,                         3.5  mg/g,                         10000  [USP'U]/g,                         10  mg/g","OINTMENT","TOPICAL","M004","STRATEGIC SOURCING SERVICES LLC","70677-1219","Bacitracin Zinc, Neomycin Sulfate, Polymyxin B Sulfate, and Pramoxine Hydrochloride","BACITRACIN ZINC;  NEOMYCIN SULFATE;  POLYMYXIN B SULFATE;  PRAMOXINE HYDROCHLORIDE","HUMAN OTC DRUG","01/29/2024","N/A","OTC MONOGRAPH DRUG","1 TUBE in 1 CARTON (70677-1219-1)  / 28.4 g in 1 TUBE","Aminoglycoside Antibacterial [EPC],  Aminoglycosides [CS],  Decreased Cell Wall Synthesis & Repair [PE],  Polymyxin-class Antibacterial [EPC],  Polymyxins [CS]","N/A","No","12/31/2025"
"TROGARZO","62064-122-02","150 mg/mL","INJECTION, SOLUTION","INTRAVENOUS","BLA761065","Theratechnologies Inc.","62064-122","ibalizumab","IBALIZUMAB","HUMAN PRESCRIPTION DRUG","04/20/2018","N/A","BLA","2 VIAL, SINGLE-USE in 1 CARTON (62064-122-02)  / 1.33 mL in 1 VIAL, SINGLE-USE (62064-122-01)","Antibodies,  Monoclonal,  Humanized [CS],  CD4-directed Antibody Interactions [MoA],  CD4-directed Blocking Antibody [EPC],  HIV 1 Post-attachment Fusion Inhibitors [MoA],  Human Immunodeficiency Virus 1 Post-attachment Fusion Inhibitor [EPC]","N/A","No","12/31/2025"
"TULA RADIANT SKIN BRIGHTENING SERUM SKIN TINT SUNSCREEN BROAD SPECTRUM SPF 30","59735-202-01","3 g/30mL,                         5  g/30mL","LOTION","TOPICAL","M020","MANA Products, Inc","59735-202","Brightening Skin Tint","AVOBENZONE;  OCTISALATE","HUMAN OTC DRUG","08/01/2022","N/A","OTC MONOGRAPH DRUG","1 TUBE in 1 CARTON (59735-202-01)  / 30 mL in 1 TUBE","N/A","N/A","No","12/31/2025"
"TULA RADIANT SKIN BRIGHTENING SERUM SKIN TINT SUNSCREEN BROAD SPECTRUM SPF 30","59735-203-01","3 g/30mL,                         5  g/30mL","LOTION","TOPICAL","M020","MANA Products, Inc","59735-203","Brightening Skin Tint","AVOBENZONE;  OCTISALATE","HUMAN OTC DRUG","08/01/2022","N/A","OTC MONOGRAPH DRUG","1 TUBE in 1 CARTON (59735-203-01)  / 30 mL in 1 TUBE","N/A","N/A","No","12/31/2025"
"TULA RADIANT SKIN BRIGHTENING SERUM SKIN TINT SUNSCREEN BROAD SPECTRUM SPF 30","59735-206-01","3 g/30mL,                         5  g/30mL","LOTION","TOPICAL","M020","MANA PRODUCTS, INC","59735-206","BRIGHTENING SKIN TINT","AVOBENZONE;  OCTISALATE","HUMAN OTC DRUG","08/01/2022","N/A","OTC MONOGRAPH DRUG","1 TUBE in 1 CARTON (59735-206-01)  / 30 mL in 1 TUBE","N/A","N/A","No","12/31/2025"
"TULA RADIANT SKIN BRIGHTENING SERUM SKIN TINT SUNSCREEN BROAD SPECTRUM SPF 30","59735-224-01","3 g/30mL,                         5  g/30mL","LOTION","TOPICAL","M020","MANA Products, Inc","59735-224","Brightening Skin Tint","AVOBENZONE;  OCTISALATE","HUMAN OTC DRUG","08/01/2022","N/A","OTC MONOGRAPH DRUG","1 TUBE in 1 CARTON (59735-224-01)  / 30 mL in 1 TUBE","N/A","N/A","No","12/31/2025"
"TULA RADIANT SKIN BRIGHTENING SERUM SKIN TINT SUNSCREEN BROAD SPECTRUM SPF 30","59735-227-01","3 g/30mL,                         5  g/30mL","LOTION","TOPICAL","M020","MANA Products, Inc","59735-227","Brightening Skin Tint","AVOBENZONE;  OCTISALATE","HUMAN OTC DRUG","08/01/2022","N/A","OTC MONOGRAPH DRUG","1 TUBE in 1 CARTON (59735-227-01)  / 30 mL in 1 TUBE","N/A","N/A","No","12/31/2025"
"TULA Ultimate Sun Serum PentaPeptide Sunscreen","72296-201-50","6 g/100mL,                         5.0076  g/100mL","LIQUID","TOPICAL","M020","Tula Life LLC","72296-201","Sunscreen Serum","TITANIUM DIOXIDE;  ZINC OXIDE","HUMAN OTC DRUG","02/12/2023","N/A","OTC MONOGRAPH FINAL","1 BOTTLE, PLASTIC in 1 CARTON (72296-201-50)  / 50 mL in 1 BOTTLE, PLASTIC","N/A","N/A","No","12/31/2024"
"TYLENOL Extra Strength","50580-457-10","500 mg/1","TABLET, FILM COATED","ORAL","M013","Johnson & Johnson Consumer Inc.","50580-457","acetaminophen","ACETAMINOPHEN","HUMAN OTC DRUG","07/10/2020","N/A","OTC MONOGRAPH DRUG","1 BOTTLE, PLASTIC in 1 CARTON (50580-457-10)  / 100 TABLET, FILM COATED in 1 BOTTLE, PLASTIC","N/A","N/A","No","12/31/2025"
"TYLENOL Extra Strength","50580-457-11","500 mg/1","TABLET, FILM COATED","ORAL","M013","Johnson & Johnson Consumer Inc.","50580-457","acetaminophen","ACETAMINOPHEN","HUMAN OTC DRUG","07/17/2020","N/A","OTC MONOGRAPH DRUG","10 BLISTER PACK in 1 CARTON (50580-457-11)  / 10 TABLET, FILM COATED in 1 BLISTER PACK","N/A","N/A","No","12/31/2025"
"TYLENOL Extra Strength","50580-457-70","500 mg/1","TABLET, FILM COATED","ORAL","M013","Johnson & Johnson Consumer Inc.","50580-457","acetaminophen","ACETAMINOPHEN","HUMAN OTC DRUG","07/17/2020","N/A","OTC MONOGRAPH DRUG","700 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (50580-457-70)","N/A","N/A","No","12/31/2025"
"TYLENOL SINUS PLUS HEADACHE","50580-598-02","325 mg/1,                         5  mg/1","TABLET, FILM COATED","ORAL","M012","Johnson & Johnson Consumer Inc.","50580-598","Acetaminophen and Phenylephrine hydrochloride","ACETAMINOPHEN;  PHENYLEPHRINE HYDROCHLORIDE","HUMAN OTC DRUG","05/08/2019","N/A","OTC MONOGRAPH DRUG","2 BLISTER PACK in 1 CARTON (50580-598-02)  / 12 TABLET, FILM COATED in 1 BLISTER PACK","Adrenergic alpha1-Agonists [MoA],  alpha-1 Adrenergic Agonist [EPC]","N/A","No","12/31/2025"
"United Spirit of America","58443-0635-3","290.25 mg/mL","STICK","TOPICAL","M019","Prime Enterprises, Inc.","58443-0635","Aluminum Chlorohydrate","ALUMINUM CHLOROHYDRATE","HUMAN OTC DRUG","08/04/2023","N/A","OTC MONOGRAPH FINAL","74 mL in 1 CANISTER (58443-0635-3)","N/A","N/A","No","12/31/2024"
"Up and Up 3 Hydrogen Peroxide Wipes","11673-327-40","30 mg/mL","CLOTH","TOPICAL","M003","Target Corporation","11673-327","HYDROGEN PEROXIDE","HYDROGEN PEROXIDE","HUMAN OTC DRUG","09/01/2020","N/A","OTC MONOGRAPH DRUG","40 PATCH in 1 CANISTER (11673-327-40)  / 4.7 mL in 1 PATCH","N/A","N/A","No","12/31/2024"
"URBAN WASH DANDRUFF","76176-201-01",".3 g/100mL","SHAMPOO","TOPICAL","M032","Ningbo Liyuan Daily Chemical Products Co., Ltd.","76176-201","pyrithione zinc","PYRITHIONE ZINC","HUMAN OTC DRUG","05/01/2023","N/A","OTC MONOGRAPH FINAL","355 mL in 1 BOTTLE, PLASTIC (76176-201-01)","N/A","N/A","No","12/31/2024"
"valsartan","59746-361-62","80 mg/1","TABLET","ORAL","ANDA203536","Jubilant Cadista Pharmaceuticals Inc.","59746-361","valsartan","VALSARTAN","HUMAN PRESCRIPTION DRUG","01/05/2015","N/A","ANDA","90 TABLET in 1 BOTTLE (59746-361-62)","Angiotensin 2 Receptor Antagonists [MoA],  Angiotensin 2 Receptor Blocker [EPC]","N/A","No","12/31/2024"
"Vanadium Bromatum","37662-3827-1","100 [hp_C]/1","PELLET","ORAL","","Hahnemann Laboratories, INC.","37662-3827","Vanadium Bromatum","VANADIUM(III) BROMIDE","HUMAN OTC DRUG","08/24/2023","N/A","UNAPPROVED HOMEOPATHIC","200 PELLET in 1 VIAL, GLASS (37662-3827-1)","N/A","N/A","No","12/31/2024"
"Vanadium Bromatum","37662-3827-2","100 [hp_C]/1","PELLET","ORAL","","Hahnemann Laboratories, INC.","37662-3827","Vanadium Bromatum","VANADIUM(III) BROMIDE","HUMAN OTC DRUG","08/24/2023","N/A","UNAPPROVED HOMEOPATHIC","500 PELLET in 1 VIAL, GLASS (37662-3827-2)","N/A","N/A","No","12/31/2024"
"Vanadium Bromatum","37662-3827-3","100 [hp_C]/1","PELLET","ORAL","","Hahnemann Laboratories, INC.","37662-3827","Vanadium Bromatum","VANADIUM(III) BROMIDE","HUMAN OTC DRUG","08/24/2023","N/A","UNAPPROVED HOMEOPATHIC","3000 PELLET in 1 BOTTLE, GLASS (37662-3827-3)","N/A","N/A","No","12/31/2024"
"Vanadium Bromatum","37662-3827-4","100 [hp_C]/1","PELLET","ORAL","","Hahnemann Laboratories, INC.","37662-3827","Vanadium Bromatum","VANADIUM(III) BROMIDE","HUMAN OTC DRUG","08/24/2023","N/A","UNAPPROVED HOMEOPATHIC","10000 PELLET in 1 BOTTLE, GLASS (37662-3827-4)","N/A","N/A","No","12/31/2024"
"Vanadium Bromatum","37662-3831-1","1 [hp_Q]/1","PELLET","ORAL","","Hahnemann Laboratories, INC.","37662-3831","Vanadium Bromatum","VANADIUM(III) BROMIDE","HUMAN OTC DRUG","08/24/2023","N/A","UNAPPROVED HOMEOPATHIC","10000 PELLET in 1 BOTTLE, GLASS (37662-3831-1)","N/A","N/A","No","12/31/2024"
"Vapor Inhaler","41163-031-01","50 mg/1","INHALANT","NASAL","part341","Supervalu Inc.","41163-031","Levmetamfetamine","LEVMETAMFETAMINE","HUMAN OTC DRUG","02/24/2021","N/A","OTC MONOGRAPH FINAL","1 INHALER in 1 BLISTER PACK (41163-031-01)  / 198 INHALANT in 1 INHALER","N/A","N/A","No","12/31/2024"
"Vegan Collagen Every Day SPF 30","61197-510-00","3 g/100mL,                         15  g/100mL,                         5  g/100mL,                         10  g/100mL","LOTION","TOPICAL","M020","Pacifica Beauty, LLC","61197-510","Avobenzone, Homosalate, Octocrylene, Octyl Salicylate","AVOBENZONE;  HOMOSALATE;  OCTISALATE;  OCTOCRYLENE","HUMAN OTC DRUG","02/09/2023","N/A","OTC MONOGRAPH FINAL","50 mL in 1 BOTTLE, PUMP (61197-510-00)","N/A","N/A","No","12/31/2024"
"Verapamil Hydrochloride","70710-1937-7","2.5 mg/mL","INJECTION, SOLUTION","INTRAVENOUS","ANDA214215","Zydus Pharmaceuticals USA Inc.","70710-1937","Verapamil Hydrochloride","VERAPAMIL HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","10/17/2023","N/A","ANDA","25 CARTON in 1 CARTON (70710-1937-7)  / 5 VIAL in 1 CARTON (70710-1937-5)  / 2 mL in 1 VIAL (70710-1937-1)","Calcium Channel Antagonists [MoA],  Calcium Channel Blocker [EPC],  Cytochrome P450 3A Inhibitors [MoA],  Cytochrome P450 3A4 Inhibitors [MoA],  P-Glycoprotein Inhibitors [MoA]","N/A","No","12/31/2024"
"VERAPAMIL HYDROCHLORIDE","50090-5253-4","180 mg/1","TABLET","ORAL","ANDA206173","A-S Medication Solutions","50090-5253","VERAPAMIL HYDROCHLORIDE","VERAPAMIL HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","10/14/2020","N/A","ANDA","30 TABLET in 1 BOTTLE (50090-5253-4)","Calcium Channel Antagonists [MoA],  Calcium Channel Blocker [EPC],  Cytochrome P450 3A Inhibitors [MoA],  Cytochrome P450 3A4 Inhibitors [MoA],  P-Glycoprotein Inhibitors [MoA]","N/A","No","12/31/2024"
"Vibramycin Calcium","0069-0971-95","50 mg/5mL","SYRUP","ORAL","NDA050480","Pfizer Laboratories Div Pfizer Inc","0069-0971","doxycycline calcium","DOXYCYCLINE CALCIUM","HUMAN PRESCRIPTION DRUG","11/01/2019","N/A","NDA","1 BOTTLE in 1 CARTON (0069-0971-95)  / 473 mL in 1 BOTTLE","Tetracycline-class Drug [EPC],  Tetracyclines [CS]","N/A","No","12/31/2025"
"Vichy Laboratoires Capital Soleil 60 Mineral Broad Spectrum SPF 60 Water Resistant 80 Minutes Sheer Tint Ultra Lightweight Sunscreen","69625-651-01","148 mg/mL","LOTION","TOPICAL","M020","Cosmetique Active Production","69625-651","Titanium Dioxide","TITANIUM DIOXIDE","HUMAN OTC DRUG","12/01/2019","N/A","OTC MONOGRAPH DRUG","1 BOTTLE in 1 CARTON (69625-651-01)  / 45 mL in 1 BOTTLE","N/A","N/A","No","12/31/2024"
"Vichy Laboratoires Normaderm Phytoaction Acne Control Daily Moisturizer","49967-606-01","20 mg/mL","GEL","TOPICAL","M006","L'Oreal USA Products Inc","49967-606","Salicylic Acid","SALICYLIC ACID","HUMAN OTC DRUG","09/01/2020","N/A","OTC MONOGRAPH DRUG","1 BOTTLE in 1 CARTON (49967-606-01)  / 50 mL in 1 BOTTLE","N/A","N/A","No","12/31/2024"
"Vichy Laboratories LiftActiv Peptide-C SPF 30 Sunscreen Phyto Peptides Vitamin C","69625-685-03","30 mg/mL,                         50  mg/mL,                         50  mg/mL,                         70  mg/mL","LOTION","TOPICAL","M020","Cosmetique Active Products","69625-685","Avobenzone, Homosalate, Octisalate and Octocrylene","AVOBENZONE;  HOMOSALATE;  OCTISALATE;  OCTOCRYLENE","HUMAN OTC DRUG","12/27/2019","N/A","OTC MONOGRAPH DRUG","1 TUBE in 1 CARTON (69625-685-03)  / 50 mL in 1 TUBE","N/A","N/A","No","12/31/2024"
"VICKS FORMULA 44DM","69423-809-12","15 mg/15mL","LIQUID","ORAL","M012","The Procter & Gamble Manufacturing Company","69423-809","Dextromethorphan HBr","DEXTROMETHORPHAN HYDROBROMIDE","HUMAN OTC DRUG","12/21/2020","N/A","OTC MONOGRAPH DRUG","354 mL in 1 BOTTLE, PLASTIC (69423-809-12)","Sigma-1 Agonist [EPC],  Sigma-1 Receptor Agonists [MoA],  Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC],  Uncompetitive NMDA Receptor Antagonists [MoA]","N/A","No","12/31/2024"
"Vilazodone Hydrochloride","16729-353-10","20 mg/1","TABLET","ORAL","ANDA208209","Accord Healthcare Inc.","16729-353","Vilazodone Hydrochloride","VILAZODONE HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","06/04/2022","N/A","ANDA","30 TABLET in 1 BOTTLE (16729-353-10)","N/A","N/A","No","12/31/2024"
"Viscum Abietis 1","48951-9301-1","3 [hp_X]/mL","LIQUID","ORAL","","Uriel Pharmacy Inc.","48951-9301","Viscum Abietis 1","VISCUM ALBUM FRUITING TOP","HUMAN OTC DRUG","08/01/2014","N/A","UNAPPROVED HOMEOPATHIC","8 AMPULE in 1 BOX (48951-9301-1)  / 1 mL in 1 AMPULE","N/A","N/A","No","12/31/2025"
"Viscum Mali e pl. tota 5%","48951-9085-2","1 [hp_X]/1","PELLET","ORAL","","Uriel Pharmacy Inc.","48951-9085","Viscum Mali e pl. tota 5%","VISCUM ALBUM FRUITING TOP","HUMAN OTC DRUG","09/01/2009","N/A","UNAPPROVED HOMEOPATHIC","1350 PELLET in 1 BOTTLE, GLASS (48951-9085-2)","N/A","N/A","No","12/31/2025"
"Vitamin A and D","53329-090-16","935 mg/g","OINTMENT","TOPICAL","M016","Medline Industries, LP","53329-090","Skin Protectant","PETROLATUM","HUMAN OTC DRUG","03/01/2010","12/31/2024","OTC MONOGRAPH FINAL","5 g in 1 PACKET (53329-090-16)","N/A","N/A","No","N/A"
"Vitamin A and D","53329-090-96","935 mg/g","OINTMENT","TOPICAL","M016","Medline Industries, LP","53329-090","Skin Protectant","PETROLATUM","HUMAN OTC DRUG","01/01/2019","12/31/2024","OTC MONOGRAPH FINAL","144 PACKET in 1 CARTON (53329-090-96)  / 5 g in 1 PACKET (53329-090-16)","N/A","N/A","No","N/A"
"Vitamin A and D","53329-090-14","935 mg/g","OINTMENT","TOPICAL","M016","Medline Industries, LP","53329-090","Skin Protectant","PETROLATUM","HUMAN OTC DRUG","01/01/2019","12/31/2024","OTC MONOGRAPH FINAL","1 TUBE in 1 BOX (53329-090-14)  / 56.6 g in 1 TUBE","N/A","N/A","No","N/A"
"Voriconazole","72572-875-01","10 mg/mL","INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION","INTRAVENOUS","ANDA090862","Civica, Inc.","72572-875","Voriconazole","VORICONAZOLE","HUMAN PRESCRIPTION DRUG","04/01/2023","N/A","ANDA","1 VIAL, SINGLE-USE in 1 CARTON (72572-875-01)  / 20 mL in 1 VIAL, SINGLE-USE","Azole Antifungal [EPC],  Azoles [CS],  Cytochrome P450 2C19 Inhibitors [MoA],  Cytochrome P450 2C9 Inhibitors [MoA],  Cytochrome P450 3A4 Inhibitors [MoA]","N/A","No","12/31/2024"
"Warfarin Sodium","51407-791-01","7.5 mg/1","TABLET","ORAL","ANDA040301","Golden State Medical Supply, Inc.","51407-791","Warfarin Sodium","WARFARIN SODIUM","HUMAN PRESCRIPTION DRUG","02/02/2021","N/A","ANDA","100 TABLET in 1 BOTTLE (51407-791-01)","Vitamin K Antagonist [EPC],  Vitamin K Inhibitors [MoA]","N/A","No","12/31/2025"
"Warfarin Sodium","51407-788-01","4 mg/1","TABLET","ORAL","ANDA040301","Golden State Medical Supply, Inc.","51407-788","Warfarin Sodium","WARFARIN SODIUM","HUMAN PRESCRIPTION DRUG","02/02/2021","N/A","ANDA","100 TABLET in 1 BOTTLE (51407-788-01)","Vitamin K Antagonist [EPC],  Vitamin K Inhibitors [MoA]","N/A","No","12/31/2025"
"Warfarin Sodium","51407-788-10","4 mg/1","TABLET","ORAL","ANDA040301","Golden State Medical Supply, Inc.","51407-788","Warfarin Sodium","WARFARIN SODIUM","HUMAN PRESCRIPTION DRUG","02/02/2021","N/A","ANDA","1000 TABLET in 1 BOTTLE (51407-788-10)","Vitamin K Antagonist [EPC],  Vitamin K Inhibitors [MoA]","N/A","No","12/31/2025"
"Warfarin Sodium","43063-176-14","5 mg/1","TABLET","ORAL","ANDA040616","PD-Rx Pharmaceuticals, Inc.","43063-176","Warfarin Sodium","WARFARIN SODIUM","HUMAN PRESCRIPTION DRUG","02/03/2016","N/A","ANDA","14 TABLET in 1 BOTTLE, PLASTIC (43063-176-14)","Vitamin K Antagonist [EPC],  Vitamin K Inhibitors [MoA]","N/A","No","12/31/2024"
"Warfarin Sodium","43063-176-30","5 mg/1","TABLET","ORAL","ANDA040616","PD-Rx Pharmaceuticals, Inc.","43063-176","Warfarin Sodium","WARFARIN SODIUM","HUMAN PRESCRIPTION DRUG","09/05/2017","N/A","ANDA","30 TABLET in 1 BOTTLE, PLASTIC (43063-176-30)","Vitamin K Antagonist [EPC],  Vitamin K Inhibitors [MoA]","N/A","No","12/31/2024"
"Well at Walgreens","0363-0504-30","","KIT","NASAL","","Walgreen Company","0363-0504","SODIUM BICARBONATE, SODIUM CHLORIDE","","HUMAN OTC DRUG","04/01/2013","N/A","UNAPPROVED DRUG OTHER","1 KIT in 1 KIT (0363-0504-30)  *  3000 mg in 1 PACKET (0363-0802-00)","N/A","N/A","No","12/31/2025"
"Western Ragweed","22840-1394-2","40000 [PNU]/mL","SOLUTION","INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS","BLA101833","Greer Laboratories, Inc.","22840-1394","Ambrosia psilostachya","AMBROSIA PSILOSTACHYA POLLEN","NON-STANDARDIZED ALLERGENIC","09/15/1981","N/A","BLA","10 mL in 1 VIAL, MULTI-DOSE (22840-1394-2)","Allergens [CS],  Cell-mediated Immunity [PE],  Increased Histamine Release [PE],  Non-Standardized Pollen Allergenic Extract [EPC],  Pollen [CS]","N/A","No","12/31/2024"
"Western Ragweed","22840-1394-4","40000 [PNU]/mL","SOLUTION","INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS","BLA101833","Greer Laboratories, Inc.","22840-1394","Ambrosia psilostachya","AMBROSIA PSILOSTACHYA POLLEN","NON-STANDARDIZED ALLERGENIC","09/15/1981","N/A","BLA","50 mL in 1 VIAL, MULTI-DOSE (22840-1394-4)","Allergens [CS],  Cell-mediated Immunity [PE],  Increased Histamine Release [PE],  Non-Standardized Pollen Allergenic Extract [EPC],  Pollen [CS]","N/A","No","12/31/2024"
"WhiskCare 375","65585-378-01","600 mL/L","GEL","TOPICAL","505G(a)(3)","Whisk Products, Inc.","65585-378","Alcohol","ALCOHOL","HUMAN OTC DRUG","07/12/2022","N/A","OTC MONOGRAPH DRUG","12 BAG in 1 BOX (65585-378-01)  / .8 L in 1 BAG","N/A","N/A","No","12/31/2024"
"WhiskCare 375","65585-378-02","600 mL/L","GEL","TOPICAL","505G(a)(3)","Whisk Products, Inc.","65585-378","Alcohol","ALCOHOL","HUMAN OTC DRUG","07/12/2022","N/A","OTC MONOGRAPH DRUG","208.2 L in 1 DRUM (65585-378-02)","N/A","N/A","No","12/31/2024"
"WhiskCare 375","65585-378-03","600 mL/L","GEL","TOPICAL","505G(a)(3)","Whisk Products, Inc.","65585-378","Alcohol","ALCOHOL","HUMAN OTC DRUG","09/19/2022","N/A","OTC MONOGRAPH DRUG",".118 L in 1 BOTTLE, PLASTIC (65585-378-03)","N/A","N/A","No","12/31/2024"
"WhiskCare 375","65585-378-04","600 mL/L","GEL","TOPICAL","505G(a)(3)","Whisk Products, Inc.","65585-378","Alcohol","ALCOHOL","HUMAN OTC DRUG","09/19/2022","N/A","OTC MONOGRAPH DRUG","24 BOTTLE, PLASTIC in 1 BOX (65585-378-04)  / .118 L in 1 BOTTLE, PLASTIC","N/A","N/A","No","12/31/2024"
"WhiskCare 375","65585-378-05","600 mL/L","GEL","TOPICAL","505G(a)(3)","Whisk Products, Inc.","65585-378","Alcohol","ALCOHOL","HUMAN OTC DRUG","09/19/2022","N/A","OTC MONOGRAPH DRUG","12 BOTTLE, PUMP in 1 BOX (65585-378-05)  / .237 L in 1 BOTTLE, PUMP","N/A","N/A","No","12/31/2024"
"WhiskCare 375","65585-378-06","600 mL/L","GEL","TOPICAL","505G(a)(3)","Whisk Products, Inc.","65585-378","Alcohol","ALCOHOL","HUMAN OTC DRUG","09/19/2022","N/A","OTC MONOGRAPH DRUG","8 BAG in 1 BOX (65585-378-06)  / 1 L in 1 BAG","N/A","N/A","No","12/31/2024"
"WhiskCare 375","65585-378-07","600 mL/L","GEL","TOPICAL","505G(a)(3)","Whisk Products, Inc.","65585-378","Alcohol","ALCOHOL","HUMAN OTC DRUG","09/19/2022","N/A","OTC MONOGRAPH DRUG","3.785 L in 1 BOTTLE, PLASTIC (65585-378-07)","N/A","N/A","No","12/31/2024"
"Winco Original Formula Eye Drops","67091-310-15",".05 g/100mL","SOLUTION/ DROPS","OPHTHALMIC","M018","WinCo Foods, LLC","67091-310","Tetrahydrozoline HCl","TETRAHYDROZOLINE HYDROCHLORIDE","HUMAN OTC DRUG","09/26/2018","N/A","OTC MONOGRAPH DRUG","1 BOTTLE, PLASTIC in 1 CARTON (67091-310-15)  / 15 mL in 1 BOTTLE, PLASTIC","N/A","N/A","No","12/31/2024"
"Witch Hazel","0363-9221-17","146 g/170g","SPRAY","TOPICAL","M016","Walgreens Company","0363-9221","Witch Hazel Spray","WITCH HAZEL","HUMAN OTC DRUG","03/01/2017","N/A","OTC MONOGRAPH DRUG","170 g in 1 CAN (0363-9221-17)","N/A","N/A","No","12/31/2025"
"WL-AAI-ZT-P-1910","63931-1910-1",".125 g/g,                         .225  g/g","POWDER","TOPICAL","part352","Nanophase Technologies Corporation","63931-1910","Titanium dioxide, Zinc Oxide","TITANIUM DIOXIDE;  ZINC OXIDE","HUMAN OTC DRUG","07/25/2023","N/A","OTC MONOGRAPH NOT FINAL","10000 g in 1 BAG (63931-1910-1)","N/A","N/A","No","12/31/2024"
"ZENSEZONE Arthmed Temporary Pain Relief Cream","82319-240-00",".25 mg/mL,                         100  mg/mL,                         150  mg/mL","CREAM","TOPICAL","M017","ZENSEZONE LLC","82319-240","CAPSAICIN, MENTHOL, METHYL SALICYLATE","CAPSAICIN;  MENTHOL;  METHYL SALICYLATE","HUMAN OTC DRUG","10/20/2021","N/A","OTC MONOGRAPH DRUG","118 mL in 1 BOTTLE (82319-240-00)","N/A","N/A","No","12/31/2024"
"Zilretta","65250-003-01","","KIT","INTRA-ARTICULAR","NDA208845","Pacira Pharmaceuticals, Inc.","65250-003","triamcinolone acetonide extended-release injectable suspension","","HUMAN PRESCRIPTION DRUG","10/06/2017","N/A","NDA","1 KIT in 1 CARTON (65250-003-01)  *  1 INJECTION, POWDER, FOR SUSPENSION, EXTENDED RELEASE in 1 VIAL, SINGLE-DOSE (65250-001-01)  *  1 INJECTION, SOLUTION in 1 VIAL, SINGLE-DOSE (65250-002-01)","N/A","N/A","No","12/31/2024"
"ZIMS MAX FREEZE","54273-012-01","760 mg/1,                         190  mg/1","PATCH","TOPICAL","M017","KOBAYASHI Healthcare International, Inc.","54273-012","LIDOCAINE HYDROCHLORIDE and MENTHOL,","LIDOCAINE HYDROCHLORIDE;  MENTHOL, UNSPECIFIED FORM","HUMAN OTC DRUG","05/10/2023","N/A","OTC MONOGRAPH DRUG","3 POUCH in 1 BOX (54273-012-01)  / 1 PATCH in 1 POUCH","Amide Local Anesthetic [EPC],  Amides [CS],  Antiarrhythmic [EPC],  Local Anesthesia [PE]","N/A","No","12/31/2024"
"zinc sulfate","70771-1848-7","1 mg/mL","INJECTION, SOLUTION","INTRAVENOUS","ANDA217074","Zydus Lifesciences Limited","70771-1848","zinc sulfate","ZINC SULFATE","HUMAN PRESCRIPTION DRUG","12/07/2023","N/A","ANDA","25 VIAL in 1 CARTON (70771-1848-7)  / 10 mL in 1 VIAL (70771-1848-1)","Copper Absorption Inhibitor [EPC],  Decreased Copper Ion Absorption [PE]","N/A","No","12/31/2024"
"zinc sulfate","70710-1876-7","1 mg/mL","SOLUTION","INTRAVENOUS","ANDA217074","Zydus Pharmaceuticals USA Inc.","70710-1876","zinc sulfate injection,","ZINC SULFATE","HUMAN PRESCRIPTION DRUG","12/07/2023","N/A","ANDA","25 VIAL in 1 CARTON (70710-1876-7)  / 10 mL in 1 VIAL (70710-1876-1)","Copper Absorption Inhibitor [EPC],  Decreased Copper Ion Absorption [PE]","N/A","No","12/31/2024"
"zinc sulfate","70710-1878-7","5 mg/mL","SOLUTION","INTRAVENOUS","ANDA217074","Zydus Pharmaceuticals USA Inc.","70710-1878","zinc sulfate injection,","ZINC SULFATE","HUMAN PRESCRIPTION DRUG","12/07/2023","N/A","ANDA","25 VIAL in 1 CARTON (70710-1878-7)  / 5 mL in 1 VIAL (70710-1878-1)","Copper Absorption Inhibitor [EPC],  Decreased Copper Ion Absorption [PE]","N/A","No","12/31/2024"
"Zolpidem Tartrate","51991-981-01","6.25 mg/1","TABLET, EXTENDED RELEASE","ORAL","ANDA213592","Breckenridge Pharmaceutical, Inc.","51991-981","Zolpidem Tartrate","ZOLPIDEM TARTRATE","HUMAN PRESCRIPTION DRUG","12/17/2020","03/31/2026","ANDA","100 TABLET, EXTENDED RELEASE in 1 BOTTLE (51991-981-01)","Central Nervous System Depression [PE],  GABA A Agonists [MoA],  Pyridines [CS],  gamma-Aminobutyric Acid-ergic Agonist [EPC]","CIV","No","N/A"
"Zylast Antiseptic S","57362-466-16","760 mL/1000mL","LIQUID","TOPICAL","505G(a)(3)","Innovative BioDefense","57362-466","Ethyl Alcohol","ALCOHOL","HUMAN OTC DRUG","01/15/2019","N/A","OTC MONOGRAPH DRUG","1000 mL in 1 CARTRIDGE (57362-466-16)","N/A","N/A","No","12/31/2024"
"Zylast Antiseptic S","57362-466-17","760 mL/1000mL","LIQUID","TOPICAL","505G(a)(3)","Innovative BioDefense","57362-466","Ethyl Alcohol","ALCOHOL","HUMAN OTC DRUG","01/15/2019","N/A","OTC MONOGRAPH DRUG","10 mL in 1 VIAL, GLASS (57362-466-17)","N/A","N/A","No","12/31/2024"
"Zylast Antiseptic S","57362-466-41","760 mL/1000mL","LIQUID","TOPICAL","505G(a)(3)","Innovative BioDefense","57362-466","Ethyl Alcohol","ALCOHOL","HUMAN OTC DRUG","01/15/2019","N/A","OTC MONOGRAPH DRUG","10 mL in 1 VIAL, GLASS (57362-466-41)","N/A","N/A","No","12/31/2024"
"¿Symphytum officinale","0220-4897-41","30 [hp_X]/30[hp_X]","PELLET","ORAL","","Boiron","0220-4897","COMFREY ROOT","COMFREY ROOT","HUMAN OTC DRUG","03/03/1983","N/A","UNAPPROVED HOMEOPATHIC","30 [hp_X] in 1 TUBE (0220-4897-41)","N/A","N/A","No","12/31/2024"